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ABSTRACT 
The presence of atherosclerotic calcification serves as a surrogate marker for plaque 
burden and a prognostic marker of cardiovascular risk. Additionally, calcification plays 
a critical role in plaque stability and heavily calcified lesions are associated with increased 
transcatheter therapy failures. The purpose of this thesis is to advance calcification-based 
cardiovascular patient management. Specifically, an improved understanding of the 
capabilities of clinical image- and blood-based biomarkers to distinguish between high-
risk patients and high-risk plaques based on calcified content is required. Additionally, 
more accurate stiffness properties for calcified and non-calcified tissue constituents will 
optimise computational predictions of plaque rupture and device-tissue interactions. 
Calcifications within ex vivo atherosclerotic lesions were quantified using micro-
computed tomography (micro-CT), clinical CT, magnetic resonance (MR), intravascular 
ultrasound (IVUS) and optical coherence tomography (OCT). Coronary artery calcium 
(CAC) scores were obtained from non-contrast chest CT scans. Circulating blood 
biomarkers of vascular calcification were measured using commercial immunoassays. 
Nanomechanical techniques were employed to characterise the stiffness of calcified and 
non-calcified tissue portions. These biomechanical techniques were coupled micro-CT, 
scanning electron microscopy, energy dispersive x-ray spectroscopy and histological 
analyses to confirm the biological content of the regions of interest being examined. 
Agatston calcium scores correlate well with calcification volumes and are therefore good 
markers of atherosclerotic burden. However, calcified particle distributions are not 
estimated and larger calcified particles have higher maximum x-ray attenuation densities. 
An assessment into the effect of decreasing CT resolution on measures of calcification 
revealed the inaccuracies acquired for calcification volume, density and particle 
measurements. Additionally, a heterogeneous distribution of calcium density was 
identified. The efficacy of coronary-derived calcium scores or the fraction of low- or 
high-density calcium to differentiate between symptomatic or asymptomatic carotid 
plaques was investigated. Neither the Agatston, Volume or Density-Volume coronary 
calcium scores could differentiate between carotid plaques based on patient preoperative 
cerebrovascular symptoms. However, asymptomatic plaques contained significantly 
lower levels of low-density calcification and higher levels of high-density calcification. 
Clinical CT also exhibited the closest correlation to micro-CT for measures of calcified 
content. 
No differences were observed between circulating blood-biomarkers of vascular 
calcification or bone formation with patient endarterectomy or number of diagnosed 
atherosclerotic locations groups. Moderate and weak negative associations were observed 
between dephospho-uncarboxylated Matrix Gla Protein and coronarty artery calcium 
(CAC) density scores, and between percent undercarboxylated osteocalcin and CAC 
scores or total volume of calcification for certain participant subgroups only.  
There is a clear distinction between the elastic modulus of calcification with respect to 
radiographic density. Furthermore, there is no difference in the behaviours of carotid 
versus lower extremity calcification. This study confirms the hypothesis that the 
mechanical properties of calcification are similar to that of human bone tissues (17–25 
GPa). Moreover, greater than 6 orders of magnitude compliance mismatch exists between 
the calcified and non-calcified portions of carotid atherosclerotic plaques. 
Collectively, this research demonstrates an improved understanding of the use of 
atherosclerotic calcification measurements in clinical diagnostics and the biomechanics 
of advanced calcified atherosclerotic plaques. 
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Cardiovascular diseases (CVD), conditions that affect the heart and blood vessels, are 
directly responsible for 31% of global mortalities. Ischemic heart disease and stroke are 
the first and second leading causes of death (Figure 1-1) (World Health Organisation 
2018). The underlying cause of these acute clinical events is atherosclerosis, a chronic 
inflammatory vascular condition. Vascular territories subject to hemodynamic 
disturbances such as areas of curvature and bifurcations are common locations for the 
development of atherosclerosis (Asakura and Karino 1990; Frangos et al. 1999). These 
include the coronary, carotid and lower extremity vasculature. Plaque formation in these 
distinct arterial territories can result in downstream myocardial infarctions (Davies and 
Thomas 1984; Hermann et al. 2016), cerebral infarctions (Spagnoli et al. 2004) or life-
style limiting claudication (McDermott 2015), respectively. This condition progresses 
silently until the occurrence of the first acute event, which is fatal in approximately 30% 
of cases. Additionally, survivors often experience secondary events and shorter lifetime 
expectancies (Koopman et al. 2013). Therefore, the identification of asymptomatic 
individuals at high-risk who may benefit from primary intervention is a healthcare priority 
(Naghavi et al. 2003; Ambrose et al. 2016). However, current algorithms that incorporate 
non-specific clinical markers of patient risk are of limited accuracy (Goff et al. 2014; 
Ambrose et al. 2016). Improved patient risk stratification beyond these traditional tools 
is required. 
 





Figure 1-1: Ischemic heart disease and stroke are the 1st and 2nd leading causes of death 
worldwide. Graph adapted from the World Health Organisation 2018. 
1.1.2 Atherosclerotic Plaque Formation 
The mechanism of atherosclerotic plaque initiation involves endothelial injury and 
dysfunction, which can be caused by a number of different factors including 
hemodynamic disturbances, hypertension and hypercholesterolemia. In the progression 
of atherosclerosis, monocytes infiltrate via the damaged endothelium and cause low-
density lipoprotein (LDL) oxidisation, provoking an inflammatory response. 
Macrophages are recruited to engulf the oxidised LDLs forming foam cells. Upon cell 
apoptosis, fragments of the dead cells and their released contents constitute areas of lipids 
within the diseased artery. Smooth muscle cells also proliferate into the space causing 
arterial remodelling, matrix synthesis and calcium phosphate deposition (Figure 1-2 (ii)) 
(Bentzon et al. 2014). The accumulation of calcified deposits within atherosclerotic 
tissues was once considered a passive process but is now understood to involve highly 
regulated and complex mechanisms (Doherty and Detrano 1994; Doherty et al. 2004; 
Sage et al. 2010), similar to bone formation (Doherty et al. 2003). There have been four 
non-mutually-exclusive theories proposed in the formation of atherosclerotic 
calcification: 1) cell apoptosis, 2) release of matrix vesicles and nucleational complexes, 
3) loss of vascular calcification inhibitors and 4) VSMC osteoblast differentiation and 
induction of bone formation (Figure 1-2 (iii)). Approximately 90% of patients with CVD 
have vascular calcification present (Allison et al. 2004; Higgins et al. 2005). 
Microcalcifications (0.5 - 50μm in spherical diameter) are evident even at the early initial 
intimal thickening stages of atherosclerosis (Otsuka et al. 2014). 





Figure 1-2: Proposed sequence of development of atherosclerotic lesions. (i) (A) intimal 
thickening, (B) intimal xanthoma, (C) formation of lipid pools, (D) fibroatheroma and the 
presence of a necrotic core and (E) advanced lesions containing calcification (Bentzon et al. 
2014). (ii) A section of excised lower extremity plaque. (iii) Illustration summarizing the current 
theories regarding the formation of atherosclerotic calcification (Speer and Giachelli 2004). 
1.1.3 Calcification 
Atherosclerotic calcification has generated much interest as it is associated with overall 
plaque burden (Rumberger et al. 1995; Sangiorgi et al. 1998) and is a significant predictor 
of cardiovascular morbidity and mortality (Bos et al. 2015). It is now also understood that 
calcification morphology plays a critical role in lesion stability (Schoenhagen and Tuzcu 




2002; Hutcheson et al. 2014; Pugliese et al. 2015). Microcalcifications can promote the 
rupture of the fibrous cap (Kelly-Arnold et al. 2013), leading to thrombosis and embolism, 
a phenomenon that is directly responsible for one-fifth of all deaths (Schurgers et al. 2018) 
(Fig.1-3(i)). Spotty calcifications have also been identified as a feature of vulnerable 
lesions (Ehara et al. 2004; Motoyama et al. 2007) (Fig.1-3(ii)). Moreover, high-density 
calcification has a protective effect (Criqui et al. 2014) and asymptomatic lesions often 
contain higher amounts of calcification than symptomatic lesions (Miralles et al. 2006; 
Mauriello et al. 2013) (Fig.1-3(iii)). 
 
 
Figure 1-3: Calcification and plaque stability. (i) Representative carotid bifurcations 
demonstrated a healthy vessel, stable plaque and an unstable plaque with emboli travelling to the 
brain. (ii) Schematic quarters illustrating the dynamic role of calcification in plaque vulnerability, 
adapted from (Schoenhagen and Tuzcu 2002). (iii) Intravascular ultrasound images from patients 
with (A) stable angina (chest pain) (B) unstable angina and (C) myocardial infarction. The angles 
of calcium are largest in those with stable lesions and smallest in those with myocardial infarctions 
(Beckman et al. 2001). 
1.1.4 Diagnosis 
Management of cardiovascular patients requires the identification of individuals who are 
deemed to be vulnerable to CVD and MACE (Naghavi et al. 2003; Arbab-Zadeh and 
Fuster 2015). Current techniques for identifying high-risk patients include the 
Framingham risk score (Wilson et al. 1998; Mahmood et al. 2014) and the atherosclerotic 




cardiovascular disease (ASCVD) risk calculator (Lloyd-Jones et al. 2014) which are 
algorithms used to estimate an individual’s risk of developing atherosclerosis. 
Additionally, circulating blood levels of C-Reactive protein is used as a marker of 
systemic inflammation (Ridker et al. 2002). However, these risk factors and the presence 
of acute inflammation are non-specific to atherosclerosis, leading to inadequate accuracy 
(Goff et al. 2014). Additionally, although atherosclerosis is a systemic disease (Dalager 
et al. 2008; Herrington et al. 2016), fewer than 1% of these plaques from autopsy studies 
have been linked to a clinical event (Strauss and Narula 2007). Therefore, it is also 
essential to identify the vulnerable plaques to stratify for treatment as well as the high-
risk patients (Waxman et al. 2007; O’Connell et al. 2016). Current recommendations from 
European and US associations on the prevention of stroke are based simply on the degree 
of carotid luminal stenosis (Kernan et al. 2014; Naylor et al. 2018). However, many 
culprit coronary lesions do not demonstrate severe luminal stenosis (Falk et al. 1995; 
Virmani et al. 2000). 
1.1.4.1 Clinical Imaging 
Arterial calcification is readily quantifiable on non-contrast Computed Tomography (CT) 
scans. In 1990 Arthur Agatston and colleagues developed the coronary artery calcium 
(CAC) score on electron beam CT (Agatston et al. 1990) to quantify the amount of 
calcium present in the 4 main coronary arteries. This method utilises a maximal density-
weighted area product for calcification and based on the acquired scores the disease is 
typically classified as none (0), mild (1-100), moderate (101-300) or severe (> 300) 
(Detrano et al. 2008) (Fig.1-4). Since calcification is associated with overall plaque 
burden (Rumberger et al. 1995; Sangiorgi et al. 1998) this score has become a marker of 
patient atherosclerotic burden and is a powerful predictor of adverse cardiovascular 
events (Hecht et al. 2017). CAC scores surpass the capabilities of the Framingham risk 
score, circulating C-Reactive protein levels (Zeb and Budoff 2015) and all other risk 
stratification tools (Mori et al. 2018) as a direct measurement of arterial disease. 
However, there is conflicting evidence on the use of CAC as a prognostic marker of stroke 
(Folsom et al. 2008; Newman et al. 2008; Gronewold et al. 2013; Hermann et al. 2013). 
Additionally, vessel- and lesion-specific calcium scores have demonstrated a greater 
capacity for identifying obstructive coronary disease (Qian et al. 2010) and the prognostic 
value of calcification has been increased by utilising several locations to quantify arterial 
calcification (Allison et al. 2012; Bos et al. 2015; Tison et al. 2015). Since studies have 
focused on the coronary artery calcium score, a trend has emerged which utilises coronary 




calcium scoring methodologies on extracoronary locations. Some researchers now 
consider the Agatston calcium score the gold standard of extracoronary calcification 
quantification (Denzel et al. 2004). Despite the wide use and prognostic value of the 
Agatston calcium score, it was originally developed without histopathological evidence 
or otherwise to guide its arbitrarily weighted cofactor methodology (Blaha et al. 2017). 
Consequently, the CAC score cannot determine plaque-specific risk (Mauriello et al. 
2013) and there is a lack of reliable calcium scoring methods developed for determining 
vessel-specific risk.  
Current methods of clinically quantifying calcification are suboptimal (Sarwar et al. 
2008). Clinical scanning protocols for Multidetector row CT (MDCT) are in the 
resolution range of approximately 200-500µm. However, CT technology is evolving and 
higher resolutions are being achieved. High-resolution peripheral quantitative computed 
tomography (HRPQCT) and flat-panel volume CT (FPVCT) are capable of producing 
spatial resolutions as low as 60μm (Manske et al. 2015) and 150μm (Gupta et al. 2006), 
respectively. These higher spatial resolutions should identify more defined calcification 
features. However, it is currently unknown to what extent the effect of CT resolution has 
on the measurement of atherosclerotic calcification (Demer et al. 2017). An appreciation 
for the effect of CT resolution on measurements of atherosclerotic calcification and the 
clinical significance of different calcium measurements in lesion-specific assessment is 
required. 





Figure 1-4: Agatston coronary artery calcium scoring representing none*, mild, moderate and 
severe disease. 
1.1.4.2 Blood-Based biomarkers 
While C-reactive protein (CRP) is a reliable inflammatory marker, it has been shown that 
patient levels of CRP do not correlate with CAC scores. Therefore, it is surmised that 
these two modalities provide discrete prognostic information (Reilly et al. 2003). It is 
well-documented that atherosclerosis is a systemic disease (Dalager et al. 2008; 
Herrington et al. 2016), with calcification often present in multiple vascular sites (Allison 
et al. 2004). The prognostic value of calcification can be increased by utilising several 
locations of arterial calcification (Bos et al. 2015; Tison et al. 2015). Therefore, estimation 
of the systemic atherosclerotic burden and risk may be improved with a more complete 
assessment of calcification (Xie and Shaw 2015). However, whole-body CT scanning is 
impractical as the standard method of patient assessment. In this regard, blood-based 
biomarkers of atherosclerotic calcification may provide an alternative diagnostic 
approach, theoretically capable of reflecting the total atherosclerotic burden. Blood 
samples are easily accessible and routinely used in clinical practice. Moreover, 
atherosclerotic tissues are in immediate contact with circulating blood, making this a 
worthwhile approach for the subclassification of CVD (Arab et al. 2006). The active 
formation of atherosclerotic calcification (Doherty et al. 2003; Demer and Tintut 2008) 
provides a unique opportunity to examine the utility of circulating biomarkers of vascular 




calcification to estimate the total amount of atherosclerotic calcification, and thus the total 
atherosclerotic burden. 
Matrix γ-carboxyglutamate (Gla) protein (MGP) is a potent local inhibitor of vascular 
calcification (Luo et al. 1997) mainly expressed by vascular smooth muscle cells 
(VSMCs) (Price et al. 1976). This calcium-binding protein impedes calcium phosphate 
deposition in vascular tissues (Roy and Nishimoto 2002). MGP also binds to bone 
morphogenetic proteins (BMP) 2 and 4 (Wallin et al. 2000; Mayer et al. 2016), preventing 
BMP-induced VSMC differentiation to an osteoblast cell phenotype (Boström et al. 
2001). However, MGP requires vitamin K-dependent glutamate carboxylation and serine 
phosphorylation to become fully functional (Schurgers et al. 2007). The inactive form of 
this protein (dephosphorylated and uncarboxylated MGP [dp-ucMGP]) is released into 
circulation where it can be quantified (Cranenburg et al. 2010; Mayer et al. 2014). 
Additionally, fetuin-A is a circulating plasma glycoprotein produced by the liver (Triffitt 
et al. 1976), contributing to half of the blood calcification inhibitory capacity (Price and 
Lim 2003). In this regard, it acts as a systemic inhibitor of vascular calcification through 
three main pathways: prevention of calcium-phosphate mineral nucleation, inhibition of 
VSMC apoptosis and enhanced apoptotic body clearance (Reynolds et al. 2005) (Fig.1-
5). It is also speculated that osteocalcin, as a marker of bone turnover (Price et al. 1980), 
correlates with the amount of vascular calcification. Moreover, inflammation plays an 
essential role in the development of atherosclerosis (Aikawa et al. 2007). Whether or not 
circulating levels of these calcification inhibitors, osteogenic regulators or inflammatory 
cytokines reflect atherosclerotic calcification requires investigation. 





Figure 1-5: Circulating biomarkers and vascular calcification. (i) Liver production of fetuin-A 
and inactive MGP (dp-ucMGP) secretion from vascular smooth muscle cells. (ii) Coronary artery 
calcium and calcification within an excised femoral plaque. 
1.1.5 Treatment 
Once stenotic segments are identified, a strategic treatment plan must be implemented to 
restore vessel patency. However, calcifications within atherosclerotic plaques limit the 
technical success of minimally invasive endovascular approaches. Stenting and 
angioplasty procedures achieve insufficient luminal expansion with calcified plaques 
(Savage et al. 1991; Hoffmann et al. 1998; Ling et al. 2008; Nakazawa et al. 2009; Okuno 
et al. 2016) (Fig. 1-5). Additionally, calcification is hypothesised to be impeding the 
adsorption of anti-proliferative agents into the vessel (Fanelli et al. 2014; Rocha-Singh et 
al. 2014). Moreover, severe calcification has been associated with perioperative 
complications such as inadvertent vessel dissection, perforation (Fitzgerald et al. 1992; 
Dimitrakakis et al. 2013; Rocha-Singh et al. 2014; Lee and Shah 2016), as well as stent 
and cutting balloon microblade fractures (Haridas et al. 2003; Sfyroeras et al. 2010; 
Morlacchi et al. 2014; Naraoka et al. 2019). This can be attributed to our inability to 
predict device-tissue interactions, increasing endovascular device failures (Chang et al. 
2011) and procedural induced complications (Müller et al. 2018). Resultantly, there is a 
high rate of surgical re-intervention (Patel et al. 2015) and cardiovascular deaths 
(Katsanos et al. 2018) associated with the transcatheter treatment of calcified 
atherosclerosis. Consequently, endarterectomy remains the recommended mode of 




treatment for symptomatic and calcified carotid (Barnett et al. 1991; Katano et al. 2014) 
and lower extremity atherosclerosis (Kang et al. 2008; Aboyans et al. 2018), despite the 
plethora of endovascular devices available on the market. 
 
Figure 1-6: Increasing stent underexpansion with higher degrees of plaque calcification 
(Nakazawa et al. 2009). 
1.1.5.1 Predicting Tissue Behaviour 
Biomechanical models have demonstrated powerful potential in predicting plaque rupture 
(Akyildiz et al. 2016) and simulating device-tissue interactions (Conway et al. 2017). 
Computational efforts have sought to analyse the relationship between calcification and 
plaque stability (Maldonado et al. 2012), in addition to anticipating the interaction of 
calcified atherosclerotic plaques with medical devices (Deokar and Klamecki 2017). 
Reliable computational simulations have the capacity to improve clinical methods of 
high-risk plaque identification and stratification for preventative intervention based on 
plaque content. However, the accuracy of these models depends largely upon 
representative material properties and constituent distribution within the plaque 
(Ebenstein et al. 2009; Akyildiz et al. 2011). Experimentally determined elastic moduli 
of atherosclerotic fibrous and calcified tissues exhibit large degrees of variation 
(Ebenstein et al. 2009; Cardoso and Weinbaum 2014). As a result, finite element 
simulations have modelled calcification with an elastic modulus of anywhere from 1MPa 
(Imoto et al. 2005; Buffinton and Ebenstein 2014), to 1GPa (Conway et al. 2017) or as 
completely rigid inclusions (Hoshino et al. 2009). A study by Cunnane et al. 
demonstrated the large discrepancies that can be generated by utilising inappropriate 
material behaviours in numerical simulations (Cunnane et al. 2015). The absence of 
accurate material properties for advanced calcified atherosclerotic lesions is obstructing 
rigorous computational research in plaque rupture and device-tissue interactions. 




1.1.5.2 Mechanical Characterisation Approaches 
Advanced atherosclerotic arteries are highly heterogeneous in nature. The main 
components of an atherosclerotic plaque include the fibrous cap, fibrotic media, necrotic 
core (or lipid pool), thrombosis (or haematoma) and calcification. Moreover, calcification 
itself exists in a diverse range of morphologies from spherical microcalcifications (Kelly-
Arnold et al. 2013) to large irregular-shaped macrocalcifications. Global mechanical 
properties of atherosclerotic plaque tissues have been extensively investigated on the 
macro scale using various modes of characterisation such as uniaxial testing, reviewed by 
Walsh et al. (Walsh et al. 2014), and compression testing, reviewed by Chai et al. (Chai 
et al. 2014). These methods of material characterisation neglect the highly heterogeneous 
nature of the lesions. Consequently, the current literature reports variability in tissue 
mechanical properties. Values for the compressive elastic modulus of calcified carotid 
tissues range from 0.14MPa (unconfined compression) (Maher et al. 2009) to 700MPa 
(nanoindentation) (Ebenstein et al. 2009), indicating the need for individual plaque 
constituent characterisation.  
Nanoindentation is an experimental technique originally developed for determining the 
hardness properties of thin films and has successfully transitioned to the characterisation 
of mineralised biological tissues such as teeth and bone (Rho et al. 1997, 1999; Zysset et 
al. 1999; Cuy et al. 2002). This method of high-resolution indentation testing, with 
accurate positioning capabilities, is an optimal approach for the precise mapping of small, 
irregular-shaped heterogeneous material (Constantinides et al. 2006), such as calcified 
deposits within atherosclerotic plaques (Stary 2000). Nanoindentation, therefore, should 
be capable of accurately determining the stiffness properties of calcification with 
atherosclerotic plaques as well as the surrounding non-calcified matrix. The 
characterisation of these properties will provide valuable information for computational 
simulations to allow for insights into plaque tissue rupture and interventional 
modification (Katano and Yamada 2007). 
Collectively, it can be argued that progress in the diagnosis and treatment of 
cardiovascular disease patients has been impeded by our inability to identify high-risk 
patients and vulnerable plaques, combined with a lack of understanding of tissue 
mechanics leading to increased endovascular device failures and periprocedural 
complications. 
  





This thesis focuses on the use of calcification in cardiovascular patient management. The 
work presented in this thesis will address the following research questions;  
Is it possible to use biomarkers of calcification in imaging and blood-based 
methodologies to improve cardiovascular patient diagnosis and also use nanoindentation 
approaches to characterise the stiffness properties of calcified plaques to improve 
prediction of tissue behaviour? 
This research question will be investigated by identifying measures of calcification on 
clinical imaging modalities, correlating circulating blood-biomarkers with the calcified 
atherosclerotic burden and characterising the stiffness properties of calcified and non-
calcified human atherosclerotic tissue. This proposed approach requires the 
accomplishment of some specific objectives: 
1. To understand the limitations of the current coronary artery calcium score for 
vessel-specific assessment, examine the effect of CT resolution on calcification 
measures and identify features of calcification distinguishable on clinical CT to 
differentiate between stable and unstable plaques. 
2. Examine the capabilities of other clinically available imaging modalities to 
identify and quantify calcification. 
3. Determine the utility of circulating blood-based biomarkers to determine calcified 
atherosclerotic status. 
4. Characterise the stiffness properties of calcified and non-calcified tissue using 
nanomechanical techniques. 
1.3 Thesis Outline 
The first part of this thesis focuses on measuring calcification using clinically available 
imaging modalities, with a focus on non-contrast computed tomography. The second part 
of this thesis investigates the utility of circulating blood biomarkers to improve calcified 
atherosclerotic burden stratification. The final part of this thesis determines the 
mechanical properties of calcified and non-calcified portions of human atherosclerotic 
tissue.  
This thesis is presented in the style of ‘thesis by publication.’ Havard referencing is used 
throughout. There is a degree of repetition in the introductions and methods sections of 
each chapter. Table 1-1 outlines the chapters from this thesis and their published status: 
under review, in revision, accepted or published. This excludes Chapters 1, 2 and 10 




which present the introduction, methods and discussion of this thesis. Chapter 6 has yet 
to be submitted to a journal for consideration. The published version of each article can 
be found in Appendix B. Additionally, 4 co-authored manuscripts that were prepared 
alongside this PhD research work, are detailed in Appendix C.  
Table 1-1: Thesis chapter number, journal of publication, status of article, and impact factor of 
each journal. 
Chapter Journal Status Impact Factor1 
3 Journal of Cardiovascular Computed 
Tomography 
Published 3.316 
4 European Journal of Radiology Under Review 2.948 
5 Stroke Accepted 6.046 
7 Atherosclerosis Submitted 4.255 
8 Acta Biomaterialia Published 6.638 
9 Experimental Mechanics Special 
Issue Special Issue on Experimental 
Advances in Cardiovascular 
Biomechanics 
Accepted 2.256 
1 Impact factors as of 2018 
In Chapter 2 a thorough description of methods employed in this thesis to obtain the 
results described in the subsequent chapters is provided. 
Chapter 3 presents a comparative analysis of high-resolution measures of atherosclerotic 
calcification against approximations for the lesion Agatston calcium scores.  
Chapter 4 quantifies the impact of decreasing CT resolution on acquired measures of 
calcification. 
Chapter 5 correlates coronary derived carotid calcium scores and measurements of 
carotid calcium density at clinical CT resolution with ipsilateral preoperative 
cerebrovascular symptoms. 
Chapter 6 compares the ability of several clinical imaging modalities to quantify 
measures of calcified burden and calcification instability compared against ground truth 
results.  
Chapter 7 investigates the use of circulating levels of blood-biomarkers to estimate the 
extent of atherosclerotic calcification in a cohort of arterial disease patients. 
Chapter 8 relates the mechanical properties of atherosclerotic calcification to 
radiographic density using a traditional nanoindentation approach. 




Chapter 9 utilises two nanomechanical approaches to characterise the calcified versus 
non-calcified components of atherosclerotic tissues.  
In Chapter 10 the main findings of this thesis are discussed and summarised. 
Additionally, recommendations for further work are briefly described. 
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This thesis is presented in the format of thesis by publication. Due to the length 
restrictions placed on journal articles the methods sections are only briefly described in 
each of the chapters. Consequently, this chapter presents a detailed account of the 
materials and the methods that were utilised to generate the results in the following 
chapters of this thesis. This includes descriptions of sample acquisition, image 
acquisition, image post processing, biochemical analysis and mechanical characterisation 
techniques. 
 Patient Recruitment and Clinical Examination 
2.1.1 Patient Recruitment 
Patients undergoing standard carotid and lower extremity endarterectomy procedures at 
the University Hospital Limerick, Ireland were recruited. This study was approved by the 
Research Ethics Committee at University Hospital Limerick adheres to the principles of 
ICH-GCP and the Declaration of Helsinki. Written informed consent was obtained from 
all patients before participation in the study. Preoperative patient assessment included 
patient demographics, comorbid conditions, cardiovascular history, preoperative 
medication, and clinical biochemical data. 
2.1.2 Sample Acquisition 
2.1.2.1 Blood Samples 
Fasting venous blood was collected preoperatively by venepuncture. Serum samples were 
prepared in serum gel tubes (S-Monovette 4.9mL Z-Gel, Sarstedt, UK) by standard 
centrifugation (15 minutes, 1580 x g). Plasma samples were prepared in K3EDTA plasma 
tubes (S-Monovette 7.5mL K3E, Sarstedt, UK) by standard centrifugation (15 minutes, 
1580 x g). Both serum and plasma collections were split into dedicated aliquots and stored 
at -80°C until time of protein quantification.  
2.1.2.2 Atherosclerotic Plaque Samples 
Excised atherosclerotic carotid and lower extremity plaque samples were collected 
postoperatively. Additionally, 2 femoral artery samples were retrieved from lower limb 
amputation procedures. Figure 2-1 presents an overview of the vascular territories of 
interest and Table 2-1 details the sample cohorts that were examined in each chapter of 
this study. 
 




Figure 2-1: Vascular territories that are examined in this thesis. 
Table 2-1: Overview of the sample cohorts that were examined in each chapter of this thesis 
(+primary cohort, */**/*** subgroups from the main cohort, same symbols indicates the same 
cohort). 
Chapter Study Sample Size 
3 
Evaluating the Agatston Calcium 
Score 
20 carotid* and 20 lower 
extremity* plaques 
4 CT Resolution and Calcification 38 carotid** plaques 
5 
Carotid Calcification and 
Cerebrovascular Symptoms 
38 carotid** plaques 
6 Alternative Imaging Modalities 
9 carotid plaques, 6 femoral 
plaques and 2 femoral arteries 
7 
Circulating Biomarkers of Calcified 
Burden 
36 carotid+ and 31 lower 
extremity+ plaques 
8 
Nanoindentation of Atherosclerotic 
Calcification 




Calcified versus Non-Calcified 
Nanoindentation 
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2.1.3 Sample Storage 
2.1.3.1 Atherosclerotic Plaque Samples 
Immediately upon surgical excision the plaque samples are placed in saline at 4°C which 
is a stable method of storage up until 24hrs (Stemper et al., 2007). The plaque samples 
are then placed in phosphate-buffered saline solution (PBS) and stored at -20°C within 
24hrs of surgical removal until time of batch analysis. Cryopreserving the tissue in this 
way has been shown to prevent the biological dehydration and deterioration of the sample, 
hence preserving its physical state for structural and mechanical analysis independent of 
the storage time (O’Leary et al. 2014). Previous studies have also demonstrated negligible 
effects of freezing on the acquired nanoindentations properties of arterial and 
atherosclerotic tissues (Ebenstein et al. 2009; Tracqui et al. 2011; Hemmasizadeh et al. 
2012). 
2.1.3.2 Blood Samples 
Both serum and plasma collections were split into dedicated aliquots and stored at -80°C 
until time of protein quantification. All samples were processed in the same manner and 
freeze-thaw cycles were minimised (Tworoger and Hankinson 2006). 
2.1.4 Plaque Tissue Chemical Fixation and Dehydration 
The intense voltage source of the micro-Computed Tomography (micro-CT) scanner can 
cause tissue shrinkage. These motion artefacts would reduce the quality of the acquired 
images series (du Plessis et al. 2017). Additionally, hydrated biological samples exhibit 
poor surface conductivity resulting in high amounts of electrical charging that interfere 
with scanning electron microscopy (SEM) images. Therefore, all plaque samples were 
chemically fixed and dehydrated prior to micro-CT or SEM analysis using a method 
described by Mulvihill et al. 2013. Additionally, samples were sputter-coated in gold to 
maximise surface conductivity prior to SEM. Table 2-2 summarises the steps taken to 
chemically fix and dehydrate the plaque samples. 
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Table 2-2: Summary of the chemical fixation and dehydration steps (Mulvihill et al. 2013). 
Step Chemical Concentration (%) Time 
Fix Methanol 100 10mins 














2.1.5 Clinical CT Scanning 
Coronary CT scanning was performed for patients postoperatively using a Siemens 
Somotom Sensation 64 (Erlangen, Germany). The scanning parameters were 200 mm 
field of view, 3mm slice thickness, acquisition 24 x 1.2mm and reconstruction increment 
of 1.5mm. The x-ray source was operated at 120 kV and all tomographic slices were 
obtained with a rotation time of 0.33 s and pitch of 0.2. Coronary artery calcium scores 
(Agatston et al. 1990) and volume scores (Callister et al. 1998) were acquired using 
Siemens Syngo calcium scoring software (Siemens AG, Erlangen, Germany). Figure 2-2 
summarises the workflow of patient examination, sample acquisition and clinical imaging 
in this thesis. 
  




Figure 2-2: Participant enrolement, sample and clinical image acquisition. (i) Patient 
identification, consent and clinical examination. (ii) Fasting blood samples were acquired 
preoperatively. (iii) Excised plaque samples were collected postoperatively. (iv) Non-contrast 
coronary artery calcium scans were conducted postoperatively. 
 
 Plaque-Specific Imaging 
2.2.1 Micro-Computed Tomography 
2.2.1.1 Principle 
High-resolution micro-computed tomography (micro-CT) is a non-destructive imaging 
modality used to produce high-resolution 3D image series. The principle of this technique 
is based on the projection of an x-ray beam through a target sample. As the x-rays pass 
through the target object, the beams are diminished: I is the intensity of the transmitted 
x-rays, I0 is the incident x-ray intensity, x is the thickness of the specimen and μ is the 
linear attenuation coefficient (Stauber and Müller 2008; Lin et al. 2019) (Eq.1). Detectors 
quantify the intensity of the final x-ray beams, which have passed through the object of 
interest. The components of a typical micro-CT scanner are presented in Figure 2-3. 
 
𝐼 = 𝐼 𝑒 µ   Eq.1 
 




Figure 2-3: Principle and components of a micro-computed tomography scan (Boerckel et al. 
2014). 
2.2.1.2 Application 
Non-contrast CT is the optimum clinical imaging modality to identify arterial 
calcifications in vivo (Agatston et al. 1990; Wang et al. 2018). However, clinical CT has 
limited spatial resolution and therefore much atherosclerotic calcification research is 
conducted ex vivo using micro-CT (Mohr et al. 2004; Vengrenyuk et al. 2006; Kelly-
Arnold et al. 2013; Barrett et al. 2016, 2017). This ex vivo technique has significantly 
higher spatial resolution potential than clinical CT (Lin and Alessio 2009) achieving up 
to 1μm isotropic dimensions (Clark and Badea 2014). Calcification area, volume and 
density (Higgins et al. 2005) can be readily quantified. Additionally, microcalcifications 
as small as 0.5-50μm in spherical diameter can be identified within atherosclerotic tissues 
using this technique (Kelly-Arnold et al. 2013). 
2.2.1.3 Micro-CT Procedure (University of Limerick) 
Micro-CT (Xradia Versa 500, Zeiss X-ray Microscopy, Germany) was utilised to analyse 
calcification within the plaque samples. The samples underwent a tissue preservation 
procedure described in section 2.1.4. The scanning was performed with a 0.4 x optical 
magnification and 2.5 s x-ray exposure time. The x-ray source was operated at 50 kV and 
81 μA and all tomographic slices were obtained with an isotropic spatial resolution of 
15.68μm. Figure 2-4 presents the micro-CT scanner, a representative image series and 3D 
sample projection. 




Figure 2-4: Micro-computed tomography. (i) Xradia versa XRM 500 Micro-CT scanner (Zeiss, 
Germany) (ii) Representative micro-CT image stack. (iii) Representative 3D sample projection. 
2.2.1.3.1 Post Processing 
2.2.1.3.1.1 Calibration 
Three-dimensional reconstructions were generated using Xradia XRM reconstructor 
(version 7.0.2817). The pixel values from these micro-CT scans are rescaled using a 
modified Hounsfield Unit (HU) calibration. The standard HU scale is a linear 
transformation of the x-ray attenuations into one in which the radiographic density of 
distilled water at standard pressure and temperature is defined as 0HU and the 
radiographic density of air at the same conditions is defined as -1000HU (Hounsfield 
1980) (Fig.2-5(i)). However, plaque samples are typically surrounded by blood and soft 
tissue in vivo, not air. Therefore a modified Hounsfield calibration was performed 
assigned air with a HU value of zero, to be more representative of blood density (40-
60HU) (Huda and Slone 2003) and the maximum values for calcifications were in the 
order of 130HU-3000HU (Galonska et al. 2008; Demer et al. 2017) (Fig.2-5(ii)). This 
minimises the ex vivo partial volume averaging errors acquired during image downscaling 
(section 2.3.4.3). 
 
Figure 2-5: Hounsfield Unit scales. (i) Standard and (ii) modified calibrations. 
2.2.1.3.1.2 Artefact Removal 
Image analysis was conducted using ImageJ image processing software (ImageJ release 
1.52a) (Schindelin et al. 2012). The image files were first manually processed to remove 
any background image artefacts ≥130HU that could be inadvertently included in the 
calcified analysis. Artefacts outside lesion boundaries were visually delineated and 
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removed by replacing the pixel attenuation density ≥130HU with a background x-ray 
attenuation density of 0HU. 
2.2.1.3.1.3 Scaling to Clinical Resolution 
CT resolution is determined by pixel dimensions (in-plane) and voxel depth (slice 
thickness). Each pixel is assigned a CT number representative of the average x-ray 
attenuation of all the tissues within that voxel. Large pixel dimensions contain large 
volumes of tissue. Therefore the CT number (HU) obtained is an average of the x-ray 
attenuation of all the tissue within the voxel dimensions. Figure 2-6 illustrates the partial 
volume averaging artefacts. Smaller pixel dimensions (micro-CT) contain smaller 
amounts of tissue and are therefore subject to less partial volume averaging artefacts 
(high-resolution images). Figure 2-7 presents the acquisition of CT spatial resolution: in-
plane dimensions and slice thicknesses. 
 
Figure 2-6: Partial volume averaging artefacts. (i) True sample dimensions and radiographic 
density. (ii) Actual CT numbers acquired due to partial volume averaging effects (Choi et al. 
2018). 
 




Figure 2-7: CT pixel dimensions and slice thickness. Representation 3D dimensions for a high-
resolution plaque scan versus a low-resolution plaque scan. 
2.2.1.4 Calcium Scoring 
Calcium scoring is a robust method of clinically quantifying coronary calcium and 
associating the findings with atherosclerotic burden and cardiovascular risk (Blaha et al. 
2017). Calcium scores are traditionally acquired within the 4 main coronary arteries: the 
right coronary artery (RCA), the left main coronary (LM), the left anterior descending 
(LAD), and the left circumflex artery (CX). 
2.2.1.4.1 The Agatston Score 
The first coronary calcium scoring algorithm was described in 1990 by Arthur Agatston 
and colleagues (Agatston et al. 1990). In this method, a maximal density-weighted 
cofactor is applied to contiguous calcified pixels (≥130HU) ≥1mm2 on each CT image 
slice. This weighted cofactor is multiplied by the area of corresponding calcification to 
give the lesion score (Eq.2). The total coronary artery calcium (CAC) score is determined 
by summing the lesion scores on each slice (Eq.3). Table 2-3 presents the weighted 
calcium scoring cofactors. 
𝐴𝑔𝑎𝑡𝑠𝑡𝑜𝑛 𝑆𝑐𝑜𝑟𝑒( ) = (𝐶𝑎𝑙𝑐𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐴𝑟𝑒𝑎) 𝑥 (𝑀𝑎𝑥𝑖𝑚𝑎𝑙 𝐶𝑜𝑓𝑎𝑐𝑡𝑜𝑟) Eq.2 
𝐴𝑔𝑎𝑡𝑠𝑡𝑜𝑛 𝑆𝑐𝑜𝑟𝑒( ) = ∑𝐴𝑔𝑎𝑡𝑠𝑡𝑜𝑛 𝑆𝑐𝑜𝑟𝑒( ) Eq.3 
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2.2.1.4.2 The Volume Score 
The Volume Score is calculated by multiplying the number of calcified pixels by the 
known voxel volume (Callister et al. 1998) (Eq.4). 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑆𝑐𝑜𝑟𝑒 (𝑚𝑚 ) = (𝐶𝑎𝑙𝑐𝑖𝑓𝑖𝑒𝑑 𝑃𝑖𝑥𝑒𝑙𝑠) 𝑥 (𝑉𝑜𝑥𝑒𝑙 𝑉𝑜𝑙𝑢𝑚𝑒) Eq.4 
2.2.1.4.3 The Density-Volume Score 
The Density-Volume calcium score is determined by multiplying the calcification volume 
by a mean density-weighted cofactor (Nakanishi et al. 2019) (Eq.5). Table 2-3 presents 
the calcium scoring weighted cofactors. 
𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑉𝑜𝑙𝑢𝑚𝑒 𝑆𝑐𝑜𝑟𝑒 = (𝐶𝑎𝑙𝑐𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑉𝑜𝑙𝑢𝑚𝑒) 𝑋 (𝑀𝑒𝑎𝑛 𝐶𝑜𝑓𝑎𝑐𝑡𝑜𝑟) Eq.5 
Table 2-3: Hounsfield Unit weighted cofactors for the coronary Agatston and Density-Volume 
calcium scores. 
Hounsfield Unit 




130-199 1 4 
200-299 2 3 
300-399 3 2 
≥400 4 1 
 
2.2.1.5 Micro-CT Procedure (Erasmus Medical Centre)  
Micro-CT images were acquired with the Quantum GX2 Micro-CT Imaging System 
(Perkin Elmer, USA). The samples were not chemically fixed or dehydrated and were 
mounted on two cannulas within a custom half-cylindrical support (Fig.2-8). Initially, the 
samples were submerged in PBS, but the liquid was removed directly before imaging. 
However, the scanning time was sufficiently short (between 14 mins and 1 hr) to avoid 
any dehydration that would create motion artefacts. The samples were scanned in high-
resolution mode with a field of view of 25 x 22 mm, and reconstruction time of 14 mins. 
The x-ray source was operated at 90 kV and 88 μA and all tomographic slices were 
obtained with an isotropic spatial resolution of 50μm. Samples longer than 22 mm were 
imaged over multiple scans and files were manually stitched post-acquisition. Acquired 
image files were automatically calibrated to a standard Hounsfield Unit Scale (Fig.2-9 
(i)). 




Figure 2-8: Computer Aided Design model of the custom half-cylindrical support used to image 
the samples with multiple non-invasive and invasive imaging modalities while maintaining the 
sample orientation. 
2.2.1.5.1 Calcification Thresholding 
The acquired x-ray attenuation density of the ex vivo atherosclerotic plaque samples on 
the standard Hounsfield Unit scale will be different from in vivo values. Therefore, the 
standard clinical threshold of 130HU for identifying calcification (Agatston et al. 1990) 
is not applicable. Sections 2.2.1.5.1.1 to 2.2.1.5.1.3 detail the methods used to determine 
an appropriate threshold for identifying calcification within these image series. 
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2.2.1.5.1.1 Plot Profile 
Plot profile allows the signal intensity across a defined shape to be quantified. Figure 2-
9 (i) displays a representative plot along a plaque cross-section, which traverses 
background (air), non-calcified tissue and calcified tissue. Figure 2-9 (ii) presents the 
corresponding changes in the signal intensity along the linear plot. 
2.2.1.5.1.2 Histogram Analysis 
Histogram analysis of high-resolution images produces defined narrow peaks. Figure 2-
9 (iii) and (iv) present a representative histogram generated a micro-CT image stacks, 
illustrating three peaks for background, non-calcified and calcified components. 
Thresholds to distinguish between the three tissue types lie between each peak. 
2.2.1.5.1.3 Particle Analysis 
Finally, by adjusting the calcification threshold, the value at which the number of calcified 
particles identified remains constant can be determined. Figure 2-9 (v) presents the areas 
of calcification in red within a plaque cross-section at incremental calcification thresholds 
(100-2500HU). Figure 2-9 (vi) demonstrates the change in calcified particle count at each 
threshold. Initially, the number of particles is high due to artefacts. The count begins to 
drop as the rising threshold disregards the noise. The number of calcified particles then 
begin to rise again due to reduced partial volume effects that separate coalesced particles. 
The threshold between which the number of particles changed the least was selected as 
the threshold for identifying calcification. 




Figure 2-9: Identifying the threshold for segmenting calcification. (i) Plot profile across plaque 
segment with calcification. (ii) Plot of the change in Hounsfield unit density along the line. (iii) 
Histogram analysis of a micro-CT image stack displaying peaks for air and non-calcified tissue. 
(iv) Histogram analysis of a micro-CT image stack displaying peaks for calcified tissue. (v) 
Increasing threshold for calcification from 100-2500HU. Calcification is identified in red. (vi) 
Calcified particle count determined for each calcification threshold. 
2.2.2 Clinical Computed Tomography 
2.2.2.1 Procedure 
Clinical CT image series were acquired with a Siemens Somatom force dual-energy CT 
scanner (Siemens, Erlangen, Germany). The samples were not chemically fixed or 
dehydrated. The samples were mounted on two cannulas within a custom half-cylindrical 
support (Fig.2-8). Initially, the samples were submerged in PBS, but the PBS was 
removed directly prior to imaging due to the similar Hounsfield density of water and non-
calcified plaque tissue, which would make post processing difficult. However, the 
scanning time was sufficiently short to avoid any tissue dehydration that would create 
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motion artefacts. The samples were scanned using the following parameters: 120 kV 
voltage source and a BV40 kernel reconstruction. The threshold for calcium was 
determined as the same value obtained from thresholding the micro-CT images as 
described in section 2.2.1.5. 
2.2.3 Magnetic Resonance Imaging 
2.2.3.1 Principle 
Magnetic resonance (MR) imaging is based on the measurement of specific proton 
nuclear spins within the body in response to a magnetic field and radio waves. Protons 
within the body are aligned in response to a strong magnetic field. Radiofrequency pulses 
alter the alignment of the protons. Once the radio waves are ceased, the nuclear spin of 
the proton returns to equilibrium, releasing electromagnetic energy that is detected by a 
coil (Fig.2-10). The relaxation times and electromagnetic energies released are dependent 
on the biophysical and biochemical composition of the tissue (Yoshioka et al. 2009). 
Similar to CT, this is a non-invasive imaging modality. However, MRI does not require 
the use of ionising radiation, unlike CT (Tarkin et al. 2016). The most commonly used 
pulse sequences are T1-weighted (spin-lattice) and T2-weighted (spin-spin) MRI 
radiofrequency waves. T1-weighted images are useful in the identification of anatomical 
structures whereas T2-weighted pulses are used to determine pathological processes 
(Chou and Carrino 2006). 
 
Figure 2-10: The fundamentals of magnetic resonance imaging, T1 and T2-weighted 
radiofrequency pulses (Rivas et al. 2016). 
2.2.3.2 Application 
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It is possible to determine atherosclerotic lesion anatomy and composition with the 
application of T1-weighted, T2-weighted and/or other MRI radiofrequency sequences 
(Choudhury et al. 2004; Yuan et al. 2012). High-resolution MRI has been used in the 
clinical assessment of coronary (Fayad et al. 2000), carotid (Yuan et al. 1998) and lower 
extremity (Corti et al. 2002) plaques. Calcified tissues are rigid and have extremely short 
transverse relaxation times. Calcium appears as delineated areas of hypointense material 
in T1-weighted MRI images (Chou and Carrino 2006). 
2.2.3.3 Procedure 
T1 weighted magnetic resonance images were acquired using a 7.0T MRI scanner 
(Discovery MR901, GE Healthcare, USA) with 4 channel surface coil with 50mm 
transaxial FOV. All MRI images were obtained with an FSPGR sequence with repetition 
time 17.5 ms, echo time 3.3 ms, bandwidth 122 Hz, fractional anisotropy 20° and 16 
averages, using a field of view of 25 x 25 mm, a matrix size of 512 and slice thickness 
0.5mm. 
2.2.3.4 Post Processing 
To correct any uneven background signal in the T1-W MR images (Fig.2-11(i)) a 
Gaussian Blur with a sigma radius of 70 was applied (Fig.2-11(ii))). The original image 
is divided by the filtered image to produce the corrected MR image (Fig.2-11(iii)). Figure 
2-11 (iv) and (v) display the original and correct background frequency in the original 
and correct images, respectively. 





Figure 2-11: Magnetic resonance image (MR) background processing. (i) Original MR image. 
(ii) Gaussian filter blur. (iii) Corrected image by dividing original image by the Gaussian blur 
filter. (iv) Plot profile of the background signal before correction. (v) Plot profile of the 
background signal after correction. 
A histogram was then created for each corrected MR image series. The combined 
histogram for all samples is presented in Figure 2-12. To identify hypointense areas of 
calcification a threshold of 0.70 was applied produced binary images. 
 
Figure 2-12: Histogram of magnetic resonance normalised grey values. 
Image noise was then reduced in the binary images (Fig.2-13(i)) by conducting an open 
followed by a close binary image operation in ImageJ. The open operation performs an 
erosion followed by dilation, which removes any isolated pixels (or noise) (Fig.2-13(ii)). 
The close operation performs a dilation followed by erosion, which fills in small holes 
and smoothes objects (Fig.2-13(iii)). 




Figure 2-13: ImageJ binary processing operations. (i) Original binary image. (ii) Open operation. 
(iii) Close operation. 
Any artefacts that remained in the images were then manually removed. These artefacts 
included air bubbles and particles outside the vessel boundaries. Figure 2-14 presents a 
schematic illustration of the synchronised original and binary image windows, delineated 
vessel border using a freeform shape, and the subsequent removal of an air bubble and an 
artefact outside of the vessel boundaries. Air bubbles were identified due to their highly 
circular nature and particles outside the vessel border were identified by the synchronised 
window freeform shape. 
  
Figure 2-14: Manual delineation of artefacts. (i) Original Image with vessel borders drawn. (ii) 
Binary image window synchronised with same vessel borders drawn. (iii) The air bubble and 
particle outside the vessel boundaries have been removed. 
2.2.4 Intravascular Ultrasound 
2.2.4.1 Principle 
Intravascular ultrasound (IVUS) is performed using a specialist catheter that has a 
miniature ultrasound probe attached at the distal end. In this regard, it is an invasive 
imaging modality. The piezoelectric transducer within the probe expands and contracts 
to generate sound waves, which travel outwards from the catheter through the arterial 
tissue and the specific reflections captured are based on the differing acoustic properties 
of tissue constituents. The probe rotates within the catheter to capture a 360° view of the 
internal vessel. The proximal end of the catheter is connected to the ultrasound equipment 
that records the images (Garcìa-Garcìa et al. 2011). 




Figure 2-15: The principle of Intravascular Ultrasound catheter imaging (Shih et al. 2018). 
2.2.4.2 Application 
IVUS is a useful tool for the clinical assessment of atherosclerotic plaque morphology 
(Nishimura et al. 1990), evaluating luminal gain following device deployment (Serruys 
et al. 2009) and serial imaging to monitoring disease progression (Nicholls et al. 2006). 
2.2.4.3 Procedure 
IVUS images were acquired using a commercially available IVUS system: TVC Imaging 
System™ (InfraredX, Inc.) with a TVC Insight XB™ catheter (Burlington, 
Massachusetts, USA). The catheter (50MHz) was advanced through the plaque sample 
and automatic pullback was performed at a speed of 0.5mm/s. A frame rate of 5.33fps 
acquired images with a slice thickness of 90μm and an axial resolution of approximately 
100μm. The maximum penetration depth of the ultrasound waves is approximately 5mm. 
2.2.4.4 Image Interpretation 
IVUS images were analysed using QCU-CMS v4.69 software (Medis Medical Imaging 
Systems B.V., Leiden, The Netherlands). Calcium is identified on IVUS images as 
hyperechogenic leading edges with posterior acoustic shadowing (Mintz et al. 2001). 
Calcification on IVUS images is typically quantified by length and angle as the sound 
waves cannot penetrate calcium to determine thickness, area or volume (Mintz et al. 2001; 
Van Der Giessen et al. 2011). 
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2.2.5 Optical Coherence Tomography 
2.2.5.1 Principle 
Optical coherence tomography (OCT) utilises low-coherence interferometry which 
scatters near-infrared light at the tissue. Similar to IVUS, OCT is another transcatheter 
imaging modality. The light emitted from the rotating fiberoptic wire is split into two 
paths: reference and measurement. The time delays from the reflected reference and 
backscattered waves are detected (Bezerra et al. 2009). 
 
Figure 2-16: Optical coherence tomography catheter imaging principle (Davis et al. 2008). 
2.2.5.2 Application 
OCT has a spatial resolution of up to 10μm, much higher than IVUS. Calcium is visible 
as signal poor regions with well-delineated borders in OCT images (Tearney et al. 2012). 
The high resolution of OCT images allows superficial calcifications to be identified. 
Additionally, OCT can penetrate calcium allowing it to quantify calcification thickness, 
area and volume (Tearney et al. 2012; Mehanna et al. 2013). A drawback of OCT is the 
poor penetration depth, limited to 1-2.5mm (Tearney et al. 2012). Therefore, deep 
calcifications may be missed. Similar to IVUS, OCT is appropriate for characterising 
different types of atherosclerosis  (Yabushita et al. 2002), as well as quantifying luminal 
gain (Serruys et al. 2009) and identifying vulnerable and culprit plaques (Iannaccone et 
al. 2016). 
2.2.5.3 Procedure 
OCT images were acquired with a commercially available frequency-domain OCT 
system (Ilumien PCI Optimization System) and an OCT catheter (DragonFly Catheter, 
St. Jude Medical, St. Paul, MN, USA). In a similar manner to the IVUS acquisition, the 
catheter was advanced through the plaque sample and an automatic pullback was 
performed (18mm/s). A frame rate of 180fps acquired images with a slice thickness of 
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100μm and an in-plane resolution of 12-15μm. The maximum penetration depth of the 
OCT system is 2.5mm. 
2.2.5.4 Image Interpretation 
OCT images were analysed using QCU-CMS v4.69 software (Medis Medical Imaging 
Systems B.V., Leiden, The Netherlands). Calcium is identified on OCT images as signal 
poor regions with sharply delineated borders (Tearney et al. 2012; Wang et al. 2017). The 
borders of calcified deposits are manually delineated using the QCU-CMS software. 
2.2.6 Calcification Quantification 
Tissue components were distinguished as detailed in each image post processing or 
interpretation section. The non-calcified and calcified portions of the atherosclerotic 
tissues were quantified separately based on their radiographic density thresholds. The 
volume of tissue was calculated by multiplying the number of pixels by the known voxel 
volume. The Calcified Volume Fraction (CVF) was determined as the ratio of calcified 
tissue volume to total plaque tissue volume. The length of calcification is determined as 
the number of image slices which contain calcification multiplied by the known slice 
thickness. The calcium angle is the total angle of which contains calcification in an image 
slice, as determined from the centroid of the lumen. The calcified particle distribution 
was examined using ImageJ ‘3D Objects Counter’ plugin (Bolte and Cordelieres 2006). 
The mean and maximum radiographic attenuation density for each calcified particle is 
also recorded as part of this process. The Calcified Particle Fraction (CPF) is determined 
as the number of calcified particles divided by the total plaque tissue volume 
(particles/mm3). The Calcified Particle Index (CPI) is the total number of calcified 
particles divided by the total calcification volume (particles/mm3). The Microcalcification 
Fraction (micro-CF) represents the number of microcalcifications (≤ 65.4 X 103µm3) 
(Kelly-Arnold et al. 2013) expressed as a fraction of the total number of calcified particles 
detected. The calcification density distribution is determined from the histogram analysis. 
The fraction of calcification density is the number of pixels within a defined calcification 
density group expressed as a fraction of the total number of calcified pixels. Figure 2-17 
demonstrates the systems used to acquire the micro-CT, CT, MR, IVUS and OCT images 
as well as a representative image slice with areas of calcification identified by red arrows. 




Figure 2-17: Imaging modality systems and sample image slices with areas of calcification 
identified by red arrows: (i) micro-computed tomography, (ii) clinical computed tomography, (iii) 
magnetic resonance imaging, (iv) intravascular ultrasound and (v) optical coherence tomography. 
 Protein Quantification Immunosorbent Assay 
2.3.1 Principle 
Immunoassays are bioanalytical test methods that employ the principle of highly specific 
biological antigen-antibody binding to detect or quantify the presence of a specific target 
(analyte) in a biological sample. The analysis of such assays is conducted using label 
activity. Commonly used immunoassay methods include enzyme-linked immunosorbent 
assays (ELISAs) and chemiluminescent immunoassays, which use colorimetric and 
emitted light signal, respectively. Experimentation is typically performed in combination 
with a set of samples with known concentrations (standards) to quantify the amount of an 
unknown sample against a standard calibration curve (Kellner et al. 1998). Additionally, 
recently developed magnetic bead multiplexing technology allows for the determination 
of multiple analytes in a single immunoassay test. The use of magnetic microspheres with 
unique dye concentrations, coated with specific capture antibodies can be identified using 
fluorescent-based detection systems. Thus, the concentration of multiple analytes of 
interest can be conducted in a single assay (Lee et al. 2010). Figure 2-18 illustrates the 
three types of immunoassays used in this thesis. 




Figure 2-18: Chemiluminescent, enzyme-linked immunosorbent and magnetic bead multiplexing 
assays. 
2.3.2 Application 
Biomarkers are useful minimally invasive clinical tools for rapid, cost-effective and 
highly-repeatable means of patient diagnosis, prognosis, monitoring and management. 
Biomarkers are typically obtained from easily accessible biological fluids such as blood, 
saliva and urine (Vasan 2006). Blood-based biomarkers are a worthwhile approach for 
the subclassification of cardiovascular disease since atherosclerotic tissues are in 
immediate contact with circulating blood (Arab et al. 2006). Moreover, the active 
formation of vascular calcification presents a unique opportunity to investigate the utility 
of blood-based biomarkers of calcified atherosclerosis (Bozic et al. 2018). 
2.3.3 Procedure 
Circulating plasma levels of fetuin-A and serum levels of carboxylated and 
uncarboxylated osteocalcin (ucOC & cOC) were quantified using commercially available 
ELISA test kits (Bio-techne, R&D Systems (MN, USA) Cat. No. DFTA00, and TaKaRa 
Bio Inc. (Japan) Cat. No. MK111 and MK118, respectively). ELISAs were carried out in 
accordance with the manufacturer’s instructions and the results were read on a multi-
mode plate reader (Synergy H1, BioTek, VT, USA) (Fig2-19(i)). All ELISA samples 
were analysed in duplicate and all samples underwent 1 freeze-thaw cycle prior to fetuin-
A, cOC and ucOC quantification. Circulating plasma levels of dephospho-uncarboxylated 
Matrix Gla Protein (dp-ucMGP) levels were quantified using the inaKtif MGP iSYS kit 
analysed on the IDS-iSYS Multi-Discipline Automated System developed by Vitak 
(Maastricht University, The Netherlands) and IDS (ImmunoDiagnosticSystems, Boldon, 
Chapter 2 Methods 
 
49 
UK) (Fig.2-19(ii)). Circulating plasma levels of Interleukin (IL)-4, 6, 8, 10, 18, Tumor 
Necrosis Factor α, Osteoprotegerin, Osteopontin, Fibroblast Growth Factor-23 and Bone 
Morphogenic Protein-2 were quantified using a custom-built Human Magnetic Luminex 
Performance Assay Base Kit (Bio-techne, R&D Systems (MN, USA) Cat. No. 
LUHM000). Results were determined using the Luminex MagPix System (Fig.2-19(iii)). 
 
Figure 2-19: Immunoassay detection systems: (i) Synergy H1 plate reader, (ii) IDS-iSYS Multi-
Discipline Automated System and (iii) the Luminex Magpix System. 
 Scanning Electron Microscopy and Energy Dispersive X-Ray 
Spectroscopy 
2.4.1 Principle 
A scanning electron microscope scans the surface of samples using a focused high-energy 
beam of electrons to create a surface image. As the electrons come into contact with the 
region of interest they produce secondary electrons, backscatter electrons and 
characteristic x-rays which form the surface image of the sample (Figure 2-20). A 
scanning electron microscope can achieve magnifications up to 100,000X (Baliyan et al. 
2019). Additional use of energy-dispersive x-ray spectroscopy (EDX) can determine the 
elemental content of the regions of interest. The electron beam excites atom electrons and 
x-rays are emitted from the sample. The number and energy of the emitted x-rays are 
detected by an energy-dispersive spectrometer creating an EDX spectrum. Every element 
has a unique atomic structure and emission spectrum, allowing the exact elemental 
composition and distribution within the sample to be determined (Williams et al. 1986). 




Figure 2-20: The basic principles of surface imaging and elemental detection with high-energy 
electron beams (Baliyan et al. 2019). 
2.4.1 Application 
SEM and EDX analysis allow the surface nanoscale ultrastructure and elemental analysis 
of atherosclerotic plaques to be determined, providing simultaneous sample 
morphological and chemical information (Bilen et al. 2019). Particularly, calcified versus 
non-calcified areas can be distinguished from each other by examining the %weight and 
stoichiometric ratio of calcium to phosphorus compared with hydroxyapatite (1.67:1) 
(Herisson et al. 2011; Bilen et al. 2019). Additionally, analysis of the surface topography 
can qualitatively determine the sample surface roughness prior to nanoindentation 
experimentation, identify patterns of calcification (Herisson et al. 2011) and confirm the 
location and quality of indents (Fig.2-21). 
2.4.2 Procedure 
Biological materials must be dried and coated with a conductive material before they can 
be imaged using SEM (see section 2.1.4). Samples then are sputter-coated in gold using 
20mA for 120s (EMITECH K550, Emitech Ltd., Kent, U.K.) to ensure sufficient 
conductivity of the surface to maximise the quality of the SEM images. The scanning 
electron microscope (Hitachi SU-70 High-Technologies Europe GmbH, Krefeld 
Germany) was operated using an accelerated voltage setting of 20kV with a working 
distance of approximately 16mm. 




Figure 2-21: Hitachi SU-70 scanning electron microscope. (i) Microcalcifications within non-
calcified matrix. (ii) Berkovich indent. (iii) Calcified energy dispersive x-ray (EDX) spectrum. 
(iv) Non-calcified EDX spectrum. 
 Nanoindentation 
2.5.1  Traditional Instrumented Indentation Principle 
Nanoindentation is an experimental technique that was originally developed for 
determining the hardness and elastic modulus of traditional engineering materials such as 
thin films. Nanoindentation instruments can record microscopic load and displacement 
data with high accuracy and precision. Analytical contact models can then used to 
determine the hardness, elastic modulus and other mechanical properties of the materials. 
Figure 2-22 illustrates the basic principles of traditional engineering nanoindentation. 
 
Figure 2-22: Principle of traditional nanoindentation. (i) Indenter engagement with the sample 
surface. (ii) Indenter contact and residual indent. (iii) Nanoindentation loading profile (adapted 
from Fischer-Cripps 2011). 
 




Global mechanical properties of atherosclerotic plaques have been extensively 
investigated on the macro scale using various modes of characterisation such as uniaxial 
testing. These methods of testing neglect the highly heterogeneous nature of 
atherosclerotic lesions. Consequently, the current literature reports highly variable 
stiffness properties for atherosclerotic tissues. Nanoindentation has been recommended 
as a reliable technique to characterise the different atherosclerotic tissue constituents 
(Ebenstein et al. 2009; Chai et al. 2014) and to map the mechanical changes across 
different material phases (Constantinides et al. 2006). This method of high-resolution 
indentation testing, with accurate positioning capabilities, is an optimal approach for the 
precise mapping of small, irregular-shaped heterogeneous material (Constantinides et al. 
2006), such as calcified deposits within atherosclerotic plaques (Fig.2-23). 
 
Figure 2-23: Relationship between indentation length-scale and heterogeneous material 
characterisation (Constantinides et al. 2006). 
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2.5.2  Calcified versus Non-Calcified Tissue Nanoindentation 
Nanoindentation of mineralised biological tissues using traditional commercial 
instruments requires little modification to experimental or data analysis techniques 
(Lewis and Nyman 2008). This technique has been successfully transitioned to the 
characterisation of mineralised biological tissues such as teeth and bone (Rho et al. 1997, 
1999; Zysset et al. 1999; Cuy et al. 2002). Conversely, nanoindentation of soft hydrated 
biological tissue requires significant adjustments to the experimental protocol including 
more accurate load detection, the use of a blunt spherical tip and the maintenance of 
sample hydration throughout the test (Ebenstein and Pruitt 2004; Oyen 2010).  
2.5.3  Ferrule-Top Cantilever Indentation 
Ferrule-top cantilever indentation (FTC) utilised a cantilever-based force measuring 
method that is similar to that used in Atomic Force Microscopy (AFM) indentation but 
employs recently developed interferometric readout technology to accurately record 
extremely small loads and deflections, which is not possible using traditional 
nanoindentation instruments. Additionally, the system can operate while completely 
submerged in liquid (Chavan et al. 2012). The use of a spherical tip creates blunt contact 
between the indenter tip and the soft biological sample, maximising elastic contact and 
minimising plastic deformation (Figure 2-24(i)). Figure 2-25 illustrates the Hertzian 
contact model between a rigid spherical indenter and an elastic half-space. Cantilever 
deflection is recorded by the interferometer light phase shifts (Figure 2-24(ii)). The piezo 
displacement (dp) and cantilever bending (dc) can be used to accurately determine the 
indentation depth (h) (Figure 2-24(iii)) (Eq.6). The indentation load can then be calculated 
using the known cantilever stiffness (Eq.7) (Mattei et al. 2017). 




Figure 2-24: Ferrule-top cantilever-based indentation. (i) Sample and indenter. (ii) Cantilever 
deflection upon sample contact. (iii) Calculation of the indentation depth from piezo displacement 
and cantilever deflection. 
 
 
Figure 2-25: Schematic of the Hertzian contact model between a rigid spherical indenter and an 
elastic half-space (Fischer-Cripps 2011). 
 
ℎ = 𝑑 − 𝑑  Eq.6 
𝑃 = 𝑘𝑑  Eq.7 
 
2.5.4 Experimental Considerations for Biological Nanoindentation 
Details of the experimental considerations for both traditional calcified nanoindentation 
and FTC-based non-calcified tissue are discussed below. 
2.5.4.1 Indentation Data Analysis 
Elastic-plastic calcified indentation data can be conducted using either basic loading or 
continuous stiffness methods described by Oliver and Pharr (Oliver and Pharr 1992, 
2004). Elastic non-calcified tissue indentation data can be analysed using the Hertz model 
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(Johnson 1985), or the Johnson, Kendall, Roberts (JKR) model if sample adhesion is 
evident (Johnson et al. 1971). A data analysis workflow is presented in Figure 2-26. 
Idealised loading profiles and models fits for each case are displayed in Figure 2-27. 
 
Figure 2-26: Data analysis workflow. 
 
Figure 2-27: Idealised loading curves and model fits. (i) Oliver and Pharr basic unloading. (ii) 
Oliver and Pharr continuous stiffness measurements. (iii) The Hertz contact model. (iv) The 
Johnson, Kendall, Roberts (JKR) model. 
2.5.4.2 Sample Fixation and Hydration 
Samples undergoing calcified nanoindentation were chemically fixed and dehydrated as 
detailed in section 2.1.4. Previous works report a slight increase in stiffness with calcified 
sample dehydration (Rho et al. 1999) and chemical fixation (Bushby et al. 2004; 
Ebenstein and Pruitt 2006), while embedding in epoxy does not make a difference (Marra 
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et al. 2006). However, the samples cannot undergo sectioning or surface preparation in 
their hydrated state. 
2.5.4.3 Indentation Depths and Proximity 
2.5.4.3.1 Surface Roughness 
Berkovich indentation depths should be at least 20 times the average surface roughness 
values to reduce errors in contact area calculation (ISO 2015). The sample surface 
roughness is minimised for calcified samples by mechanical grinding and polishing 
procedures. However, the gold standard for minimising soft hydrated tissue surface 
roughness is sectioning samples using histological microtoming techniques (Ebenstein 
and Pruitt 2006; Akhtar et al. 2009). 
2.5.4.3.2 Substrate Effects 
While an indentation depths smaller than 10% of the sample thickness is valid to negate 
substrate effects for engineering materials (Fischer-Cripps 2000), soft biological 
materials should undergo even smaller indentation depths to avoid substrate interference 
(~5%) (Selby et al. 2014). 
2.5.4.3.3 Hertz Model Assumptions 
The Hertz model assumes contact between a rigid sphere and an elastic half-space 
(Johnson 1985). Additionally, the model requires the use of a parabolic tip. Therefore, 
the maximum indentation depth for a spherical-tipped cantilever is 16% of the spherical 
radius (Lin et al. 2009). 
2.5.4.4 Tip Selection 
The Oliver and Pharr model is based on elastic-plastic deformation. Therefore, sharp tips, 
such as a Berkovich tip, are used to induce plastic deformation even at shallow depths. 
However, this tip is not suitable for soft materials as damage can occur prior to 
registration of indentation loads. Moreover, surface detection can be a challenge for soft 
hydrated materials to identify the correct point of contact. Therefore, flat punches or 
relatively blunt indenter tips (such as spherical) are used in soft tissue analysis (Oyen 
2010). These tips prevent plastic deformation from occurring to remain predominantly in 
elastic contact. Additionally, the Hertz model assumes contact between a spherical tip 
and a flat elastic half-space (Johnson 1985).   
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2.5.4.5 Viscoelastic Behaviour 
Insufficient hold times can result in an over-estimation of the elastic modulus calculated 
with the Oliver and Pharr model based on unloading contact stiffness (Hardiman et al. 
2016). Figure 2-28 displays the ‘nose’ effect with insufficient hold periods for biological 
materials (Ebenstein and Pruitt 2006). As creep times for calcification have been recorded 
as high as 20min (Lee et al. 1992), and a holding time greater than 15s is recommended 
for bone tissue (Wu et al. 2011), a creep investigation was carried out to determine an 
effective hold period to employ for basic loading on a calcified sample. Three indents 
were plotted in a single femoral sample with a hold time of 16min (960s). Fig. 2-29 
displays a representative graph of results for additional indentation depth (nm) versus 
hold time and corresponding creep rate (nm/s) versus hold time. The additional 
displacement saturates and the creep rate drastically slows after approximately 200 
seconds. It wa deemed that the crucial effects of viscoelastic deformation have diminished 
after this hold period. Therefore, a hold time of 240s was selected as an appropriate hold 
time. Viscoelastic behaviour is not considered for non-calcified sample indentation as the 
loading curve (as opposed to the unloading curve) is use for analysis. 
 
Figure 2-28: (i) Nose present due to viscoelastic effects of biological tissues with no hold period 
at the maximum load. (ii) A hold period at maximum load prior to unloading reduces the 
viscoelastic errors (adapted from (Ebenstein and Pruitt 2006)). 
 




Figure 2-29: Representative results for additional displacement into sample surface (nm) with 
respect to hold time (s) at max load (mN) and corresponding creep rate (nm/s) vs hold time (s). 
2.5.4.6 Continuous Stiffness Measurements 
An alternative to the basic unloading profile with an extended hold period is the use of 
continuous stiffness measurements. In this method, a small dynamic oscillation is 
continuously applied during the loading phase of the indentation cycle to obtain 
continuous stiffness readings. This procedure is advantageous to the basic unloading 
analysis as the results do not rely on a single unloading curve and elastic modulus is 
presented as a function of depth (Oliver and Pharr 1992, 2004; Li and Bhushan 2002). If 
the elastic modulus (E) obtained is relatively constant over the depth of the indent this 
indicates that there has been no transition through different biological material phases. 
Figure 2-30 illustrates an example of a useful elastic modulus measurement (blue) and a 
measurement to be discarded due to severe fluctuations observed in elastic modulus 
results (orange). 
 
Figure 2-30: Continuous stiffness measurement displaying constant elastic modulus indicating a 
single material phase (blue) and a fluctuating elastic modulus as a function of indentation depth 
(orange), indicating changing on tissue constituent. The red dots indicate the elastic modulus 
values averaged between the 200 and 1800nm indentation depths. 
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2.5.5 Traditional Instrumented Indentation Procedure 
The chemically fixed and dehydrated plaque samples were embedded without vacuum in 
‘EpoxiCure,’ (Buehler, Illinois Tool Works Inc, Illinois), at room temperature in 
cylindrical moulds. Once cured, the cylinders were sectioned at the point of internal 
calcification using a low-speed diamond saw (IsoMet® Low-Speed Saw, Buehler) 
running at 200 rpm with continuous water irrigation. The sample surfaces were then 
polished using an automated polisher (Phoenix 4000, Buehler) running at 150 rpm first 
using progressive grades of silicon carbide grinding paper (600, 800, 1200 µgrit) followed 
by polishing with 1µm and 0.05µm alumina powder suspensions. Between each step, the 
surface debris was removed using ultrasonic cleaning in water for 10s. Following surface 
preparation, the exposed sample surfaces were imaged on a light microscope (Zeiss Axio 
Imager.A1) and a corresponding micro-CT image slice was manually selected.  
All calcified tissue nanoindentation measurements were obtained at room temperature 
using the G200 Nano Indenter (Keysight Technologies) (Fig.2-31(i)), fitted with a 
Berkovich tip. The tip shape function was assessed by carrying out indentations on a 
reference fused silica sample and comparing the results to the manufacturers’ 
specifications. The corresponding micro-CT image slice was used as a visual guide and 
positions were selected within calcified locations with a radiographic density. Indent 
locations were then manually positioned on the calcified sample surface imaged using the 
light microscope coupled with the G200 system. Indents were programmed to a depth of 
2µm using an indentation strain rate of 0.05s-1. A constant oscillating displacement 
amplitude of 2nm at a frequency of 45Hz is performed to obtain continuous measurements 
of contact stiffness, and thus Elastic Modulus (Continuous Stiffness Measurements). The 
Elastic Modulus for each sample was determined as the averaged result between the 
200nm and 1800nm depths. A spacing of at least 75µm was kept between indents to avoid 
any neighbouring plastic deformation interference. 
2.5.6 Ferrule-Top Cantilever Indentation Procedure  
Whole plaque samples were defrosted to room temperature and regions of interest are 
dissected to fit within the cryomoulds. Samples were then frozen in Optimal Cutting 
Temperature (OCT) medium using supercooled methyl-2-butane submerged in liquid 
nitrogen. Frozen samples were stored at -80°C, pending cryosectioning. Tissues were then 
sectioned to 100µm thickness for scanning electron microscopy and FTC measurements. 
Adjacent 15µm thick tissue sections were mounted on separate microscope slides and 
taken for histological analysis. Defrosted 15µm thick tissue sections were rinsed in PBS 
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followed by fixing in 4% paraformaldehyde solution. Sections were then stained with 
Alizarin Red followed by dehydration with alcohol and protection using mounting 
medium and a coverslip. The tissue sections were then imaged using an Olympus CKX53 
Inverted Microscope with a Canon DS126621 camera to analyse the tissue structure and 
identify any areas of calcification, and thus the non-calcified tissue. Tissue slices for FTC-
nanoindentation were defrosted and dried in the open air for approximately 30mins to 
maximise sample adhesion to the slide. After the first 10mins, the tissue was surrounded 
with a hydrophobic sealant barrier and this was left to cure for the remaining 20mins. The 
fluid-cell formed was then filled with PBS and the sample was rehydrated for a further 
10mins before commencing the indentation experiments.   
All non-calcified tissue FTC-nanoindentation measurements were obtained at room 
temperature using a Chiaro nanoindenter (Optics11, the Netherlands) (Fig.2-31(ii)) fitted 
with a spherical 20.5µm radius glass cantilever tip with a spring constant of 0.021N/m. 
Prior to the testing of the samples, the cantilever was calibrated against a thick glass slide 
submerged in PBS. The sample slides were mounted onto the inverted microscope (Zeiss 
LSM 710 Confocal Microscope) so the sample may be visualised using the brightfield 
image setting during experimentation. The stained adjacent tissue section acts as a visual 
guide to avoid any areas of calcification and to select appropriate non-calcified locations 
for indentation. Any areas of tissue folds or tears in the tissue were also avoided. Spacing 
of at least 10µm was kept between indents, the maximum indentation depth was 6µm and 
the loading velocity was 1µm/s. Between 30 and 45 indents were programmed per 
sample. Data were recorded during the loading, 1s holding and unloading phases of the 
testing. The Elastic Modulus (E) of the tissues were calculated from these readings using 
the Optics11 Piuma DataViewer v2 software by fitting the Hertz contact model to 50% 
of the indentation loading curve. All sample indentation experiments were completed 
within 3 hours of the initial defrosting. 




Figure 2-31: Commercially available nanoindenters. (i) Keysight G200 Nanoindenter and (ii) 
Optics11 Life Chiaro nanoindentation set-up with an inverted Zeiss LSM 710 Confocal 
Microscope. 
2.5.7  Theory and Data Analysis 
2.5.7.1 Oliver and Pharr 
The sample modulus (Es) can be related to the reduced modulus (Er), provided that the 
indenter modulus (Ei) and Poisson’s ratios of the sample and indenter (ʋs and ʋi, 









The Oliver and Pharr method of obtaining Elastic modulus (E) values from stiffness data 
is widely described (Oliver and Pharr 1992). The contact depth as measured from the total 
depth of indentation is given by, whereby ε is the shape factor of the indenter:  












The contact stiffness (S = dP/dh) is obtained by evaluating the slope of curve fit at the 











For a diamond indenter, Ei = 1141GPa and υi = 0.07. The cited Poisson’s ratio for cortical 
bone range between 0.2 and 0.5 with an average of 0.3 (Reilly et al. 1974; Wirtz et al. 
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2000). Additionally, the Poisson’s ratio for mineral hydroxyapatite has been measured at 
0.3 (Grenoble et al. 1972). Therefore, a Poisson’s ratio value of 0.3 was deemed 
appropriate for the calcified tissue in this study. 
2.5.7.2 Hertzian Contact 
Hertz (Johnson 1985) determined that the radius of the circle of contact (a) could be 









The curvature of the contacting bodies is expressed in terms of their relative radii. For 











The displacement of the surface for a rigid spherical indenter as a function of the distance 












, 𝑟 ≤ 𝑎 
Eq.14 
The distance from the specimen free surface to the depth of the radius of the circle of 
contact at max load, P is: 





Combing the two equations gives the distance of mutual approach of the indenter and the 









Substituting the deflection h (Eq.16) into the relationship between the radius of circle of 
contact, indenter load and indenter radius (Eq.12), the distance of mutual approach can 
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In the case of soft materials, the indenter modulus is assumed to be much stiffer than the 
sample modulus (Ei ≫ Es). Therefore, the effective elastic modulus for soft biological 
materials is described below:  
𝐸 = 𝐸 (1 − ν ) Eq.18 








The Poisson’s ratio for soft hydrated biological tissues is often assumed to be 0.5 
(incompressible) due to the high water content. However, healthy and atherosclerotic 
coronary arteries were found to be almost incompressible (ν ~ 0.49) regardless of strain 
rate (Karimi et al. 2016). Therefore, a Poisson’s ratio of 0.49 was selected for this study. 
Table 2-4 presents a summary of the experimental and analysis difference in traditional 
instrumented indentation of calcified tissue and soft biological indentation of non-
calcified tissue. 
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Table 2-4: Summary of the experimental and analytical differences between traditional 
instrumented nanoindentation and FTC-based indentation. 
  Experimentation 




dehydration and epoxy 
embedding. 
Freezing in OCT medium and 
storage at -80°C 
Surface 
Preparation 
Low speed saw sectioning 
followed by mechanical 
grinding and polishing 
Cryostat sectioning,  
100µm thick sections 
Component 
Identification 












Indenter Tip Diamond Berkovich Glass Spherical 
Temperature Room Room 
Hydration Status Dehydrated Hydrated in PBS 




Piezo displacement-controlled  
Loading Profile Continuous Stiffness Trapezoidal 
Loading Condition 0.05/s 1µm/s 




Hertzian Contact Model  
Reported Values 
Elastic Modulus (as a 







Piuma DataViewer Software 
V2 
 




This chapter presents a thorough description of the sample acquisition, storage and 
preservation protocols. Additionally, it details the imaging, biological, structural and 
mechanical analysis techniques employed in the characterisation of atherosclerotic tissue. 
Each section details the experimental parameters with justifications (if appropriate) and 
will be summarised in the methods section of the following chapters. 
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The Agatston coronary calcium score is the current gold standard of arterial calcium 
quantification. However, Agatston scores cannot identify vulnerable lesions. The 
following chapter presents a study that compares measures of calcification volume and 
particles within ex vivo carotid and lower extremity atherosclerotic plaques with 
approximations for their Agatston calcium scores. The published version of this study is 
presented in Appendix B of this thesis. 
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Background: The Agatston Calcium Score is a predictor of major adverse cardiovascular 
events but it is unable to identify high-risk lesions. Recent research suggests that 
examining calcification phenotype could be more indicative of plaque stability.  
Objectives: To examine the Agatston score’s ability to determine atherosclerotic 
calcification phenotype.  
Methods: Micro-Computed Tomography was performed on 20 ex vivo carotid and 20 ex 
vivo peripheral lower limb lesions. ImageJ histogram analysis quantified the non-calcified 
(30 - 129HU) and calcified (≥ 130HU) tissue volumes. ImageJ ‘3D Objects Counter’ 
plugin determined the calcified particle count, volumes and maximum x-ray attenuation 
density of each particle. Image stacks were subsequently downsampled to a resolution of 
0.7 X 0.7 X 3mm and approximations for the extracoronary calcium scores (ECCS) were 
calculated. Spearman’s correlation examined the relationships between ECCS 
approximations and calcification parameters.  
Results: ECCS approximations have extremely strong positive correlations with 
calcification volume (rs = 0.991, p < 0.0005) and the Calcified Volume Fraction (CVF) 
(rs = 0.865, p < 0.0005), weaker correlations with calcified particle count (rs = 0.676, p < 
0.0005), Calcified Particle Fraction (rs = 0.422, p = 0.007) and the Microcalcification 
Fraction (rs = 0.361, p = 0.022). There is no correlation evident between ECCS and 
Calcified Particle Index (CPI) (rs = -0.162, p = 0.318). It is apparent that there is a high 
prevalence of microcalcifications in both carotid and lower extremity lesions. 
Additionally, larger calcified particles have higher maximum x-ray attenuation densities 
at both micro-CT and clinical CT resolutions.   
Conclusion: The density-weighted Agatston calcium scoring methodology needs to be 
reviewed. Calcium scoring which differentiates between critical calcification 
morphologies, rather than presenting a density-weighted score, is required to direct high-
risk plaques towards tailored treatment. 
  




3 Comparative Analysis of Calcification Parameters with 
Agatston Score Approximations for ex vivo Atherosclerotic 
Lesions 
3.1 Introduction 
The Coronary Calcium Score (CCS) is computed using the Agatston scoring 
methodology (Agatston et al. 1990) and is a powerful predictor of adverse cardiovascular 
events (Hecht et al. 2017). This coronary scoring methodology is now considered the gold 
standard of extracoronary calcification quantification by some researchers (Denzel et al. 
2004). Despite the wide use and prognostic value of the Agatston calcium score it was 
originally developed without histopathological evidence or otherwise to guide its 
arbitrarily weighted cofactor methodology, assuming a worse prognosis for higher 
density calcification. Consequently, it is now understood that the Agatston score can only 
identify high-risk patients and not the high-risk lesions (Mauriello et al. 2013) that should 
be targeted for treatment, limiting our ability to intervene appropriately. 
Since the development of the CCS, the role of calcification in atherosclerotic plaque 
stability has been extensively investigated. It is widely accepted that microcalcifications 
can negatively impact the biomechanical stability of plaques (Hutcheson et al. 2014), 
promoting rupture at the fibrous cap (Kelly-Arnold et al. 2013). Spotty calcifications have 
also been identified as a feature of vulnerable lesions (Ehara et al. 2004; Motoyama et al. 
2007). Moreover, recent work suggests a protective role of heavier weighted, high-density 
calcification (Criqui et al. 2014). These studies complement previous findings that 
symptomatic coronary and carotid lesions contain lower amounts of calcification than 
asymptomatic ones (Miralles et al. 2006; Mauriello et al. 2013) and that higher carotid 
Agatston calcium scores are associated with a lower likelihood of cerebrovascular 
symptoms (Yoon et al. 2018). Collectively, these investigations indicate that calcification 
morphology, specifically calcified particle distribution, could be essential in high-risk 
lesion identification.  
Micro-Computed Tomography (micro-CT) is an ex vivo technique, with significantly 
higher resolution capabilities than clinical CT (Lin and Alessio 2009). Micro-CT can 
accurately quantify calcification volume and density (Higgins et al. 2005) and identifying 
microcalcifications within atherosclerotic tissues (Kelly-Arnold et al. 2013). It is not clear 
whether calcification volume or calcified particle information correlates with Agatston 




calcium scores, or how calcified particle volume is associated with maximum 
radiographic x-ray attenuation. Therefore, the objective of this study was to analyse the 
volume, distribution and maximum attenuation density (Hounsfield Unit (HU)) of 
calcified particles within ex vivo atherosclerotic lesions using micro-CT and correlate 
these findings to extracoronary calcium score (ECCS) approximations for each sample. 
3.2  Materials and Methods 
3.2.1 Patient Examination 
Thirty-nine patients were enrolled in this study in a manner that conformed to the 
Declaration of Helsinki and was approved by the hospital’s Ethical Research Committee. 
Nineteen patients underwent carotid endarterectomies, nineteen patients underwent 
peripheral lower limb endarterectomies and one patient underwent both. Preoperative 
patient assessment included demographics, comorbid conditions and preoperative 
medication data. Patient characteristics are presented in Table 3-1. 
3.2.2 Atherosclerotic Sample Acquisition 
Plaque specimens (twenty carotid and twenty peripheral lower limb) were acquired from 
thirty-nine different patients undergoing consecutive standard endarterectomies 
performed at the University Hospital Limerick. Immediately after surgical removal, all 
plaques were frozen in phosphate buffer solution and stored at -20˚C until time of use. 
3.2.2.1 Chemical Fixation 
To prepare the tissue for micro-CT analysis, all plaques underwent a tissue preservation 
process to minimise any tissue damage or shrinkage under the intense voltage source, as 
previously described (Mulvihill et al. 2013). 
  




Table 3-1: Patient characteristics. 
Patient Characteristics 
Entire 
Cohort      
(n=39) 





Demographics    
Age, years (mean ± SD) 69 ± 8 71 ± 8 66 ± 7 
Sex, Male, n (%) 30 (77) 13 (68) 16 (84) 
Comorbidities    
Systolic Blood Pressure (mmHg)  
(mean ± SD) 
145 ±  20 150 ± 19 139 ±  21 
Body Mass Index (kg/m2)  
(mean ± SD) 
26 ±  5 26 ±  5 27 ±  5 
Obesity, n (%) 9 (23) 4 (21) 5 (26) 
Diabetes Mellitus, n (%) 9 (23) 1 (5) 8 (42) 
Chronic Kidney Disease, n (%) 1 (3) 0 (0) 1 (5) 
Ischemic Heart Disease, n (%) 16 (41) 7 (37) 9 (47) 
Dyslipidemia, n (%) 29 (74) 13 (68) 16 (84) 
Hypertension, n (%) 32 (82) 17 (89) 14 (74) 
Atrial Fibrillation, n (%) 8 (21) 4 (21) 4(21) 
Chronic Obstructive Pulmonary Disease,  
n (%) 
7 (18) 2 (11) 4 (21) 
Peripheral Artery Disease, n (%) 39 (100) 19 (100) 19 (100) 
Osteoporosis, n (%) 3 (8) 2 (11) 1 (5) 
Increased C2H5OH Levels, n (%) 5 (13) 3 (16) 2 (11) 
Previous Myocardial Infarction, n (%) 8 (21) 4 (21) 4 (21) 
Previous Cerebrovascular Event, n (%) 4 (10) 4 (21) 0 (0) 
Smoker (current or ex), n (%) 37 (95) 18 (95) 18 (95) 
Medication    
Ace Inhibitor, n (%) 13 (33) 5 (26) 7 (37) 
Angiotensin 2 Block, n (%) 6 (15) 4 (21) 2 (11) 
Anticoagulant Therapy, n (%) 11 (28) 4 (21) 7 (37) 
Antiplatelet, n (%) 10 (26) 2 (11) 7 (37) 
Aspirin, n (%) 29 (74) 15 (79) 13 (68) 
B Blocker, n (%) 22 (56) 11 (58) 10 (53) 
Calcium Antagonist, n (%) 11 (28) 6 (32) 4 (21) 
Insulin, n (%) 3 (8) 0 (0) 3 (16) 
Nitrates, n (%) 1 (3) 1 (5) 0 (0) 
Oral Hypoglycaemic, n (%) 7 (18) 1 (5) 6 (32) 
Statin, n (%) 32 (82) 15 (79) 16 (84) 
SD = standard deviation    
 
  




3.2.3 Micro Computed-Tomography 
3.2.3.1 Image Acquisition 
Micro-CT was utilised to analyse the internal structure of all plaque samples (Xradia versa 
XRM 500 Carl Zeiss X-ray Microscopy Inc.). The scanning was performed with a 0.4x 
optical magnification and 2.5s x-ray exposure time. The x-ray source was operated at 
50kV and 81μA and all tomographic slices were obtained with an isotropic spatial 
resolution of 15.68μm. Three-dimensional reconstructions were generated using Xra-
diaXRM reconstructor (version 7.0.2817). The pixel values were rescaled as described 
(Barrett et al. 2015). 
3.2.3.2 Image Post-Processing 
Image analysis was conducted using ImageJ image processing software (ImageJ release 
1.52a) (Schindelin et al. 2012). The image files were first manually processed to remove 
any background image artefacts ≥130HU that could be inadvertently included in the 
calcified particle analysis or produce errors in the ECCS approximations. Artefacts were 
removed by replacing the pixel attenuation density ≥130HU with a background density 
of 0HU (Fig.3-1(i)-(ii)). 
3.2.3.2.1 Calcification Parameters 
The non-calcified and calcified portions of the atherosclerotic tissues were quantified 
separately based on their radiographic density thresholds: (30 - 129HU and ≥130HU, 
respectively) using custom histogram macros in ImageJ (Schindelin et al. 2012). The 
Calcified Volume Fraction (CVF) for each sample was determined as the ratio of calcified 
tissue volume to total plaque tissue volume. The calcified particle distribution of each 
sample was examined using ImageJ ‘3D Objects Counter’ plugin (Bolte and Cordelieres 
2006) with a calcified particle threshold of 130HU (Agatston et al. 1990) (Fig.3-1(iii)-
(iv)). The volume of each particle was calculated by multiplying the number of volume 
pixels by the known voxel volume (3.86 X 10-6 mm3). The maximum radiographic 
attenuation density for each calcified particle was also recorded as part of this process 
(Fig.3-1(v)). The Calcified Particle Fraction (CPF) for each sample is determined as the 
number of calcified particles divided by the total plaque tissue volume (particles/mm3). 
The Calcified Particle Index (CPI) is the total number of calcified particles divided by the 
total calcification volume (particles/mm3). The Microcalcification Fraction (micro-CF) 
represents the number of microcalcified particles (≤ 65.4 X 103µm3 (Kelly-Arnold et al. 
2013)) expressed as a fraction of the total number of calcified particles detected. 




3.2.3.2.2 Extracoronary Calcium Score Approximations 
The spatial resolution of the processed image files was downsampled from 15.68µm to 
705.6µm in the x- and y-planes, and from 15.68µm to 2994.88µm in the z-direction. The 
resulting image stacks approximate the spatial resolution that is defined for computing a 
clinical coronary Agatston Score (0.7 X 0.7 X 3mm) (Agatston et al. 1990) (Fig.3-1(vi)). 
Custom macros recorded the maximum attenuation density and area of calcification 
(≥130HU) in each image slice and the ECCS approximations were then calculated as 
described (Agatston et al. 1990) (Fig.3-1(vii)). A complete image processing workflow 
is presented in Figure 3-1. 
3.2.4 Coronary Calcium Score Acquisition 
Coronary CT scanning was also performed on thirty-seven of the patients prior to, or 
following, endarterectomy procedures using a Siemens Somotom Sensation 64, Erlangen, 
Germany. The scanning parameters were 200mm field of view, 3mm slice thickness, 
acquisition 24 x 1.2mm and reconstruction increment of 1.5mm. The x-ray source was 
operated at 120kV and all tomographic slices were obtained with a rotation time of 0.33s 
and pitch of 0.2. CCS were acquired using Syngo Calcium Scoring software (Siemens 
AG, Erlangen, Germany) by an experienced radiologist. 
3.2.5 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics version 22. Descriptive 
statistics summarising patient characteristics using mean ± SD or number (percentage) as 
appropriate are presented in Table 3-1. Shapiro–Wilk and histogram shape analysis were 
performed to assess the distribution of continuous data. All variables were determined to 
be not normally distributed. Therefore, Mann-Whitney U analysis was employed to 
compare calcification parameters, ECCS and CCS results between the carotid and 
peripheral lower limb patient groups. Spearman’s correlation was used to assess the 
relationships between ECCS approximations and calcification parameters. All continuous 
data results are presented using the median with 25th to 75th percentiles in square 
brackets. Statistical significance was defined as p < 0.05 in this study and all p-values 
presented are for two-tailed tests throughout. 
 





Figure 3-1: Complete image processing workflow. (i) Original Micro-CT image files 
(background artefacts circled in white). (ii) Replacing background artefacts ≥130 Hounsfield 
Units (HU) with 0HU. (iii) Histogram analysis of pixel density (Non-calcified tissue: ≥30HU, 
<130HU, calcified tissue: ≥130HU). (iv) Plaque models displaying non-calcified tissue (red) and 
calcified tissue (green). (v) ImageJ ‘3D Objects Counter’ plugin used to analyse the calcified 
particles (≥130HU). (vi) Calcified particle count, volume and maximum radiographic attenuation 
density recorded. (vii) Image downsampling and creation of new stack representative of the in 
vivo Agatston scoring resolution (0.7 X 0.7 X 3mm) (viii) Calculation of ECCS approximation. 
3.3 Results 
3.3.1 Calcification Parameters 
Table 3-2 presents the calcification parameter results. Lower extremity lesions have 
significantly larger calcification volumes (398.03 [233.33 - 625.88] mm3 versus 58.27 
[16.47 - 100.11] mm3, p < 0.0005), CVF (0.48 [0.29 – 0.54] versus 0.17 [0.07 – 0.30], p 
< 0.0005), calcified particle counts (5,608 [938 - 23642.50] versus 831 [322.50 - 2722], 
p = 0.007) and micro-CF (0.76 [0.40 – 0.89] vs 0.46 [0.39 – 0.70], p = 0.043) than carotid 
lesions. There are no statistically significant differences between the CPF (3.47 [1.03 – 




8.24] vs 7.53 [1.67 – 13.08], p = 0.242) or CPI (28.37 [11.20 – 54.91] vs 17.50 [4.97 – 
28.49], p = 0.174) of carotid versus lower extremity lesions. Figure 3-2 displays the 
frequency of calcified particles versus the maximum x-ray attenuation density with 
respect to calcified particle volume for (i) micro-CT and (ii) MDCT resolution. In both 
image resolution analysis there is an inverse relationship between the frequency of 
calcified particles and their maximum x-ray attenuation with respect to their volume. 
There is a high prevalence of microcalcifications evident with the micro-CT analysis that 
are underestimated at clinical MDCT resolution. There are 300,099 calcified particles 
identified at micro-CT resolution, while only 116 are detected at Agatston resolution. 
 
Table 3-2: Calcification parameter results presented as median values with 25th to 75th percentiles 
in square brackets with p-values obtained from Mann-Whitney U tests. 
Calcification Measurements 
Carotid           
(n=20) 




Total Calcification Volume (mm3) 
58.27              
[16.47 - 100.11] 
    398.03       
[233.33 - 625.88] 
< 0.005 
Calcified Volume Fraction 
0.17 
[0.07 – 0.30] 
0.48 
[0.29 - 0.54] 
< 0.005 
Total Calcified Particle Count 
831                 
[322.50 - 2722] 
5,608                  
[938 - 23642.50] 
0.007 
Calcified Particle Fraction 
(particles/mm3) 
3.47 
[1.03 – 8.24] 
7.53 
[1.67 – 13.08] 
0.242 
Calcified Particle Index 
(particles/mm3) 
 
28.37                
[11.20 – 54.91] 
17.50                      




0.46                  
[0.39 - 0.70] 
0.76                   
[0.40 - 0.89] 
0.043 
 





Figure 3-2: Calcified particle frequency versus maximum x-ray attenuation density with respect 
to calcified particle volume (image resolution voxels) for (i) micro-CT and (ii) MDCT image 
series. Bars represent mean values with error bars extending to one standard deviation. 
3.3.2 Correlating Extracoronary Calcification Score Approximations 
with Calcification Parameters 
Figure 3-3 presents scatterplots of the ECCS approximations versus (i) the calcification 
volume, (ii) the Calcified Volume Fraction (CVF), (iii) the calcified particle count, (iv) 
the Calcified Particle Fraction (CPF), (v) the Calcified Particle Index (CPI) and (vi) the 
micro-Calcification Fraction (micro-CF). There is a very strong correlation between the 
ECCS approximations and the total volume of calcification (rs = 0.986, p < 0.0005). This 
significance extends to both carotid and peripheral lower limb specific correlations, rs = 
0.980, p < 0.0005 and rs = 0.982, p < 0.0005.  There is also very strong positive correlation 
between the ECCS approximations and CVF (rs = 0.865, p < 0.0005). Similarly, this 
significance extends to carotid (rs = 0.949, p < 0.0005) but not peripheral lower limb data 
(rs = 0.421, p = 0.06). There is a weaker correlation between the ECCS approximations 
and the total calcified particle count (rs = 0.696, p < 0.0005). There is poor correlation 
between ECCS approximations and total calcified particle count in carotid lesions (rs = 
0.328, p = 0.158) but a moderate/strong correlation was found for peripheral lower limb 
lesions (rs = 0.713, p < 0.0005). However, there are weak positive correlations between 
ECCS approximations and CPF (rs = 0.422, p = 0.007) and micro-CF (rs = 0.361, p = 
0.022). There is no correlation between ECCS and CPI (rs = -0.162, p = 0.318). There are 
also no correlations between either carotid or peripheral lower limb-specific ECCS and 
CPF, CPI or micro-CF. 





Figure 3-3: Extracoronary Calcium Score (ECCS) approximations versus (i) calcification 
volume, (ii) calcified volume fraction, (iii) calcified particle count, (iv) calcified particle fraction, 
(v) calcified particle index and (vi) the microcalcification fraction for carotid and peripheral lower 
limb samples. 
3.3.3 Coronary and Extracoronary Calcium Scores 
Table 3-3 presents the CCS and ECCS approximation calcium scoring results. CCS 
acquired for peripheral lower limb patients (n=19) are higher (1820 [526 – 2529]) than 
CCS acquired for carotid patients (n=17) (803 [398 – 1616]) but the difference was not 
statistically significant (p = 0.061). ECCS approximations for peripheral lower limb 




lesions (n=20) (666 [400 – 1098]) are significantly higher than approximations for carotid 
lesions (n=20) (72 [5 – 155]), p < 0.0005. 
Table 3-3: Calcium scoring results presented as median values with 25th to 75th percentiles in 
square brackets with p-values from Mann-Whitney U tests. 




Coronary Calcium Score 803 [398 – 1616]a 1820 [526 – 2529]b 0.061 
Extracoronary Calcium 
Score Approximation 
72 [5 – 155]c 666 [400 – 1098]c < 0.0005 
p-value < 0.0005 0.022   
an=17    
bn=19    
cn=20    
 
3.4  Discussion 
The CCS was devised as a predictor of major adverse cardiovascular events (Hecht et al. 
2017) but is unable to diagnose unstable plaques (Mauriello et al. 2013). It is now 
understood that microcalcifications destabilise plaques (Maldonado et al. 2012; Kelly-
Arnold et al. 2013) and spotty calcifications are often present in culprit lesions (Ehara et 
al. 2004; Motoyama et al. 2007). Therefore, the purpose of this study was to correlate 
ECCS approximations with defined calcification parameters to assess the Agatston 
score’s ability to determine atherosclerotic calcification phenotype. We demonstrate the 
strong positive correlation between ECCS and calcification volume and volume fractions, 
but expose the moderate, weak or non-existent correlations with calcified particle count, 
CPF, CPI and micro-CF. Moreover, we examined the relationship between calcified 
particle volume and maximum attenuation density and determined that larger calcified 
particles have higher maximum densities at both high and low CT resolutions. 
Furthermore, there is significant particle underestimation at MDCT resolution. 
The Agatston score is commonly used to quantify extracoronary calcification (Denzel et 
al. 2004). However, data comparing Agatston scores in different arterial beds are scarce 
and the need for revising recommendations has been highlighted (Allison et al. 2012). 
Carotid calcium scoring could be critical in the prediction of cerebrovascular events. Yet, 
research examining Agatston calcium scores in carotid arteries discovered double 
symptomatic peaks (Katano et al. 2015) or inverse relationships (Miralles et al. 2006; 




Yoon et al. 2018). This should not be unexpected as the Agatston method was not 
designed for extracoronary sites (Blaha et al. 2017). In this manner, we found no 
correlation between carotid ECCS and CPF, CPI or micro-CF for ex vivo carotid and 
peripheral lower limb samples.  
We determined that peripheral lower limb lesions have an overall larger volumes and 
fraction of calcified tissue and higher micro-CF than carotid lesions. Our ECCS are also 
higher for peripheral lower limb samples than carotids. This complements previous work 
which shows that femoral lesions have a higher calcium content than carotid lesions 
(Herisson et al. 2011). Additionally, calcification is typically confined to the carotid 
bifurcation (Paprottka et al. 2017), whereas it can occur throughout lesions in the lower 
extremities (Diehm et al. 2006).  
On average, coronary samples analysed at 6.7µm contain 4,199 ± 3,007 calcified particles 
(Maldonado et al. 2012), which is more than our carotid samples (3,056 ± 5,404) and less 
than our peripheral lower limb samples (11,949 ± 13,939). We examined extracoronary 
lesions at a micro-CT resolution of 15.68µm, which may result in more partial volume 
effects and subsequently detect less calcified particles than 6.7µm resolution. The results 
presented for coronary calcified particles is also skewed to the right (Maldonado et al. 
2012), indicating a high prevalence of microcalcifications in all three anatomical 
locations. However, another study utilising 2.1µm micro-CT resolution found almost 
35,000 microcalcifications in coronary fibrous caps. Future studies should endeavour to 
use close to 2µm micro-CT resolution to avoid underestimation of the number of 
microcalcifications present (Kelly-Arnold et al. 2013). As far as the authors are aware, 
no previous works have compared the calcified particle distribution of coronary, carotid 
and peripheral lower limb lesions. 
The Agatston score is currently weighted upward for increasing density, assuming a 
worse prognosis (Agatston et al. 1990). Our results indicate that larger calcified particles 
have higher maximum attenuation density. Therefore these larger, more dense calcified 
particles could be considered a more stable calcification phenotype (Criqui et al. 2014; 
Yoon et al. 2018). This is additional evidence arguing against the upward weighted-
cofactor scoring approach. It has been shown that CT underestimates calcified plaque 
density (Arnold et al. 2010) and microcalcifications may present as ‘low density’ 
calcification, attributed to partial volume effects (Cahalane et al. 2018). The steep incline 
of maximum attenuation density from 23 voxels to 212 micro-CT voxels could be 




indicative of diminishing partial volume effects for microcalcifications. However, more 
work is warranted in this regard. 
Our study demonstrates that the Agatston score correlates extremely well with 
calcification volume and CVF but not with calcified particle count, CPF, CPI or micro-
CF. These results complement previous verdicts that larger particles (high-density, low 
risk) take precedence in the Agatston methodology and that microcalcifications (low-
density, high risk) are not considered (Motoyama et al. 2007). Recent works also found 
high degrees of correlation between Agatston calcium scores, mass of calcium 
hydroxyapatite (Denzel et al. 2004) and volume scores (Criqui et al. 2014). However, it 
is known that absolute calcification volume is not a good measure of plaque vulnerability 
(Nandalur et al. 2007). 
3.4.1 Limitations 
There are some inherent limitations associated with this study. Firstly, the sample cohort 
did not include coronary endarterectomy specimens for comparison. However, coronary 
plaques are not typically removed via endarterectomy and are therefore inaccessible, so 
CCS was included as a substitute measure. The workspace of the micro-CT is fixed 
according to image resolution; as a result, some of the larger specimen’s edges may have 
extended beyond the defined workspace. Background image artefacts were manually 
removed by replacing the pixel values with 0HU. Consequently, some particles may have 
been missed. However, any errors which may have ensued are deemed negligible with 
respect to the overall calcified particle count. We used a threshold of 30HU-129HU to 
identify non-calcified tissue and ≥130HU to identify calcification; although these values 
are well documented, they are arbitrary. ECCS approximations were acquired via 
downsampling of the high-resolution images to construct in vivo mimics. In this process 
higher attenuation tissues may have been averaged with background attenuation (0HU), 
this would not be the case in vivo. Additionally, large clinical studies are required to 
confirm whether calcified particle information is an improved method of identifying high-
risk plaques (Andrews et al. 2018). If proven, our study validates the necessity for a novel 
calcium scoring system capable of identifying high-risk calcification phenotype and thus 
plaque stability. 
Despite the aforementioned limitations, this high-resolution ex vivo investigation 
proposes an explanation towards the ineffectiveness of the Agatston calcium score at 
identifying individual high-risk plaques: it does not correlate with calcified particle 




measurements. Further work is warranted concerning the role of calcification 
morphology, and its location, in plaque rupture (Hutcheson et al. 2014). Calcium scoring, 
which describes the calcification morphology related to plaque vulnerability (Ehara et al. 
2004), rather than a weighted score (Blaha et al. 2017), could improve our prediction and 
prevention of major adverse cardiovascular events. 
3.5  Conclusion 
The Agatston score cannot determine calcification phenotype, providing a potential 
explanation towards its inability to identify high-risk atherosclerotic lesions. ECCS 
correlate extremely well with calcification volume (rs = 0.991, p < 0.0005) and Calcified 
Volume Fraction (rs = 0.865, p < 0.0005), moderately with calcified particle counts (rs = 
0.696, p < 0.0005), poorly with Calcified Particle Fraction (rs = 0.422, p = 0.007) and 
micro-Calcification Fraction (rs = 0.361, p = 0.022), and does not correlate with Calcified 
Particle Index (rs = -0.162, p = 0.318). Calcified particle maximum x-ray attenuation 
increases with increasing particle volume, supporting reports that the upward weighted-
cofactor scoring methodology needs to be reviewed. Future scoring methodologies should 
focus on a measure of calcification in a meaningful way, such as destabilising calcified 
particle phenotypes, to tailor treatment towards vulnerable lesions. 
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The following chapter presents a study that quantifies the impact of decreasing CT 
resolution on acquired ex vivo measures of atherosclerotic calcification. An appreciation 
for the errors acquired in clinical CT scans will allow recommendations for corrections 
to or for novel clinical CT calcium measurements to be made.  
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Background: Calcification is readily quantified using non-contrast Computed 
Tomography (CT). Currently described calcium scoring methodologies utilise different 
measures of calcification. However, the effect of CT resolution on these measurements 
remains largely unknown. 
Objective: To examine the effect of CT resolution on measures of calcification volume, 
density and particles in a cohort of excised carotid atherosclerotic plaques. 
Methods: Micro-Computed Tomography (CT) was performed on 38 ex vivo carotid 
lesions. Image series were scaled to represent the resolutions for a range of clinical and 
preclinical CT modalities. Calcification volume is determined as the number of calcified 
pixels (≥130 Hounsfield Units) multiplied by the known CT voxel volume. Maximal and 
mean calcification densities were identified for each sample. Additionally, the density 
fractions were quantified according to the 4 defined Agatston calcium grades. Finally, the 
calcified particle distribution of each sample was determined. 
Results: CT resolutions below 150μm have decreased sensitivity in calcium detection. 
Small volumes of calcification (≤3mm3) are underestimated, while large volumes 
(≥60mm3) are proportionately overestimated with reducing CT resolution. Additionally, 
both the maximum and mean calcium density values decrease with lower CT resolutions. 
However, the fraction of high- versus low-density calcification decrease and increase, 
respectively, with decreasing CT resolution. All calcified particles smaller than the CT 
voxel volume will be missed. 
Conclusion: Consideration should be given to the spatial resolution of different CT 
scanning protocols and the inherent errors acquired in calcification measurements. 
Whether the analysis of calcium density distribution in clinical CT scans carries clinical 
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4 On the effect of computed tomography resolution to 
quantify atherosclerotic calcification within ex vivo carotid 
atherosclerotic plaques 
4.1  Introduction 
Calcification is present in up to 90% of atherosclerotic lesions (Higgins et al. 2005) and 
is associated with plaque burden (Sangiorgi et al. 1998). Non-invasive non-contrast 
Computed Tomography (CT) readily identifies and quantifies arterial calcification 
(Higgins et al. 2005). Consequently, several calcium scoring methodologies have been 
developed aimed at quantifying coronary atherosclerotic calcification as a surrogate 
marker for atherosclerotic burden and thus cardiovascular risk. The most widely used 
score is the Agatston coronary artery calcium score (Agatston et al. 1990) which is a 
powerful prognostic marker for major adverse cardiovascular events and all-cause 
mortality (Hecht et al. 2017). This method utilises a maximal density-weighted area 
product of calcified CT pixels ≥130 Hounsfield Units. Other calcium scoring 
methodologies utilise calcification volume (Callister et al. 1998) or mean density-
weighted volume products (Nakanishi et al. 2019). However, spotty calcifications (Ehara 
et al. 2004; Motoyama et al. 2007) and microcalcifications (Hutcheson et al. 2014) have 
been associated with plaque vulnerability. Quantification of these small calcified particles 
will help diagnose atherosclerotic disease earlier (Arnold et al. 2010) and may hold 
importance in vessel-specific risk assessment (Cahalane et al. 2019). 
Clinical CT has limited spatial resolution with the current scanning protocols for 
Multidetector row CT (MDCT) in the range of 200-500µm. However, CT technology is 
evolving and higher resolutions are being achieved. High-resolution peripheral 
quantitative computed tomography (HRPQCT), flat-panel volume CT (FPVCT) and dual-
energy CT (DECT) are capable of producing spatial resolutions as low as 60μm (Manske 
et al. 2015), 150μm (Gupta et al. 2006) and 400μm (Dettmer et al. 2013) respectively. 
These higher spatial resolutions should delineate more defined calcification features. 
However, it is currently unknown to what extent the effect CT resolution has on the 
measurement of atherosclerotic calcification (Demer et al. 2017). 
Much ex vivo research is conducted using high-resolution micro-computed tomography 
(micro-CT) (Mohr et al. 2004; Higgins et al. 2005; Vengrenyuk et al. 2006; Barrett et al. 
2017; Cahalane et al. 2019). This non-destructive imaging technique (Mohr et al. 2004) 
has significantly higher resolution potential than clinical CT (Lin and Alessio 2009), 
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capable of accurately quantifying calcification volume, density and particles (Higgins et 
al. 2005; Vengrenyuk et al. 2006). Additionally, micro-CT of ex vivo human carotid 
calcified atherosclerotic tissues strongly correlate with findings from the gold standard 
histological analysis (Ababneh et al. 2014). Therefore, this study aims to investigate the 
effect of non-contrast CT resolution on measures of calcification volume, density and 
particles. Samples will be scanned using high-resolution micro-computed tomography 
(micro-CT). Image series will then be scaled to represent resolutions for a range of clinical 
and preclinical CT modalities. Measurements of calcification volume, calcium density 
and calcified particles will be determined at each resolution. 
4.2  Materials and Methods 
4.2.1 Sample Acquisition 
Thirty-eight carotid plaque specimens were acquired from thirty-eight different patients 
undergoing standard carotid endarterectomy procedures. Within 24hrs of surgical 
removal, the samples were frozen in phosphate-buffered saline solution (PBS) and stored 
at -20°C until time of analysis. Table 4-1 summarises the characteristics of the patient 
population in this study. 
4.2.1.1 Chemical Fixation 
To prepare the tissue for micro-CT scanning, the samples underwent a tissue preservation 
process to prevent any detrimental effects to the tissue structure under the x-ray beams, 
which would reduce the quality of the micro-CT images. The samples were defrosted and 
washed in fresh PBS, fixed with methanol, dehydrated in a graded series of increasing 
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Table 4-1: Patient characteristics. 
Patient Variables 
Total 
(n = 38) 
Demographics  
Age, years (mean ± SD) 70 ± 10 
Sex, Male, n (%) 31 (82) 
Comorbidities  
Smoker (current or ex), n (%) 31 (82) 
Systolic Blood Pressure (mmHg) (mean ± SD) 150 ± 25 
Body Mass Index (kg/m2) (mean ± SD) 27 ± 5 
Obesity, n (%) 8 (21) 
Diabetes Mellitus, n (%) 7 (18) 
Chronic Kidney Disease, n (%) 2 (5) 
Ischemic Heart Disease, n (%) 18 (47) 
Dyslipidemia, n (%) 29 (76) 
Hypertension, n (%) 31 (81) 
Atrial Fibrilliation, n (%) 6 (16) 
Chronic Obstructive Pulmonary Disease, n (%) 4 (11) 
Osteoporosis, n (%) 2 (5) 
Increased C2H5OH Levels, n (%) 3 (8) 
Peripheral Artery Disease, n (%) 38 (100) 
Previous Myocardial Infarction, n (%) 7 (18) 
Medication  
Ace Inhibitor, n (%) 9 (24) 
Angiotensin 2 Block, n (%) 10 (26) 
Anticoagulant Therapy, n (%) 6 (16) 
Antiplatelet, n (%) 8 (21) 
Aspirin, n (%) 31 (82) 
B Blocker, n (%) 17 (45) 
Calcium Antagonist, n (%) 13 (34) 
Insulin, n (%) 1 (3) 
Nitrates, n (%) 2 (5) 
Oral Hypoglycaemic, n (%) 6 (16) 
Statin, n (%) 32 (84) 
SD = standard deviation  
 
Chapter 4 CT Resolution and Calcification 
 
94 
4.2.2 Micro-Computed Tomography Acquisition 
High-resolution micro-CT (Xradia Versa 500, Zeiss, Germany) imaging was used to 
accurately quantify the calcified content of each of the samples. The scanning was 
performed with a 0.4x optical magnification, low energy pass filter and 2.5s x-ray 
exposure time. The x-ray source was operated at 50kV and 81μA and all tomographic 
slices were obtained with a pixel resolution of 15.68μm and calibrated to Hounsfield Unit 
(HU) values (Barrett et al. 2015). To reduce downscale averaging inaccuracies, air was 
assigned a HU density of 0 rather than -1000, to more closely resemble in vivo blood 
values (Qanadli et al. 2015). 
4.2.2.1 Image Processing 
The spatial resolution of the micro-CT series was scaled to approximate resolutions for a 
range of CT technologies as demonstrated in Table 4-2. The measures of calcification 
obtained from the micro-CT images are considered as an approximation to the ground 
truth (Ababneh et al. 2014). Figure 4-1 presents the 2D image slices and 3D sample 
projections for a representative sample across each CT resolution examined in this study. 
4.2.2.2 Calcification Measurements 
Calcification is quantified using ImageJ image processing software release 1.52a 
(National Institute of Health, MD, USA). The calcified portions of the atherosclerotic 
tissues were quantified based on their Hounsfield Units (≥130HU) using custom 
histogram macros. The calcification volume is determined by multiplying the number of 
identified calcified pixels by the known voxel volume (Table 4-2). The maximal and 
mean density for the calcification within each sample was also determined. Additionally, 
the density was categorised according to the 4 Agatston Grades: 1 (130-199HU), 2 (200-
299HU), 3 (300-399HU) and 4 (≥400HU), where the density fraction is the number of 
pixels within a grade divided by the total number of calcified pixels. Finally, the calcified 
particle distribution is determined using the ‘3D Objects Counter’ ImageJ plugin. 
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Table 4-2: Computed tomography (CT) modalities and associated spatial resolutions: Micro-CT, 
high-resolution peripheral quantitative CT (HRPQCT), flat-panel volume CT (FPVCT), multi-
detector CT [1-4] (MDCT) and dual-energy CT (DECT). 
  In-Plane Slice Thickness Voxel Volume 
    (µm) (µm) (mm3) 
Micro-CT  15.68 15.68 38.55 x 10-7 
HRPQCT 
Actual 62.72 62.72 24.67 x 10-5 
Reference 60 60 
 
FPVCT 
Actual 156.80 156.80 38.55 x 10-4 
Reference 150 150  
MDCT [1] 
Actual 235.20 501.76 27.76 x 10-3 
Reference 235 500  
DECT 
Actual 392.00 392.00 60.24 x 10-3 
Reference 400 400  
MDCT [2] 
Actual 501.76 501.76 12.63 x 10-2 
Reference 500 500  
MDCT [3] 
Actual 705.60 705.60 35.13 x 10-2 
Reference 700 700  
MDCT [4] 
Actual 705.60 2994.88 1.49 








Figure 4-1: Representative 2D image slices (uppercase letters) and 3D image projections 
(lowercase letters) for the computed tomography (CT) resolutions analysed in this study: (A, a) 
micro-computed tomography (Micro-CT), (B, b) high-resolution peripheral quantitative CT 
(HRPQCT), (C, c) flat-panel volume CT (FPVCT), (D, d), (F, f), (G, g) (H, h) Multi-Detector CT 
(MDCT), and (E, e) Dual-energy CT (DECT). Calcification is identified on non-contrast CT 
images as high-density areas ≥130 Hounsfield Units. The area of calcification and the number of 
2D calcified particles are denoted on the 2D image slides. White dash border-box indicates the 
areas of calcification in red. Calcification volume and number of 3D calcified particles identified 
are denoted on the 3D image projections. The white volume scale bars represent 3mm. Calc = 
calcification. 
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4.2.3 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics version 26. Shapiro–Wilk 
analysis was performed to assess the distribution of all continuous data. All datasets were 
determined to be not normally distributed. Therefore, results are presented in Tukey 
boxplots and written as median with interquartile range in square brackets. Kruskal-
Wallis H tests with pairwise comparisons were used to assess the difference between 
calcification measurements across CT resolutions. Statistical significance was defined in 
this study as a two-tailed p-value of less than 0.05. 
4.3 Results 
4.3.1 Sensitivity 
Calcification was present in all samples analysed at high-resolution micro-CT with the 
volumes ranging from 0.12mm3 – 433.74mm3. Table 4-3 presents the true-positive and 
false-negative calcification detection for each downsampled resolution in this study. False 
negative detection of calcification began to occur at resolutions lower than 150µm 
(FPVCT). There is decreasing sensitivity of calcification detection with lower CT 
resolutions. The sensitivity for calcification detection is 100% for HRPQCT and FPVCT, 
97% for MDCT [1] and DECT, 92% for MDCT [2 and 3] and 79% for MDCT [4].  
Table 4-3: Sensitivity of calcification detection across CT resolution. 








HRPQCT 38 0 100 
FPVCT 38 0 100 
MDCT [1] 37 1 97 
DECT 37 1 97 
MDCT [2] 35 3 92 
MDCT [3] 35 3 92 
MDCT [4] 30 8 79 
 
4.3.2 Volume 
Figure 4-2(i) illustrates the difference in calcification volume calculated at reducing CT 
resolution. There is an increasing difference in the volume calculated from HRPQCT to 
MDCT [2] CT resolution (0.66 [0.02 - 1.69] mm3 to 11.44 [1.19-26.59]mm3), with a slight 
decrease observed from MDCT [3] (9.46 [0.00 - 20.03]mm3) to MDCT [4] (7.12 [-0.63 
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to 20.23]mm3). Figure 4-2(ii) presents the absolute volume error (%). Similar to the 
difference in volume, there is increasing % volume error from HRPQCT to MDCT [2] 
CT resolution (2.62 [1.51 – 3.51]% to 32.99 [25.55 - 39.39]%), with a slight decrease 
observed at MDCT [3] resolution (28.18 [20.43 – 38.41]%) and then a final increase at 
MDCT [4] (38.64 [26.63 - 56.47]%). Calcification volume is underestimated by up to 
7.45mm3 and overestimated by up to 191.02mm3 in this cohort. The differences in 
calcification volume and the % absolute error (median, IQR) recorded at decreasing CT 
resolutions are presented in Table 4-4. 
Figure 4-2 (iii) presents a scatterplot of the calcification volume calculated at high-
resolution micro-CT versus the difference in volume with decreasing CT resolution. 
Calcification volumes below 3.09mm3 were underestimated and volumes above 
55.57mm3 were overestimated. Therefore, we propose that plaques with ground truth 
calcification volumes ≤ 3mm3 may be missed, and volumes ≥ 60mm3 will be exaggerated 
in size when scanned at clinically relevant CT resolutions. 
 
Figure 4-2: The effect of computed tomography resolution on measures of calcification volume. 
(i) Boxplots of calcification volume difference (mm3) compared with micro-CT results across 
decreasing CT resolutions. (ii) Boxplots of absolute calcification volume error (%) compared with 
micro-CT results across decreasing CT resolutions. (iii) Scatterplot of micro-CT calcification 
volume versus the difference in calcification volume measurements at each CT resolutions 
(logarithmic scale axis). Dotted boxes represent the volume cut-offs for typically underestimated 
(≤3mm3) and overestimated (≥60mm3) calcification volumes in this study. 
4.3.3 Density 
Figure 4-3 (i) presents boxplots of the change in maximum calcification density (HU) for 
each sample across CT resolutions (log scale). The maximum CT number is significantly 
decreased at HRPQCT (749 [656 - 779] HU) compared with micro-CT (809 [670 - 875] 
HU), p<0.005. The decrease in maximum density continues across CT resolution to 
values of 435 [325 - 464] HU at MDCT [4]. Similarly, figure 4-3 (ii) presents the 
distribution of mean calcium density across CT resolution. Here, HRPQCT has similar 
mean density values (400 [328 - 443] HU) compared with micro-CT (408 [331 - 452] 
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HU). However, all other resolutions are significantly reduced in mean density values. 
Values decrease to 213 [199 – 233] HU at MDCT [4].  
Figure 4-3 (iii) displays a 3D bar chart with the median calcification density fractions for 
Agatston Grades 1-4 presented for each CT modality. Calcification exhibits a 
heterogenous distribution with low- and high-density portions in some CT cases. These 
measurements of calcification density fractions transition with decreasing CT resolution. 
Of particular interest, while the fraction of high-density calcification (Grade 4) decreases 
with decreasing CT resolution (0.65 – 0.05), conversely the fraction of low-density 
calcification (Grade 1) increases (0.15 – 0.51). The fractions of density grades 2 and 3 
remain relatively constant compared with grades 1 and 4. 
 
Figure 4-3: The effect of computed tomography resolution on measures of calcium density. (i) 
Boxplot  of the maximal Hounsfield unit distributions across CT resolution (log scale). (ii) 
Boxplot of the mean Hounsfield unit distributions across CT resolution. (iii) Median calcification 
density fractions for Agatston grades 1-4 across CT resolution. Statistical significance: ** p < 
0.005, *** p < 0.0005. 
4.3.4 Particles 
The calcified particle count for all samples is consistently and increasingly 
underestimated with lower CT resolutions. There is a significant increase in absolute % 
error from HRPQCT (90.75 [73.68 - 94.47]) to MDCT [4] (99.95 [99.74 – 99.98]) 
(Fig.4(i)). However, after excluding the number of calcified particles that were smaller 
than the CT voxel volume from the analysis, the actual calcified particle counts are within 
3.25-26.67% of the expected values (Fig.4(ii)), as detailed in Table 4-4. Therefore, all 
calcified particles smaller than the CT voxel volume will be missed. Figure 4-4 (ii) 
presents a scatterplot of micro-CT calcified particle count versus the particles 
underestimated at each CT resolution. The larger number of calcified particles identified 
in each sample, the increasing number of particles that become underestimated with 
decreasing resolution. 




Figure 4-4: The effect of computed tomography resolution on identification of calcified particles. 
(i) Boxplot of the % error in calcified particle count across decreasing CT resolutions. (ii) Bar 
chart of expected versus actual calcified particle counts. (iii) Scatterplot of the number of 
underestimated particles versus the number of particles identified at micro-CT. 
Table 4-4: Volume difference (mm3) and % absolute error in calcification volume measurements 
across decreasing CT resolution. Underestimation in calcified particle count (% error) and 
expected versus actual counts (% error). 
  Calcification Volume 
CT 
Resolution 
Volume Difference  
(mm3) 
Absolute Volume Error 
(%) 
HRPQCT 0.66 [0.23 - 1.69] 2.62 [1.51 - 3.51] 
FPVCT 3.16 [0.60 - 7.56] 11.30 [7.91 - 13.13] 
MDCT [1] 5.89 [1.08 - 14.26] 18.46 [14.98 - 25.01] 
DECT 9.12 [1.32 - 21.82] 26.40 [21.34 - 32.86] 
MDCT [2] 11.44 [1.35-26.59] 32.99 [25.55 - 39.39] 
MDCT [3] 9.46 [1.35 - 20.03] 28.18 [20.43 - 38.41] 
MDCT [4] 7.12 [3.44 - 20.23] 38.64 [26.63 - 56.47] 
  Calcified Particle Count 
 Underestimation 
(% Absolute Error) 
Expected vs Actual 
(% Error) 
HRPQCT 90.75 [73.68 - 94.47] 7.08 
FPVCT 98.91 [96.02 - 99.47] 25.67 
MDCT [1] 99.62 [98.06 - 99.83] 19.85 
DECT 99.71 [98.83 - 99.89] 14.44 
MDCT [2] 99.81 [99.07 - 99.92] 12.13 
MDCT [3] 99.86 [99.37 - 99.95] 3.25 
MDCT [4] 99.95 [ 99.74 - 99.98] 17.07 
 
4.4  Discussion 
Atherosclerotic calcification is a surrogate marker of atherosclerotic burden and its 
morphology plays a critical role in plaque stability. An understanding of the effect of CT 
resolution on measurements of calcification is required to improve the diagnostic 
accuracy of calcium measurements and the translation of calcium scoring methodologies 
across a variety of CT modalities. This is the first study to examine the differences in the 
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measurements of calcification volume, density and particles within ex vivo carotid human 
endarterectomy specimens across a range of clinical and preclinical CT resolutions.  
Strengths of this study include the method of downsampling high-resolution CT images 
to produce clinically relevant resolutions. Inconsistent sample orientation and motion 
artefacts effects that occur with repeated in vivo scanning is not a concern using this 
methodology. Additionally, this study examined a relatively large sample size of human 
carotid endarterectomy specimens that exhibited a wide range of calcification volumes.  
In this study, we determined that small volumes of calcification (≤3mm3) will be 
underestimated at low-resolution CT. Partial volume averaging effects of incomplete 
calcification within a voxels means that at critically large pixels sizes, the overall CT 
number of the voxel will have dropped below the standard threshold for identifying 
calcification (130HU), and the calcification will be missed. A previous study determined 
that these calcified particles would have to have unrealistically high HU values to still be 
identified after partial volume averaging effects (Kristanto et al. 2012). Previous works 
also determined that calcifications smaller than 2.1mm in length, 36° in angle (Van Der 
Giessen et al. 2011), or 215μm diameter (Kristanto et al. 2012) cannot be detected by 
MDCT. These findings underscore recommendations that a clinical calcium score of 0 
cannot definitively rule out the presence of coronary calcification or coronary artery 
disease (Greenland and Bonow 2008).  
This study also demonstrates that large calcifications (≥60mm3) are proportionately 
overestimated, with larger volumes at lowest resolutions having the greatest errors in their 
measurements. Similar to above, incomplete calcification within pixels below a critically 
large size will still produce CT numbers greater than the threshold for identifying 
calcification (≥130HU), overestimating the size of the actual calcification present. These 
results complement previous findings that CT derived arterial calcification area (Barrett 
et al. 2017) and volume (Arnold et al. 2010) are exaggerated in size. These changes in 
the perceived size of calcifications will significantly modify calcium scores that 
incorporate weighted cofactors into their calcification (Agatston et al. 1990; Nakanishi et 
al. 2019), producing unnecessarily erroneous scores (Demer et al. 2017). 
Both the maximum and mean measurements of calcification density are underestimated 
with decreasing clinical CT resolution, similar to the findings of another study (Arnold et 
al. 2010). Maximum (Agatston et al. 1990) and mean (Nakanishi et al. 2019) weighted 
cofactors assume false homogeneity in calcification density (Demer et al. 2017). 
However, coronary calcium density is inversely associated with coronary artery disease 
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and cardiovascular risk (Criqui et al. 2014). Therefore, consideration for this 
heterogeneity in calcium density might improve risk stratification. Here we propose the 
measurement of the calcium density fractions. Interestingly, with decreasing CT 
resolution the fraction of high-density calcification decreases while the fraction of low-
density calcification increases.  
As previously demonstrated, the majority of calcified particles within atherosclerotic 
lesions are classified as microcalcifications (Vengrenyuk et al. 2006; Cahalane et al. 
2019). The results from this study confirm that calcified particles smaller than the voxel 
volume will be missed. CT resolutions capable of distinguishing these calcified particles 
are laboratory-based techniques (Mohr et al. 2004), not applicable in the clinic. However, 
we hypothesise that use of the heterogeneous calcium density distributions, as discussed 
above, can estimate the true calcification morphologies that exist. Furthermore, these 
values can be extracted from current clinical CT imaging technologies. Advances in the 
field of artificial intelligence and radiomics to analyse large databases of patient scans 
(Nicol et al. 2019) should be able to determine whether these density measurements carry 
any clinical significance or prognostic value. 
4.4.1  Limitations 
This study has several limitations to be discussed. First, this is an ex vivo study scanning 
carotid calcification via high-resolution micro-CT imaging. Our micro-CT scans had an 
isotropic resolution of 15.68μm. However, as the majority of microcalcifications are less 
than 15μm in spherical diameter (Kelly-Arnold et al. 2013). Therefore, this resolution 
may still not be high enough to accurately determine the calcified particle count. 
Therefore, the ground truth calcified particle results used in this study could be 
underestimated. Secondly, clinical CT scans also incorporate different acquisition modes 
and reconstruction kernels optimised to identify different components of pathological 
human tissue. Our ex vivo analysis does not integrate any of these settings. Thirdly, CT 
angiography is also commonly used in patient assessment. Our non-contrast findings may 
not be representative of contrast-enhanced scan results. Further work is required to 
determine the effect of contrast material and resolution on calcification measurements. 
Finally, some of the CT resolutions utilised in this study are not yet applicable to the 
clinical examination of the carotid arteries. 
  
  




CT resolution significantly affects the measurements of calcification volume, calcium 
density and calcified particles. Calcification volume is proportionately overestimated for 
larger volumes of calcification, while small volumes are underestimated. Both measures 
of maximal and mean calcium density decrease with reducing CT spatial resolution. 
Interestingly, while the fraction of high-density calcification decreases with decreasing 
CT resolution, the fraction of low-density calcification increases. Calcified particles are 
consistently and increasingly underestimated with reducing CT spatial resolution. 
Consideration should be given to CT resolution when quantifying atherosclerotic 
calcification and the inherent errors acquired with different measurements. Whether 
measures of heterogeneous calcium density can be utilised to more accurately estimate 
calcification morphology and identify high-risk plaques should be investigated in future 
works. 
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Calcium scores that are indicative of vessel-specific risk have not yet been developed. 
The following chapter presents a study comparing currently described coronary calcium 
scoring methodologies or measures of calcium density fractions, as identified in the 
previous chapter, for use on ex vivo carotid plaques to associate with preoperative 
cerebrovascular symptoms. This chapter is currently accepted as a Brief Report article in 
Stroke. The accepted version of the manuscript can be found in Appendix B of this thesis.  
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Background and Purpose: Coronary calcium scoring is a robust marker of 
atherosclerotic plaque burden. However, limited evidence exists on its adaptation in the 
carotid arteries to predict stroke. The purpose of this study is to examine the ability of ex 
vivo derived Agatston, Volume and Density-Volume calcium scores or calcium density 
measurements to differentiate between carotid plaques based on preoperative 
cerebrovascular symptomatology. 
Methods: Excised carotid plaques were acquired from patients undergoing standard 
endarterectomy (n = 38). Patients were categorised based on their preoperative symptoms: 
asymptomatic (n = 4), transient ischemic attack (n = 19) or ischemic stroke (n = 15). 
Micro-computed tomography (CT) was performed on the ex vivo plaques. Image series 
were downsampled to represent the resolution of clinical Multidetector-CT (MDCT) 
(0.5mm)3. Calcification volume is determined as the number of calcified pixels (≥130 
Hounsfield Units) multiplied by the voxel volume. Agatston and Density-Volume 
calcium scores were calculated according to described coronary methodologies. 
Additionally, the fractions of low- and high-density calcification were quantified. Carotid 
calcification results were then compared between plaques from asymptomatic versus 
symptomatic patients.  
Results: Importantly, coronary Agatston, Volume and Density-Volume calcium scores, 
when applied to carotid plaques, could not differentiate between lesions from 
asymptomatic versus symptomatic patients. However, carotid calcification within 
plaques from asymptomatic patients had significantly lower fractions of low-density 
calcification and higher fractions of high-density calcification than symptomatic 
counterparts.  
Conclusions: Screening for carotid calcium density in non-contrast CT could indicate 
plaque stability and identify patients at risk of cerebral infarctions. 
 
  




5 Correlating ex vivo carotid calcification measurements 
with cerebrovascular symptoms: a proof of concept study  
5.1 Introduction 
Stroke is the second leading cause of death and a major cause of disability worldwide 
(Feigin et al. 2017). The rupture and embolisation of vulnerable carotid plaques are 
considered a major contributor in the occurrence of cerebrovascular infarcts (Spagnoli et 
al. 2004; Levy et al. 2008; Dempsey et al. 2010). Symptomatic patients with a high degree 
of carotid stenosis benefit from endarterectomy (Barnett et al. 1991). However, the 
identification and management of asymptomatic patients at high risk of cerebrovascular 
events remains unsolved. The Agatston coronary artery calcium score (CAC) (Agatston 
et al. 1990) is a surrogate marker for total atherosclerotic burden (Sangiorgi et al. 1998) 
and is an independent predictor for major adverse cardiovascular events and all-cause 
mortality (Hecht et al. 2017). However, there is conflicting evidence on the use of CAC 
as a prognostic marker of stroke (Folsom et al. 2008; Newman et al. 2008; Gronewold et 
al. 2013; Hermann et al. 2013).  
It has been suggested to utilise calcium scoring in vessel-specific locations to predict 
downstream events (Thilo et al. 2010; Blaha et al. 2017; Nakanishi et al. 2019). The 
Agatston (Agatston et al. 1990), Volume (Callister et al. 1998) and Density-Volume 
(Nakanishi et al. 2019) calcium scores have been described to quantify coronary 
calcification and predict cardiovascular risk. However, the efficacy of these coronary 
calcium scores in the carotid arteries has had limited investigation. Coronary calcium 
density is also inversely related to coronary heart disease and cardiovascular events 
(Criqui et al. 2014). It has been advocated as a measure to be considered in future calcium 
scores (Criqui et al. 2014; Blaha et al. 2017).  
Hence, there is much scope for the development of carotid-specific calcium scores 
capable of predicting cerebrovascular incidents. Therefore, the objective of this study was 
to investigate the ability of either carotid calcium scores or calcium density measurements 








5.2 Materials and Methods 
5.2.1 Patient Examination and Sample Acquisition 
Patients undergoing carotid endarterectomy procedures at the University Hospital 
Limerick were recruited (n = 38). This study received full ethical approval from the 
Research Ethics Committee and adheres to the principles of ICH-GCP and the 
Declaration of Helsinki. Patients were classified as symptomatic if an ipsilateral ischemic 
event (stroke or infarct (n = 15) or transient ischemic attack (TIA) (n = 19)) occurred 
preoperatively. Asymptomatic patients had incidental findings of carotid stenosis without 
cerebrovascular symptoms (n = 4). Plaque specimens were acquired, stored and processed 
as previously described (Cahalane et al. 2019). The study cases are presented in Table 5-
1. 
  




Table 5-1: Study cases age, sex, preoperative ipsilateral symptoms and stenosis as determined by 
ultrasound. 
Case Age Sex Symptoms Preoperative Stenosis 
1 73 M TIA 70-99% 
2 79 F TIA 50-69% 
3 62 F Stroke or Infarct High Grade 
4 68 M TIA 70-79% 
5 67 F Stroke or Infarct 90-99% 
6 75 M TIA 90-99% 
7 73 F Stroke or Infarct 90-99% 
8 83 M TIA 50-69% 
9 59 F Stroke or Infarct 50-69% 
10 62 M TIA High Grade 
11 81 M TIA - 
12 75 M TIA High Grade 
13 64 M Stroke or Infarct 70-99% 
14 82 M Stroke or Infarct 90-99% 
15 72 M TIA - 
16 74 M TIA 70-79% 
17 81 F TIA High Grade 
18 69 M Stroke or Infarct 90-99% 
19 55 M Stroke or Infarct Nearly Complete Occlusion 
20 65 M TIA 60-69% 
21 59 M TIA 80-89% 
22 47 M Stroke or Infarct 60-69% 
23 75 F Stroke or Infarct High Grade 
24 62 M Stroke or Infarct 90-99% 
25 78 M TIA High Grade 
26 49 M Stroke or Infarct 80-89% 
27 67 M None - 
28 69 F None - 
29 68 F None - 
30 69 F TIA 70-79% 
31 66 M Stroke or Infarct 50-69% 
32 59 F TIA 90-99% 
33 80 M Stroke or Infarct 50-69% 
34 89 F TIA 70-79% 
35 77 M Stroke or Infarct 50-69% 
36 60 M None 90-99% 
37 82 M TIA 20-49% 
38 75 F TIA 50-69% 
 
  




5.2.2 Micro-Computed Tomography Acquisition 
High-resolution micro-CT (Xradia Versa 500, Zeiss Microscopy, Germany) scanning was 
performed on the samples with a 0.4x optical magnification, low energy pass filter and 
2.5s x-ray exposure time. The x-ray source was operated at 50kV and 81μA and all 
tomographic slices were obtained with an isotropic image resolution of 15.68μm 
calibrated to Hounsfield Unit (HU) values (Barrett et al. 2015). However, air was 
assigned a value of 0HU instead of -1000HU to reduce downscale averaging inaccuracies. 
5.2.2.1  Image Post Processing 
The spatial resolution of micro-CT images series was downscaled to approximate the 
resolution capabilities of clinical Multidetector CT (MDCT) scanners (0.5mm x 0.5mm 
x 0.5mm) (Lin and Alessio 2009). Table 5-2 presents a comparison of the micro-CT and 
MDCT spatial resolutions. Representative 2D images series with Agatston calcification 
density grades and 3D sample projections are presented in Figure 5-1 (i) and (ii), 
respectively. 
 Table 5-2: CT resolution of micro-CT and MDCT image scans. 
  Micro-CT MDCT 
In-Plane (µm) 15.68 501.76 
Slice Thickness (µm) 15.68 501.76 
Voxel Volume (mm3) 38.55 x 10-7 12.63 x 10-2 
 
  





Figure 5-1: Representative 2D image slices and 3D sample projections. (i) 2D image slice at 
high-resolution micro-CT and low-resolution clinical MDCT. The areas of calcification are 
coloured coded according to the 4 Agatston grades (Px = pixel). (ii) 3D sample projection at 
micro-CT versus MDCT resolutions. 
5.2.2.2 Calcification Quantification 
The Agatston (Agatston et al. 1990), Volume (Callister et al. 1998) and Density-Volume 
calcium scores (Nakanishi et al. 2019) are calculated as described using ImageJ image 
processing software (National Institutes of Health, USA) (Schindelin et al. 2012). The 
density cofactors for each scoring methodology are presented in Table 5-3. The volume 
of calcification is calculated by multiplying the number of calcified pixels ≥130 
Hounsfield Units (HU) by the known MDCT voxel volume (Table 5-2). The calcification 
density is quantified as low- or high-density according to Agatston Grades 1 (130-
199HU) and 4 (≥400HU), respectively. The fraction of calcification density is defined as 
the number of Grade 1 or 4 density pixels expressed as a fraction of the total number of 
calcified pixels (≥130HU) (Table 5-3). 
Agatston Scorelesion = (Calcification Area) X (Maximal Cofactor) 
Agatston Scoretotal = ∑Agatston Scorelesion 
Volume (mm3) = (Calcified Pixels) X (Voxel Volume) 
Density-Volume Score = (Calcification Volume) X (Mean Cofactor) 
 




Table 5-3: Hounsfield Unit weighted cofactors for the Agatston and Density-Volume scoring. 











130-199 1 4 Low 
200-299 2 3 N/A 
300-399 3 2 N/A 
≥400 4 1 High 
 
5.2.3 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics v26. Shapiro–Wilk analysis 
was employed to assess the distribution of all continuous data. All datasets except one 
were not normally distributed therefore results are presented in Tukey boxplots and 
written as median [25th-75th percentiles] throughout. Mann-Whitney U tests were used 
to assess the difference in calcification measurements between asymptomatic and 
symptomatic cohorts. Statistical significance was defined as a two-tailed p-value <0.05. 
5.3  Results 
The distribution of carotid Agatston scores across patient cerebrovascular categories is 
presented in Figure 5-2(i). There is no statistical difference in the Agatston scores 
obtained for asymptomatic (487.04 [269.26–1172.33]) versus symptomatic lesions: 
transient ischemic attack (571.25 [270.27–821.75]) and stroke (74.52 [16.74–375.25]), p 
= 0.535. Similarly, there is no statistical difference in the volume of calcification within 
plaques from asymptomatic (61.52 [34.23–147.48]mm3), and symptomatic patients: 
transient ischemic attack (76.55 [36.95–103.52]mm3) and stroke (10.11 [3.47–
48.70]mm3), p=0.535 (Fig.5-2(ii)). The Density-Volume calcium scores for each patient 
symptom category are presented in Figure 5-2 (iii). There is also no significant difference 
in the scores between asymptomatic (123.04 [68.47–294.97]) versus symptomatic cohorts 
(transient ischemic attack (188.48 [84.26–275.07]) or stroke patients (25.77 [10.42–
126.70]), p = 0.766. 





Figure 5-2: Carotid calcium scores across patient cerebrovascular symptoms: (i) Agatston, (ii) 
Volume and (iii) Density-Volume calcium scores.  
This distribution of low- and high-density calcification fractions across patient 
cerebrovascular symptoms is displayed in Figure 5-3.  Asymptomatic patients have 
significantly lower fractions of low-density calcification (0.19 [0.18–0.22]) and higher 
fractions of high-density calcification (0.34 [0.33–0.35]) than transient ischemic attack 
(Low: 0.29 [0.24–0.34] and High: 0.24 [0.14–0.30]) or stroke (Low: 0.29 [0.27–0.37] and 
High: 0.23 [0.18–0.28]) cohorts, p<0.005 and p<0.05, respectively. 
 
Figure 5-3: Calcium density fractions across patient cerebrovascular symptoms: (i) low- and (ii) 
high-density calcification. Statistical significance: **p<0.005, *p<0.05. 
5.4  Discussion 
There is scope for the development of carotid-specific calcium scores to identify 
vulnerable lesions at risk of causing downstream cerebral infarctions. The purpose of this 
investigation was to assess the ability of either coronary derived calcium scores or the 
fractions of low- and high-density calcification to distinguish between carotid plaques 
from asymptomatic versus symptomatic patients. The results from this proof of concept 
study demonstrate that coronary calcium scoring methodologies cannot be translated to 
carotid arteries to predict cerebral infarctions. However, calcium density measurements 
can distinguish between plaques from patients with or without preoperative ipsilateral 
cerebrovascular symptoms. 




Atherosclerosis is a systemic disease and current coronary artery calcium scores are 
surrogate markers for total plaque burden and predict general cardiovascular risk. 
However, this does not identify the unstable lesions that require intervention (Mauriello 
et al. 2013). In that regard, we found no differences between carotid Agatston or Density-
Volume scores across patient symptom categories. Asymptomatic coronary and carotid 
plaques have been previously found to contain a higher degree (Mauriello et al. 2013), 
volume (Miralles et al. 2006) or more extensive calcification (Hunt et al. 2002) than 
symptomatic lesions. These results are reinforced by our previous work demonstrating a 
strong positive correlation between plaque calcified volume fractions and Agatston score 
approximations, and that larger particles have higher maximum x-ray attenuations 
(Cahalane et al. 2019). While total carotid calcium region volume scores have been shown 
to predict stroke (Nandalur et al. 2006), other studies have found no association between 
carotid-specific Agatston scores and cerebrovascular symptoms (Culebras et al. 1989) or 
inverse associations (Yoon et al. 2019). Although the Agatston calcium scoring technique 
is a robust marker of major adverse cardiovascular events when used in the coronary 
arteries, the results of this study indicate that it does not correlate with downstream 
cerebrovascular events when applied to the carotid arteries. 
Calcification morphology plays a critical role in plaque stability. Spotty calcifications 
have been associated with increased vulnerability (Ehara et al. 2004; Motoyama et al. 
2007; Zhang et al. 2019) and microcalcifications can promote rupture of the fibrous cap 
(Kelly-Arnold et al. 2013; Hutcheson et al. 2014). Researchers have previously 
postulated that the interfacial area of calcium deposits is a determinant of plaque stability 
(Richardson et al. 1989; Abedin et al. 2004; Huang et al. 2020). Similarly, we previously 
hypothesised that calcified particle measurements could be more indicative of plaque 
instability than currently described coronary calcium scores (Cahalane et al. 2019). 
However, the limited spatial resolution of clinical CT is not able to distinguish such 
features.  
Clinical CT has been previously shown to underestimate calcification density (Arnold et 
al. 2010; Kristanto et al. 2012). Additionally, microcalcifications and the edge of larger 
calcified deposits present as low-density calcification, confirmed by scanning electron 
microscopy (Cahalane et al. 2018). This can be attributed to partial volume averaging 
effects where the CT number of a single voxel is representative of the combined density 
of all tissues within that voxel. Therefore, it is reasonable to consider that high-density 
calcium is a surrogate marker for fully calcified regions while low-density calcification 




represents both calcified and non-calcified portions. The latter is hypothesised to correlate 
with an increased number of calcified and non-calcified tissue interfaces, elevating the 
potential for debonding and rupture. In this study, the fractions of low-density 
calcification were higher in symptomatic samples. 
CAC density is inversely associated with Coronary Heart Disease and CVD (Criqui et al. 
2014, 2017) and dense calcification is commonly associated with stable lesions (Nakahara 
et al. 2017). Additionally, high-density calcification (>1000HU) quantified on coronary 
computed tomography angiography (CCTA) scans is associated with a lower risk for 
future coronary events in patient and lesion-specific assessment (van Rosendael et al. 
2020). The results of this study support these findings. However, the results from the 
CCTA study (van Rosendael et al. 2020) did not demonstrate significance for the lower 
density calcification group. The calcium blooming artefacts observed with contrast-
enhanced CT scans may affect the detection and quantification of partially calcified 
voxels. 
The samples examined in this study were acquired from standard endarterectomy 
procedures. This methodology has inherent limitations. First, no severely disabled stroke 
patients underwent surgery and are thus excluded from the study. It is also uncommon for 
patients to have incidental findings of carotid stenosis without cerebrovascular symptoms, 
elect for surgery and consent to be part of a research study. Consequently, we have a small 
asymptomatic cohort (n = 4). Additionally, ex vivo micro-CT scanning was conducted, 
therefore the acquired x-ray attenuation may not be directly comparable with in vivo CT 
numbers. Moreover, the patient symptoms are also only classified at a single time point. 
Therefore, the prognostic value of low-density calcification fraction requires 
confirmation. Additionally, embolic debris causing cerebral infarcts is assumed to 
originate from the ipsilateral carotid lesions. Calcium scoring in the coronary arteries is 
easily automated. However, the proximity of carotid arteries to the neck and skull may 
present difficulties in the automation of scoring algorithms based on x-ray attenuation 
thresholding and segmentation. Finally, we adopted the Agatston Grades 1 and 4 for 
classifying calcification density, which is largely arbitrary. Future studies could examine 
custom density grades or tertiles of calcification. 
Despite the aforementioned limitations, this proof of concept study aimed to generate 
preliminary findings for clinical validation. We hypothesise that calcium density can be 
utilised as a risk stratification tool. A strength of this study includes determining 
calcification density fractions, which are more representative of an entire plaque. 




Additionally, this measure is not affected by weighted cofactors, unlike other calcium 
scoring methodologies, preserving measurement rigour and reproducibility (Demer et al. 
2017). 
5.5 Conclusion 
In summary, the observations from this study demonstrate that calcium density can 
distinguish between carotid plaques from patients based on preoperative ipsilateral 
cerebrovascular symptoms. The clinical utility and prognostic value of carotid calcium 
density measurements should be validated in larger cohorts. 
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There is no clinical consensus on the optimal imaging modalities to determine 
atherosclerotic plaque burden or vulnerability due to calcified content. The following 
chapter presents a study comparing the ability of several clinical and preclinical imaging 
modalities to quantify measures of calcification associated with endovascular device 
failure or plaque instability compared against ground truth micro-CT results. Chapter 6 
has yet to be submitted to a journal for consideration.
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Abstract   
Introduction: Specific morphologies of calcification can negatively impact endovascular 
device outcomes or increase the risk of plaque rupture. The accurate identification of 
these morphologies in both the clinical and research settings is of critical importance to 
advance the management and understanding of calcified atherosclerosis. However, a 
variety of imaging techniques are available in the clinic and there is a lack of consensus 
on the optimal modalities for discriminating between calcification phenotypes.  
Purpose: Therefore, the purpose of this study was to compare the ability of a range of 
clinical and preclinical imaging modalities to quantify calcification.  
Methods: Nine carotid plaques, six femoral plaques and two femoral arteries were 
imaged with Micro-computed tomography (CT), clinical CT, Magnetic Resonance 
imaging (MR), intravascular ultrasound (IVUS) and optical coherence tomography 
(OCT). The results acquired from the micro-CT images are considered the ground truth. 
The image series were registered and comparable stacks were used to calculate 
calcification volume, length and the number of calcified particles. 104 registered cross-
sections were identified and the calcification area, angle and calcified particles were 
measured. Additionally, the distance of the calcifications from the lumen was determined 
using the micro-CT images. 
Results: CT results displayed the closest correlation to the micro-CT results for 
quantifying calcification volume (ICC = 0.987, p < 0.0005), area (ICC = 0.974, p < 
0.0005), length (ICC = 0.936, p < 0.0005) and angle (ICC = 0.750, p < 0.0005). MR 
presented a high sensitivity for detecting calcium in the samples (100%), however, it is 
also had a high false-positive detection rate (48%) which led to overestimations in all 
measurements of calcification and a lack of sensitivity for identifying calcified particles. 
IVUS demonstrated good agreement between calcification length (ICC = 0.895, p < 
0.0005) and angles (ICC = 0.656, p < 0.0005) compared with the ground truth and the 
penetration depth was sufficient for carotid and lower extremity samples examined here. 
However, the shortcoming of IVUS is its lack of ability to penetrate the calcium. OCT 
exhibited the lowest affinity for identifying calcification in this study. However, 39 ± 
26% of the calcifications in this study are beyond 2mm distance from the lumen.  
Conclusion: The results of this study suggest that clinical CT is a reliable modality for 
quantifying calcification volume, length, area and angle, which are determinants of 
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endovascular device success. However, more work is warranted with regards to the 
accurate assessment of superficial calcified particles associated with plaque instability.  
6 Evaluation of atherosclerotic calcification: comparative 
analysis of computed tomography, magnetic resonance, 
intravascular ultrasound and optical coherence 
tomography 
6.1 Introduction 
Cardiovascular disease is the leading cause of death worldwide (World Health 
Organisation 2018). Atherosclerosis commonly affects large elastic arteries such as the 
carotid and lower extremity vascular territories, leading to cerebral infarctions and critical 
lower limb ischemia, respectively. Varying degrees and morphologies of calcification 
exist within these diseased arterial tissues. While the mechanics governing its formation 
and progression are still under investigation, the presence of calcification is known to be 
clinically significant (Demer and Tintut 2014). 
Heavily calcified plaques are frequently associated with endovascular device failures. 
The high stiffness of calcified plaques (Cahalane et al. 2018) creates a rigid barrier which 
limits device expansion or inflation. As a result, stenting and angioplasty procedures often 
result in insufficient luminal enlargement with calcified plaques (Savage et al. 1991; 
Hoffmann et al. 1998; Ling et al. 2008). It is also hypothesised that calcification may be 
impeding the penetration of antiproliferative agents from drug-eluting devices into the 
arterial wall (Fanelli et al. 2014; Rocha-Singh et al. 2014). Failure to predict the 
interactions of endovascular devices and calcified atherosclerotic tissue can result in the 
occurrence of procedural complications such as vessel dissection and perforation 
(Fitzgerald et al. 1992; Ito et al. 2015). Moreover, treating complications such as stent 
underexpansion is more challenging than preventing the underexpansion in the first place 
(Latib et al. 2014). Consequently, there is a high rate of surgical re-intervention and 
cardiovascular deaths associated with the minimally invasive treatment of calcified 
atherosclerosis (Katsanos et al. 2018). Proper evaluation of calcified plaque burden in 
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preoperative assessments will stratify plaques for treatment based on the predicted 
response, maximising procedural success and reducing the occurrence of adverse events.  
Additionally, calcification morphology plays a critical role in plaque stability. Spotty 
calcifications are associated with unstable plaques (Ehara et al. 2004; Motoyama et al. 
2007) and microcalcifications in the fibrous cap can trigger plaque rupture (Vengrenyuk 
et al. 2006; Maldonado et al. 2012; Kelly-Arnold et al. 2013; Hutcheson et al. 2014). 
Conversely, asymptomatic lesions often contain higher degrees (Mauriello et al. 2013), 
volumes (Miralles et al. 2006) and density (Criqui et al. 2014; Nakahara et al. 2017) 
calcification. It is hypothesised that measures of calcified particle distributions 
(Hutcheson et al. 2014; Cahalane et al. 2019), rather than calcium scoring techniques, 
will work towards predicting the impact of calcifications on plaque stability. Reliable 
clinical identification of these calcification morphologies will progress knowledge of 
vulnerable calcification phenotype stratification and diagnosis of individuals at high-risk 
for a major adverse atherosclerotic event.  
Imaging modalities that can optimally differentiate between these two distinct 
manifestations of calcification (Figure 6-1) are of considerable clinical importance. While 
micro-CT is the gold standard ex vivo technique to quantify calcification within excised 
specimens (Mohr et al. 2004; Ababneh et al. 2014), this technique cannot be used on 
patients in the clinical setting. No such consensus exists on the optimum imaging 
modality or modalities to identify and characterise these calcification phenotypes in 
preoperative plaque assessment. Therefore, the purpose of this study was to image ex vivo 
plaque samples using a range of clinically relevant imaging modalities: computed 
tomography (CT), magnetic resonance imaging (MR), intravascular ultrasound (IVUS) 
and optical coherence tomography (OCT). The ability of each modality to quantify the 
calcified content is determined and results are compared against micro-CT findings. 
  





Figure 6-1: Representative schematic of two distinct phenotypes of calcification. Spotty patterns 
of calcifications and microcalcification are complex morphologies that increase the risk of plaque 
rupture, while they do not inhibit the device performance such as stent expansion. 
Macrocalcifications have been linked with plaque stabilisation, however their presence 
contributes to endovascular device failure. 
6.2  Materials and Methods 
6.2.1 Sample Acquisition 
Atherosclerotic tissues were obtained from consenting patients undergoing standard 
carotid and femoral endarterectomy and lower limb amputations procedures at the 
University Hospital Limerick. The cohort included 9 carotid plaques, 6 femoral plaques 
and 2 lower extremity arteries. This study received full ethical approval from the Research 
Ethics Committee at University Hospital Limerick and adheres to the principles of ICH 
GCP and the Declaration of Helsinki. Written consent was obtained from all patients prior 
to participation. 
Table 6-1: Case data. 
Case Sample Age Sex 
1 Femoral Plaque 57 Male 
2 Femoral Artery  65 Male 
3 Carotid Plaque 82 - 
4 Carotid Plaque 63 Male 
5 Femoral Plaque 64 Male 
6 Popliteal Plaque 67 Male 
7 Femoral Plaque 68 - 
8 Carotid Plaque 90 Female 
9 Carotid Plaque 80 Female 
10 Femoral Plaque 69 Male 
11 Carotid Plaque 60 Male 
12 Carotid Plaque - - 
13 Carotid Plaque - - 
14 Tibial Artery - - 
15 Femoral Plaque 78 Male 




6.2.2 Sample Preparation 
Within 24hrs of surgical removal, the samples were frozen in phosphate-buffered saline 
(PBS) solution and stored at -20°C until time of image analysis. Upon defrosting, the 
samples were dissected to a suitable size and any endarterectomy incisions were sealed 
using adhesive. The samples were then attached to cannulas and secured between two 
rods in a half-cylindrical support. The samples were submerged and flushed with PBS. 
The use of this support allowed both invasive and non-invasive imaging to be carried out 
while maintaining sample orientation. Care was taken to avoid altering the position of the 
sample between each modality. 
6.2.3 Image Acquisition and Post-Processing 
Micro-CT, MR, IVUS and OCT images were acquired for each sample within 36hrs. 
Between each acquisition < 12 hrs the samples were stored in PBS at room temperature 
and >12 hrs the samples were stored in PBS at 4°C. However, due to instrument and 
technician availability, the CT images could not be acquired during those 36hrs. 
Therefore, samples were refrozen at -20°C prior to CT acquisition. 
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6.2.3.1 Micro-Computed Tomography Acquisition 
Micro-computed tomography images were acquired with the Quantum GX2 Micro-CT 
Imaging System (Perkin Elmer, USA). Initially, the samples were submerged in PBS, 
however, the solution was removed directly before imaging to be able to identify the 
lumen in the post-processing steps. The scanning time was sufficiently short (between 
14mins and 1 hr) that any dehydration effects are negligible. The samples were scanned 
in high-resolution mode with a field of view of 25 x 22mm, and reconstruction time of 
14mins. The x-ray source was operated at 90kV and 88μA and all tomographic slices 
were obtained with an isotropic spatial resolution of 50μm. Samples longer than 22mm 
were imaged over multiple scans and files were manually stitched post-acquisition. 
Acquired image files are automatically calibrated to a standard Hounsfield Unit (HU) 
Scale. As the samples are scanned ex vivo, the density of the tissue is slightly different 
from in vivo and the standard threshold of 130HU (Agatston et al. 1990) does not apply. 
6.2.3.1.1 Calcification Thresholding 
A combination of three techniques were used to determine a suitable threshold for 
quantifying calcification from the CT images. Each of the three processes are performed 
in ImageJ image processing software (National Institutes of Health, Maryland USA) 
(Schindelin et al. 2012). 
6.2.3.1.1.1 Plot Profile 
Plot profile graphs the change in signal intensity across a defined space. Figure 6-2(i) 
presents a representative micro-CT cross-section. A line is drawn which traverses the 
background air, the non-calcified and the calcified tissue. Figure 6-2(ii) presents the 
corresponding changes in radiographic density across the components. The x-ray 
attenuation density for air is approximately -1000HU, for non-calcified tissue is 
approximately 0HU and the calcified tissue reaches attenuation densities over 3000HU. 
6.2.3.1.1.2 Histogram Analysis 
High-resolution imaging histogram analysis produces defined peaks that represent 
different tissue constituents. Here, custom stack histogram analysis in ImageJ revealed 
three distinct peaks for all samples representing the three main components: air, non-
calcified and calcified tissues. Figure 6-2(iii) and (iv) present a representative histogram 
illustrating values for non-calcified tissue peak around 0HU while the peak for calcified 
tissue is just over 2500HU. The thresholds that should be used to distinguish between 
calcified and non-calcified tissue exists in the gap between the two tissue peaks. 
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6.2.3.1.1.3 Particle Analysis 
To gauge the threshold even more accurately the effect of calcification thresholds on the 
calcified particle count were examined. ImageJ 3D Objects Counter Plugin (Bolte and 
Cordelieres 2006) was used to determine the calcified particle count at thresholds from 
100HU to 2000HU in 100HU increments. Figure 6-2(v) illustrates a representative cross-
section with calcification identified in red for each incremental threshold. Figure 6-2(vi) 
plots the calcified particle count against the selected threshold, and the difference in 
number of particles particles between each threshold. The calcified particle count is 
initially high due to the presence of noise at low thresholds. The calcified particle count 
decreases as the artefacts are removed with higher thresholds. The count begins to rise 
again as higher thresholds separate coalesced calcifications. The smallest difference in 
particles occurred between 800HU and 900HU thresholds. Therefore, 800HU was chosen 
as the threshold to calcification in micro-CT and CT image series in this study. 




Figure 6-2: Calcification thresholding. (i) Plot profile across calcified plaque cross-section. (ii) 
A plot of the change in x-ray attenuation density across the defined line. (iii)-(iv) Representative 
histogram analysis displaying three peaks identifying air, non-calcified tissue and calcified tissue. 
(v) Cross-sections identifying the calcified areas in red for each incremental threshold. (vi) 
Calcified particle count and mean difference between thresholds for calcification. 
6.2.3.2 Clinical Computed Tomography 
Clinical CT image series were acquired with a Siemens Somatom force dual-energy CT 
scanner (Siemens, Erlangen, Germany) using the following scan parameters: 120kV and 
BV40 kernel reconstruction. Initially, the samples were submerged in PBS but the 
solution was removed directly before imaging to be able to identify the lumen in the post-
processing steps. The scanning time was sufficiently short to tissue dehydration. The 
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threshold identified for calcification in section 6.2.3.1.1 was also used to identify 
calcification in the CT images (800HU). 
6.2.3.3 T1 Weighted Magnetic Resonance Imaging 
T1 weighted magnetic resonance images were acquired using a 7.0T MRI scanner 
(Discovery MR901, GE Healthcare, USA) with 4 channel surface coil with 50mm 
transaxial FOV. All MRI images were obtained with an FSPGR sequence with TR 
17.5ms, TE 3.3ms, BW 122Hz, FA 20° and 16 averages, using a field of view of 25 x 
25mm, a matrix size of 512 and slice thickness of 0.5mm. T1-weighting is the optimal 
MR sequence to identify calcium since it presents more delineated contours and contrast 
(Chou and Carrino 2006). 
6.2.3.3.1 Post Processing 
To correct any uneven background signal in the T1-W MR images (Fig.6-3(i)) a Gaussian 
Blur with a sigma radius of 70 was applied (Fig.6-3(ii))). The original image is divided 
by the filtered image to produce the corrected MR image (Fig.6-3(iii)). Figure 6-3 (iv) 
displays the original and corrected background frequencies. A histogram was created for 
the combined MR image series (Fig.6-3(v)). To identify areas of hypointense calcium a 
threshold of 0.70 was applied and a representative binary image produced post 
thresholding is presented in Figure 6-3 (vi). Images were corrected for noise signal by 
performing a binary open followed by a close operation in ImageJ. The open operation 
performs an erosion followed by dilation that removes any isolated pixels (or noise) 
(Fig.6-3(vii)). The close operation performs a dilation followed by erosion that fills in 
small holes and smooths objects (Fig,63(viii)). Any artefacts that remained in the images 
following this were manually removed. This included air bubbles and particles that exist 
outside the vessel boundaries. Figure 6-3 (ix) and (x) presents a schematic illustration of 
the synchronisation of original and processed binary MR image windows. This vessel 
border is delineated in the original image using a freeform tool. The same shape is also 
projected onto the processed binary image. Figure 6-3(x) illustrates artefacts outside the 
vessel boundary and an air bubble which is characterised by its highly circular nature. 
Figure 6-3 (xi) demonstrates the manual removal of such artefacts. 




Figure 6-3: Magnetic resonance (MR) image processing. (i) Original MR image. (ii) Gaussian 
filter to estimate the background signal. (iii) The background signal is removed from the original 
image. (iv) Plot profile demonstrates the signal before and after background subtraction is 
performed. (v) Combined histogram of the normalised grey values from the background-
subtracted images. (vi) Binary produced following calcification thresholding. (vii) Binary image 
open operation. (viii) Binary image close operation. (ix) Original Image with a freeform shape 
drawn around vessel border. (x) Synchronised binary image with vessel borders projected. (xi) 
Air bubble artefact and noise outside the vessel borders removed. 
6.2.3.4 IVUS 
IVUS images were acquired using a commercially available IVUS system: TVC Imaging 
System™ (InfraredX, Inc.) with a TVC Insight XB™ catheter (Burlington, 
Massachusetts, USA). The catheter (50MHz) was advanced through the plaque sample 
and automatic pullback was performed at a speed of 0.5mm/s. Images were acquired with 
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a frame rate of 5.33fps, a slice thickness of 90μm and an axial resolution of approximately 
100μm. The maximum penetration radius of the ultrasound probe is approximately 5mm. 
6.2.3.4.1 Image Interpretation 
IVUS images were analysed using QCU-CMS v4.69 software (Medis Medical Imaging 
Systems B.V., Leiden, The Netherlands). Calcium is identified on IVUS images as 
hyperechogenic leading edges with posterior acoustic shadowing (Mintz et al. 2001). 
Calcification on IVUS images is typically quantified by length and angle as the sound 
waves cannot penetrate calcium to determine thickness, area or volume (Mintz et al. 2001; 
Van Der Giessen et al. 2011).   
6.2.3.5 OCT 
OCT images were acquired with a commercially available frequency-domain OCT 
system (Ilumien PCI Optimization System) and an OCT catheter (DragonFly Catheter, 
St. Jude Medical, St. Paul, MN, USA). In a similar manner to the IVUS acquisition, the 
catheter was advanced through the plaque sample and an automatic pullback was 
performed (18mm/s). Images were acquired with a frame rate of 180fps, a slice thickness 
of 100μm and an in-plane resolution of 12-15μm. The maximum penetration radius of the 
OCT system is 2.5mm. 
6.2.3.5.1 Image Interpretation 
OCT images were analysed using QCU-CMS v4.69 software (Medis Medical Imaging 
Systems B.V., Leiden, The Netherlands). Calcium is identified on OCT images as signal 
poor regions with sharply defined borders (Tearney et al. 2012; Wang et al. 2017). The 
borders of calcified deposits were manually delineated using the QCU-CMS software. 
6.2.4 Image Coregistration 
The image series were manually aligned using the locations of the cannulas within the 
image stacks, calcifications as landmarks and the known slice thickness of each modality. 
The accuracy of alignment was confirmed by assessing the shape of the lumen in matched 
segments across each modality for proximal, middle and distal sections within the 
samples. In instances where plaque features were missing from a series, for example the 
distal end is cut off, then these features were also excluded in the other modalities when 
quantifying calcification volume, length or particles. To capture a diverse range of 
calcification morphologies for cross-sectional analysis comparable segments were 
selected every 1.8mm along continuous segments of calcification within the micro-CT 
images. A total of 104 cross-sectional regions of interest were identified. 2 cross-sections 
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were disregarded as the IVUS and OCT images extending beyond the image acquisition 
window. A further 9 OCT regions were disregarded due to the catheter entering a false 
lumen in the sample. Micro-CT slices approximating the slice thickness of each modality 
were averaged in the z-direction to create a directly comparable slice. Figure 6-4 presents 
a representative schematic illustrating the imaging modalities, a schematic of the 
comparable volumes and cross-sectional areas, landmarks identified across each imaging 
modality and coregistered image cross-sections. 
 
Figure 6-4: Image coregistration utilising cannula positions, image landmarks and known slice 
thicknesses. Comparable volumes are selected for 3D assessment and cross-sections are identified 
for 2D assessment. Image landmarks are identified in yellow arrows for each imaging modality 
for (i) computed tomography (CT), (ii) magnetic resonance (MR), (iii) optical coherence 
tomography (OCT), (iv) intravascular ultrasound (IVUS) and (v) micro-CT. Registered cross-
sections are presented for (vi) CT, (vii) MR, (viii) OCT, (ix) IVUS and (x) micro-CT. Scale bars 
on the images represent 4mm. 
6.2.5 Calcification Measurements 
Measurements of calcified plaque burden include calcification volume, area, length and 
angle. The calcification volume was determined by multiplying the number of calcified 
pixels by the voxel volume. The area of calcification is calculated as the number of 
calcified pixels multiplied by the pixel area. The length of calcification was determined 
as the number of frames containing calcification multiplied by the slice thickness. The 
angle of calcification is determined as the total angle of calcium measured from the 
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centroid of the lumen, or the centroid of the sample if the lumen could not be 
distinguished. The ability of each modality to determined plaque risk was assessed using 
calcified particle analysis. ImageJ 3D OC plugin determined the number of calcified 
particles in the volumetric analysis (where possible) and particles were quantified on each 
cross-section using the respective image analysis software. For the IVUS analysis 
particles were defined as separate circumferential calcifications. Table 6-2 summarises 
the resolution and measurements that can be determined with each modality. Figure 6-5 
presents schematics of each calcification measurement. To determine the position of 
calcification within each plaque sample luminal masking and incremental expansion was 
performed using ImageJ on the micro-CT image sequences. The fractions of calcification 
existing in 1mm incremental depths from the lumen border were calculated. 
 
Figure 6-5: Volumetric and cross-sectional measurements of calcification in this study. 
 
Table 6-2: Image modality resolutions and capabilities. 
   Dimensions Micro-CT CT MR OCT IVUS 
Dimensions 
In-plane (μm) 50 234.4 48 90 20 
Slice Thickness (μm) 50 600 499 100 90 
Maximum Imaging 
Diameter (mm) 
N/A N/A N/A 10 16 
Penetration Depth (mm) N/A N/A N/A 1-2.5 5 
Analysis 
Volume      
Length      
3D Particle Distribution      
Presence      
Area      
2D Particles      
Angle      
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6.2.6 Statistical Analysis 
Statistical analysis was completed using IBM SPSS Statistics version 26. Shapiro–Wilk 
and histogram shape analysis were performed to assess the distribution of continuous 
data. Carotid and lower extremity calcification distributions were normally distributed 
are therefore presented in bar charts, written as mean ± standard deviation (SD) and 
compared using independent t-tests. All other calcification measurement data were not 
normally distributed and were therefore summarised as median values with 25th to 75th 
percentiles in square brackets, presented in boxplots and compared between groups using 
either Mann-Whitney U or Kruskal-Wallis tests. Data is compared across modalities 
using scatterplots with a micro-CT (ground truth) line of equality superimposed. 
Correlation between the clinical modalities and micro-CT findings are determined using 
intraclass correlation coefficients (ICC) determined with a two-way missed model. 
Additionally, Bland-Altman analysis was used to estimate the limits of agreement 
between the clinical data and the ground truth results. Statistical significance is deemed 
in this study as a p-value less than 0.05. 
6.3  Results 
6.3.1 Carotid versus Lower Extremity Results 
15 samples were examined for calcification volume, length and 3D particles. The results 
from the ground truth micro-CT scans revealed that carotid samples had an average of 
65.32 ± 52.74mm3 calcium volume, 12.61 ± 8.24mm calcium length and 115 ± 78 
calcified particles. In comparison, lower extremity samples contained 139.64 ± 
131.48mm3 (p = 0.186), 19.23 ± 12.32mm length (p = 0.251) and 78 ± 69 calcified 
particles (p = 0.346) (Figure 6-6).  
 
Figure 6-6: Carotid versus lower extremity (i) calcification volume, (ii) calcification length and 
(iii) number of calcified particles samples determined from the micro-CT images. 
6.3.2 Radial Distribution of Calcification  
Figure 6-7 presents the radial distribution of calcification from the lumen. Carotid and 
lower extremity samples follow a similar distribution profile. In this cohort, calcification 
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was present up to 7mm away from the lumen in carotid samples and up to 6mm in lower 
extremity samples.   
 
Figure 6-7: Mean and standard deviation for the fractions of calcification with increasing radial 
distance from the lumen boundary. 
6.3.3 Modality Sensitivity 
The true-positive and false-negative rates for the presence of calcification within the 
samples is presented in Table 6-3. MR images identified the presence of calcification in 
100% of the cases. CT and IVUS both had a sensitivity of 93%. OCT had the lowest 
sensitivity of 60%.  
Table 6-3: Rate of true-positive, false-negative and sensitivity for overall detection of 
calcification within samples (n=15). 
 Micro-CT MR CT IVUS OCT 
True-Positive (n) 15 15 14 14 9 
False-Negative (n) - 0 1 1 6 
Sensitivity (%) - 100 93.33 93.33 60 
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6.3.4 Calcific Burden 
6.3.4.1 Volume 
Figure 6-8 (i) presents a scatterplot of the 3D MR and CT calculated calcification volume 
plotted against micro-CT results. The MR volumes are overestimated (ICC = 0.881, p < 
0.0005) while the CT volumes are slightly underestimated (ICC = 0.987, p < 0.0005). The 
percentage error for MR calculated calcification volume 93 [35 – 315]% is significantly 
higher than that of CT -23 [-476 to -3]%, p < 0.0005 (Fig.6-8(ii)). The 95% limits of 
agreement between MR and Micro-CT are much larger (Fig.6-6(iii)) than the CT 
agreement (Fig.6-6(iv)) as demonstrated by the Bland-Altman plots.   
 
Figure 6-8: Calcification volume measurements. (i) Scatterplot of MR and CT volumes against 
calcification volume determined using micro-CT (line of equality). (ii) Boxplot of % volume error 
for MR and CT calcification volume results. Statistical significance: ***p < 0.0005. The dotted 
line indicates 0 error. Bland-Altman plots demonstrating the 95% limits of agreement between 
the micro-CT and (iii) MR or (iv) CT calculated calcification volumes. The black line represents 
0% error and the dotted lines represent the 95% confidence intervals.  
  




Figure 6-9 (i) presents a scatterplot of the calcification area determined from cross-
sectional image analysis for MR, CT and OCT plotted against the ground truth micro-CT 
results. The MR areas are overestimated (ICC = 0.881, p < 0.0005) while the CT area 
most closely resembles micro-CT results (ICC = 0.974, p < 0.0005). OCT area is 
underestimated to a high degree (ICC = 0.117, p = 0.154). Figure 6-9 (ii) presents 
boxplots for the calcification area % error. Calcification area is overestimated in MR 
images by 50 [11 – 125%], close to correct in CT images -1 [-5 to 1]% and often 
completely missed in OCT images -100 [-100 to -94]%, p < 0.0005 in all cases. The limits 
of agreement between micro-CT and MR, CT and OCT are presented in Figure 6-9 (iii) 
– (v). The difference increases with larger calcification areas for each modality.  
 
Figure 6-9: Calcification area measurements. (i) Scatterplot of calcification area determined for 
Magnetic Resonance (MR) images, Computed Tomography (CT) images and Optical Coherence 
Tomography (OCT) images plotted against Micro-CT results. (ii) Boxplot of % calcification area 
for MR and CT. Statistical significance: *** p < 0.0005. The black line represents 0% error and 
the dotted lines represent the 95% confidence intervals. Bland-Altman plots demonstrating the 
limits of agreement calcification area determined from micro-CT versus (iii) MR, (iv) CT and (v) 
OCT images. The dotted lines indicate the 95% limits of agreement. 
  




Figure 6-10 (i) presents a scatterplot of MR, CT, IVUS and OCT determined calcium 
length plotted against the ground truth micro-CT results. The MR lengths are 
overestimated particularly at micro-CT lengths <20mm (ICC = 0.878, p < 0.0005). In 
comparison, CT (ICC = 0.936, p < 0.0005), IVUS (ICC = 0.895, p < 0.0005) and OCT 
(ICC = 0.415, p = 0.018) calcium lengths are underestimated. CT and IVUS have 
comparable errors in their length calculations: 15 [-34 to -10]% and -12 [-41 to -4]%, 
respectively. However, the % error in length determined with MR is significantly 
overestimated compared with the other modalities (3 [0 - 49]%, p < 0.005). Similarly, the 
% error in length determined with OCT is significantly underestimated compared with 
the other modalities (-92 [-100 to -66]%, p < 0.05). The limits of agreements are presented 
in Bland-Altman plots for (iii) MR, (iv) CT, (v) IVUS and (vi) OCT. The difference in 
calcification length increases with increasing average length for OCT images (Fig.6-
10(vi)).  
 
Figure 6-10: Calcification length measurements. (i) Scatterplot of MR, CT, IVUS and OCT 
calcification length plotted against calcification length determined using micro-CT (line of 
equality). (ii) Boxplot of % volume error for MR, CT, IVUS and OCT calcification length. 
Statistical significance: *** p < 0.0005. ** p < 0.005. Bland-Altman plots demonstrating the 
limits of agreement between the micro-CT versus (iii) MR, (iv) CT, (v) IVUS and (vi) OCT 
calcium lengths. The black line represents 0% error and the dotted lines represent the 95% 
confidence intervals. 
  




Figure 6-11 (i) presents a scatterplot of calcification angle results determined from cross-
sectional images for MR, CT, IVUS and OCT plotted against micro-CT results. CT and 
IVUS analysis display moderate correlations with ground truth calcium angles: ICC = 
0.750, p < 0.0005 and ICC = 0.656, p < 0.0005.  In contrast, MR and OCT calcium angles 
are weaker: ICC = 0.488, p < 0.0005 and ICC = 0.335, p < 0.0005. Figure 6-11 (ii) 
presents the boxplots for % error in calcification angle estimation against micro-CT 
findings. MR calcium angles are significantly overestimated compared with the other 
modalities (41 [14 – 150] %, p < 0.0005). Similarly, OCT angles are significantly 
underestimated compared with other modalities (-100 [-100 to -75]%, p < 0.0005). Figure 
6-11 (iii)-(vi) presents the limits of agreement in Bland-Altman plots for each modality. 
For all modalities, the difference observed increases with larger calcium angles. 
 
Figure 6-11: Calcification angle measurements. (i) Scatterplot of calcium angle determined from 
Magnetic Resonance (MR), Computed Tomography (CT), Intravascular Ultrasound (IVUS) and 
Optical Coherence Tomography (OCT) images. (ii) Boxplot of % calcium angle error for MR, 
CT, IVUS and OCT. Statistical significance: *** p < 0.0005. The black line represents 0% error 
and the dotted lines represent the 95% confidence intervals. Bland-Altman plot demonstrating the 
limits of agreement between the micro-CT versus (iii) MR, (iv) CT, (v) IVUS and (vi) OCT 
calcium angles. The dotted lines indicate the 95% limits of agreement. 
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6.3.5 Calcified Particles 
6.3.5.1 3D Analysis 
Figure 6-12 presents a scatterplot of the number of calcified particles identified within 
samples using micro-CT, MR and CT. The number of particles determined using MR are 
overestimated for low numbers of particles and underestimated for high numbers of 
particles with no correlation observed: ICC = 0.388, p = 0.173. The number of particles 
identified at CT are consistently underestimated with no correlation observed (ICC = 
0.020, p = 0.463). The % error is higher for CT determined calcified particle count 97 [94 
– 98]% than MR results 54 [17 – 63]%, p < 0.0005 (Fig.6-12(ii)). The limits of agreement 
for MR and CT calculated calcified particles are presented in figure 6-12 (iii) and (iv). 
There is an increasing difference in the calcified particle count with a higher amount of 
calcified particles detected for both MR and CT.  The calcified particle distribution for 
micro-CT, MR and CT is presented in Figure 6-12 (v). A high prevalence of small 
calcified deposits is evident from micro-CT analysis. However, the MR and CT image 
analysis do not identify these deposits.  
 
Figure 6-12: 3D calcified particle analysis. (i) Scatterplot of MR and CT number of calcified 
particles plotted against micro-CT results (line of equality). (ii) Boxplot of % calcified particle 
count error for MR and CT. Statistical significance: ***p < 0.0005. (iii) Bland-Altman plot 
demonstrating the limits of agreement between the micro-CT versus (iii) MR and (iv) calcified 
particle counts. (n = number of particles). The black line represents 0% error and the dotted lines 
represent the 95% confidence intervals. (v) Bar chart indicated the total frequency of particles for 
all samples within the defined particle volume bins for Micro-CT, MR and CT. (n = number of 
particles). 
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6.3.5.2 2D Particles 
Calcified particle detection was also compared across registered image cross-sections for 
all modalities. Table 6-4 presents the sensitivity and false discovery rate for each 
modality. Although MR has the highest sensitivity rate (91.06%) it also has the highest 
false positive detection rate (48.17%). Decreasing sensitivity was observed for IVUS 
(39.16%), CT (24.84%) and OCT (5.93%) with a false discovery rate also determined for 
IVUS (9.68%). Overall, there was a moderate positive agreement between cross-sectional 
MR particles and micro-CT results (ICC = 0.529, p < 0.0005) and poor agreement with 
CT (ICC = 0.202, p = 0.033). There were no significant agreements identified for IVUS 
(ICC = 0.134, p = 0.124) or OCT (ICC = 0.037, p = 0.358). Figure 6-14 (ii) illustrates the 
% error in calcified particle counts for MR, CT, IVUS and OCT. MR calcified particle 
counts are overestimated (75 [25 – 215] %), while CT (-75 [-91 to -50])%, IVUS (-50 [-
89 to 0]%) and OCT (-100 [-100 to -91]%) are underestimated. MR is significantly 
overestimated and OCT is significantly underestimated calcified particles compared with 
all other modalities (p < 0.0005 in both cases).  Figure 6-13 (iii)-(vi) presents the limits 
of agreement in Bland-Altman plots for each modality. In all cases, the difference in the 
number of particles increases with higher calcified particle counts.  
Table 6-4: Positive and negative rates for calcified particle detection at registered image cross-
sections for MR, CT, IVUS and OCT (n = number). 
  MR CT IVUS OCT 
True-Positive (n) 438 114 112 29 
False-Positive (n) 407 0 12 0 
False-Negative (n) 43 345 174 460 
Sensitivity (%) 91 25 40 6 
False Discovery Rate (%) 48 0.00 10 0.00 
 




Figure 6-13: 2D calcified particle analysis. (i) Scatterplot of MR, CT, IVUS and OCT number of 
calcified particles plotted against micro-CT results (line of equality). (ii) Boxplot of % calcified 
particle count error for MR, CT, IVUS and OCT. Statistical significance: *** p < 0.0005. The 
black line represents 0% error and the dotted lines represent the 95% confidence intervals. (ii) 
Bland-Altman plot demonstrating the limits of agreement between the micro-CT versus (iii) MR, 
(iv) CT, (v) IVUS and (vi) OCT. The dotted lines indicate the 95% limits of agreement. 
6.4 Discussion 
The severity of atherosclerotic calcification is a determinant of endovascular procedural 
success. Moreover, identification of advanced atherosclerotic plaques at risk of rupture 
remains a challenge in cardiovascular patient assessment. The fundamental objective of 
atherosclerotic cardiovascular imaging is to identify high-risk lesions and plan 
interventions (Bailey et al. 2016). However, there is limited consensus on the accuracy 
of different imaging modalities to identify and quantify atherosclerotic calcification. 
Therefore, this purpose of this study was to compare the ability of 4 clinical and 
preclinical imaging techniques to quantify the calcified content of ex vivo peripheral 
atherosclerotic lesions against gold standard micro-CT results. CT exhibited the closest 
correlation to the ground truth results for the measures of calcification volume, area, 
length and angle. A considerable amount of image artefacts in the MR images led to 
overestimations and false-positive detections. While IVUS demonstrates good agreement 
for its measures of length and angle, the inability to penetrate the calcium is a drawback. 
OCT exhibited the lowest capacity for identifying calcification. None of the modalities 
examined in this study could accurately determine the calcified particle content.  
There is a general agreement that larger calcification angles, length and thicknesses are 
associated with endovascular device failures (Mintz 2015) and some efforts have been 
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made to establish cut-offs for predicting stent underexpansion (Fujino et al. 2018). Proper 
procedural planning to prevent occurrences such as stent underexpansion or inadvertent 
vessel dissection is preferred to the more challenging treatment of these consequences 
(Latib et al. 2014). Atherosclerotic calcification has also been identified as a major 
contributor to plaque rupture. Spotty calcifications have been associated culprit plaques 
(Ehara et al. 2004; Motoyama et al. 2007) and microcalcifications lead to stress 
accumulation which destabilise fibrous caps (Maldonado et al. 2012; Kelly-Arnold et al. 
2013; Hutcheson et al. 2014). These specific morphologies corroborate previous 
hypotheses that failure stress is expected to concentrate at the calcified and non-calcified 
tissue interfaces (Richardson et al. 1989) and total surface area of calcium may be the 
most valuable prognostic marker (Abedin et al. 2004). Proper clinical evaluation of 
calcification will provide valuable information for predicting plaque rupture and directing 
surgical strategies. 
The overall accuracy for CT to identify calcification within lesions in this study was 93%. 
Additionally, the CT results displayed the highest intraclass correlation coefficients out 
of all modalities compared with micro-CT results for quantifying calcification volume, 
area, length and angle. CT has been regarded as the most accurate method of identifying 
arterial calcification. However, the sensitivity for CT to identify calcified particles in this 
study was only 25%. The calcified particles are consistently underestimated with no 
correlation observed with the micro-CT results. These results are not unexpected as the 
limited spatial resolution of clinical CT (Sarwar et al. 2008) does not allow defined 
features of small calcified particles to be distinguished. Many other studies have 
demonstrated the ability of CT to detect large volumes of atherosclerotic calcification 
(Mintz et al. 1995; Van Der Giessen et al. 2011; Kristanto et al. 2012). CT is less sensitive 
in the recognition calcification smaller than 2.1mm in length, 36° in angle (Van Der 
Giessen et al. 2011) or 215μm diameter (Kristanto et al. 2012). However, areas of calcium 
which not visible with CT do not appear to inhibit stent expansion (Wang et al. 2017). 
Therefore, CT is a viable non-invasive means of assessing calcified atherosclerotic 
burden in the carotid (Nandalur et al. 2006) and lower extremity (Chowdhury et al. 2017) 
vasculature territories.  
In this work, we present a semi-automatic quantification method for identifying 
calcification within T1-weighted MR images. Overall, MR identified calcification in 
100% of the samples in this study. However, a high false-positive detection rate (48%) 
led to overestimations in calcification volume, area, length and angle measurements. 
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These findings contrast an in vivo study which demonstrates that calcification quantified 
using MR is less than that of CT (Mujaj et al. 2017). However, the samples are subject to 
different ex vivo partial volume averaging artefacts than an in vivo CT scan. Air has an x-
ray attenuation density of approximately -1000HU, whereas in vivo this would 
approximate the values for blood (40-60HU) (Huda and Slone 2003). Therefore, the CT 
measurements presented for calcification in this study may be underestimated. 
Additionally, an increased amount of image artefacts are introduced with an ex vivo 
sample analysis. In terms of calcification particle analysis, the number of calcified 
particles identified using MR are overestimated for low numbers of particles and 
underestimated for higher particle counts. Compared with CT, MRI lacks ionising 
radiation and demonstrates superior soft-tissue characterisation (Tarkin et al. 2016). 
Additionally, carotid arteries are commonly assessed using MR (Wang et al. 2018) and 
calcification has been differentiated with high accuracy in the MR assessment of both 
carotid (Cai et al. 2002) and peripheral arteries (Yang 2009). 
IVUS atherosclerosis analysis had an overall sensitivity of 93% for determining whether 
or not a sample contained calcium. IVUS was also the second-best modality for 
determining calcification length and had a moderate correlation with ground truth angles. 
Previous studies demonstrate good sensitivity for the detection of calcification with IVUS 
imaging (Van Der Giessen et al. 2011; Wang et al. 2017). However, IVUS does not 
penetrate calcification and cannot determine calcium thickness. IVUS is, therefore, 
unable to quantify calcification area or volume. In this regard, IVUS can  underestimate 
the depth of calcium by 45% (Kostamaa et al. 1999). Evaluation of calcium thickness is 
an important precursor of stent expansion (Maejima et al. 2016). Furthermore, the cross-
sectional analysis here revealed that IVUS had only 39% sensitive at identifying separate 
angles of calcification and had a 10% false discovery rate. While IVUS identifies smaller 
calcifications better than CT angiography (Van Der Giessen et al. 2011), 
microcalcifications are still missed. Dense fibrous tissue can also cast shadows in IVUS 
analysis (Mintz 2015), which might explain the false-positive findings in this study. IVUS 
is reported to be used in the carotid (Wang et al. 2018) and lower extremity (Arthurs et 
al. 2010) arteries. Additionally, the radial distribution analysis here confirmed that IVUS 
penetration depth is sufficient to capture the majority of the calcifications that were 
observed for the samples examined in this study.   
OCT displayed to lowest overall sensitivity for identifying calcifications within plaque 
samples (60%). While OCT has the advantage of identifying calcification area over IVUS 
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(Kume et al. 2010), we found that calcification was often missed and underestimated with 
OCT. Due to this, there were poor correlations observed between the OCT and the micro-
CT findings for calcification area and length. Moreover, only 25% of the calcified 
particles on the cross-sectional analysis were identified with OCT. Calcification can be 
underestimated within OCT images with the presence of overlying low-attenuation 
features such as lipid- or macrophage-rich regions (Yahagi et al. 2016), as well as those 
with poorly defined abluminal borders as the imaging dimensions (Mehanna et al. 2013). 
Moreover, OCT has a limited penetration depth into the atherosclerotic tissue. We 
determined that 39 ± 26% of the calcifications in this study are beyond 2mm distance 
from the lumen borders. In contrast to studies indicating the feasibility of OCT imaging 
applied to the carotid arteries during stenting procedures (Reimers et al. 2011; Yoshimura 
et al. 2011), we demonstrate that the calcification can be critically underestimated.  
6.4.1 Limitations 
There are some limitations to be acknowledged concerning this study. First, this is an ex 
vivo study utilised excised endarterectomy specimens. The samples were manipulated 
upon defrosting to seal any surgical incisions using adhesive. However, this step is 
necessary to improve the quality of the IVUS and OCT images. Micro-CT, MR, IVUS 
and OCT scans were performed for each sample within 36 hrs. However, due to clinical 
CT and technician availability, samples had to be removed from the holders and stored 
again at -20°C prior to CT imaging. Images were acquired of the sample within the holder 
prior to its removal and storage to replicate the sample orientation and length upon 
defrosting. In addition to this, the effects of tissue freezing on the CT image acquisition 
signal are not well understood, however, limited tissue degradation is expected to occur 
in a second freeze-thaw cycle, particularly calcified tissue. IVUS and OCT image 
interpretation involved manual delineation of calcifications within the images. No 
intraobserver or interobserver variability analysis conducted. However, the images were 
delineated following the instructions from the expert consensus documents for IVUS and 
OCT studies (Mintz et al. 2001; Tearney et al. 2012). Areas of atherosclerotic 
haemorrhage also appear as hypointense regions within the T1-weighted MR images. 
While air bubbles and background artefacts are removed as described in the methods 
section, areas of haemorrhage are not as easily distinguished. The Dragonfly Imaging 
Catheter is intended for use in vessels 2.0 to 3.5 mm in diameter only. However, it was 
observed that both the carotid and lower extremity lumens were much larger than 3.5mm 
in diameter, particularly at bifurcations. Moreover, in such advanced lesions, the lumen 
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often deviates from a perfectly circular shape, further diminishing the capacity of OCT 
imaging outside of the coronary vessels. Careful interpretation of this study results are 
required as in vivo conditions are different from the ex vivo conditions. 
A strength of the current study is the focus on measures of calcification within carotid 
and lower extremity lesions. Advanced calcified atherosclerotic lesions are often 
excluded from other trials (Wang et al. 2017) and the majority of research has focused on 
the characterisation of coronary plaques and coronary calcifications. Furthermore, this 
study compares 4 modalities against a ground truth, where previous studies have 
primarily compared two modalities (Pundziute et al. 2008; Van Der Giessen et al. 2011). 
To overcome the limitation of the IVUS not being able to determine calcification 
thickness, virtual-histology IVUS (VH-IVUS) utilises radiofrequency ultrasound 
backscatter data to determine the plaque components using mathematical algorithms. 
Plaque components are characterised as either necrotic core, fibro-fatty, fibrous or dense-
calcium (Vince et al. 2006). This method has demonstrated good accuracy (Nair et al. 
2007) and correlation with CT derived calcification (Pundziute et al. 2008). Commercial 
VH-IVUS technologies are available including the widely used Volcano Corporation 
(San Diego, California). Additionally, much research is being carried out aimed at the 
automatic quantification of components from both MR (Smits et al. 2016) and OCT 
images (Lee et al. 2020). Automatic quantification of atherosclerotic components with 
these technologies will resolve intra- and interobserver variations, reduce clinical image 
processing time and increase the adoption of these imaging modalities in both research 
and practice. 
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6.5  Conclusions 
Clinical CT most accurately quantifies calcification volume, area, length and angle 
compared with micro-CT findings. CT is, therefore, a viable non-invasive means of 
assessing calcific plaque burden during preoperative intervention planning. However, 
neither MR, CT, IVUS or OCT could accurately determine the calcified particle 
distribution of the ex vivo plaque samples. This study also indicates that the limited 
penetration depth of OCT catheters are unsuitable for quantifying extracoronary calcified 
plaque burden. Future studies should examine the accuracy of VH-IVUS. Additionally, 
the advent of automatic image analysis for MR and OCT modalities will reduce observer 
variation and increase the uptake of these procedures in both clinical and research 
settings. 
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Blood-based biomarkers have been advocated as an alternative cardiovascular diagnostic 
tool. The following chapter presents a study comparing levels of circulating blood-based 
biomarkers against measures of atherosclerotic calcification that represent cardiovascular 
risk. This study has been submitted to Atherosclerosis. This chapter contains an additional 
analysis of a selection of mineralisation regulators and inflammatory cytokines for a 
subset of the cohort. 
Atherosclerosis (Submitted)





Background and Aims: Atherosclerotic calcification is a powerful predictor of 
cardiovascular morbidity and mortality. This study aimed to determine whether 
circulating blood levels calcification inhibitors or a marker of bone turnover correlate 
with measures of atherosclerotic calcification.  
Methods: Clinical computed tomography (CT) was performed on arterial disease patients 
undergoing endarterectomy. Coronary artery calcium (CAC) scores, volumes and average 
density scores were acquired from the scans (n = 42). Micro-CT performed on excised 
carotid (n = 36) and lower extremity (n = 31) specimens. The total volume of 
extracoronary calcification was measured from the micro-CT images. The total volume 
of atherosclerotic calcification was determined as the sum of coronary and extracoronary 
volumes. Additionally, the number of diagnosed atherosclerotic locations was computed 
for each participant. Plasma levels of dp-ucMGP and fetuin-A and serum levels of 
carboxylated and uncarboxylated osteocalcin (ucOC) were quantified using commercial 
immunoassays. 
Results: There were no differences observed between the circulating protein levels across 
endarterectomy or number of diagnosed location groups. A moderate negative correlation 
is observed between carotid participant CAC density score and plasma dp-ucMGP (rp = -
0.642, p = 0.033). %ucOC weakly correlated with CAC scores for carotid patients (rs = -
0.438, p = 0.047), and total volume of calcification for carotid (rs = -0.587, p = 0.045) and 
total (rs = -0.431, p = 0.051) participant groups. No associations were observed between 
fetuin-A and calcification.  
Conclusions: Circulating levels of dp-ucMGP, %ucOC or Fetuin-A do not consistently 
correlate with measures of atherosclerotic calcification. 
  











7 On the use of circulating levels of blood-based biomarkers 
to quantify atherosclerotic calcification in a cohort of 
arterial disease patients 
7.1 Introduction 
Individuals with subclinical atherosclerosis are a priority for risk stratification and 
primary prevention of major adverse cardiovascular events such as myocardial and 
cerebral infarctions (Naghavi et al. 2006). The Coronary Artery Calcium (CAC) Score 
(Agatston et al. 1990) is a widely used marker of atherosclerotic burden (Sangiorgi et al. 
1998) and is a powerful predictor of cardiovascular morbidity and mortality (Hecht et al. 
2017). However, it is well-documented that atherosclerosis is a systemic disease (Dalager 
et al. 2008; Herrington et al. 2016), with calcification often present in multiple vascular 
territories (Allison et al. 2004, 2012). It has recently been demonstrated that the 
prognostic value of the traditional CAC score can be increased by identifying the number 
of calcified coronary arteries (Blaha et al. 2016) or additional quantification of 
extracoronary calcification on routine non-contrast chest Computed Tomography (CT) 
scans (Tison et al. 2015). Coronary artery calcium density has also been inversely related 
to coronary heart disease and cardiovascular risk (Criqui et al. 2014, 2017). Moreover, 
large volumes of calcification in distinct vascular beds are associated with increased 
cardiovascular disease (CVD) mortality (Bos et al. 2015). Therefore, screening for 
calcification in the coronary arteries alone may have limited value in estimating 
atherosclerotic burden (Xie and Shaw 2015). However, utilising whole-body CT to 
quantify the total calcific burden in all major atherosclerotic vessels would not be 
practical or cost-effective as the standard method of risk stratification. 
In this regard, blood-based biomarkers may provide an alternative diagnostic approach, 
theoretically capable of reflecting the total atherosclerotic burden. Moreover, 
atherosclerotic tissues are in immediate contact with circulating blood, making this a 
feasible approach for the subclassification of CVD (Arab et al. 2006). The active 
formation of atherosclerotic calcification (Doherty and Detrano 1994; Doherty et al. 
2003; Demer and Tintut 2008) provides a unique opportunity to examine the utility of 
circulating biomarkers of vascular calcification to estimate total atherosclerotic 
calcification, and thus indicate total atherosclerotic burden. Current theories for the 
formation of vascular calcification include (but are not limited to) the reduced expression 




of mineralisation inhibitors and the increased expression of osteogenic regulators (Sage 
et al. 2010). 
Matrix γ-carboxyglutamate (Gla) protein (MGP) is a potent inhibitor of vascular 
calcification (Luo et al. 1997) mainly expressed locally by vascular smooth muscle cells 
(VSMCs) (Price et al. 1976). MGP is a calcium-binding protein, impeding calcium 
phosphate growth in vascular tissues (Roy and Nishimoto 2002). MGP also binds to bone 
morphogenetic proteins (BMP) 2 and 4 (Wallin et al. 2000; Mayer et al. 2016), 
modulating BMP-induced VSMC differentiation to an osteoblast cell phenotype 
(Boström et al. 2001). The dephosphorylated and uncarboxylated isoform of this protein 
(dp-ucMGP) has a low affinity for intravascular calcium deposits and is readily released 
into circulation (Cranenburg et al. 2010). This inactive MGP species has been proposed 
as a biomarker of cardiovascular risk (Mayer et al. 2014) and vascular calcification 
(Cranenburg et al. 2008, 2010; Dalmeijer et al. 2013a). Fetuin-A is a circulating plasma 
glycoprotein produced by the liver (Triffitt et al. 1976), which contributes to the 
calcification inhibitory capacity of the circulating blood (Price and Lim 2003). Fetuin-A 
suppresses vascular calcification through three main pathways: prevention of calcium-
phosphate mineral nucleation, inhibition of VSMC apoptosis and enhanced apoptotic 
body clearance (Reynolds et al. 2005). Since the formation of vascular calcification is 
similar to bone (Doherty et al. 2003), and osteocalcin is a marker of bone turnover in 
healthy participants and those with a range of bone diseases (Price et al. 1980), it is 
expected that there could be a relationship between circulating osteocalcin and vascular 
calcification. 
Therefore, the objective of this study was to determine whether associations exist between 
the circulating levels of local and systemic calcification inhibitors (dp-ucMGP and fetuin-
A) or a marker of bone turnover (osteocalcin) with the extent of atherosclerotic 
calcification in cohorts of arterial disease participants undergoing endarterectomy. 
Multidetector row CT (MDCT) is used to determine the in vivo coronary artery calcium 
(CAC) scores and volumes. From these readings, average CAC density values can also 
be obtained. High-resolution micro-computed tomography (micro-CT) is used to quantify 
the amount of calcification within the excised plaque specimens. Additionally, a subset 
of patients were also analysed for the association between circulating mineralisation 
regulators and proinflammatory cytokines with atherosclerotic calcification. 
 




7.2 Materials and Methods 
7.2.1 Recruitment 
Arterial disease participants undergoing standard endarterectomy procedures at the 
University Hospital Limerick, Ireland were recruited for this study between September 
2016 and March 2019 (n = 64). Written informed consent was obtained from all 
participants. This study was approved by the Research Ethics Committee at the University 
Hospital Limerick and conforms to the principles of ICH-GCP and the ethical guidelines 
of the 1975 Declaration of Helsinki. Preoperative participant assessment included 
demographics, comorbid conditions, preoperative medication, clinical data and 
cardiovascular history as presented in Table 7-1. 
7.2.2 Sample Acquisition  
7.2.2.1  Blood Samples 
Fasting venous blood was preoperatively collected from each participant by venepuncture 
(n = 64). Serum samples were prepared in serum gel tubes (S-Monovette 4.9mL Z-Gel, 
Sarstedt, UK ) by standard centrifugation (15 minutes, 1580 x g) and plasma samples 
were prepared in K3EDTA plasma tubes (S-Monovette 7.5mL K3E, Sarstedt, UK) by 
standard centrifugation (15 minutes, 1580 x g). Both serum and plasma collections were 
split into dedicated aliquots and stored at -80°C until time of protein quantification. 
7.2.2.2  Atherosclerotic Plaques 
67 plaque specimens, 36 carotid and 31 lower extremity (2 aorto-iliac and 29 ilio-femoral) 
were acquired from 64 different participants undergoing standard carotid and lower 
extremity endarterectomy procedures. Three participants underwent two separate 
endarterectomy procedures (multiple [n = 3]). Within 24 hours of surgical removal, the 
carotid and lower extremity plaque samples were frozen in phosphate-buffered saline 
solution and stored at -20°C until time of analysis. 
7.2.3 Coronary Artery Calcium Imaging 
Coronary CT scanning was performed for 55 of the participants; 2 preoperatively and 53 
postoperatively (postoperative duration 51 ± 54 days, maximum 32 weeks), using a 
Siemens Somotom Sensation 64 (Erlangen, Germany). The scanning parameters were 
200mm field of view, 3mm slice thickness, acquisition 24 x 1.2mm and reconstruction 
increment of 1.5mm. The x-ray source was operated at 120kV and all tomographic slices 
were obtained with a rotation time of 0.33s and pitch of 0.2. CAC scores and volumes 




were acquired using Syngo calcium scoring software (Siemens AG, Erlangen, Germany) 
by experienced radiologists. CAC scan results for participants with coronary artery 
bypass grafts (CABG) (n=8), pacemakers (n=2), coronary stents (n = 2) or both a CABG 
and a pacemaker (n=1) were excluded (n=13). Average CAC density scores were 
calculated as previously described (Criqui et al. 2014). Briefly, the CAC volume score 
(mm3) is divided by the slice thickness (3mm) to obtain an average area score (mm2). The 
CAC score is then divided by the average score to compute an average CAC density score 
for each participant. 
7.2.4 Plaque-Specific Image Acquisition and Post Processing 
As the preoperative patient assessment of peripheral arterial disease varied between 
ultrasound, MRI or CT angiography on a case-by-case basis, the calcified content within 
carotid and lower extremity plaques was determined using high-resolution micro-CT 
imaging (Xradia versa 500, Zeiss, Germany). 
7.2.4.1 Chemical Fixation 
To prepare the tissue for high-resolution ex vivo micro-CT scanning, the samples 
underwent a three-stage preservation process. The samples were fixed with methanol, 
dehydrated in a graded series of increasing ethanol concentrations and finally chemically 
dried in a graded series of hexamethyldisilazane. This process prevents any destructive 
effects on the tissue structure under the intense micro-CT x-ray voltage source that would 
reduce the quality of the images (Mulvihill et al. 2013). 
7.2.4.2  Scanning Parameters 
The scanning was performed with a 0.4x optical magnification, low energy pass filter and 
2.5s x-ray exposure time. The x-ray source was operated at 50kV and 81μA and all 
tomographic slices were obtained with a pixel resolution of 15.68μm. Images were 
calibrated to Hounsfield Unit values (HU) (Barrett et al. 2015) and the scanning 
procedure was kept constant for all samples. 
7.2.4.3  Calcification Quantification 
The non-calcified and calcified portions of the excised plaques were quantified separately 
based on their radiographic density thresholds: (non-calcified: 30 - 129HU, calcified: 
≥130HU) using histogram analysis on ImageJ (Schindelin et al. 2012) (National Institutes 
of Health, Maryland, USA). The volume of calcification is calculated by multiplying the 
number of calcified pixels by the known voxel volume. The degree of excised plaque 




calcification was represented by the calcified volume fraction (CVF), the ratio of 
calcification volume to total plaque volume (Barrett et al. 2016). 
7.2.5 Atherosclerotic Burden  
The methods of obtaining CAC score, CAC volume, CAC density and extracoronary 
plaque calcification volume and CVF are described above. The total calcified 
atherosclerotic burden, or total volume of calcification, was estimated as the sum of the 
coronary and extracoronary calcification volumes. Participants who did not undergo a 
CAC scan or were excluded from the CAC analysis were not included in the total calcified 
volume analysis (n = 22). Participants were also categorised according to the number of 
diagnosed atherosclerotic locations: aorto-iliac, coronary artery, carotid artery, and/or 
lower limb disease (PAD). Carotid, aorto-iliac and ilio-femoral disease were confirmed 
by the performance of an endarterectomy. Coronary artery disease was defined as a 
history of ischemic heart disease (IHD) and/or a CAC score greater than zero. Participants 
without a history of IHD and who did not receive a CAC scan to confirm the absence of 
coronary artery disease were excluded from the diagnosed location analysis (n = 6). 
Lower limb peripheral artery disease (PAD) was diagnosed in patients who exhibited 
lower limb claudication at the time of surgery or during a return hospitalisation. 
Claudication symptoms were confirmed by MRI, CT Angiogram or an Ankle Brachial 
Index assessment. 
7.2.6 Protein Quantification 
Circulating plasma levels of dp-ucMGP levels were quantified using the inaKtif MGP 
iSYS kit analysed on the IDS-iSYS Multi-Discipline Automated System developed by 
Vitak (Maastricht University, The Netherlands) and IDS (ImmunoDiagnosticSystems, 
Boldon, UK). Sample aliquots underwent a minimum of 1 and a maximum of 3 freeze-
thaw cycles before protein quantification. Circulating plasma levels of fetuin-A and 
serum levels of cOC and ucOC were quantified using commercially available ELISA test 
kits (Bio-techne, R&D Systems (MN, USA) Cat. No. DFTA00, and TaKaRa Bio Inc. 
(Japan) Cat. No. MK111 and MK118, respectively). ELISAs were carried out in 
accordance with manufacturer’s instructions and the results were read on a multi-mode 
plate reader (Synergy H1, BioTek, VT, USA). All ELISA samples were analysed in 
duplicate and all samples underwent 1 freeze-thaw cycle prior to fetuin-A, cOC and ucOC 
quantification. Circulating plasma levels of Interleukin (IL)-4, 6, 8, 10, 18, Tumor 
Necrosis Factor (TNF)-α, Osteoprotegerin (OPG), Osteopontin (OPN), fibroblast growth 




factor (FGF)-23 and bone morphogenic protein (BMP)-2 were quantified using a custom 
Human Magnetic Luminex Performance Assay Base Kit (Bio-techne, R&D Systems 
(MN, USA) Cat. No. LXSAHM). Results were determined using the Luminex MagPix 
System. Circulating osteocalcin is described using percentage uncarboxylated osteocalcin 
to total osteocalcin (%ucOC). Samples from any participants who were receiving calcium 
antagonists at the time of recruitment were excluded from the dp-ucMGP and %ucOC 
(vitamin K-dependent proteins) analysis (n = 23). Figure 7-1 presents an overview of the 
sample details, measurements obtained and exclusion criteria that were used in this study. 





Figure 7-1: Flow chart of participant sample acquisition, measurements performed and any 
exclusion criteria. 64 participants were recruited. Fasting venous blood samples were acquired 
preoperatively (n=64). Bloods from participants taking calcium antagonists were excluded 
(n=23). Circulating levels of dephospho-uncarboxylated Matrix Gla Protein (dp-ucMGP), 
carboxylated and uncarboxylated osteocalcin (cOC and ucOC) and fetuin-A were measured. 
Plaques were acquired from endarterectomy procedures (n=67). No plaques samples were 
excluded. Calcification volume and calcified volume fraction (CVF) were determined. Coronary 
artery calcium (CAC) scans were performed on participants postoperatively (n=55). Participants 
with the presence of coronary artery bypass grafts (CABG), pacemakers or stents were excluded 
(n=13). CAC scores and volumes were calculated from the CAC scans. Atherosclerotic burden 
analysis measured the total volume of calcification and the number of diagnosed atherosclerotic 
locations. Participants without CAC scans to confirm coronary artery disease or calculation 
coronary calcification volume were excluded (n=9). 
  




7.2.7 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics version 26. Descriptive 
statistics were used to summarise participant characteristics. Participants are grouped 
according to endarterectomy location(s). Categorical data were compared across 
participant cohorts using Chi-squared tests. Shapiro–Wilk and histogram shape analysis 
were performed to assess the distribution of continuous data. All data determined to be 
normally distributed were summarised as mean ± SD, presented in boxplots and compared 
between groups using independent t-tests or one-way ANOVA, as appropriate. Similarly, 
all data determined to be not normally distributed were summarised as median values 
with 25th to 75th percentiles in square brackets, presented in boxplots and compared 
between groups using Mann-Whitney U or Kruskal-Wallis H tests. Extracoronary plaque 
calcification measures and CAC scores are compared between carotid and lower 
extremity participant groups. Levels of circulating biomarkers are compared between 
participant endarterectomy location and the number of diagnosed atherosclerotic 
locations. Additionally, correlations between quantitative variables are determined using 
Pearson’s (rp) or Spearman’s correlation (rs), depending on the data normality, to identify 
any associations between circulating proteins and calcification measurements: CAC 
score, CAC density and total volume of calcification. The effect of potential confounding 
variables would be examined where a significant relationship was identified. A two-tailed 
p-value less than 0.05 is deemed to be statistically significant in this study. 
7.3  Results 
7.3.1 Patient Characteristics 
The descriptive characteristics for participants undergoing carotid, lower extremity and 
multiple endarterectomy procedures are presented in Table 7-1. Participants undergoing 
carotid endarterectomy were an average age of 70 ± 9 years (63% male), participants 
undergoing lower extremity endarterectomy were an average age of 66 ± 10 years (77% 
male) and participants that underwent two separate endarterectomy procedures were an 
average age of 68 ± 11 years (100% male). These participant groupings are comparable 
cohorts with the exception of blood pressure (BP), diabetes mellitus, lower extremity 
PAD and the occurrence of a cerebrovascular event. Carotid participants have higher 
systolic (152 ± 24) and diastolic (80 ± 16) BP than lower extremity participants (139 ± 
23, 71 ± 11), p = 0.043 and p = 0.011, respectively. Additionally, 46% of participants 
undergoing lower extremity endarterectomy were diabetic, versus 17% of carotid 
endarterectomy participants (p = 0.012). Unsurprisingly, 92% of carotid endarterectomy 




participants had a preoperative cerebrovascular event and only 20% exhibited lower limb 
PAD symptoms versus 8% and 92% of the lower extremity endarterectomy participants 
(p < 0.001 in both cases). Importantly, no participants included this study were diagnosed 
with chronic kidney disease (CKD), end-stage renal disease (ESRD) or aortic valve 
disease (AVD).  
  




Table 7-1: Patient Characteristics. 
Patient Variables 











Demographics      
Age, years (mean ± SD) 68 ± 9 70 ± 9 66 ± 10 0.165 68 ± 11 
Sex, Male, n (%) 45 (70) 22 (63) 20 (77) 0.570 3 (100) 
Comorbidities      
Systolic Blood Pressure (mmHg) (mean ± SD) 147 ± 24 152 ± 24 139 ± 23 0.043 150 ± 31 
Diastolic Blood Pressure (mmHg) (mean ± SD) 76 ± 15 80 ± 16 71 ± 11 0.011 67 ± 17 
Body Mass Index (kg/m2) (mean ± SD) 26 ± 5 27 ± 5 26 ± 5 0.370 25 ± 4 
Obesity, n (%) 11 (17) 7 (20) 4 (15) 0.883 0 (0) 
Smoker (current or ex), n (%) 56 (88) 29 (83) 24 (92) 0.280 3 (100) 
Diabetes Mellitus, n (%) 19 (30) 6 (17) 12 (46) 0.014 1 (33) 
Dyslipidemia, n (%) 52 (81) 27 (77) 23 (88) 0.285 2 (67) 
Hypertension, n (%) 51 (80) 28 (80) 20 (77) 0.772 3 (100) 
Atrial Fibrilliation, n (%) 11 (17) 5 (14) 5 (19) 0.606 1 (33) 
Chronic Obstructive Pulmonary Disease, n (%) 10 (16) 3 (9) 5 (19) 0.223 2 (67) 
Osteoporosis, n (%) 4 (6) 2 (6) 2 (8) 0.758 0 (0) 
Increased C2H5OH Levels, n (%) 5 (8) 3 (9) 2 (8) 0.901 0 (0) 
Medication           
Ace Inhibitor, n (%) 19 (30) 8 (23) 9 (35) 0.311 2 (67) 
Angiotensin 2 Receptor Blocker, n (%) 15 (23) 9 (26) 6 (23) 0.813 0 (0) 
B Blocker, n (%) 29 (45) 15 (43) 12 (46) 0.798 2 (67) 
Calcium Antagonist, n (%) 23 (36) 13 (37) 9 (35) 0.839 1 (33) 
Nitrates, n (%) 2 (3) 1 (3) 1 (4) 0.968 0 (0) 
Anticoagulant Therapy, n (%) 11 (17) 5 (14) 6 (23) 0.115 0 (0) 
Antiplatelet, n (%) 20 (31) 8 (23) 11 (42) 0.105 1 (33) 
Aspirin, n (%) 51 (80) 28 (80) 20 (77) 0.772 3 (100) 
Insulin, n (%) 6 (9) 1 (3) 4 (15) 0.078 1 (33) 
Oral Hypoglycaemic, n (%) 15 (23) 5 (14) 9 (35) 0.062 1 (33) 
Statin, n (%) 54 (84) 29 (83) 22 (85) 0.854 3 (100) 
Cardiovascular Health and History           
Lower Limb Peripheral Artery Disease, n (%) 34 (53) 7 (20) 24 (92) <0.001 3 (100) 
Ischemic Heart Disease, n (%) 30 (47) 16 (46) 13 (50) 0.740 1 (33) 
Previous Cardiac Event, n (%) 10 (16) 5 (14) 5 (19) 0.606 0 (0) 
Previous Cerebrovascular Event, n (%) 36 (56) 32 (91) 2 (8) <0.001 2 (67) 
SD = Standard Deviation      
p-value compares carotid and lower extremity groups     
 
  




7.3.2 Atherosclerotic Calcification 
7.3.2.1  Extracoronary Calcification 
All extracoronary plaques contained calcification when analysed with micro-CT. Figure 
7-2 (i) presents a comparison of the extracoronary plaque calcification volume for carotid 
(41.28 [6.18 – 73.28] mm3) (n = 36) versus lower extremity (382.98 [233.43 – 608.65] 
mm3) (n = 31). As expected, lower extremity samples contained significantly larger 
volumes of calcification than carotid lesions (p < 0.001). Similarly, lower extremity 
plaques contained significantly higher fraction of calcification (0.47 [0.33 – 0.52]) than 
carotid plaques (0.17 [0.05 – 0.24]), p < 0.001 (Fig.7-2(ii)). 
 
Figure 7-2: Calcification within carotid versus lower extremity excised plaque samples. (i) 
Calcification volume (mm3). (ii) Calcified volume fraction. Statistical significance: ***p < 0.001. 
7.3.2.2  Coronary Artery Calcification 
The corresponding CAC scores computed for carotid and lower extremity participant 
groups are presented in Figure 7-3. Participants undergoing lower extremity 
endarterectomy had significantly higher CAC scores (1663.10 [398.51 – 2484.00]) than 
carotid participants (401.00 [73.05 – 1300.90]), (p = 0.005) (Fig.7-3(i)). Similarly, 
participants undergoing lower extremity endarterectomy had significantly higher CAC 
volumes (1417.60 [344.00 – 1950.00] mm3) than carotid participants (335.10 [67.75 – 
1040.12] mm3), (p = 0.006) (Fig.7-3(ii)). However, there is no statistical difference in the 
average CAC density score for carotid (3.61 [3.32 – 3.74]) versus lower extremity patients 
(3.64 [3.58 – 3.81]), p = 0.232 (Fig.7-3(iii)). 





Figure 7-3: Coronary artery calcium (CAC) results compared between carotid and lower 
extremity participants. (i) CAC scores. (ii) CAC volumes. (iii) Average CAC density scores. 
Statistical significance: *p < 0.01. 
7.3.3 Circulating Protein Levels 
7.3.3.1  Dp-ucMGP 
Nine samples had dp-ucMGP levels that were below the machine detection limit 
(<300pM). These samples were therefore assigned a dp-ucMGP value of 299pM, in line 
with previous work (Griffin et al. 2019). Figure 7-4 (i) presents a boxplot of circulating 
dp-ucMGP across participant cohorts. There were no significant differences in the levels 
of circulating dp-ucMGP in participants undergoing carotid (442.50 [353.25 – 547.75] 
pM) or lower extremity (391.00 [318.00 – 531.00] pM) endarterectomy, (p = 0.547). 
Participants that underwent multiple endarterectomy procedures had circulating dp-
ucMGP levels in the range of 455.00 [450.50 – 459.50] pM. Additionally, there was no 
difference in the distribution of dp-ucMGP across participants with one (405.50 [403.75 
– 407.25] pM), two (441.00 [319.75 – 542.75] pM) or three (389.00 [388.00 – 547.00] 
pM) diagnosed atherosclerotic locations, p = 0.912 (Fig.7-4(ii)). 
7.3.3.2 Fetuin-A 
Figure 7-4 (iii) presents a box plot of circulating fetuin-A levels across participant 
cohorts. Similar to the other circulating proteins, there were no significant differences in 
the levels of circulating fetuin-A in participants undergoing carotid (589.75 ± 150.08 
μg/mL) or lower extremity (615.62 ± 134.96 μg/mL) endarterectomy, p = 0.490. 
Participants that underwent multiple endarterectomy procedures had 579.43 ± 211.16 
μg/mL fetuin-A. Furthermore, there was no significant difference in the distribution of 
fetuin-A across participants with one (410.95 ± 56.07 μg/mL), two (601.32 ± 152.39 
μg/mL) or three (623.98 ± 126.84 μg/mL) diagnosed atherosclerotic locations, p = 0.187 
(Fig.7-4(iv)). 
  





Figure 7-4 (v) presents the distribution of percentage circulating uncarboxylated 
osteocalcin (%ucOC) across participant cohorts. There were no significant differences in 
the %ucOC of participants undergoing carotid (35.93 ± 14.85 %) or lower extremity 
(39.62 ± 15.88 %) endarterectomy, p = 0.460. Participants that underwent multiple 
endarterectomy procedures had 55.77 ± 36.08 %ucOC. Additionally, there was no 
statistical difference in the %ucOC between participants with one (52.84 ± 33.95 %), two 
(39.34 ± 15.66 %) or three (23.97 ± 11.18 %) diagnosed atherosclerotic locations, p = 
0.152 (Fig.7-4(vi)). 
 
Figure 7-4: Boxplots of the distributions of circulating blood proteins across participant 
groupings. (i) dephospho-uncarboxylated Matrix Gla Protein (dp-ucMGP) and endarterectomy 
groups. (ii) dp-ucMGP and number of diagnosed atherosclerotic locations. (iii) Fetuin-A results 
and endarterectomy groups. (iv) Fetuin-A and number of diagnosed atherosclerotic locations. (v) 
Percent uncarboxylated osteocalcin (%ucOC) and endarterectomy groups. (vi) %ucOC and 
number of diagnosed atherosclerotic locations. 
  




7.3.4 Correlations between circulating protein and atherosclerotic 
calcification 
Figure 7-5 presents scatterplots of circulating dp-ucMGP, %ucOC and fetuin-A 
correlated with coronary artery calcium (CAC) scores, average CAC density scores and 
the total volumes of calcification. Correlation coefficients and p-values for the regression 
analysis are presented in Table 7-2. A moderate negative correlation is observed between 
dp-ucMGP and CAC density score for the carotid participant cohort (rp = -0.642, p = 
0.033). Additionally, a weak negative correlation is found between circulating %ucOC 
and CAC scores for the total cohort (rs = -0.438, p = 0.047). Similarly, weak negative 
correlations were observed between %ucOC and total volume of calcification for the 
carotid (rs = -0.587, p = 0.045) and total (rs = -0.431, p = 0.051) groups, but not lower 
extremity group (rs = -0.325, p = 0.394). 37 samples underwent additional osteogenic 
regulatory and proinflammatory protein quantification. 5, 26 and 30 results were below 
the standard curve for IL-6, IL-10 and BMP-2. There is a moderate negative association 
between TNF-α and CAC density for carotid participants: rs = -0.669, p = 0.012 and a 
moderate positive association between both FGF-23 and IL-8 with CAC density for lower 
extremity cohorts (rs = 0.604, p = 0.029 for both). Figure 7-6 presents a heatmap of the 
correlation coefficients for all blood biomarkers quantified in this study against the 
atherosclerotic calcification measures. 
  





Figure 7-5: Scatterplots of circulating proteins versus measurements of atherosclerotic 
calcification. (i) Dephospho-uncarboxylated Matrix Gla Protein (dp-ucMGP) versus 
extracoronary plaque coronary artery calcium score. (ii) Dp-ucMGP versus average coronary 
artery calcium (CAC) density score. (iii) Dp-ucMGP versus total volume of coronary and 
extracoronary calcification. (iv) Percent uncarboxylated osteocalcin (%ucOC) versus coronary 
artery calcium score. (v) %ucOC versus CAC density score. (vi) %ucOC versus total volume of 
calcification. (vii) Fetuin-A versus coronary artery calcium score. (viii) Fetuin-A versus CAC 
density score. (ix) Fetuin-A versus total volume of calcification. 
  




Table 7-2: Pearson’s (grey) and Spearman’s (white) correlation coefficients are presented 
followed by associated p-values (r; p) describing the relationships between circulating protein 
levels and measurements of calcification for carotid, lower extremity and total participant cohorts. 
  













-0.039 -0.254 -0.348 -0.642 0.153 -0.369 0.085 0.017 -0.213 
0.905 0.509 0.122 0.033 0.695 0.100 0.794 0.965 0.354 
(n = 12) (n = 9) (n = 22) (n = 11) (n = 9) (n = 21) (n = 12) (n = 9) (n = 22) 
Fetuin-A 
-0.226 -0.254 -0.163 -0.078 0.431 0.266 -0.319 -0.179 -0.157 
0.313 0.362 0.336 0.743 0.084 0.102 0.148 0.507 0.348 
(n = 22) (n = 17) (n = 41) (n = 20) (n = 17) (n = 39) (n = 22) (n = 17 (n = 41) 
%ucOC 
-0.452 -0.441 -0.438 -0.436 0.136 -0.142 -0.587 -0.325 -0.431 
0.140 0.235 0.047 0.130 0.728 0.538 0.045 0.394 0.051 
(n = 12) (n = 9) (n = 22) (n = 11) (n = 9) (n = 21) (n = 12) (n = 9) (n = 22) 
 
 
Figure 7-6: Heatmap of correlation coefficients for circulating blood proteins and coronary 
artery calcium score, coronary artery calcium density score and total volume of calcification for 
carotid, lower and total patient groups. 
7.4  Discussion 
A method of quantifying total calcified atherosclerotic burden could have the predictive 
capacity that surpasses traditional risk factors for cardiovascular disease participant 
assessment. Therefore, the purpose of this study was to correlate levels of circulating 
blood biomarkers of calcification with measures of atherosclerotic calcification derived 
from in vivo coronary artery calcium scans and ex vivo micro-CT scans of excised 
endarterectomy specimens in a cohort of arterial disease patients. There were no statistical 




difference in the levels of circulating blood-biomarkers between participant 
endarterectomy groupings or the number of diagnosed atherosclerotic locations. Some 
moderate and weak correlation were observed between dp-ucMGP and %ucOC with 
CAC score, CAC density or total volume of calcification. However, the correlations were 
only observed for certain population subgroups. 
Lower extremity plaques contained significantly larger volumes and fractions of 
calcification than carotid lesions (Fig.7-2). These results complement previous findings 
that femoral samples have a higher calcium content than carotid plaques (Herisson et al. 
2011; Cunnane et al. 2016). Additionally, participants undergoing lower extremity 
endarterectomy had higher CAC scores and volumes than the carotid cohort (Fig.7-3). A 
previous autopsy study reported the earliest onset of arterial disease in the coronary 
arteries, followed by the carotid and finally the superficial femoral vasculature (Dalager 
et al. 2008). Atherosclerosis progression in this order would explain the higher CAC 
scores that were observed in lower extremity participants. However, we observed no 
difference in the average CAC density based on participant endarterectomy location. 
This study does not confirm that circulating calcification inhibitors can distinguish 
between carotid and lower extremity atherosclerosis or determine atherosclerotic burden 
(Figures 7-4 and 7-5). Additionally, the dp-ucMGP and fetuin-A levels reported in this 
study are not different from values reported for healthy reference populations: dp-ucMGP 
(age 66-80 years) 525 ± 243 pM (Cranenburg et al. 2010), upper limit 532pM (Griffin et 
al. 2019) and fetuin-A 400-800μg/mL (Schäfer et al. 2005). These findings extend the 
observations of previous studies which did not demonstrate associations between dp-
ucMGP levels with chronic heart disease, stroke risk (Dalmeijer et al. 2014) or 
cardiovascular calcification (Meuwese et al. 2015; Danziger et al. 2016; Zwakenberg et 
al. 2018). Conversely, other studies have demonstrated the potential utility of circulating 
dp-ucMGP levels to indicate arterial calcification and stiffness in specific participant 
cohorts including end-stage renal disease, aortic valve disease (Cranenburg et al. 2010; 
Schurgers et al. 2010) and heart failure (Ge et al. 2018). The results from this study add 
to the conflicting evidence existing regarding the use of circulating non-functional MGP 
or fetuin-A to predict CAC (O’Donnell et al. 2004; Hamano et al. 2010; Shea et al. 2011; 
Dalmeijer et al. 2013; Xiao et al. 2013; Meuwese et al. 2015) or extracoronary 
calcification (Schurgers et al. 2010; Delanaye et al. 2014; Liabeuf et al. 2015). It is 
apparent that a perplexing relationship exists between circulating levels of calcification 




inhibitors and the presence or extent of atherosclerotic calcification, which remains 
incompletely characterised (Barrett et al. 2018). 
MGP and osteocalcin are both vitamin k-dependent proteins (VKDPs) that require 
carboxylation to become fully functional (Hauschka et al. 1989; Schurgers et al. 2007). 
A moderate negative correlation observed between dp-ucMGP and carotid participant 
CAC density (rp = -0.642, p = 0.033) and weak negative associations between %ucOC 
with CAC scores for the total cohort (rs = -0.438, p = 0.047) and with total volume of 
calcification for the carotid (rs = -0.587, p = 0.045) and total (rs = -0.431, p = 0.051) 
populations. Similarly, serum ucOC levels have been inversely related to abdominal 
aortic calcification scores in male diabetic participants (Ogawa-Furuya et al. 2013). In 
contrast, higher measures of uncarboxylated osteocalcin and osteocalcin ratio (ucOC:OC) 
have been associated with coronary calcification in men (Choi et al. 2015), and serum 
ucOC levels are associated with carotid calcification independent of renal function 
(Okura et al. 2010). Danziger et al. previously did not find a relationship between 
circulating VKDPs (including MGP and osteocalcin) and vascular calcification (Danziger 
et al. 2016). Recent reviews have also highlighted the inconsistent associations between 
VKDPs and cardiovascular morbidity and mortality (van Ballegooijen and Beulens 2017; 
Lees et al. 2019). Our findings support this as an inconsistent relationship demonstrated 
between dp-ucMGP and %ucOC with measures of atherosclerotic calcification. 
This study measured calcification in the form of in vivo coronary artery calcium scores 
and ex vivo excised plaque specimen calcium volume. There are inconsistent approaches 
reported for measuring vascular calcification to predict CVD participant risk. 
Calcification within the aortic arch (Bos et al. 2015), carotid, thoracic or iliac vascular 
territories (Allison et al. 2012) have been recommended as enhanced predictors of 
morbidity and mortality compared with the coronary vasculature. We hypothesise that a 
measurement which reflects the total calcified atherosclerotic burden would be superior 
risk indicator than any single-site indication. However, the assessment of atherosclerotic 
calcification requires standardisation and complete examination of all dominant vascular 
territories would be difficult. Furthermore, higher density calcium is now considered a 
marker of plaque stability (Nakahara et al. 2017; van Rosendael et al. 2020). 
Cardiovascular calcification can exist in a variety of disease states including 
atherosclerosis and aortic valve stenosis (Demer and Tintut 2008). Moreover, medial 
calcification causes vascular stiffening and may be a distinct pathological entity from 
intimal atherosclerotic calcification (Ho and Shanahan 2016). The current study did not 




include any measures of subclinical atherosclerotic or medial calcification. The 
manifestation of medial calcification is accelerated in participants with chronic kidney 
disease and end-stage renal disease (Lanzer et al. 2014) and can be measured non-
invasively using pulse wave velocity (Laurent et al. 2002). This could explain the elevated 
levels of dp-ucMGP in these specific participant cohorts (Delanaye et al. 2014; Griffin et 
al. 2019). Although a recent study also found similar associations between dp-ucMGP 
and aortic stiffness in the general population (Mayer et al. 2016). 
It is also necessary to consider that circulating levels of blood protein do not necessarily 
reflect tissue levels (Dalmeijer et al. 2012). Although the concentration of a biomarker 
may be concentrated at the diseased site (Schurgers et al. 2005), it certainly becomes 
diluted upon excretion into the circulating blood (Hood et al. 2006). This concept is 
supported in an exploratory study which determined that plasma dp-ucMGP and t-ucMGP 
concentrations do not reflect plaque ucMGP levels (Zwakenberg et al. 2018). Given this, 
and the lack of statistical association determined in this study, future work would be 
beneficial which examines proteins at the tissue-level. Such studies would contribute a 
mechanistic insight into the formation of vascular calcification, and how these 
measurements correspond with circulating blood levels, indicating the clinical 
significance and utility of the latter. 
This study has some associated limitations that merit consideration. First, the study 
population included a small sample of those undergoing endarterectomy at a single 
healthcare centre. This selection of advanced disease participants may not be 
representative of community-based or clinical populations and it is unknown what effect 
any prior therapeutic interventions may have had on the results. Additionally, the 
examination of endarterectomy specimens precludes any calcification that is not removed 
from the site during surgery. Secondly, the dietary patterns of the participants is not 
recorded to determine nutritional vitamin-k status. Finally, a recent review determined 
that no single isoform of MGP has a stronger predictive power over another (Barrett et 
al. 2018). This study focused on the non-functional isoform of MGP (dp-ucMGP) as it 
has been proposed as a biomarker of cardiovascular risk (Mayer et al. 2014) and no 
commercial assays currently exist to quantify the other MGP species. Additionally, MGP 
can form a high molecular mass complex with calcium phosphate and fetuin (Price et al. 
2002) and this complex has been found to correlate with coronary artery calcium scores 
better than fetuin-A levels (Hamano et al. 2010). Examination of this mineral-complex in 
the analysis of vascular calcification has been recommended (Barrett et al. 2018). 




7.5  Conclusion 
To conclude, circulating levels of a local and systemic vascular calcification inhibitor and 
a marker of bone formation do not reliably reflect measures of atherosclerotic 
calcification in a cohort of arterial disease participants undergoing standard 
endarterectomy. Circulating levels of dp-ucMGP, Fetuin-A and %ucOC cannot 
distinguish between carotid and lower extremity endarterectomy groups or the number of 
diagnosed atherosclerotic locations of the participants. A moderate negative correlation 
is observed between carotid participant CAC density score and plasma dp-ucMGP (rp = -
0.642, p = 0.033). A weak negative correlation is also found between circulating %ucOC 
and CAC scores for the total cohort (rs = -0.438, p = 0.047). Similarly, weak negative 
correlations were observed between %ucOC and total volume of calcification for the 
carotid (rs = -0.587, p = 0.045) and total (rs = -0.431, p = 0.051). However, these 
correlations were not consistent among all participant subgroups. Additionally, no 
correlations were observed between fetuin-A and any calcification measurements. The 
relationship between circulating blood-biomarkers and the calcified atherosclerotic 
burden remains incompletely characterised. Future studies should adopt more robust 
measures for estimating total vascular calcification. Additionally, the relationship 
between protein expressions within calcified arterial tissue versus the levels of clinically 
targetable species in circulating blood requires confirmation. 
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To predict the outcome of endovascular treatment methods, an understanding of the 
biomechanics of atherosclerotic calcification is required. The following chapter relates 
the mechanical properties of carotid and lower extremity atherosclerotic calcification to 
radiographic density using a traditional nanoindentation approach. The published version 
of this chapter can be found in Appendix B of this thesis. 
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Calcification is associated with decreased atherosclerotic plaque stability and increased 
failure rates for endovascular interventions. Computational efforts have sought to 
elucidate the relationship between calcification and plaque rupture in addition to 
predicting tissue response during aggressive revascularisation techniques. However, 
calcified material properties are currently estimated and may not reflect real tissue 
conditions. The objective of this study is to correlate calcification mechanical properties 
with three radiographic density groups obtained from corresponding Computed 
Tomography (CT) images.  
Seventeen human plaques extracted from carotid (n=10) and peripheral lower limb (n=7) 
arteries were examined using micro-computed tomography (µCT), simultaneously 
locating the calcified deposits within their internal structure and quantifying their 
radiographic densities. Three radiographic density groups were defined based on the 
sample density distribution: (A) 130-299 Hounsfield Units (HU), (B) 300-449HU and (C) 
>450HU. Nanoindentation was employed to determine the Elastic Modulus (E) and 
Hardness (H) values within the three density groups. Scanning Electron Microscopy 
(SEM) analysis was used to qualitatively assess the tissue structure and indents. 
Results reveal a clear distinction between mechanical properties with respect to 
radiographic density groups (p<0.0005). The elastic modulus determined for density 
groups A, B and C were 8.47 ± 8.84GPa, 17.64 ± 6.63GPa and 25.26 ± 6.18GPa, 
respectively. No significant differences exist in the density-specific behaviours observed 
between carotid and lower extremity calcification. Previously defined calcification 
classifications indicate an association with specific radiographic density patterns. SEM 
examination revealed that density group A regions consist of both calcified and non-
calcified tissue components. Further research is required to define the radiographic 
thresholds which identify varying degrees of tissue calcification.  
This study demonstrates that the mechanical properties of fully mineralised 
atherosclerotic calcification emulate that of bone tissues (17-25GPa), affording 
computational models with more accurate material parameters. 
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8 Relating the mechanical properties of atherosclerotic 
calcification to radiographic density: a nanoindentation 
approach 
8.1 Introduction 
Calcification is a significant predictor of cardiovascular morbidity and mortality (Bos et 
al. 2015), and calcification morphology plays a critical role in determining atherosclerotic 
plaque stability (Hutcheson et al. 2014). Moreover, calcifications within atherosclerotic 
plaques limit the technical success of the minimally invasive endovascular stenting and 
angioplasty approaches, with insufficient luminal enlargement (Savage et al. 1991; 
Hoffmann et al. 1998) leading to clinical failure or adverse events such as reocclusion, 
dissection and stent fracture (Fitzgerald et al. 1992; Chang et al. 2011). Cutting Balloon 
Angioplasty and Atherectomy, have been developed to aggressively debulk these rigid 
inclusions and modify the plaque to improve the outcome of stenting. Computational 
efforts have sought to analyse the relationship between calcification and stability 
(Maldonado et al. 2012) in addition to anticipating the interaction of calcified tissues with 
recently developed interventions (Deokar and Klamecki 2017). However, computational 
studies investigating these circumstances are predominantly impeded by insufficient 
information on the mechanical properties of the calcification (Marra et al. 2006; Kot et 
al. 2011). The estimated calcification material parameters and morphologies used may 
not accurately reflect true tissue properties. The absence of accurate methodologies for 
predicting the calcified tissue behaviours is obstructing rigorous computational research. 
Global mechanical properties of atherosclerotic plaque tissues have been extensively 
investigated on the macro scale using various modes of characterisation such as uniaxial 
testing (Teng et al. 2014, 2015), reviewed by Walsh et al. (Walsh et al. 2014) and 
compression testing, reviewed by Chai et al. (Chai et al. 2014). These methods of material 
characterisation neglect the highly heterogeneous nature of the lesions. Consequently, the 
current literature reports high variability in tissue mechanical properties. Values for the 
compressive elastic modulus of calcified carotid tissues range from 140kPa (unconfined 
compression) (Maher et al. 2009) to 0.7GPa (nanoindentation) (Ebenstein et al. 2009), 
indicating the need for individual plaque constituent characterisation. Nanoindentation is 
an experimental technique originally developed for determining the hardness properties 
of thin films and has successfully transitioned to the characterisation of mineralised 
biological tissues such as teeth and bone (Rho et al. 1997, 1999; Zysset et al. 1999; Cuy 
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et al. 2002). This method of high resolution indentation testing, with accurate positioning 
capabilities, is an optimal approach for the precise mapping of small, irregular-shaped 
heterogeneous material (Constantinides et al. 2006), such as calcified deposits within 
atherosclerotic plaques (Stary 2000). The characterisation of the elastic modulus and 
hardness properties of calcification will provide valuable information for computational 
simulations to allow for insights into plaque modification (Katano and Yamada 2007).   
The evaluation of calcification density and its correlation with tissue mechanics has been 
recommended as a valuable interpretation for further predicting these tissue behaviours 
(Barrett et al. 2015). Computed tomography (CT) imaging is a non-invasive method that 
provides a three-dimensional view of the internal structure of atherosclerotic lesions, 
including identifying the presence of calcified deposits (Agatston et al. 1990) which can 
be used in pre-operative patient assessment prior to surgical intervention (Katano et al. 
2007; Wintermark et al. 2008). The use of Hounsfield Units (HU) is the standardised 
method of expressing CT density numbers and its use in surgical prognosis is widely 
described for mineralised tissues (Misch 1999; de Oliveira et al. 2008; Gücük and 
Uyetürk 2014). The Agatston scoring system (Agatston et al. 1990) is widely utilised for 
the quantification of calcium within coronary lesions. In this method, weighted cofactors 
are assigned to the calcification based on the maximal computed tomography number 
(HU) in each image slice: (1) 130 - 199HU, (2) 200 - 299HU, (3) 300 - 399HU and (4) ≥ 
400HU. The radiographic density distribution of carotid and peripheral calcifications 
have been determined in this study and the following density thresholds have been 
recommended to create proportionate volumes for mechanical characterisation: (A) 130-
299HU (B) 300-449HU and (C) ≥450HU. Radiographic density has not yet been utilised 
to quantify the tissue mechanical properties. 
This research aims to investigate the capability of CT density values (HU) to predict 
calcification mechanical properties of elastic modulus and hardness. Mechanical 
properties and structural categories of arterial calcification from carotid and peripheral 
lower limb regions obtained using nanoindentation will be correlated with the 
corresponding density values obtained from Micro-Computed Tomography (µCT) 
imaging. 
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8.2 Materials and Methods 
8.2.1 Patient Examination 
10 carotid and 7 peripheral lower limb (6 femoral and 1 iliac) plaque specimens from 17 
different patients were acquired from standard endarterectomy procedures that were 
performed at the University Hospital Limerick, Ireland in a manner that conformed to the 
Declaration of Helsinki and was approved by the hospital’s Ethical Research Committee. 
Patient demographics are presented in Table 8-1. Immediately after surgical removal, all 
plaques were frozen in phosphate buffer solution (PBS) at -20˚C until time of use. 







Age, (average years ± standard 
deviation) 
73 ± 7.26 64 ± 7.93 
Gender, (male/female) 7/3 6/1 
Smoking, n (%) 10 (100) 7 (100) 
Diabetes, n (%) 1 (10) 3 (43) 
Hypertension, n (%) 9 (90) 5 (71) 
Previous use of statin, n (%) 8 (80) 5 (71) 
 
8.2.2 Chemical Fixation 
To prepare the tissue for Micro-Computed Tomography (µCT) analysis, all plaques 
underwent a tissue preservation process to minimise damage and shrinkage to the tissue 
structure under the intense voltage source (Mulvihill et al. 2013). The samples were 
defrosted and cleaned in fresh PBS followed by fixation using 100% methanol. The fixed 
samples were washed in 100% ethanol prior to a dehydration process involving the 
specimen becoming subject to ascending grades of ethanol concentrations. Chemical 
drying of the samples was achieved using hexamethyldisilazane. 
8.2.3 Image Acquisition µCT and Post Processing 
µCT (Xradia versa XRM 500 Carl Zeiss X-ray Microscopy Inc.) was performed to 
analyse the internal structure of all plaque samples. The scanning was performed with a 
0.4x optical magnification and 2.5s x-ray exposure time. The x-ray source was operated 
at 50kV and 81μA and all tomographic slices were obtained with a pixel resolution of 
15.5μm. Three-dimensional reconstructions were generated using Xradia XRM 
reconstructor (version 7.0.2817). The pixel values were rescaled using a standard 
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Hounsfield Unit (HU) calibration using air, water and hydroxyapatite phantom (Barrett 
et al. 2016). This procedure was kept constant for all samples. 
8.2.4 Density Mapping 
Prior to any mechanical characterisation, density groups were defined to map locations 
for indent plotting. The authors analysed the radiographic density distribution of 21 
samples (13 carotid and 8 peripheral lower limb) using a custom-made MATLAB script 
(Matlab®, R2015b, The MathWorks Inc.) programmed to count pixels within a defined 
threshold range for each image slice. Volume results were obtained for each sample in 
density intervals of 10HU ranging from 130HU to 770HU. The total volume occupied by 
the pixels was determined by multiplying the number of pixels by the known voxel 
volume (15.5µm3). The volume distribution at each interval was determined by the 
Calcification Density Fraction (CDF), which is the ratio of calcification density interval 
volume (mm3) to total calcification volume (mm3). 
Figure 8-1(i) shows a boxplot of the calcium radiographic density distribution in intervals 
of 10HU from 130-770HU. In all boxplots presented in this study the line represents the 
median value, the boxes encompass the middle 50% of the data and the extruding bars 
extend to the upper and lower 1.5 IQ range. Outliers (greater than 1.5 times the IQ range) 
are represented by a hollow circle and extreme outliers (over 3 times the IQ range) by a 
triangle. The 4 Agatston density weightings (Grade 1-4) for use with coronary lesions are 
overlaid onto the graph. It is evident that the majority of the calcification is classified as 
Grade 4. Figure 8-1(ii) presents a boxplot of the total CDF for each density grade. Mean 
CDF for each of the Agatston weighted density grades were: CDF1 = 0.18, CDF2 = 0.15, 
CDF3 = 0.15, and CDF4 = 0.54. There is high statistical significance between Grade 4 and 
each of the other Grades (p<0.0005) analysed by a Kruskal Wallis H test with Dunn-
Bonferroni pairwise comparisons. 




Figure 8-1: Calcification density distribution with the Agatston grades. (i) Radiographic density 
distribution of the carotid and peripheral lower limb samples with an overlay of the four Agatston 
weighted cofactor grades. (ii) Boxplot of the total CDF within each of the Agatston grades. 
The ranges defined by Agatston et al. were subsequently modified to provide more equal 
areas for nanoindentation to be carried out. Grades 1 and 2 were combined to form 
Density Group A (130-299HU). The subsequent interval between grade 3 and 4 was 
increased to 150HU, culminating Density Group B with a threshold of 300-449HU. 
Finally, Density Group C (C) has a threshold of ≥450HU. Figure 8-2 (i) shows a boxplot 
of the radiographic density distribution with the three new modified density groups 
overlaid onto the graph. Figure 8-2 (ii) presents a boxplot of the total CDF for the 
modified density groups. Mean values for CDFA CDFB CDFC are now 0.33, 0.31 and 
0.36, respectively. The three groups now tend towards more equal volumes. No statistical 
significance was determined between any of the three groups as analysed by a one-way 
ANOVA with tukey post hoc multiple comparisons. Therefore, the following thresholds 
were therefore defined to create three proportional radiographic density groups:  
 A: 130 - 299 HU 
 B: 300 - 449 HU 
 C: ≥ 450 HU 




Figure 8-2: Calcification density distribution with the modified grades. (i) Radiographic density 
distribution of the carotid and peripheral lower limb samples with an overlay of the three modified 
density groups A, B and C. (ii) Boxplot of the total CDF within each of the modified groups. 
Figure 8-3 compares the mapped areas of Agatston Density Grades 1-4 (Fig. 8-1 (i) and 
(ii)) with the mapped areas of Density Groups A-C (Fig.8-2 (i) and (ii)) on the cross-
sections of a representative carotid and femoral sample. The 4 density grades defined by 
the coronary Agatston scoring method when applied to carotid and peripheral 
calcifications left the calcification area dominated by grade 4 (blue), with very small areas 
for Grades 1-3. It is evident once the thresholds are altered the mapped areas become 
more proportional, establishing more equal areas for nanoindentation experimentation to 
be carried out. 
 
Figure 8-3: Comparison of Agatston Density Grades 1-4 with modified density groups A, B and 
C. Representative (i) carotid and (ii) femoral cross sections with Agatston density grades mapped 
onto the surface. (iii)-(iv) Cross-sections with mapped modified density groups. Relevant 
Hounsfield Unit thresholds and associated colours are presented on the left hand side. 
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8.2.5 Sample Preparation 
Each plaque model was reconstructed using 3D Slicer medical image processing software 
(version 4.6.2, Open Source, 3DSlicer.org) (Fig. 8-4(i)b). The calcified and non-calcified 
tissues were modelled separately based on their threshold values (30 – 129HU, 
respectively). This procedure simultaneously locates the internal calcified deposits within 
the samples and evaluates their density in terms of HU values (Fig. 8-4(i)).  
The calcifications were grouped into four structural categories defined by Barrett et al. 
2016: speckled, diffuse spherical nodes, arc-shaped calcification and macro-inclusions 
(Barrett et al. 2016) to qualitatively analyse density patterns from the 2D µCT image 
tissue cross-sections. 
The plaque samples were embedded without vacuum in ‘EpoxiCure,’ (Buehler, Illinois 
Tool Works Inc, Illinois), at room temperature in cylindrical moulds (Fig. 8-4(ii)a). The 
samples were cured in the orientation which would allow the desirable cross-section to 
be exposed for indentation. The areas of calcification within the internal structure of the 
plaque specimens are easily identified in the 3D reconstructed models (Fig. 8-4(i)c). The 
epoxy cylinders are sectioned at this point using a low-speed diamond saw (IsoMet® 
Low-Speed Saw, Buehler) running at 200rpm with continuous water irrigation (Fig. 8-
4(ii)b). The samples were then polished using an automated polisher (Phoenix 4000, 
Buehler) running at 150rpm first using progressive grades of silicon carbide grinding 
paper (600, 800, 1200μgrit) followed by polishing with 1µm and 0.05µm alumina powder 
suspensions (Fig. 8-4(ii)c). Between each step, the surface debris was removed using 
ultrasonic cleaning for 10 seconds. This procedure was kept constant for all samples. 
Atomic Force Microscopy was carried out to validate this sample preparation procedure 
by obtaining a value for the resulting sample surface roughness. It is recommended that 
the indentation depth should be 20 times larger than the surface roughness value to 
minimise calculation errors (ISO 2015). A representative sample surface roughness value 
is presented in Fig. 8-5.  
An image of the exposed sample surface was taken using an optical microscope and 
manual image tiling was carried out to allow the specimen cross-section to be matched to 
a specific µCT slice (Fig. 8-4(ii)d). Upon μCT slice selection the three density groups A, 
B and C were mapped using 3D Slicer onto the sample surface (Fig. 8-4(iii)), creating the 
locations for nanoindentation to be carried out. 
  




All nanoindentation measurements were obtained using the G200 Nano Indenter 
(Keysight Technologies, formally Agilent Technologies), fitted with a diamond 
Berkovich tip, which is commonly used for the nanoindentation of mineralised tissues. 
Representative loading curves for each density group are presented in Figure 8-6. 
8.2.6.1 Plaque Specimens 
The locations of the indents were spatially mapped according to the three density groups 
previously visualised using µCT imaging and 3D Slicer (Fig. 8-4(iv)). Indents were 
manually positioned on the sample surface from the microscope window in the NanoSuite 
software (Keysight Technologies, United States). Indents were programmed to a 
maximum depth of 2µm using an indentation strain rate of 0.05s-1. A constant oscillating 
displacement amplitude of 2nm at a frequency of 45Hz is performed to obtain continuous 
measurements of contact stiffness during the loading cycle. In order to ensure accurate 
identification of the sample surface, the surface was initially approached from a distance 
of 1µm at velocity of 10nm/s. A spacing of at least 75μm was kept between indents to 
avoid neighbouring plastic deformation effects. Data was recorded during the 
approximately trapezoidal loading, hold and unloading phases of the testing and the 








Figure 8-4: Sample Preparation and Testing Procedure: (i) (a) Plaque specimens undergo a 
chemical preservation procedure described by [30] which protects the samples from the intense 
voltage source and maintain their structural integrity for the rest of the testing procedure. (b) 
Samples are imaged using µCT, presented are selected image slices associated with the preserved 
plaque sample. (c) The image files acquired in (b) are uploaded in 3D Slicer Medical Imaging 
Software and plaque models are reconstructed using thresholds for non-calcified and calcified 
tissues. The generated models reveal the calcified deposits (green) embedded within the plaque 
tissue (red). This process simultaneously locates the areas of calcification within the internal 
plaque structure and quantifies their densities. (ii) (a) Once the area of calcification has been 
identified the sample is embedded in epoxy resin. (b) The epoxy ‘puck’ is sectioned at the site of 
calcification using a low-speed diamond saw to expose a cross section for indentation. (c) The 
sectioned surface requires further preparation to yield the smooth surface finish required to 
minimise any calculations error from the nanoindentation data. The surface is grinded with 
increasing grades of silicon carbide paper followed by polishing with alumina suspensions. (d) 
The exposed sample cross section is imaged using optical microscopy and thus matched to a µCT 
image slice. (iii) Following CT image selection the radiographic density of the calcification is 
examined in 3D Slicer. The three radiographic density groups are mapped onto the sample surface 
to provide the areas for nanoindentation. (iv) The location of the indents (blue triangles) are 
manually positioned within the three density areas from the microscope window integrated into 
the nanoindentation interface. An SEM image displays a sample grid of 3 X 3 indents within the 
density group C area. 
 





Figure 8-5: AFM surface roughness profile for a representative peripheral lower limb 
calcification following the surface preparation procedure outlined in section 8.2.5. Approximate 
Surface Roughness values obtained are Ra = 40.4nm. 
 
 
Figure 8-6: Representative loading curves for density groups A, B and C, displaying the 
displacement into sample (nm) versus load on sample (mN). 
8.2.6.2 Theory 
The Oliver and Pharr method of obtaining Elastic modulus (E) and Hardness (H) values 
from continuous stiffness measurement (CSM) indentation data is widely described. Prior 
to the testing of the set of samples analysed in this study, the tip shape function was 
assessed by carrying out indentations on the reference fused silica sample and comparing 
the results obtained to the manufacturers’ specifications.  Hardness is defined in Equation 
1 as the load (P) divided by the projected contact area (A) (Oliver and Pharr 1992). The 
contact area (A) is deduced by using the area function for the indenter tip geometry as 






The specimen modulus (Es) is related to the reduced modulus (Er), as described in 
Equation 2, provided the indenter modulus (Ei) is known and the Poisson’s ratios of the 
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specimen and indenter, ʋs and ʋi respectively, are known or can be estimated. For a 
diamond indenter, Ei= 1141GPa and υi=0.07 and the Poisson’s ratio for arterial 
calcification (υs) is assumed to be 0.3 in this study, in accordance with values obtained 









The contact stiffness (S) is obtained by evaluating the slope of curve fit at unloading. The 
contact stiffness is related to the reduced elastic modulus (Er) using the Equation 3 
(Sneddon 1965). Elastic modulus is derived from Equation 3 using the relationship 








8.2.7 Scanning Electron Microscopy 
SEM analysis was carried out at the sites of indentation to analyse the degree of tissue 
calcification and to assess the quality of the indents. SEM imaging also allowed for the 
examination of the surface morphology of the calcified tissues. To maximise the 
conductivity of the samples and improve the quality of the images obtained by Scanning 
Electron Microscopy (SEM) the samples were first sputter-coated in gold using 35mA 
for 120s (EMITECH K550, Emitech Ltd., Kent, U.K.) to ensure complete and even gold 
deposition. The microscope was operated using an accelerated voltage setting of 20kV 
with a working distance of 15mm. Energy dispersive spectroscopy microscopy (EDX) 
was used to confirm the presence of calcification by analysing the %weight and 
stoichiometric hydroxyapatite ratio of calcium to phosphorous of 1.67:1. 
8.2.8 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics-22. Shapiro–Wilk analysis 
was performed to assess the distribution of the data sets and select the most appropriate 
statistical test to employ. All datasets were not normally distributed. Therefore, Mann-
Whitney U tests were used to compare carotid and peripheral lower limb data sets and 
Kruskal-Wallis H test with Dunn-Bonferroni multiple pairwise comparisons were used to 
assess the relationship between mechanical properties and radiographic density groups. 
A p-value of less than 0.05 was deemed to be statistically significant in this study. 
  





A total of 880 indents were plotted in this study: 225 in A (130-199.99HU), 290 in B 
(300-449.99HU) and 365 in C (≥450). Out of 880 indents, a total of 752 tests provided 
usable results, 17 of which were disregarded due to incorrect indentation depth or having 
a loading curve indicative of incorrect contact between the indenter tip and the sample. A 
total of 735 results were analysed and are presented in this article. Mechanical properties 
were averaged between the 200nm and 1800nm depths in all cases. The elastic modulus 
and hardness information derived from the indents were categorised according to three 
HU groups; A (n=131), B (n=260) and C (n=343). Representative load-displacement 
curves obtained for Density Group A, B and C are depicted in Figure 8-6.   
Mean Elastic Modulus (E) and Hardness (H) values in the three radiologically classified 
density groups were: EA = 8.47GPa, EB = 17.64GPa, EC = 25.26GPa, HA = 0.38GPa, HB 
= 0.65GPa and HC = 0.92GPa. Results are presented in Fig. 5(i) and (ii). Post-hoc analysis 
revealed statistically significant differences between each pair of the three density ranges 
with respect to mechanical properties E and H (p<0.0005 in all cases). A summary of 
indent information, mean and standard deviations for mechanical properties with respect 
to density range are presented in Table 8-2. 
The mechanical properties exhibited within each density range were further analysed by 
comparing the carotid versus peripheral calcification behaviours. Results are also 
presented in Fig. 8-7 (i) and (ii). Distributions for EA and HA values were not statistically 
significantly different between carotid and peripheral lower limb samples, p = 0.773 and 
p = 0.342, respectively. EB distributions were not statistically significantly different 
between carotid and peripheral, p = 0.094, however HB distributions were, p = 0.011. 
Distributions for EC and HC values were also not statistically significantly different 
between carotid and peripheral, p = 0.514 and p = 0.653. A summary of indent 
information, mean and standard deviations for total and carotid versus peripheral density 
ranges are presented in Table 8-2. Figure 8-8 compares the elastic modulus for density 
groups A, B and C to previously published properties for other mineralised biological 
tissues. 




Figure 8-7: Total, carotid and peripheral lower limb mechanical properties. (i) Elastic Modulus 
(E) and (ii) Hardness (H), for the three radiographic density groups A, B and C. The boxes 
encompass the middle 50% of the dataset, the line within the box represents the median value and 
the extruding bars extend to the 25th and 75th percentiles. Outliers, greater than 1.5 times the 
Interquartile range, are represented by a circle. Statistical significance: *** p < 0.0005. 
 
 
Figure 8-8: Comparison of the Elastic Modulus for Density Groups A, B and C with published 
nanoindentation data for (i) arterial calcifications: Carotid calcifications (Ebenstein et al. 2009), 
AAA Calcifications (Marra et al. 2006) and Aortic Calcifications (Kot et al. 2011) and (ii) 
mineralised biological tissues: human molar cementum (Ho et al. 2004), human trabecular bone 
(longitudinal direction) (Rho et al. 1999) and human tibial cortical bone (Rho et al. 1997). 
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Table 8-2: Summary of indent information and mechanical data for Density Groups A, B and C separated into carotid and peripheral results with total results displayed 
in the right-hand columns. Results are presented as Mean ± Standard Deviations for Elastic Modulus and Hardness with Median values given in brackets (GPa). 
Density 
Group 
Location No. of Indentations Elastic Modulus Hardness 




8.71 ± 9.75 (4.1) 
8.47 ± 8.84 (4.7) 
0.39 ± 0.54 (0.14) 0.38 ± 0.49 
(0.17) 




19.42 ± 6.45 (19.1) 17.64 ± 6.63 
(18.4) 
0.75 ± 0.39 (0.68) 
0.65 ± 0.3 (0.63) 




25.21 ± 5.92 (25.1) 25.26 ± 6.18 
(24.7) 
0.95 ± 0.33 (0.91) 
0.92 ± 0.32 (0.9) 
Peripheral 195 26.10 ± 6.79 (24.5) 0.98 ± 0.36 (0.89) 




SEM analysis was utilised to further analyse the calcification structure and verify the 
location of the indents on single carotid, iliac and femoral samples. Figure 8-9 (i) displays 
an indent in density group A versus figure 8-9 (ii) which displays an indent in density 
group C. Grid lines represent the µCT image resolution of 15.5μm. The overlay of 
gridlines affords the approximation of pixel size with respect to tissue constituents. A 
white arrow identifies the indented shape in Fig.8-9 (i) which incorporates both non-
calcified and calcified tissues, confirmed by EDX analysis (Fig. 8-9 (iii) and (iv)). 
Inclusions of microcalcifications approximately 5μm in size can be seen embedded in the 
non-calcified tissue matrix independent of the larger deposit, identified by white circles. 
In contrast, figure 8-9 (ii) presents an indent from density group C which is completely 
calcified. Areas of cracking can be observed around the border of the Berkovich shape. 
 
Figure 8-9: Scanning electron microscopy (SEM) and energy dispersive x-ray (EDX) analysis. 
(i) Non-calcified (T) and calcified tissue (C) interface. Non calcified tissues are portrayed in dark 
grey with areas of calcification in light grey. The white arrow identifies an indent implanted into 
Density Group A area. The resulting contact area within density group A incorporates both non-
calcified and calcified tissues. The grid overlay represents the 15.5µm Micro-CT resolution. 
Micro-inclusions of calcification embedded in the soft tissue away from the primary calcified 
deposit are identified by white circles. (ii) An indent placed onto the calcification surface within 
a Density Group C area, exhibiting evidence of cracking around the plastically deformed 
Berkovich tip shape. The grid overlay depicts the 15.5µm Micro-CT resolution. (iii) 
Representative EDX spectra for the non-calcified (T) regions. (iv) Representative EDX spectra 
for the calcified (C) areas.  
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8.3.3 Density Patterns 
Fig.8-10 illustrates representative calcification structural classifications in this study 
within the µCT images, endorsing previous findings for calcification structures identified 
in carotid lesions (Barrett et al. 2016): speckled inclusions (Fig. 8-10(i)), diffuse spherical 
nodes (Fig. 8-10(ii)), sheet-like structures (Fig. 8-10(iii)) and macro-nodes (Fig. 8-
10(iv)). Carotid samples consistently presented with spherical nodes (Fig. 8-10(ii)), sheet-
like inclusions (Fig. 8-10(iii)) and large calcifications (Fig. 8-10(iv)) whereas peripheral 
samples exhibit highly irregular shapes including speckled inclusions (Fig. 8-10(i)) in 
addition to sheet-like structures (Fig. 8-10(iii)) and large deposits (Fig. 8-10(iv)). 
Speckled inclusions are typically low density, with a majority of pixels falling into density 
category A. As speckled inclusions coalesce and form larger deposits they typically 
increase in density with more pixels falling into density group B (Fig. 8-10(i)). 
Spherically shaped nodes typically exhibit all three density ranges, with increasing 
density towards the centre point (Fig. 8-10(ii)). Arc-shaped calcifications encompassing 
a portion of the circumference of the lesions have pixels that fall into density group B, C 
or a combination of both (Fig. 8-10(iii)). Furthermore, the larger the calcified deposit, the 
larger number of pixels appear to fall into density category C (Fig. 8-10(iv)). 
 
Figure 8-10: Representative calcification structural classifications and associated density patterns 
identified from µCT image slices. (i) Speckled sections of micro-inclusions as seen in a peripheral 
lesion composed of density group A. (ii) Spherical nodes presented in a carotid sample showing 
increasing density towards the centre point. (iii) Sheet-like calcification from a peripheral plaque 
consisting of mixed density groups B and C. (iv) Macro-calcified deposit from a carotid sample 
displaying large amounts of density group C. 
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8.4  Discussion 
Calcified components of atherosclerotic tissues have previously been identified as key 
contributors to plaque stability and endovascular treatment failure. In addition to this, 
clinicians lack mechanisms for predicting lesion rupture and tissue response prior to 
surgical intervention selection (Katano and Yamada 2007). In this study, the mechanical 
properties of arterial calcifications from carotid and peripheral lower limb regions were 
correlated against three radiographic density ranges obtained from µCT images.  
Significant differences in mechanical properties were identified between the density 
groups (p<0.0005). There is a larger difference in mechanical results between groups A 
and B than groups B and C. Density group A encompasses the outer perimeter of the 
calcified deposits and it is apparent from figure 8-9(i) that the threshold of 130HU at an 
image resolution of 15.5μm for identifying calcification includes partially calcified tissue. 
Consequently, density group A results are skewed due to the non-calcified tissue 
influence. Further work is warranted to define the radiographic thresholds which identify 
varying degrees of tissue calcification at differing clinical and laboratory image resolution 
capabilities.   
Peripheral lower limb lesions, in particular femoral samples, have been shown to contain 
a higher calcium content than those originating from the carotid region (Herisson et al. 
2011). Overall, no significant differences were found when comparing mechanical 
behaviours between carotid and peripheral samples: EA, EB, EC, HA and HC (p = 0.773, 
p=0.094, p = 0.342, p = 0.514 and p = 0.653). There is only statistical significance 
between HB for carotid and peripherals (p = 0.011). The similar mechanical behaviours 
between density groups from carotid and peripheral specimens indicates that the 
behaviours of fully calcified tissues from different arterial locations may be the same.  
Three previous authors have characterised arterial calcified deposits using 
nanoindentation (Marra et al. 2006; Ebenstein et al. 2009; Kot et al. 2011). Fig. 8-8(i) 
compares the elastic modulus of density group A, B and C to this published data. Previous 
E results for carotid calcifications exhibit a wide range (0.69 ± 2.3GPa), with outliers as 
high as 21GPa (Ebenstein et al. 2009). The authors concluded that the actual values 
expected for carotid calcifications should be within the range of 15-25GPa. E values 
reported for Abdominal Aortic Aneurysms (AAA) (Marra et al. 2006) fall between the 
results obtained for density range EB and EC obtained in this study. Kot et al. also 
examined the properties of AAA calcifications in two orthogonal directions. It was 
demonstrated that E and H did not differ between the two directions, indicating isotropic 
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behaviour for calcifications (Kot et al. 2011). The two-directional results for EAAA also 
fall between that of EB and EC in this study. These results support the hypothesis that 
calcification from different vascular territories have the same mechanical properties. 
Arterial calcification is commonly related to other mineralised tissues, such as bone (Duer 
et al. 2008; Herisson et al. 2011). Fig. 8-8(ii) presents the relation of calcification density 
results in this study to that of other mineralised biological tissues (Rho et al. 1997, 1999; 
Ho et al. 2004). EA compares well with published results for E of ultrasectioned, wet 
human dental cementum (Ho et al. 2004), EB with human vertebral trabecular bone 
(longitudinal direction) (Rho et al. 1999) and EC with human tibial cortical bone 
(interstitial lamellae, longitudinal direction) (Rho et al. 1997). In all cases, the standard 
deviation for arterial calcification properties were significantly larger than that of bone or 
tooth tissue results. It could be argued that the former tissues are highly organised 
structures (Rho et al. 1998), unlike arterial calcification (Stary 2000), deciphering the 
decreased deviations occurring with bone tissues. This study confirms the assumption that 
fully calcified atherosclerotic tissue has a modulus similar to bone tissue (17-25GPa) 
(Rho et al. 1997, 1999). 
Calcification structure types identified in this study complement previously described 
structures in literature; (1) speckled or spotty calcification (Friedrich et al. 1994; Ehara et 
al. 2004), (2) diffuse moderately sized spherical nodes (Barrett et al. 2015), (3) arc-shaped 
structures encompassing a significant portion of the lesion circumference (Hoffmann et 
al. 1998; Ehara et al. 2004; Barrett et al. 2015) and (4) large, irregular macro-nodes 
(Friedrich et al. 1994; Barrett et al. 2015). The density ranges within these 4 structural 
classifications follow distinct patterns. The areas of speckled calcification (type 1) consist 
of the lowest density range A (green). It is hypothesised that these inclusions have a lower 
degree of mineralisation due to their immaturity. Over time these speckled areas may 
grow and eventually coalesce to form larger nodes (Stary 2000). Moderately-sized 
spherical nodes (type 2) typically increase in density towards the internal core, in line 
with previous findings for calcified aortic valves (Halevi et al. 2015). This arrangement 
of density could be associated with continuous deposition over time, resulting in compact 
calcification at the centre of deposits, with larger deposits more likely to have a higher 
density. The arc-shaped calcifications around the perimeter of the plaques (type 3) 
exhibited density group B, C or a combination of both. The largest existing spherical 
macro-nodes (type 4) exhibit large quantities of the highest density group C. In addition, 
it was noted that the lowest density A consistently occurred on the exterior of all nodes, 
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presumable due to partial volume averaging effects including surrounding non-calcified 
tissues.  
Using this density pattern theory, the indents plotted within the AAA calcifications 
studied by Marra et al. and Kot et al. would presumably have been located in the centre 
of the deposits, implying a B or C density group. This provides a justification for EAAA to 
exist between that of EB and EC in this study. This is also potential evidence for 
corresponding density patterns between calcifications from different arterial regions. 
Future works should examine calcification morphologies that may be more prevalent or 
specific to distinct atherosclerotic prone regions, which could be attributed to local 
geometrical or haemodynamic patterns.  
With this knowledge of calcification density with respect to mechanical properties, it is 
now possible to incorporate true calcified tissue material properties for use computational 
models that assess either the relationship between plaque vulnerability and calcification 
or calcified tissue interaction with endovascular device deployment. Accurate 
representations of calcified plaque morphology and related mechanical properties should 
achieve more realistic tissue heterogeneity and subsequently produce more accurate 
computational predictions. In addition, should commercially available clinical imaging 
techniques achieve sufficiently high resolution (MacNeil and Boyd 2007; Gupta et al. 
2008), then this study would support superior evaluation of calcification structure and 
properties in vivo. 
8.4.1 Limitations 
There are a number of unavoidable limitations affiliated with this study. Chemical 
fixation of the tissue can lead to an increase in mechanical properties (Bushby et al. 2004). 
The samples underwent a chemical fixation process to minimise tissue damage and 
shrinkage under the intense voltage source of the µCT using methanol, ethanol and 
HMDS. The samples are embedded in ‘EpoxyCure’ to restrain the lesions in place during 
sample preparation and testing. Minor increases have been found between EAAA for 
epoxy-embedded specimens compared with free specimens (Marra et al. 2006). Grinding 
and polishing techniques used to provide the fine surface finish required for 
nanoindentation destroys specific surface structural features, limiting this study’s 
capability for analysing specific anatomical features. Moreover, the modification of tissue 
structure at the surface may affect the resulting mechanical properties retrieved, therefore 
indentation data was analysed between 200 and 1800µm depths, avoiding shallow depths 
(<200nm).  
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Optical microscope image reconstructions of the sample surface were visually matched 
to a corresponding µCT image slice to allow the three radiographic density groups to be 
mapped out. This visual method of identifying a corresponding µCT image has inherent 
limitations. However, the fine slice thickness (15.5µm) minimises potential errors. 
Similarly, the optical microscope window incorporated into the nanosuite software 
obligates the user to manually select the position of the indents on the sample surface. In 
this study, a µCT map external to the nanoindenter software was used to guide the position 
of the indents on the sample surface. However, this may permit errors in the precise indent 
location. For this reason, the authors chose to utilise three radiographic density groups to 
overcome this positioning limitation by allowing any migration to remain within the 
selected density group. 
There is an increased amount of ‘failed’ indents in density group A, partially calcified 
tissue. It is surmised that the tissue may have polished at a quicker rate than the other 
regions, resulting in a rougher surface. It is more challenging for the indenter tip to make 
correct contact with a low and uneven surface, validating the reduced rate of indent 
success in this area (58%) compared with ranges B (90%) and C (94%). Further works 
may evaluate alternative methods of surface preparation for partially calcified tissues.  
Statistical significance was acquired relating the radiographic density groups to 
mechanical properties due to the large number of tests carried out. However, only 
representative results are presented in this study that relates radiographic density patterns 
to specific calcification morphology. Methodologies to quantify this relationship between 
radiographic density and calcification morphology should be investigated in future works. 
8.5  Conclusion 
This study presents a method for estimating arterial calcification mechanical properties 
from radiographic densities by correlating mechanical behaviours to three density ranges 
obtained from µCT images. There is a positive correlation between each of the three 
radiographic density groups defined in this study and associated mechanical behaviours 
(p < 0.0005 in all cases). The wide variation in properties published for arterial 
calcifications has been clarified in this work by the stratification of calcified constituents 
according to radiographic density. This investigation confirms the hypothesis that fully 
calcified plaque tissues exhibit similar mechanical properties to bone tissue (17-25GPa). 
This research provides improved material parameters for use in computational models 
that endeavour to associate specific calcification structures with plaque rupture and 
predict tissue modification during aggressive endovascular debulking approaches. 
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Plaque stresses are concentrated at the calcified and non-calcified tissue interfaces. 
However, there are extensive ranges reported for the stiffness properties of both these 
tissue portions. The following chapter utilises two nanomechanical approaches coupled 
with high-resolution imaging techniques to characterise the mechanical properties of both 
calcified and non-calcified components of carotid atherosclerotic plaques.  
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Background: Biomechanical models predicting plaque rupture and device-tissue 
interactions rely on accurate material properties to produce reliable simulation results. 
However, there is a wide variation in the reported stiffness properties for advanced 
atherosclerotic lesions. 
Objective: The purpose of this study was to characterise isolated calcified and non-
calcified portions of ex vivo carotid atherosclerotic tissues using nanomechanical 
techniques and compare the results against previous studies. 
Methods: 11 carotid plaque samples were acquired from patients undergoing 
endarterectomy. Calcification was characterised using traditional instrumented 
indentation (TII) (n=6) and micro-computed tomography (micro-CT) was used to identify 
areas of calcification.  Ferrule-top cantilever nanoindentation (FTC) was conducted on 
non-calcified tissue regions (n=5) and adjacent tissue slices were stained with Alizarin 
Red to select regions of non-calcified tissue for testing. Scanning electron microscopy 
was employed to qualitatively assess the sample surface roughness of the calcified and 
non-calcified samples. 
Results: The results from this study demonstrate over 6 orders of magnitude difference 
in stiffness between the elastic modulus of calcified (22.40 [17.70 – 27.55] GPa) and non-
calcified (8.16 [3.85 – 14.78] kPa) carotid atherosclerotic tissues. Microscopy analysis 
indicates a larger variation in surface roughness produced with non-calcified tissue 
cryosectioning than with calcified tissue metallographic preparation, which may account 
for the increased amount of indent failures with FTC (32%) than with TII (11%). 
Conclusions: Performing high-resolution imaging and nanomechanical approaches in 
parallel produce results that clarify the wide range in reported properties for advanced 
atherosclerotic lesions. Finite element models can now incorporate more accurate 
material parameters in their simulations to produce more representative results. 
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9 Nanoindentation of calcified and non-calcified components 
of atherosclerotic tissues 
9.1 Introduction 
Cardiovascular disease is the leading cause of death worldwide (World Health 
Organisation 2018). The rupture of vulnerable coronary and carotid plaques is the root 
cause of downstream myocardial (Davies and Thomas 1984) and cerebral infractions 
(Spagnoli et al. 2004), respectively. Stresses within the plaque are concentrated at the 
calcification-fibrous interface, due to the compliance mismatch of the two tissues 
(Richardson et al. 1989; Buffinton and Ebenstein 2014), which induces cavitation, 
debonding and subsequent rupture (Maldonado et al. 2013). Additionally, calcified 
plaques are associated with increased endovascular device failures (Chang et al. 2011) 
and periprocedural complications (Müller et al. 2018). Consequently, endarterectomy is 
still the recommended mode of treatment for complex calcified carotid lesions (Barnett 
et al. 1991; Katano et al. 2014), despite the abundance of transcatheter devices available 
on the market.  
Biomechanical models have demonstrated powerful potential in predicting plaque rupture 
(Akyildiz et al. 2016) and simulating the response of diseased tissue to medical device 
deployment (Conway et al. 2017). Reliable computational simulations, therefore, have 
the capacity to improve methods of high-risk plaque identification and stratification for 
preventative intervention based on plaque content. However, the accuracy of these 
models depends largely upon representative material properties and constituent 
distribution within the plaque (Ebenstein et al. 2009; Akyildiz et al. 2011). 
Advanced atherosclerotic arteries are highly heterogeneous in nature. The main 
components of an atherosclerotic plaque include the fibrous cap, fibrotic media, necrotic 
core (or lipid pool), thrombus (or haematoma) and calcification. Moreover, calcification 
itself exists in a diverse range of morphologies from spherical microcalcifications (Kelly-
Arnold et al. 2013; Cahalane et al. 2019) to large irregular-shaped macrocalcifications 
(O’Reilly et al. 2020). The main material components of atherosclerotic plaques may thus 
be broadly sub-categorised as calcified or non-calcified (Figure 9-1) (Oyen 2015). Global 
mechanical characterisation methods, such as uniaxial extension (Walsh et al. 2014) or 
compression testing (Chai et al. 2013; Akyildiz et al. 2014), neglect this tissue diversity. 
Consequently, there is a large variation in the reported properties of atherosclerotic 
tissues, ranging from 1-2,300kPa (Cardosa and Weinbaum 2014) with both high inter- 
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and intra-specimen variability observed (Maher et al. 2009). Finite element simulations 
estimate calcification stiffness within plaque models to be anywhere from 10 times 
(Cheng et al. 1993; Imoto et al. 2005) to 4 orders of magnitude (Maldonado et al. 2012) 
stiffer than the fibrous tissue. Buffington and Ebenstein demonstrated that plaque stress 
magnitude and location varies the most with respect to increasing stiffness values for 
calcification (1MPa – 10GPa) (Buffinton and Ebenstein 2014). Therefore, accurate 
characterisation of the stiffness properties of the calcified and non-calcified portions of 
plaque tissue is of substantial importance to clarify this extensive range.  
Nanoindentation has been recommended as a reliable technique to characterise the 
different atherosclerotic tissue constituents (Ebenstein et al. 2009; Chai et al. 2014) and 
to map the mechanical changes across different material phases (Constantinides et al. 
2006). Biological indentation is frequently referred to as ‘nanoindentation’ when in fact 
it ranges from true nanoindentation to microindentation (Oyen 2010). Nanomechanical 
analysis of mineralised biological tissues using traditional commercial instruments 
requires little modification to experimental or data analysis techniques (Lewis and Nyman 
2008). Conversely, nanoindentation of soft biological tissue requires significant 
adjustments to the experimental protocol including the use of a blunt spherical tip and the 
maintenance of sample hydration throughout the testing (Ebenstein and Pruitt 2004; Oyen 
2010). Atomic Force Microscopy (AFM)-based indentation has been employed for such 
soft biological tissue characterisation (Hayenga et al. 2011; Tracqui et al. 2011; Rezvani-
Sharif et al. 2019a, 2019b). Another recently developed technology, ferrule-top cantilever 
indentation, utilises interferometric readouts, can operate while completely submerged in 
liquid (Chavan et al. 2012). 
Therefore, the purpose of this study is to separately characterise the calcified and non-
calcified portions of ex vivo carotid atherosclerotic tissues using two different methods of 
nanoindentation: traditional instrumented indentation (TII) and ferrule-top cantilever 
indentation (FTC), respectively. To classify the components of the tissue samples high-
resolution imaging and biochemical methods are used, as previously recommended 
(Ebenstein et al. 2009). Micro-computed tomography (CT) is employed to identify areas 
of calcification within lesions undergoing TII, while histological staining with Alizarin 
Red is used to identify areas of calcification in adjacent tissue sections in samples 
undergoing FTC. Additionally, to resolve the range in reported properties, the results 
from this study will be compiled and compared to those from other nanomechanical 
studies that have examined atherosclerotic tissues. While studies have demonstrated the 
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relatively smooth surfaces produced through metallographic surface preparation methods 
for calcified tissues (Rho and Pharr 1999; Cahalane et al. 2018), no investigation has been 
conducted into the effects of microtoming on soft biological samples. Therefore a sub-
objective of this study include a qualitative assessment the sample surface roughness 
produced using approaches to prepare the calcified and non-calcified tissues for 
nanomechanical analysis. 
 
Figure 9-1: Idealised cross-sectional view of an atherosclerotic artery, an excised plaque and a 
revascularised artery. The non-calcified components of an atherosclerotic plaque include the 
fibrotic media, fibrous cap, necrotic core and thrombus. The calcified components include the 
micro- and macrocalcifications. 
9.2 Methods 
9.2.1 Sample Acquisition 
Eleven carotid plaque specimens were acquired from eleven different patients undergoing 
standard endarterectomy procedures performed at the University Hospital Limerick. The 
study was approved by the hospital's Ethical Research Committee and was conducted in 
a manner that conforms to the Declaration of Helsinki. The specimens were initially 
stored at 4°C post-excision and within 24hrs the samples were then placed in phosphate-
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(n = 5) 
Total    
(n = 11) 
 
Age, Years (mean ± SD) 74 ± 8 67 ± 17 71 ± 13 
Sex, Male [n (%)] 3 (50) 2 (40) 5 (45) 
 
9.2.2 Calcified Tissue Workflow 
The calcified tissue process has been previously described (Cahalane et al. 2018). To 
prepare the tissue for micro-Computed Tomography (CT) all plaques underwent a tissue 
preservation process to minimise damage and shrinkage to the tissue (Mulvihill et al. 
2013). The samples were defrosted and cleaned in fresh PBS followed by fixation using 
100% methanol. The fixed samples were then washed in 100% ethanol prior to a 
dehydration process involving the specimen becoming subject to ascending grades of 
ethanol concentrations. Chemical drying of the samples was achieved using 
hexamethyldisilazane (Fig.9-2(i)).  
9.2.2.1 Micro-Computed Tomography Acquisition and Post Processing 
Micro-CT was performed to identify calcification within the internal structure of all 
samples (Xradia Versa 500, Zeiss, Germany). The scanning was performed with a 0.4 x 
optical magnification and 2.5 s X-ray exposure time. The x-ray source was operated at 50 
kV and 81 µA and all tomographic slices were obtained with a pixel resolution of 
15.50µm. Three-dimensional reconstructions were generated using Xradia XRM 
reconstructor (version 7.0.2817). The pixel values were rescaled using a standard 
Hounsfield Unit (HU) calibration using air, water and hydroxyapatite phantom (Barrett 
et al. 2016). This procedure was kept constant for all calcified samples. Image analysis 
was conducted using ImageJ image processing software (release 1.52a) (Schindelin et al. 
2012). The calcified portions of the tissue were identified based on their radiographic 
density thresholds (≥130HU). A representative 3D image projection of the internal 
structure of a carotid atherosclerotic plaque is presented in Figure 9-2(ii). 
9.2.2.2 Sample Preparation and Mounting 
The fixed plaque samples were embedded without vacuum in ‘EpoxiCure,’ (Buehler, 
Illinois Tool Works Inc, Illinois), at room temperature in cylindrical moulds. Once cured, 
the samples were sectioned to expose a cross-section of calcification using a low-speed 
diamond saw (IsoMet® Low-Speed Saw, Buehler) running at 200 rpm with continuous 
Chapter 9 Calcified versus Non-Calcified Nanoindentation 
 
216 
water irrigation (Fig.9-2(iii)). The sample surfaces were then polished using an automated 
polisher (Phoenix 4000, Buehler) running at 150 rpm first using progressive grades of 
silicon carbide grinding paper (600, 800, 1200 µgrit) followed by polishing with 1µm and 
0.05µm alumina powder suspensions. Between each step, the surface debris was removed 
using ultrasonic cleaning in water for 10s. Following surface preparation, the exposed 
sample surface was imaged on a light microscope (Zeiss Axio Imager.A1) and a 
corresponding micro-CT image slice was selected based on the exposed cross-sectional 
sample shape (Fig.9-2(iv)). Areas of calcified tissue were identified as those ≥300HU on 
the corresponding micro-CT images (Cahalane et al. 2018) (Fig.9-2(v)). Samples were 
stored in a sealed container were tested within 1 week of preparation.   
9.2.2.3 Instrumented Nanoindentation 
As the testing in the current study is in the range of ~10µm, the term nanoindentation will 
be used throughout. Calcification cannot be examined using the ferrule-top 
nanoindentation technique as cantilevers with a high enough stiffness to induce 
indentation into the sample (i.e. avoid a h value of 0nm) have not yet been developed 
(Chavan et al. 2012). All calcified tissue nanoindentation measurements were therefore 
obtained at room temperature using the G200 Nano Indenter (Keysight Technologies), 
fitted with a Berkovich tip (Fig.9-2(vi)). The tip shape function was assessed by carrying 
out indentations on a reference fused silica sample and comparing the results to the 
manufacturers’ specifications. Indent locations were then manually positioned on the 
calcified sample surface imaged with the light microscope coupled with the G200 system 
using identifiable landmarks. Indents were programmed to a depth of 2µm using an 
indentation strain rate of 0.05s-1. A constant oscillating displacement amplitude of 2nm 
at a frequency of 45Hz is performed to obtain continuous measurements of contact 
stiffness during the loading cycle (Fig.9-2(vii)). Elastic Modulus readings are obtained as 
a function of indentation depth and results averaged between the 200nm and 1800nm 
depths. An effort was made to distribute the indents over the available sample but a 
spacing of at least 75µm was kept between indents to avoid any neighbouring plastic 
deformation interference. Indents were dispersed throughout the available calcified tissue 
area. At least 20 indents were plotted per sample, 152 indents were programmed in total. 
The elastic modulus was obtained using the widely described Oliver and Pharr 
methodology (Oliver and Pharr 1992). The specimen modulus (Es) can be related to the 
reduced modulus (Er), provided that the indenter modulus (Ei) and Poisson’s ratios of the 
specimen and indenter (ʋs and ʋi, respectively) are known or can be estimated (Eq. 1). 
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The contact stiffness (S) is obtained by evaluating the slope of curve fit at the onset of 
unloading (Equation 2). The contact stiffness is related to the reduced elastic modulus 
(Er) using the Equation 1. The elastic modulus of the sample is derived from Equation 1 
using the relationship described in Equation 2. For a diamond indenter, Ei= 1141GPa and 
υi=0.07 and the Poisson’s ratio for arterial calcification (υs) is assumed to be 0.3 as 


















9.2.3 Non Calcified Tissue Workflow 
9.2.3.1 Tissue Sectioning 
Whole plaque samples are defrosted to room temperature and regions of interest are 
dissected to fit within the cryomoulds. Samples were then frozen in Optimal Cutting 
Temperature medium using supercooled methyl-2-butane submerged in liquid nitrogen. 
Frozen samples were stored at -80°C, pending cryosectioning. Tissues were then 
sectioned to 100µm thickness for scanning electron microscopy and nanoindentation 
measurements. Adjacent 15µm thick tissue sections were mounted on separate 
microscope slides and taken for histological analysis (Fig.9-2(viii)). Microtoming is 
considered the recommended surface preparation technique for soft, hydrated biological 
tissues that cannot be polished (Ebenstein and Pruitt 2006; Akhtar et al. 2009). A thick 
section (100μm) is used to avoid any substrate interference. 
9.2.3.2 Histology 
Defrosted 15µm thick tissue sections were rinsed in PBS followed by fixing in 4% 
paraformaldehyde solution. Sections were then stained with Alizarin Red followed by 
dehydration with alcohol and protection using mounting medium and a coverslip. The 
tissue sections were then imaged using an Olympus CKX53 Inverted Microscope with a 
Canon DS126621 camera to analyse the tissue structure and identify any areas of 
calcification. A representative 15µm histology image is shown in Figure 9-2(ix). 
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9.2.3.3 Sample Preparation and Mounting 
Tissue slices for nanoindentation (100µm thick) were defrosted and dried in the open air 
for a total of 30mins to maximise sample adhesion to the slide. After the first 10mins, the 
tissue was surrounded with a hydrophobic sealant barrier which dried to touch during the 
remaining 20mins. The fluid-cell was then filled with PBS and the sample was rehydrated 
for at least 10mins before commencing the indentation experiments, which lasted up to 
2.5 hours.   
9.2.3.4 Nanoindentation 
All non-calcified tissue nanoindentation measurements were obtained at room 
temperature using a Chiaro nanoindenter (Optics11, the Netherlands) fitted with a 
spherical 20.5µm radius glass cantilever tip with a spring constant of 0.021N/m (Fig. 9-
2(x)). Prior to the testing of the samples, the cantilever was calibrated against a thick glass 
slide and submerged in PBS. The sample slides were mounted onto the inverted 
microscope (Zeiss LSM 710 Confocal Microscope) so the sample may be visualised using 
the brightfield image setting during experimentation. The stained adjacent tissue section 
acts as a visual guide to select appropriate non-calcified locations for indentation, 
avoiding any areas of calcification that would interfere with the results. Indent locations 
were randomly positioned by tracking the location of the indenter tip and using landmarks 
identifiable with the inverted Zeiss microscope. Any areas of tissue folds or tears in the 
tissue were also avoided. Spacing of at least 10µm was kept between each indent and an 
effort was made to disperse the indents throughout the available non-calcified tissue area. 
Most indents had greater than 100µm distance between them. The maximum indentation 
depth was 6µm and the loading velocity was 1µm/s. Between 30 and 45 indents were 
programmed per sample. Data was recorded during the loading, 1s holding and unloading 
phases of the testing. All indentation experiments were completed within 3 hours of the 
initial defrosting. The Elastic Modulus (E) of the tissues were calculated from these 
readings using the Optics11 Piuma DataViewer v2 software by fitting the Hertz contact 
model to the initial 50% of the indentation loading curve (Fig.9-2(xi)) (Equation 3). The 
Poisson’s ratio for atherosclerotic tissue has been previously determined as 0.49 (Karimi 
et al. 2016). An overview of the differences in TII and FTC indentation experimental 
techniques used in this study are presented in Table 9-2. 
𝐸 =









Figure 9-2: Tissue processing and experimental workflows for calcified and non-calcified 
nanoindentation. (i) A sample prepared for micro-CT. (ii) A 3D Projection created from the 
micro-CT image stacks identifies the internal calcified deposits (white). (iii) Samples are 
embedding and sectioned at this site of calcification. (iv) After grinding and polishing, the surface 
is matched to a corresponding micro-CT slice. (v) Areas of calcification are identified as ≥300HU 
(red). (vi) Traditional instrumented indentation is conducted with a diamond Berkovich tip. (vii) 
Theoretical loading curve with continuous stiffness measurements. (viii) Frozen samples are 
cryosectioned into 100μm thick sections for indentation and adjacent 15μm thick sections for 
Alizarin Red staining. (ix) Alizarin red stain identified areas of calcification within the tissue 
section. (x) A hydrophobic barrier is constructed around the tissue sample to create a fluid cell, 
maintaining the sample hydration with PBS throughout the testing. FTC-based nanoindentation 
is conducted with a glass spherical tipped cantilever. (xi) Theoretical loading curve with the Hertz 
contact model fit to the initial 50% of the loading curve. 
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Table 9-2: Summary of the experimental differences between calcified and non-calcified tissue 
nanoindentation approaches used in this study. 
  Experimentation 




dehydration and epoxy 
embedding 
Freezing in OCT medium and 
storage at -80°C 
Surface 
Preparation 
Low speed saw sectioning 
followed by mechanical 







Alizarin red staining of 












Indenter Tip Diamond Berkovich Glass Spherical 
Temperature Room Room 
Hydration Status Dehydrated Hydrated in PBS 
Poisson's Ratio 0.3 0.49 
Control Mode Depth-controlled Piezo displacement-controlled 
Loading Profile Continuous Stiffness Trapezoidal 
Loading Condition 0.05/s 1µm/s 




Hertz Contact Model 
Reported Values 
Elastic Modulus (as a 







Piuma DataViewer Software 
V2 
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9.2.4 Scanning Electron Microscopy 
SEM analysis was carried out on representative samples to qualitatively assess the surface 
roughness. The 100µm thick tissue sections were dehydrated using drops of methanol, 
ethanol and HMDS, left to air dry, then sputter-coated in gold using 20mA for 120s 
(EMITECH K550, Emitech Ltd., Kent, U.K.). The cross-sections of calcified tissue were 
also sputter-coated in gold using 20mA for 120s. The scanning electron microscope 
(Hitachi SU-70 High- Technologies Europe GmbH, Krefeld Germany) was operated 
using an accelerated voltage setting of 20kV with a working distance of approximately 
16mm. 
9.2.5 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics version 26. Descriptive 
statistics summarising patient age and gender using mean ± SD or number (percentage), 
as appropriate (Table 9-1). Shapiro–Wilk analysis was performed to assess the 
distribution of continuous data. All statistical groupings contained at least one data set 
that was determined to be not-normally distributed. Therefore, the intersample variance 
was assessed using Kruskal-Wallis H tests and comparisons between calcified and non-
calcified results were conducted using Mann-Whitney U tests. Correlations between 
variables were assessed with Spearman’s correlation coefficients. Additionally, all 
resulted are presented as median [25th – 75th percentiles] with Tukey boxplots. Statistical 
significance was defined as p < 0.05 in this study and all p-values presented are for two-
tailed tests throughout. 
9.3  Results 
9.3.1 Patients Characteristics 
The demographics for the patients involved in this study are presented in Table 9-1. 
Samples taken from patients for calcified analysis (n=6) were 50% male with an average 
age of 74 years. Samples for non-calcified analysis (n=5) were 40% male with an average 
age of 67 years. 
9.3.2 Calcified Tissue Properties 
A total of 152 indents were programmed for the calcified tissue experiments. The 
approach test segment failed or invalid displacement caused the system to abort 17 of the 
indents. Accordingly, a total of 135 results were analysed and are presented in this study. 
A representative calcified tissue loading curve is presented in figure 9-3 (i). The loading 
curves acquired for all samples in this study are presented in Appendix A. The median 
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elastic modulus of calcified carotid atherosclerotic tissue was determined to be 22.40 
[17.70 – 27.55] GPa. Figure 9-3 (ii) presents a histogram of the results (bin width = 
1GPa). As evident, the results are approximately normally distributed. The inter-sample 
variance is presented in Figure 9-3 (iii). Sample 3 has statistically significantly lower 
elastic moduli (17.40 [14.50 – 19.40] GPa, p < 0.05) and sample 4 has statistically 
significantly higher elastic moduli (35.10 [29.93 – 37.45] GPa, p < 0.005) than all other 
samples. 
 
Figure 9-3: Calcified sample results. (i) Representative calcified nanoindentation loading curve. 
(ii) Histogram of elastic moduli results for calcified tissue (bin width = 1 GPa) (n = 135). (iii) 
Calcified elastic moduli inter-sample variance. The number of indents analysed per sample is 
denoted under each sample. 
9.3.3 Non-Calcified Tissue Properties 
A total of 197 indents were programmed for the non-calcified tissue experiments. 70 of 
these results were not used due to either no contact occurring between the indenter and 
the sample (n=9), the indentation depth was greater than 6µm (n = 6) or the profile of the 
loading curve was not correct (n = 55). Therefore, a total of 127 results are presented and 
analysed. In some cases (n=11) the loading curves displayed a softer initial indentation. 
In these cases, the Hertz model was still fit to the largest portion of the initial 50% of the 
loading curve. A representative calcified tissue loading curve is presented in figure 9-4 
(i). All the loading for curves for all samples in this study are presented in Appendix A 
of this thesis. The variation of indentation depths is presented in figure 9-4 (ii). As the 
indentation depth varied between 0µm and 6µm and the indentation velocity was constant 
at 1µm/s the strain rate applied for each test was slightly different. The relationship 
between elastic modulus acquired and estimated strain rate (𝜀̇ =
̇
) is presented in figure 
9-4 (iii). As the elastic modulus is highly dependent on the strain rate (rs = 0.964, p < 
0.0005), the results are presented according to 3 strain rate groups. The elastic modulus 
of non-calcified tissue acquired at <0.5s-1, 0.5-1s-1 and >1s-1 is 2.79 [1.46 – 5.52] kPa, 
8.73 [5.92 – 11.98] kPa and 22.30 [15.75 – 34.53] kPa, respectively (Fig.9-4(iv). The 
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inter-sample variance is presented in Figure 9-4 (v). Sample 1 had statistically 
significantly higher elastic moduli (16.24 [11.62 – 34.90] kPa) than all other samples (p 
< 0.05). However, this intersample variation appears to be related to the applied strain 
rates (Fig.9-4(vi)). 
 
Figure 9-4: Non-calcified sample results. (i) Representative non-calcified nanoindentation curve. 
(ii) Histogram of indentation depths (bin width = 0.1µm). (iii) Scatterplot of Elastic modulus 
versus strain rate. (iv) Elastic modulus for 3 strain rate groups. (v) Intersample variance elastic 
modulus. (vi) Intersample variance strain rate. Statistical significance: * p < 0.05, ** p < 0.005. 
 
As expected, there is a clear distinction between the elastic moduli of calcified (22.40 
[17.70 – 27.55] GPa) versus non-calcified (8.16 [3.85 – 14.78] kPa) carotid 
atherosclerotic tissue, p < 0.0005. The results from this study specify over 6 orders of 
magnitude difference in tissue stiffness between calcified and non-calcified portions as 
illustrated in Figure 9-5. 
Representative surface roughness scanning electron microscopy images are presented in 
Figure 9-6. The calcified surface preparation methods produced highly smooth surfaces. 
A Berkovich indent is visible in Figure 9-6 (iii). Representative surface roughness images 
for non-calcified samples are presented in Figure 9-6 (iv) - (ix). There appears to be a 
much wider variation in the sample surface roughness for cryosectioned non-calcified 
samples compared with that of the calcified samples. Figure 9-6 (iv) – (vi) present a 
relatively rough area, while figures (vii) – (ix) present a smoother area in comparison.   
 





Figure 9-5: Boxplot of calcified and non-calcified tissue elastic moduli (*** p < 0.0005). 
 
 
Figure 9-6: Scanning Electron Microscopy images of representative calcified and non-calcified 
sample surface roughness post-respective surface-preparation methods. (i)-(ii) Surface view of a 
calcified sample after undergoing mechanical polishing and grinding. (iii) A Berkovich indent is 
clearly visible in a calcified sample. (iv)-(vi) Representative images of a relatively rough non-
calcified tissue surface post cryosectioning. (vii)-(ix) Representative images of a relatively 
smooth non-calcified tissue surface post cryosectioning. 
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Figure 9-7 presents a chart comparing the elastic moduli reported for different 
atherosclerotic tissues compared with the results obtained in this study. Previous TII 
indentation of abdominal calcifications produced similar elastic moduli to this study (~20-
25GPa) (Marra et al. 2006; Kot et al. 2011). The elastic modulus for lower density 
calcification (A) underestimates the tissue properties as the indents incorporate both 
calcified and non-calcified tissue portions (Cahalane et al. 2018). Another study, which 
utilised FTIR to characterise the components of carotid plaques, reported a large range in 
the properties of calcified and partially calcified tissue, spanning six orders of magnitude 
(Ebenstein et al. 2009). However, the authors attributed this wide variation in data to the 
high surface roughness of the samples combined with incomplete isolation of the calcified 
deposits and predicted values for fully calcified tissue are more likely to be within the 
range of 10-20GPa (Coughlin 2005). AFM-based indentation of calcification report much 
lower properties than those determined with TII, 96.1 ± 18.8kPa and 103.7 ± 19.5kPa for 
coronary (Rezvani-Sharif et al. 2019b) and aortic samples (Rezvani-Sharif et al. 2019a), 
respectively. The properties reported for non-calcified fibrous tissue determined with TII 
(Ebenstein et al. 2009) are also stiffer than those determined with AFM (Tracqui et al. 
2011; Rezvani-Sharif et al. 2019b, 2019a). The properties of human carotid plaques are 
less compliant when examined using microindentation tests rather than nanoindentation. 
AFM-indentation tests report that fibrous tissues are stiffer than lipid pools, in all cases 
(Tracqui et al. 2011; Rezvani-Sharif et al. 2019b, 2019a), apart from one study which 
reported general plaque properties for murine suprarenal aortic plaques (Hayenga et al. 
2011). The results for non-calcified carotid tissue in this study fall between the reported 
values for lipid pool and fibrotic ranges for AFN studies (Tracqui et al. 2011; Rezvani-




Figure 9-7: Chart indicating the elastic moduli reported for atherosclerotic tissues determined by either traditional instrumented (TII), ferrule-top cantilever (FTC), 
Atomic Force Microscopy (AFM) or microindentation (micro). Values are presented as mean ± standard deviation (black bars with mean indicated in between), 25th 
– 75th percentiles (blue bars), minimum–maximum values (green bars) or median values (red circle) as reported in the relevant publications. Results from this study 
are highlighted in yellow. The atherosclerotic samples examined are from either coronary (Rezvani-Sharif et al. 2019b), carotid (Ebenstein et al. 2009; Chai et al. 
2013; Cahalane et al. 2018), aortic (Marra et al. 2006; Hayenga et al. 2011; Kot et al. 2011; Tracqui et al. 2011; Rezvani-Sharif et al. 2019a) or lower extremity 
(Cahalane et al. 2018) locations. One study presents the results from a murine thrombus model (Slaboch et al. 2012). The species is human in each study, unless 
otherwise specified (murine (Hayenga et al. 2011; Tracqui et al. 2011; Slaboch et al. 2012)) 
 




To improve the accuracy of computational simulations in predicting plaque rupture and 
device-tissue interactions, precise material characteristics are required for individual 
plaque components. In this study, we described two separate nanoindentation approaches 
(traditional instrumented nanoindentation and ferrule-top cantilever nanoindentation) 
coupled with high-resolution imaging techniques (micro-CT and histological staining) to 
determine the elastic moduli of isolated calcified and non-calcified carotid atherosclerotic 
tissue components. We demonstrate greater than 6 orders of magnitude difference in 
tissue stiffness between calcified and non-calcified portions and resolved some of the 
broad range of reported stiffness values for calcified plaques. 
The elastic modulus of calcified carotid tissue from this study is comparable with reported 
properties for human bone (Rho et al. 1997, 1999), as previously predicted (Ebenstein et 
al. 2009), as well as aortic (Kot et al. 2011) and aortic aneurysm (Marra et al. 2006) 
calcification. This suggests that calcification has similar properties for all atherosclerotic 
regions. The approach of coupling local characterisation methods with high-resolution 
imaging resolves the wide range of moduli obtained for partially calcified and calcified 
carotid tissues determined by Ebenstein et al., classified based on Fourier-transform 
infrared spectroscopy data. Additionally, there was no surface preparation performed in 
contrast to this study and others where the samples underwent mechanical grinding and 
polishing to produce flat surfaces prior to testing (Marra et al. 2006; Kot et al. 2011; 
Cahalane et al. 2018). The authors attribute this variation in results to a lack of surface 
preparation and the use of gross morphology and FTIR to classify the tissue samples 
(Ebenstein et al. 2009). An additional study is also mentioned in the discussion that 
determined that the correct elastic moduli for carotid calcified tissue is approximately 10-
20GPa, which confirms the results of this study (Coughlin 2005). However, AFM-based 
indentation methods appear to significantly underestimate the mechanical properties of 
calcification (Rezvani-Sharif et al. 2019b, 2019a) compared with these results (Coughlin 
2005; Marra et al. 2006; Ebenstein et al. 2009; Kot et al. 2011; Cahalane et al. 2018). 
Calcification had not previously been macroscopically isolated and characterised 
(Akyildiz et al. 2014), likely due to its irregular, and often small nature (Kelly-Arnold et 
al. 2013; Cahalane et al. 2019). Recently, however, a study by O’Reilly et al. describes 
the uniaxial extension and compression testing of discrete fibrous tissue and calcified 
deposits dissected from iliofemoral and carotid plaques. Calcification is reported as being 
over two orders of magnitude stiffer than the non-calcified fibrous tissue. These values 
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are similar to the lower range of those reported in Ebenstein et al. 2009. However, during 
endovascular procedures and normal physiological loading, the stretch capacity is 
primarily burdened by the non-calcified tissue (Barrett et al. 2018). Therefore low strain 
characterisation is appropriate for determining the properties of calcification, while non-
calcified tissues should be characterised at different length scales. Additionally, the 
macro-characterisation of large calcified particles may introduce some inhomogeneity in 
the tissue. 
Two previous studies have conducted AFM on human coronary and abdominal plaques 
(Rezvani-Sharif et al. 2019b, 2019a). Similar experimental approaches were used to 
identify the tissue components by conducting histological analysis on adjacent tissue 
sections and classified non-calcified components as lipid-rich, fibrous cap and fibrous 
tissue. It is well documented that lipid-rich plaques are softer than highly fibrous ones. 
As the tissue in this study was classified as non-calcified, it is expected the results should 
be within these two sub-categorised components, as evident in Figure 9-7. Future works 
should expand on this study by analysing the differences in the mechanical properties of 
sub-categories of non-calcified carotid plaque tissue using AFM or FTC-indentation. 
Microindentation results are slightly stiffer than the properties obtained with AFM-
indentation. However, microindentation evaluates a larger contact area of tissue that 
could explain the increase in properties. Similarly, these values are lower than reported 
tensile elastic modulus for the same tissues (Mulvihill et al. 2013; Teng et al. 2014). 
However, this is to be expected, as nanoindentation is conducted at smaller length-scales 
and strains than tensile tests, and this decrease has been previously found for soft 
biological tissues (McKee et al. 2011). Additionally, reported fibrous tissue properties 
are stiffer when characterised using TII (Ebenstein et al. 2009) than with AFM (Tracqui 
et al. 2011; Rezvani-Sharif et al. 2019a, 2019b). However, the resolution of engineering 
nanoindentation instruments is not optimal for detecting the small loads and 
displacements associated with hydrated soft biological tissue. 
The cryosectioning procedure used for non-calcified tissue characterisation resulted in 
much larger deviations in surface roughness than the calcified samples (Figure 9-6). This 
increased roughness can affect the contact between the indenter tip and the samples which 
provides a justification for the increased number of indents that did not make correct 
contact with the non-calcified sample surface (32%), compared with calcified samples 
(11%). A larger spherical tip radius of 100μm has been recommended for the 
characterisation of soft biological tissues (Ebenstein and Pruitt 2004), which could 
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overcome this issue. However, the larger contact area would result in a loss of spatial 
resolution. An alternative improvement would be the reduction in the roughness of 
sectioned tissues. As far as the authors are aware, no study has been conducted to 
investigate to optimal soft biological tissue microtoming techniques to optimise the 
resulting sample surface for indentation. Additionally, surface roughness should be 
quantitatively measured for non-calcified sample sections while submerged in liquid, to 
resemble the state of the sample during testing. 
There is a significant stiffness mismatch between the calcified and non-calcified carotid 
tissue examined in this study. However, these results were anticipated as mineralised and 
soft biological tissues are known to exhibit significantly different properties (Budday et 
al. 2019). However, some researchers still underrate these differences (Huang et al. 
2020). Calcified deposits are composed of calcium and phosphate minerals similar to 
bone (Doherty et al. 2003). In comparison, the non-calcified plaque matrix consists of 
cells, collagen, elastin, smooth muscle, hematoma, among other ECM proteins. The 
divergence in compliance at the calcification-tissue junction creates large stress gradients, 
inducing interfacial debonding and cavitation that promotes subsequent plaque rupture 
(Richardson et al. 1989; Maldonado et al. 2013; Buffinton and Ebenstein 2014). 
However, biomechanical models investigating these cases simulate calcified deposits 
anywhere from 1MPa (Imoto et al. 2005) to rigid inclusions (Hoshino et al. 2009), which 
has produced variations in numerical conclusions (Buffinton and Ebenstein 2014; Barrett 
et al. 2019). Future simulations should endeavour to adopt more representative calcified 
and non-calcified carotid plaque properties as determined in this study, to produce more 
realistic results. 
As an increasing number of studies are conducted in this field, a thorough review and 
standardisation, similar to uniaxial extension (Walsh et al. 2014) and compression studies 
(Chai et al. 2014), will establish best practices for the nanoindentation of atherosclerotic 
specimens (Oyen 2010, 2015). 
9.4.1 Limitations 
The strengths of this study include the separate nanoindentation of calcified and non-
calcified atherosclerotic tissue components using two different nanoindentation 
approaches, and coupling these approaches with high-resolution imaging modalities 
(micro-CT and histology) to fully isolate the tissue constituents prior to characterisation. 
However, some inherent limitations need to be acknowledged. 
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Firstly, this study does not utilise the same ex vivo samples to characterise the calcified 
and non-calcified tissues due to sample collection, storage and time of testing constraints. 
However, the methodology can theoretically be adapted to examine calcified and non-
calcified components from the same sample, by dissecting the regions of interest from the 
outset and then following the procedures accordingly. Additionally, endarterectomy 
specimens are devoid of arterial tissue and any residual stresses existing in vivo have been 
removed. 
The samples were stored at -20°C prior to testing due to logistical constraints. Non-
calcified tissues were also frozen a second time to -80°C to conduct tissue cryosectioning. 
Previous studies have demonstrated negligible effects of freezing cycles on arterial and 
atherosclerotic tissues (Ebenstein et al. 2009; Tracqui et al. 2011; Hemmasizadeh et al. 
2012). However, these studies only investigated the effect of one freeze-thaw cycle, not 
two. Additionally, the calcified samples were first fixed, dehydrated and embedded. 
Previous works report an increase in stiffness with calcified sample dehydration (Rho et 
al. 1999) and chemical fixation (Bushby et al. 2004; Ebenstein and Pruitt 2006), however, 
embedding in epoxy does not make a difference (Marra et al. 2006). The values acquired 
for calcified tissue in this study are also on a par with previously reported values for 
calcified samples that were not chemically fixed (but were also not hydrated) (Marra et 
al. 2006; Kot et al. 2011). Additionally, it is not understood what impact the short 
dehydration-rehydration cycle has on the non-calcified tissue structure and subsequent 
mechanics. However, sample detachment from the slide was frequently observed when 
the samples are rehydrated immediately upon defrosting. A study has demonstrated that 
different ex vivo porcine tissues reabsorb fluid nonlinearly after dehydration, with 
significant mass increases for up to 30 mins (Meyer et al. 2013). Therefore, we speculate 
that a large portion of the fluid was recovered in the time prior to nanoindentation. 
Nanoindentation allows for local material characterisation at small strains, however, this 
does not capture the nonlinear behaviour which is relevant for certain physiological and 
clinical loading conditions (Ebenstein et al. 2009; Cardosa and Weinbaum 2014; Chai et 
al. 2014). Nanoindentation test methods capable of achieving large strains have yet to be 
developed (Ebenstein et al. 2009). As mentioned above, the stretch capacity of 
atherosclerotic plaques is primarily burdened by the non-calcified tissue (Barrett et al. 
2018). Macro-mechanical methods, such as uniaxial extension testing, have characterised 
these atherosclerotic plaques at such deformations (Mulvihill et al. 2013; Cunnane et al. 
2015; Barrett et al. 2018). However, the low strain behaviour can be difficult to appreciate 
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from these tests due to the applied pre-loads and the signal-noise ratio in the low strain 
regions. Therefore, low strain properties obtained from nanomechanical experiments can 
assist in deciphering the behaviour of non-calcified atherosclerotic tissues at a thorough 
range of length scales. 
Furthermore, the Hertz model assumes a linear elastic and isotropic material response, 
which is not the case for biological tissues. However, the model is assumed to be valid at 
small indentations strains (Lin et al. 2009). The Hertz model also does not account for 
adhesion or viscoelastic effects. Minimal evidence of sample adhesion was observed in 
the loading curves. However, creep and stress relaxation behaviour is evident during the 
1 s hold period, demonstrating some hysteresis. The viscoelastic behaviour of non-
calcified atherosclerotic tissues should be characterised in future works by performing 
sample creep, stress relaxation or dynamic mechanical analysis. Additionally, all indents 
in this study were conducted in the axial direction only. There is conflicting evidence 
regarding the directional properties of these tissues with some studies identify isotropic 
behaviour (Marra et al. 2006; Kot et al. 2011; Chai et al. 2013), while others demonstrate 
anisotropy (Holzapfel et al. 2004; Chai et al. 2015). Additionally, all experiments were 
conducted at room temperature as the instruments utilised lack heating capabilities, and 
are also sensitive to thermal drift. 
Finally, this study only classified ex vivo carotid atherosclerotic tissues as either calcified 
or non-calcified. Non-calcified tissues can be further sub-categorised into fibrous tissue, 
lipid pools and thrombus (Ebenstein et al. 2009; Chai et al. 2013; Rezvani-Sharif et al. 
2019a, 2019b) or cellular and hypocellular regions (Tracqui et al. 2011). However, tissue 
sub-categorisation was deemed beyond the scope of this study. Future works should 
analyse the differences in nanomechanical properties of non-calcified atherosclerotic 
plaque tissue components. 
9.5 Conclusion 
Coupling nanoindentation approaches with high-resolution imaging improves the 
visibility and isolation of calcified and non-calcified components of atherosclerotic 
lesions advancing the heterogeneous characterisation. Accordingly, the results acquired 
in this study have provided clarity on the wide variations in reported stiffness properties 
for calcified lesions. This is the first study describing the separate nanomechanical 
characterisation of the calcified and non-calcified portions of atherosclerotic tissues. The 
elastic modulus of carotid calcifications was determined to be 22.40 [17.70 – 27.55] GPa 
and the elastic modulus of non-calcified carotid atherosclerotic tissue was determined to 
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be 8.16 [3.85 – 14.78] kPa. There is over 6 orders of magnitude difference in the stiffness 
of calcified and non-calcified carotid atherosclerotic components. Although a large 
mismatch in tissue stiffness has been previously postulated for these components, the 
results of this study demonstrate the difference conclusively. Cryosectioning of soft 
biological tissues produces increased fluctuation in the surface roughness of samples 
compared with mechanical grinding and polishing of calcified samples, decreasing the 
successful implementation of nanoindentation. This study will contribute to future 
computational investigations simulating plaque fissure and medical device deployment 
within advanced atherosclerotic arteries. A thorough review and standardisation of the 
experimental and analytical techniques for the nanoindentation of atherosclerotic tissues, 
particularly non-calcified is required. Future works should optimise non-calcified sample 
preparation and characterise the sub-categories of non-calcified atherosclerotic tissues. 
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10.1 Discussion 
The key to enhancing cardiovascular patient outcomes is the accurate identification of 
unstable plaques that require preventative intervention. The risk stratification of 
asymptomatic cardiovascular disease (CVD) patients and the identification of high-risk 
plaques, however, remains a challenge. Furthermore, there is a wide range in the reported 
mechanical properties of calcified atherosclerotic tissues, leading to inaccuracies in our 
prediction of plaque rupture and device-tissue interactions. The overall objective of this 
thesis was to investigate image- and blood-based biomarkers of atherosclerotic burden 
and high-risk plaques, respectively, and to improve the knowledge base of the stiffness 
properties of calcified atherosclerotic tissues. 
The Agatston coronary artery calcium (CAC) score is the most widely used risk 
stratification marker for CVD patients. Additionally, it is extensively utilised as an 
extracoronary calcification quantification tool. However, it is reported that the Agatston 
scores cannot be utilised in vessel-specific regions to identify unstable plaques (Mauriello 
et al. 2013). It is necessary to fully comprehend what measures of calcification are 
associated with Agatston calcium scores. The beginning of this thesis presents a 
comparison of high-resolution calcification measurements against estimations for the 
lesion Agatston calcium scores. The results from Chapter 3 demonstrate that while the 
Agatston scores strongly correlate with calcification volume and volume fractions, they 
do not correlate as well with calcified particle measurements. These results support the 
use of CAC scores in calcification quantification as surrogate markers of calcification 
volume. Larger calcified particles also display higher maximum x-ray attenuation 
densities. Therefore, these larger, denser particles (considered a more stable phenotype 
(Criqui et al. 2014)) influence the calculation of the CAC score. Similar to the findings 
of Maldonado et al. for coronary samples, there is a high prevalence of 
microcalcifications within both carotid and lower extremity lesions. This finding has 
recently been confirmed in another study (O’Reilly et al. 2020). Using the defined 
resolution to compute the Agatston scores, over 99% of the small particles and 
microcalcifications will be missed, underlining its inappropriate application to identify 
high-risk plaques (Mauriello et al. 2013). Given the proposed importance of 
microcalcifications in destabilising plaques (Hutcheson et al. 2014), it is crucial to 
identify image based-biomarkers of vulnerable plaques from clinical imaging modalities. 




To establish improved clinical image-based biomarkers of vessel-specific risk, Chapter 
4 of this thesis examined the effect of CT resolution on measurements of atherosclerotic 
calcification. A range of resolutions representative of a variety of clinical and preclinical 
CT scans were selected and comparisons were made for measurements of calcification 
volume, calcified particles and calcium density. Decreasing CT resolution 
proportionately overestimates large volumes of calcification (≥60mm3) while 
underestimating smaller calcification volumes (≤3mm3). Akin to the findings from the 
previous chapter and as anticipated, calcified particles smaller than the CT voxel volume 
will be missed. These results underscore the limitations of current CT scanner protocols 
(Lin and Alessio 2009) and the inaccuracies in the perceived measures of calcification 
that will produce considerable errors (Demer et al. 2017) in calcium scores that 
incorporate weighted cofactors (Agatston et al. 1990; Nakanishi et al. 2019). 
Furthermore, it stresses the inability of a CAC score of zero to categorically dismiss the 
presence of atherosclerotic calcification (or atherosclerosis) (Greenland and Bonow 
2008). Of interest, however, the calcium density results demonstrate a heterogeneous 
distribution across some CT resolutions. Whether or not these measurements carry 
clinical significance was examined in the subsequent chapter of this thesis. 
The purpose of Chapter 5 was to examine the efficacy of coronary-derived calcium 
scores in the carotid arteries to distinguish between plaques from patients based on 
cerebrovascular symptomology. Additionally, the distribution of low- and high-density 
calcification was examined based on the findings from the previous chapter. Agatston, 
Volume and Density-Volume scores were calculated using the described coronary 
methodologies (Agatston et al. 1990; Callister et al. 1998; Nakanishi et al. 2019). As 
predicted, the Agatston calcium scores were not significantly different between 
symptomatic and asymptomatic plaques, neither were the volume or density-volume 
calcium scores. These results support the findings from Mauriello et al., which 
demonstrate that the Agatston coronary scores cannot identify high-risk plaques. While 
asymptomatic carotid plaques have been shown to contain larger volumes of calcification 
(Hunt et al. 2002; Miralles et al. 2006) than symptomatic ones, our results did not confirm 
this. However, the previous studies examined much larger cohorts (specifically 
asymptomatic cohorts) than the current study. Despite the small sample size, this study 
did determine that plaques from patients without prior cerebrovascular symptoms have 
significantly less low-density calcification and significantly more high-density 
calcification than the symptomatic analogues. These results support the findings from the 




Multi-Ethnic Study of Atherosclerosis (MESA) trial in which calcium density was 
inversely related to cardiovascular risk (Criqui et al. 2014, 2017). CT x-ray attenuation 
numbers are subject to partial volume averaging effects. Therefore, low-density 
calcification can be considered a surrogate marker of regions of calcified and non-
calcified atherosclerotic tissue. These interfaces have been speculated as areas for stress 
concentrations (Richardson et al. 1989), confirmed by computational simulations (Kelly-
Arnold et al. 2013; Buffinton and Ebenstein 2014) and micro-CT studies (Maldonado et 
al. 2012). Screening for calcium density in current clinical CT images should indicate 
plaque stability. We recommend calcium density measurements as a crucial starting point 
for the development of vessel-specific calcium scores. Moreover, density fraction 
measurements should be reliable and reproducible, unaffected by weighted cofactors as 
described in other calcium scoring methods. The results of this proof of concept study 
require validation in large clinical cohorts. 
Since the advent of non-contrast CT in CVD patient assessment, an abundance of 
alternative imaging technologies have been developed. However, there has been no 
general consensus on the optimal modality(ies) to quantify calcific burden or distinguish 
high-risk calcification phenotypes. Chapter 6 presents an evaluation of atherosclerotic 
calcification measures corresponding to either the extent of calcification (volume, area, 
length and angle) or morphologies contributing to plaque disruption (calcified particle 
distribution). Compared with magnetic resonance (MR), intravascular ultrasound (IVUS) 
and optical coherence tomography (OCT), CT displayed the highest correlation with 
ground truth micro-CT results in the estimation of calcification volume, length, area and 
angle. IVUS demonstrated good agreements for calcification length and angle, however 
the drawback of IVUS imaging is that the sound waves cannot pass through the calcium. 
IVUS is therefore unable to quantify calcification thickness or area, determinants of 
transcatheter therapy outcomes (Maejima et al. 2016). Although the MR and OCT images 
theoretically had significantly higher resolution capabilities than the clinical CT, the 
results of this study did not reflect this. High amounts of image artefacts created 
difficulties with image processing and it was not possible to differentiation between what 
may have been small calcified particles and image noise. Advancements in automatic 
image segmentation algorithms may resolve these complications in future works (Smits 
et al. 2016). Additionally, a significant portion of calcifications within the samples 
examined in this study are beyond the maximum penetration depth of the OCT system. 
However, studies have assessed the feasibility of OCT in carotid artery stenting 




procedures and advocate its application (Reimers et al. 2011; Yoshimura et al. 2011). 
Identification of superficial calcified particles within reach of the OCT light depth may 
be adequate in predict plaque rupture, however more studies are required to validate this. 
Screening for calcification beyond the coronary arteries holds the potential for improved 
CVD patient risk stratification. To investigate this, Chapter 7 of this thesis focused on 
correlating circulating levels of blood-based biomarkers of vascular calcification against 
measures of atherosclerotic calcification in a cohort of arterial disease patients. However, 
the results from this chapter indicate these circulating markers cannot distinguish between 
carotid versus lower extremity patients or indicate the number of diagnosed 
atherosclerotic locations. Furthermore, while moderate and weak correlations were 
determined between dp-ucMGP and %ucOC between CAC density and total volume of 
calcification the associations were only significant for certain patient subgroups. These 
findings contribute to the conflicting evidence existing regarding blood-based biomarkers 
and vascular calcification. The use of a blood-based biomarker is an appealing means of 
clinical risk stratification in CVD patient assessment. However, it remains elusive. It is 
likely that one single biomarker may not be sufficient to conduct such an assessment 
(Eslava-Alcon et al. 2020). Future studies should endeavour to standardise methods of 
measuring vascular calcification and consider the relationship between tissue protein 
expression and circulating species.  
Global characterisation techniques disregard the highly heterogeneous nature of 
atherosclerotic tissues required to determine accurate biomechanics. Moreover, there is a 
dearth of experimental studies that separately characterise the calcified and non-calcified 
plaque portions. Consequently, large variations exist in the published properties for 
calcification. The purpose of Chapter 8 was to utilise a combined approach of micro-CT 
and traditional nanoindentation to accurately identify and determine the elastic modulus 
and hardness of calcified deposits within ex vivo atherosclerotic samples. The location of 
indents were mapped within three defined radiography density groups A (130-229HU), 
B (300-449HU) and C (≥450HU). The use of micro-CT and surface preparation 
procedures allowed precise areas of calcification to be identified and surface roughness 
errors alleviated, as previously recommended (Ebenstein et al. 2009). Examination of 
sample cross-sections with SEM and EDX identified areas of partial volume averaging 
effects, even with a micro-CT resolution 15.68μm. The results of this study confirm the 
hypothesis that fully calcified tissue has similar stiffness properties to human bone tissue. 
Additionally, there were no differences observed in the behaviours of carotid and lower 




extremity calcifications, or between the results from this study and those for aortic 
abdominal and aneurysm calcifications. Therefore, is it possible that uniform properties 
may be applied to fully calcified tissue from different vascular territories. These 
exceptionally stiff tissue behaviours highlight the rigid barrier posed by large calcified 
plaque burdens against endovascular medical devices that lead to interventional failure, 
supporting the use of aggressive lesion preparation techniques (Dini et al. 2019; Perfetti 
et al. 2019). 
Moreover, studies have demonstrated that calcified particles play a critical role in the 
rupture of fibrous caps caused by the compliance mismatch between the calcified and 
non-calcified tissue constituents. However, as mentioned above, the range of stiffness 
values reported for calcified atherosclerotic lesions varies greatly. To address this issue, 
Chapter 9 presents two methodologies for the characterisation of calcified versus non-
calcified ex vivo carotid plaque tissue. Like above, histological processing techniques 
were used to identify areas of non-calcified tissue for characterisation using FTC-based 
indentation. The results indicate over 6 orders of magnitude difference in stiffness 
between calcified and non-calcified carotid tissues. This challenges previous studies that 
employed much lower differences in tissue stiffness in their finite element simulations. 
Biomechanical models which utilise more representative tissue stiffness values will 
produce rigorous results to interpret the manifestations of calcification which negatively 
affect plaque tissue integrity, and those responsible for the onset of downstream 
symptoms.   
There are some limitations associated with the work presented in this thesis, all of which 
are addressed in full within each chapter. Primarily, there is a lack of preoperative clinical 
imaging available to confirm the ex vivo findings. Future studies should evaluate the use 
of calcium density in clinical non-contrast CT scans as measures of plaque stability. 
However, it should be noted that the preliminary ex vivo imaging data presented in this 
thesis is required to advocate for such clinical trials to be initiated. This and some other 
aspects for future work in line with that presented in this thesis are discussed in section 
10.3. 
  





A number of key conclusions and important contributions can be drawn from the findings 
of the work presented in this thesis: 
 The Agatston calcium score can be used as a proxy for calcification volume. 
However, it should not be adopted to determine vessel-specific risk. There is a 
high prevalence of microcalcifications within carotid and lower extremity 
atherosclerotic lesions. Additionally, larger calcified particles have higher x-ray 
attenuation densities.  
 CT resolution plays an important role in calcification quantification. Large 
volumes of calcification will be overestimated in size while calcification below a 
certain threshold will be underestimated and missed. Additionally, clinical CT is 
a poor tool to estimate the calcified particle distribution. However, there is a 
heterogeneous distribution of calcium density that may carry clinical significance.  
 Coronary-derived carotid calcium scores cannot differentiate between carotid 
plaques from patients based on cerebrovascular symptomology. However, 
plaques from symptomatic patients exhibit higher fractions of low-density 
calcification and lower fractions of high-density calcification. Screening for 
carotid calcium density in routine clinical CT could identify those at risk of 
cerebrovascular events. 
 Clinical CT is the most reliable indicator of calcific burden, a predictor of 
endovascular device success. Reliable clinical methods of identifying superficial 
microcalcifications and spotty calcifications associated with lesion instability 
have yet to be established. 
 The use of a blood-based biomarker as a diagnostic for calcified atherosclerotic 
burden remains attractive yet elusive. Some moderate and weak negative 
correlations were observed between circulating dp-ucMGP and %ucOC with 
CAC scores and densities. Areas requiring standardisation and considerations for 
further studies are presented. 
 Calcification exhibits distinct tissue stiffness properties with respect to 
radiographic density. Fully calcified carotid and lower extremity atherosclerotic 
tissues exhibit similar elastic modulus to human bone (17-25GPa). 
 There is a high compliance mismatch between calcified and non-calcified tissues 
which exceeds 6 orders of magnitude. 




Much research undervalues the significance of calcification in cardiovascular patient 
diagnosis and treatment. This thesis presents a novel measure of calcium density fraction, 
which may be used to screen for lesion-specific risk and identifies some associations 
between circulating blood biomarkers and calcified patient risk markers (CAC scores and 
density). More refined stiffness properties for fully calcified tissue will assist in the 
stratification of plaques for treatment based on their predict response to a variety of 
interventions. The optimisation of atherosclerotic disease diagnosis and treatment will 
ultimately improve patient outcomes.   
10.3 Future Work 
10.3.1 Calcified Plaque Imaging 
10.3.1.1 Carotid Artery Calcium Guidelines 
Societies such as the society for cardiovascular computed tomography produce guidelines 
for healthcare providers worldwide based on the most recent scientific findings from well-
designed clinical studies while taking logistic constraints such as costs into consideration. 
There are currently no guidelines on the prognostic use of calcium measurements in the 
carotid arteries (Hecht et al. 2017). The results from the proof of concept study in 
Chapter 5 of this thesis indicate that calcium density fractions may indicate carotid 
plaque stability associated with downstream cerebral infarcts. However, these results 
require confirmation in longitudinal clinical studies. A study of carotid arterial disease 
could be initiated, similar to the Multi-Ethnic Study of Atherosclerosis (Bild et al. 2002), 
which examines a large number of asymptomatic individuals from multiple healthcare 
centres. Baseline non-contrast CT images of the carotid arteries should be acquired and 
individuals could then be followed up over a defined period of time to record the 
occurrence and severity of cerebral infarcts. If the calcium density fraction measures are 
determined to be a significant prognostic marker of cerebrovascular events, it is likely 
that guidelines produced by expert committees to assist clinicians in healthcare decision 
making will include these measures. 
10.3.1.2 Radiomics 
In Chapter 4 we determined that the distribution of calcium density is heterogeneous at 
clinically-relevant CT resolutions. We hypothesised that these density measurements 
could be clinically significant. This theory was supported by the results from Chapter 5 
demonstrated that asymptomatic patients have higher fractions of high-density 
calcification and lower fractions of low-density calcification than those from 




symptomatic patients. Currently, clinical image analysis is based on user-dependent semi-
quantitative interpretation; identification of high-risk features or the use of calcium 
scoring software. Often reader agreement and reproducibility are poor (Callister et al. 
1998, Maroules et al. 2018). Radiomics is an approach that utilises large datasets of 
medical images to extract quantitative features and conducts analysis via data integration 
and machine-learning model building against specific outcomes (Gillies et al. 2016). This 
approach could be utilised in the analysis of non-contrast CT scans examining 
atherosclerotic calcification to determine features of high-risk calcified plaques that are 
less dependent on the use of experienced radiologists (Kolossváry et al. 2019). Some 
defined high-risk plaque features have already been more accurately discriminated using 
radiomics approach compared with conventional identification (Kolossváry et al. 2017). 
We hypothese that specific patterns of x-ray attenuation density distributions, specifically 
estimated morphologies and proximity to the lumen, will be associated with certain 
cardiovascular outcomes including rupture, erosion or stabilisation. Improved assessment 
of calcification patterns within atherosclerotic lesions should identify those that are likely 
to self-stabilise or regress, respond to medication or require physical intervention. This 
approach would permit the use of calcium density measurements in clinical practice. 
 
Figure 10-1: Proposed radiomics workflow for the identification of high-risk calcium density 
patterns. Radiomics and Machine Learning features are extracted from Kolossváry et al. 2019. 
10.3.1.3 Positron-Emission Tomography 
In Chapter 4 of this thesis, it was determined that CT resolution is the limiting factor in 
calcified particle detection. The highest resolution achieved by clinical CT technology is 
60μm (HRPQCT), which is still larger than the defined dimensions for 
microcalcifications (<50μm in spherical diameter) (Kelly-Arnold et al. 2013). Moreover, 
small calcified particles were not accurately identified using alternative imaging 
modalities in Chapter 6. The accurate detection of biologically active microcalcification 
growth within vascular tissue, therefore, remains a challenge. Positron-emission 
tomography (PET) is a form of nuclear medicine functional imaging modality that utilises 




radiotracers to observe biological metabolic processes. 18F-sodium fluoride (18F-NaF) 
has emerged as a radiotracer capable of identifying calcified deposits. This radiotracer 
binds to the surface of calcified deposits, and in this manner, it can distinguish between 
the two primary calcification phenotypes: microcalcifications and macrocalcifications, 
due to the difference in surface areas (Irkle et al. 2015). This modality holds much 
potential in the discrimination between these critical calcification morphologies.  It has 
also been shown that sites of 18F-NaF uptake correspond with culprit plaques (Joshi et al. 
2014), PET-positive regions of atherosclerotic plaques (where CT signal is negative) and 
the presence of microcalcifications (Creager et al. 2019). Additionally, PET scanning 
provides distinct information from CAC scoring (Dweck et al. 2012). Therefore, the 
combined use of CT and 18F-NaF PET has the potential to simultaneously identify high-
risk calcification morphologies and the extent of macrocalcifications associated with 
transcatheter therapy failures. Figure 10-2 presents the relationships between CT x-ray 
attenuation density and PET 18F-NaF radiotracer uptake within cross-sections of ex vivo 
human carotid plaques. 
 
Figure 10-2: 18-NaF Positron Emission Tomography (PET) radiotracer uptake versus Computed 
Tomography (CT) Hounsfield Unit (HU) density across sections of calcified carotid plaques (Irkle 
et al. 2015). 
10.3.2 Tissue Microenvironment Characterisation 
The results from Chapter 7 of this thesis demonstrated that circulating biomarkers of 
vascular calcification did not correlate with the calcific burden of arterial disease patients. 
The discussion within that chapter concluded that circulating proteins do not necessarily 
correspond directly with the pathological expressions at the diseased site. Therefore, 
future work characterising biological activity at the atherosclerotic tissue level may be 




more informative and provide a mechanistic insight. Calcification does not respond well 
to traditional medications (Nicholls et al. 2007) and the mechanisms involved in 
calcification progression and lesion stabilisation are not well understood. However, it is 
known that large, dense macrocalcifications have a stabilising effect. A hypothesis has 
thus been proposed to develop therapeutic strategies capable of leveraging calcification 
growth towards plaque stabilisation (Hutcheson et al. 2014). The key to the development 
of such therapeutics may lie in an understanding of the difference between the 
microenvironments surrounding stable versus unstable phenotypes of calcification rather 
than the calcifications themselves (Shi et al. 2020). Due to the heterogeneous nature of 
atherosclerotic plaques, a proteomic analysis of an entire specimen would not be 
appropriate to determine these microenvironmental differences. Therefore, a proposed 
workflow capable of distinguishing between results from distinct regions within calcified 
plaques is presented in Figure 10-3. This procedure would involve serial tissue sectioning 
followed by the determination of coregistered 1) histological features, 2) biomechanical 
features and 3) cellular profiling. Such a workflow would create and integrate 
multidimensional data across sections of heterogeneous human atherosclerotic tissue, 




requiring a discovery data analysis approach (Rogers and Aikawa 2018), which may be 
able to answer the vital question: why do some calcifications stabilise the plaque?  
 
Figure 10-3: Proposed workflow: (i) Tissue acquisition and serial sectioning. (ii) Histological 
and immunoflourescence analysis. (iii) Cellular resolution biomechanical characterisation. (iv) 
Single cell RNA sequencing. (v) Multidimensional data integration and analysis. 
10.3.3 Mechanics 
Computational simulations require accurate sample geometries, component distributions 
and material properties to produce reliable results (Ebenstein et al. 2009). Calcified lesion 
geometries can be obtained from imaging modalities or estimated from idealised models. 
The calcified particle distribution of coronary samples has been described elsewhere 
(Maldonado et al. 2012) and the calcified particle distribution for carotid and lower 
extremity samples are presented in Chapter 3 of this thesis. These findings emphasise 
the necessity to include calcification within numerical simulations. However, a large 
variation previously existed in the mechanical properties defined for calcified 




atherosclerotic properties, which was addressed with the use of nanomechanical 
characterisation methods in Chapter 8 and Chapter 9. However, a drawback of 
nanoindentation experimentation is that the testing is performed at small strains and 
therefore the high-strain non-linear behaviour, which is relevant for conditions such as 
physiological loading in the fibrous cap and the response of the tissue to device 
deployment at large deformations, is not captured (Cardosa and Weinbaum 2014; Chai et 
al. 2014). To obtain these behaviours tensile and compressive extension testing could be 
performed on the non-calcified and calcified tissue segments, respectively. A strip of 
tissue containing minimal calcification can be sectioned from the plaque, while large 
calcified deposits can also be pried from the main plaque body (Fig.10-4(i)). The results 
of the mechanical characterisation experiments can be used to build strain energy density 
functions with curve fitting techniques, similar to the approach described in Reilly et al. 
2020. Figure 10-4 (ii) presents an example of a Yeoh fit to stress-stretch experimental 
data for carotid atherosclerotic plaques (Teng et al. 2015). Such expressions can be input 
into finite element solvers to conduct computational simulations requiring non-linear 
tissue behaviour. 
 
Figure 10-4: Macrocharacterisation of calcified and non-calcified carotid atherosclerotic tissue. 
(i) Idealised carotid plaque model containing a variety of calcified particles. A strip of tissue 
devoid of calcification can be excised for tensile testing while a large calcified deposit can be 
removed from the tissue from unconfined compression testing. (ii) Cauchy stress–stretch ratio 
plots for 21 carotid plaque specimens characterised as fibrous cap, media, lipid and intraplaque 
haemorrhage. Yeoh strain energy density functions are fit to each of the plaque components (Teng 
et al. 2015). 
Summary 
The use of radiomic analysis on large medical imaging datasets will accelerate the clinical 
implementation of calcium density measurements. Additionally, the coupled use of PET 
and CT will identify microcalcifications in early atherosclerotic lesions, and 
macrocalcifications. A platform to analyse the spatial heterogeneity of advanced 
atherosclerotic plaques, specifically the microenvironment surrounding different 




calcified phenotypes, will yield mechanistic information required to develop 
pharmacological therapies. Mechanical characterisation of tissues at physiologically 
appropriate stretches will describe the high-strain non-linear behaviour of advanced 
atherosclerotic plaques. Simultaneously, these approaches will advance 1) the clinical 
assessment of atherosclerotic cardiovascular disease patients, 2) discovery therapeutic 
agents for lesion stabilisation and 3) more accurately predict the behaviour of these tissues 
in simulated physiological loading conditions.   
References 
Agatston, A.S., Janowitz, W.R., Hildner, F.J., Zusmer, N.R., Viamonte, M., Detrano, R. (1990) 
‘Quantification of coronary artery calcium using ultrafast computed tomography’, Journal of the 
American College of Cardiology, 15(4), 827–832. 
Barrett, H., O’Keeffe, M., Kavanagh, E., Walsh, M., O’Connor, E. (2018) ‘Is Matrix Gla Protein 
Associated with Vascular Calcification? A Systematic Review’, Nutrients, 10(4), pii: E415. 
Bild, D.E., Bluemke, D.A., Burke, G.L., Detrano, R., Diez Roux, A. V., Folsom, A.R., Greenland, 
P., Jacobs, D.R., Kronmal, R., Liu, K., Nelson, J.C., O’Leary, D., Saad, M.F., Shea, S., Szklo, 
M., Tracy, R.P. (2002) ‘Multi-Ethnic Study of Atherosclerosis: Objectives and design’, American 
Journal of Epidemiology, 156(9), 871–881. 
Buffinton, C.M., Ebenstein, D.M. (2014) ‘Effect of Calcification Modulus and Geometry on 
Stress in Models of Calcified Atherosclerotic Plaque’, Cardiovascular Engineering and 
Technology, 5(3), 244–260. 
Callister, T.Q., Cooil, B., Raya, S.P., Lippolis, N.J., Russo, D.J., Raggi, P. (1998) ‘Coronary 
artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric 
method.’, Radiology, 208(3), 807–814. 
Cardosa, L., Weinbaum, S. (2014) ‘Changing Views of the Biomechanics of Vulnerable Plaque 
Rupture, a Review’, Ann Biomed Eng, 42(2), 415–431. 
Chai, C.K., Speelman, L., Oomens, C.W.J., Baaijens, F.P.T. (2014) ‘Compressive mechanical 
properties of atherosclerotic plaques - Indentation test to characterise the local anisotropic 
behaviour’, Journal of Biomechanics, 47(4), 784–792. 
Creager, M.D., Hohl, T., Hutcheson, J.D., Moss, A.J., Schlotter, F., Blaser, M.C., Park, M.A., Ho 
Lee, L., Singh, S.A., Alcaide-Corral, C.J., Tavares, A.A.S., Newby, D.E., Kijewski, M.F., 
Aikawa, M., Di Carli, M., Dweck, M.R., Aikawa, E. (2019) ‘18F-fluoride signal amplification 
identifies microcalcifications associated with atherosclerotic plaque instability in positron 
emission tomography/computed tomography images’, Circulation: Cardiovascular Imaging, 
12(1), e007835. 
Criqui, M., Denenberg, J.O., Ix, J.H., McClelland, R.L., Wassel, C.L., Rifkin, D.E., Carr, J.J., 
Budoff, M.J., Allison, M.A. (2014) ‘Calcium Density of Coronary Artery Plaque and Risk of 
Incident Cardiovascular Events’, Jama, 311(3), 271–278. 
Criqui, M.H., Knox, J.B., Denenberg, J.O., Forbang, N.I., McClelland, R.L., Novotny, T.E., 
Sandfort, V., Waalen, J., Blaha, M.J., Allison, M.A. (2017) ‘Coronary Artery Calcium Volume 
and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of 
Atherosclerosis’, JACC: Cardiovascular Imaging, 10(8), 845–854. 
Demer, Tintut, Nguyen, Hsiai, Lee (2017) ‘Rigor and Reproducibility in Analysis of Vascular 
Calcification’, Circulation, 120(8), 1240-1242. 




Dini, C.S., Nardi, G., Ristalli, F., Mattesini, A., Hamiti, B., Mario, C. Di (2019) ‘Contemporary 
Approach to Heavily Calcified Coronary Lesions’, Interventional Cardiology Review, 14(3), 
154–163. 
Dweck, M.R., Chow, M.W.L., Joshi, N. V., Williams, M.C., Jones, C., Fletcher, A.M., 
Richardson, H., White, A., McKillop, G., Van Beek, E.J.R., Boon, N.A., Rudd, J.H.F., Newby, 
D.E. (2012) ‘Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology’, 
Journal of the American College of Cardiology, 59(17), 1539–1548. 
Ebenstein, D.M., Coughlin, D., Chapman, J., Li, C., Pruitt, L.A. (2009) ‘Nanomechanical 
properties of calcification, fibrous tissue, and hematoma from atherosclerotic plaques’, Journal of 
Biomedical Materials Research - Part A, 91(4), 1028–1037. 
Eslava-Alcon, S., Extremera-García, M.J., González-Rovira, A., Rosal-Vela, A., Rojas-Torres, 
M., Beltran-Camacho, L., Sanchez-Gomar, I., Jiménez-Palomares, M., Alonso-Piñero, J.A., 
Conejero, R., Doiz, E., Olarte, J., Foncubierta-Fernández, A., Lozano, E., García-Cozar, F.J., 
Rodríguez-Piñero, M., Alvarez-Llamas, G., Duran-Ruiz, M.C. (2020) ‘Molecular signatures of 
athersoclerotic plaques: An up-dated panel of protein related markers’, Journal of Proteomics, 
Epub. 
Gillies, R.J., Kinahan, P.E., Hricak, H. (2016) ‘Radiomics: Images are more than pictures, they 
are data’, Radiology, 278(2), 563–577. 
Hecht, H.S., Cronin, P., Blaha, M.J., Budoff, M.J., Kazerooni, E.A., Narula, J., Yankelevitz, D., 
Abbara, S. (2017) ‘2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast 
noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and 
Society of Thoracic Radiology’, Journal of Cardiovascular Computed Tomography, 11, 74-84. 
Hunt, J.L., Fairman, R., Mitchell, M.E., Carpenter, J.P., Golden, M., Khalapyan, T., Wolfe, M., 
Neschis, D., Milner, R., Scoll, B., Cusack, A., Mohler 3rd, E.R. (2002) ‘Bone formation in carotid 
plaques: a clinicopathological study’, Stroke, 33(5), 1214–1219. 
Hutcheson, J.D., Maldonado, N., Aikawa, E. (2014) ‘Small entities with large impact: 
Microcalcifications and atherosclerotic plaque vulnerability’, Current Opinion in Lipidology, 
25(5), 327–332. 
Imoto, K., Hiro, T., Fujii, T., Murashige, A., Fukumoto, Y., Hashimoto, G., Okamura, T., 
Yamada, J., Mori, K., Matsuzaki, M. (2005) ‘Longitudinal structural determinants of 
atherosclerotic plaque vulnerability: A computational analysis of stress distribution using vessel 
models and three-dimensional intravascular ultrasound imaging’, Journal of the American 
College of Cardiology, 46(8), 1507–1515. 
Irkle, A., Vesey, A.T., Lewis, D.Y., Skepper, J.N., Bird, J.L.E., Dweck, M.R., Joshi, F.R., 
Gallagher, F.A., Warburton, E.A., Bennett, M.R., Brindle, K.M., Newby, D.E., Rudd, J.H., 
Davenport, A.P. (2015) ‘Identifying active vascular microcalcification by 18F-sodium fluoride 
positron emission tomography’, Nature Communications, 6, 7495. 
Joshi, N. V, Vesey, A.T., Williams, M.C., Shah, A.S.V., Calvert, P.A., Craighead, F.H.M., Yeoh, 
S.E., Wallace, W., Salter, D., Fletcher, A.M., Van Beek, E.J.R., Flapan, A.D., Uren, N.G., Behan, 
M.W.H., Cruden, N.L.M., Mills, N.L., Fox, K.A.A., Rudd, J.H.F., Dweck, M.R., Newby, D.E. 
(2014) ‘18F-fluoride positron emission tomography for identification of ruptured and high-risk 
coronary atherosclerotic plaques: A prospective clinical trial’, The Lancet, 383(9918), 705–713. 
Kelly-Arnold, A., Maldonado, N., Laudier, D., Aikawa, E., Cardoso, L., Weinbaum, S. (2013) 
‘Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries’, 
Proceedings of the National Academy of Sciences, 110(26), 10741–10746. 
Kolossváry, M., De Cecco, C.N., Feuchtner, G., Maurovich-Horvat, P. (2019) ‘Advanced 
atherosclerosis imaging by CT: Radiomics, machine learning and deep learning’, Journal of 
Cardiovascular Computed Tomography, 13(5), 274–280. 
Kolossváry, M., Karády, J., Szilveszter, B., Kitslaar, P., Hoffmann, U., Merkely, B., Maurovich-
Horvat, P. (2017) ‘Radiomic Features Are Superior to Conventional Quantitative Computed 




Tomographic Metrics to Identify Coronary Plaques with Napkin-Ring Sign’, Circulation: 
Cardiovascular Imaging, 10(12), e006843. 
Lin, E., Alessio, A. (2009) ‘What are the basic concepts of temporal, contrast, and spatial 
resolution in cardiac CT?’, Journal of Cardiovascular Computed Tomography, 3(6), 403–408. 
Maejima, N., Hibi, K., Saka, K., Akiyama, E., Konishi, M., Endo, M., Iwahashi, N., Tsukahara, 
K., Kosuge, M., Ebina, T., Umemura, S., Kimura, K. (2016) ‘Relationship between thickness of 
calcium on optical coherence tomography and crack formation after balloon dilatation in calcified 
plaque requiring rotational atherectomy’, Circulation Journal, 80(6), 1413–1419. 
Maldonado, N., Kelly-Arnold, A., Vengrenyuk, Y., Laudier, D., Fallon, J.T., Virmani, R., 
Cardoso, L., Weinbaum, S. (2012) ‘A mechanistic analysis of the role of microcalcifications in 
atherosclerotic plaque stability: potential implications for plaque rupture’, AJP: Heart and 
Circulatory Physiology, 303(5), H619–H628. 
Maroules, C.D., Hamilton-Craig, C., Branch, K., Lee, J., Cury, R.C., Maurovich-Horvat, P., 
Rubinshtein, R., Thomas, D., Williams, M., Guo, Y., Cury, R.C. (2018) ‘Coronary artery disease 
reporting and data system (CAD-RADSTM): Inter-observer agreement for assessment categories 
and modifiers’, Journal of Cardiovascular Computed Tomography, 12(2), 125–130. 
Mauriello, A., Servadei, F., Zoccai, G.B., Giacobbi, E., Anemona, L., Bonanno, E., Casella, S. 
(2013) ‘Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque’, 
Atherosclerosis, 229(1), 124–129. 
Miralles, M., Merino, J., Busto, M., Perich, X., Barranco, C., Vidal-Barraquer, F. (2006) 
‘Quantification and Characterization of Carotid Calcium with Multi-detector CT-angiography’, 
European Journal of Vascular and Endovascular Surgery, 32(5), 561–567. 
Nakanishi, R., Delaney, J., Post, W., Dailing, C., Blaha, M., Palella, F., Witt, M., Brown, T., 
Kingsley, L., Osawa, K., Ceponiene, I., Nezarat, N., Rahmani, S., Kanisawa, M., Jacobson, L., 
Budoff, M. (2019) ‘A novel density-volume calcium score by non-contrast CT predicts coronary 
plaque burden on coronary CT angiography: Results from the MACS (Multicenter AIDS cohort 
study)’, Journal of Cardiovascular Computed Tomography, S1934-5925. 
Nicholls, S.J., Tuzcu, E.M., Wolski, K., Sipahi, I., Schoenhagen, P., Crowe, T., Kapadia, S.R., 
Hazen, S.L., Nissen, S.E. (2007) ‘Coronary Artery Calcification and Changes in Atheroma 
Burden in Response to Established Medical Therapies’, Journal of the American College of 
Cardiology, 49(2), 263–270. 
O’ Reilly, B.L.O., Hynes, N., Sultan, S., Mchugh, P.E., Mcgarry, J.P. (2020) ‘An Experimental 
and Computational Investigation of the Material Behaviour of Discrete Homogenous Iliofemoral 
and Carotid Atherosclerotic Plaque’, Journal of Biomechanics, DOI: 
https://doi.org/10.1016/j.jbiomech.2020.109801. 
Perfetti, M., Fulgenzi, F., Radico, F., Toro, A., Procopio, A., Maddestra, N., Zimarino, M. (2019) 
‘Calcific lesion preparation for coronary bifurcation stenting’, Cardiology Journal, 26(5), 429–
437. 
Reimers, B., Nikas, D., Stabile, E., Favero, L., Saccà, S., Cremonesi, A., Rubino, P. (2011) 
‘Preliminary experience with optical coherence tomography imaging to evaluate carotid artery 
stents: Safety, feasibility and techniques’, EuroIntervention, 7(1), 98–105. 
Richardson, P.D., Davies, M.J., Born, G.V.R. (1989) ‘Influence of plaque configuration and stress 
distribution on fissuring of coronary atherosclerotic plaques’, The Lancet, 334(8669), 941–944. 
Rogers, M.A., Aikawa, E. (2018) ‘Cardiovascular calcification: artificial intelligence and big data 
accelerate mechanistic discovery’, Nature Reviews Cardiology,16(5), 261-274. 
Shi, X., Gao, J., Lv, Q., Cai, H., Wang, F., Ye, R., Liu, X. (2020) ‘Calcification in Atherosclerotic 
Plaque Vulnerability: Friend or Foe?’, Frontiers in Physiology, 11, 56. 




Smits, L.P., Van Wijk, D.F., Duivenvoorden, R., Xu, D., Yuan, C., Stroes, E.S., Nederveen, A.J. 
(2016) ‘Manual versus automated carotid artery plaque component segmentation in high and 
lower quality 3.0 tesla MRI scans’, PLoS ONE, 11(12), 1–12. 
Teng, Z., Yuan, J., Feng, J., Zhang, Y., Brown, A.J., Wang, S., Lu, Q., Gillard, J.H. (2015) ‘The 
influence of constitutive law choice used to characterise atherosclerotic tissue material properties 
on computing stress values in human carotid plaques’, Journal of Biomechanics, 48(14), 3912–
3921. 
Yoshimura, S., Kawasaki, M., Yamada, K., Hattori, A., Nishigaki, K., Minatoguchi, S., Iwama, 



















Figure A-2: Elastic modulus versus depth for continuous stiffness measurements for calcified 
sample analysis.  
 
  





Figure A-3: Non-calcified loading curves and Hertz fit (sample 1).  
 
  

























Figure A-6: Non-calcified loading curves and Hertz fit (sample 4). 
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A B S T R A C T
Background: The Agatston Calcium Score is a predictor of major adverse cardiovascular events but it is unable to
identify high-risk lesions. Recent research suggests that examining calcification phenotype could be more in-
dicative of plaque stability.
Objective: To examine the Agatston score's ability to determine atherosclerotic calcification phenotype.
Methods: Micro-Computed Tomography was performed on 20 carotid and 20 peripheral lower limb lesions.
ImageJ pixel histogram analysis quantified the non-calcified (≥30HU, < 130HU) and calcified (≥130HU) tissue
volumes. ImageJ ‘3D Objects Counter’ plugin determined the calcified particle count, volumes and maximum
attenuation density of each particle. Image stacks were subsequently downsampled to a resolution of
0.7 × 0.7 × 3 mm and an approximation for the Extra-Coronary Calcium Scores (ECCS) were calculated.
Spearman's correlation examined the relationships between ECCS approximations and calcification parameters.
Results: ECCS has a strong positive correlation with the Calcified Volume Fraction (CVF) (rs = 0.865,
p < 0.0005), weak positive correlations with Calcified Particle Fraction (CPF) (rs = 0.422, p = 0.007) and
Microcalcification Fraction (micro-CF) (rs = 0.361, p = 0.022). There is no correlation evident between ECCS
and Calcified Particle Index (CPI) (rs = −0.162, p = 0.318). It is apparent that there is a high prevalence of
microcalcifications in both carotid and peripheral lower limb lesions. Additionally, an inverse relationship exists
between calcified particle volume and maximum-recorded attenuation density.
Conclusion: The density-weighted Agatston calcium scoring methodology needs to be reviewed. Calcium scoring
which differentiates between critical calcification morphologies, rather than presenting a density-weighted
score, is required to direct high-risk plaques towards tailored treatment.
1. Introduction
The Coronary Calcium Score (CCS), computed using the Agatston
scoring methodology,1 is a powerful predictor of adverse cardiovascular
events.2 This coronary scoring methodology is now considered the gold
standard of extra-coronary calcification quantification by some re-
searchers.3 Despite the wide use and prognostic value of the Agatston
calcium score, it was originally developed without histopathological
evidence or otherwise to guide its arbitrarily weighted cofactor
methodology, assuming a worse prognosis for higher density calcifica-
tion. Consequently, it is now understood that the Agatston score can
only identify high-risk patients and not high-risk lesions4 that should be
targeted for treatment, limiting our ability to intervene appropriately.
Since the development of the CCS, the role of calcification in
atherosclerotic plaque stability has been extensively investigated. It is
widely accepted that microcalcifications have a negative impact on the
biomechanical stability of plaques,5 promoting rupture at the fibrous
cap.6 ‘Spotty calcifications’ have also been identified as a feature of
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vulnerable lesions.7,8 Moreover, recent work suggests a protective role
of heavier weighted, high density calcification.9 These studies com-
plement previous findings that symptomatic coronary and carotid le-
sions contain a lower degree4 or volume10 of calcification than
asymptomatic ones, and that higher carotid Agatston calcium scores are
associated with a lower likelihood of cerebrovascular symptoms.11
Collectively, these investigations indicate that calcification mor-
phology, specifically calcified particle distribution, could be essential in
high-risk lesion identification.
Clinical CT has limited spatial resolution therefore much research is
conducted using Micro-Computed Tomography (micro-CT).6,12–14 This
ex vivo technique has significantly higher resolution potential,15 cap-
able of accurately quantifying calcification volume and density,16 and
identifying microcalcifications in atherosclerotic tissues.6 It is not clear
if calcification volume or particle information correlate with Agatston
calcium scores, or how calcified particle volume is associated with
maximum radiographic attenuation density. Therefore, the objective of
this study was to analyse the volume, distribution and maximum at-
tenuation density (Hounsfield Unit (HU)) of calcified particles within ex
vivo atherosclerotic lesions using micro-CT and correlate the findings to
extra-coronary calcium score (ECCS) approximations for each sample.
2. Materials and methods
2.1. Patient examination
Thirty-nine patients were enrolled in this study. Nineteen patients
underwent carotid endarterectomies, nineteen patients underwent
peripheral lower limb endarterectomies and one patient underwent
both. Preoperative patient assessment included demographics, co-
morbid conditions and preoperative medication data. Patient
characteristics are presented in Table 1.
2.2. Atherosclerotic sample acquisition
Plaque specimens (twenty carotid and twenty peripheral lower
limb) were acquired from thirty-nine different patients undergoing
consecutive standard endarterectomies performed at the University
Hospital Limerick in a manner that conformed to the Declaration of
Helsinki and was approved by the hospital's Ethical Research
Committee. Immediately after surgical removal, all plaques were frozen
in phosphate buffer solution at −20 °C until time of use.
2.3. Image acquisition and post processing
2.3.1. Chemical fixation
To prepare the tissue for micro-CT analysis, all plaques underwent a
tissue preservation process to minimise damage and shrinkage to the
tissue structure under the intense voltage source as previously de-
scribed.17
2.3.2. Image acquisition
Micro-CT (Xradia versa XRM 500 Carl Zeiss X-ray Microscopy Inc.)
was utilised to analyse the internal structure of all plaque samples. The
scanning was performed with a 0.4× optical magnification and 2.5s x-
ray exposure time. The x-ray source was operated at 50 kV and 81 μA
and all tomographic slices were obtained with an isotropic spatial re-
solution of 15.68 μm. Three-dimensional reconstructions were gener-
ated using Xra-diaXRM reconstructor (version 7.0.2817). The pixel
values were rescaled using a standard HU calibration using air, water
and hydroxyapatite phantom.13
Table 1
Descriptive characteristics of the patient population.
Patient Characteristics Entire Cohort (n = 39) Carotid (n = 19) Peripheral Lower Limb (n = 19)
Demographics
Age, years (mean ± SD) 69 ± 8 71 ± 8 66 ± 7
Sex, Male, n (%) 30 (77) 13 (68) 16 (84)
Comorbidities
Systolic Blood Pressure (mmHg) (mean ± SD) 145 ± 20 150 ± 19 139 ± 21
Body Mass Index (kg/m2) (mean ± SD) 26 ± 5 26 ± 5 27 ± 5
Obesity, n (%) 9 (23) 4 (21) 5 (26)
Diabetes Mellitus, n (%) 9 (23) 1 (5) 8 (42)
Chronic Kidney Disease, n (%) 1 (3) 0 (0) 1 (5)
Ischemic Heart Disease, n (%) 16 (41) 7 (37) 9 (47)
Dyslipidemia, n (%) 29 (74) 13 (68) 16 (84)
Hypertension, n (%) 32 (82) 17 (89) 14 (74)
Atrial Fibrillation, n (%) 8 (21) 4 (21) 4 (21)
Chronic Obstructive Pulmonary Disease, n (%) 7 (18) 2 (11) 4 (21)
Peripheral Artery Disease, n (%) 39 (100) 19 (100) 19 (100)
Osteoporosis, n (%) 3 (8) 2 (11) 1 (5)
Increased C2H5OH Levels, n (%) 5 (13) 3 (16) 2 (11)
Previous Myocardial Infarction, n (%) 8 (21) 4 (21) 4 (21)
Previous Cerebrovascular Event, n (%) 4 (10) 4 (21) 0 (0)
Smoker (current or ex), n (%) 37 (95) 18 (95) 18 (95)
Medication
Ace Inhibitor, n (%) 13 (33) 5 (26) 7 (37)
Angiotensin 2 Block, n (%) 6 (15) 4 (21) 2 (11)
Anticoagulant Therapy, n (%) 11 (28) 4 (21) 7 (37)
Antiplatelet, n (%) 10 (26) 2 (11) 7 (37)
Aspirin, n (%) 29 (74) 15 (79) 13 (68)
B Blocker, n (%) 22 (56) 11 (58) 10 (53)
Calcium Antagonist, n (%) 11 (28) 6 (32) 4 (21)
Insulin, n (%) 3 (8) 0 (0) 3 (16)
Nitrates, n (%) 1 (3) 1 (5) 0 (0)
Oral Hypoglycaemic, n (%) 7 (18) 1 (5) 6 (32)
Statin, n (%) 32 (82) 15 (79) 16 (84)
SD = standard deviation.
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2.3.3. Image post processing
Image analysis was conducted using ImageJ image processing soft-
ware (ImageJ release 1.52a).18 The image files were first manually
processed to remove any background image artefacts ≥130HU that
could be inadvertently included in the particle analysis or produce er-
rors in the ECCS approximations. Artefacts outside lesion boundaries
were visually delineated and removed by replacing the pixel attenua-
tion density ≥130HU with a background density of 0HU (Fig. 1(i)-(ii)).
2.3.3.1. Calcification parameters. The non-calcified and calcified
portions of the atherosclerotic tissues were quantified separately
based on their radiographic density thresholds: (≥30HU, < 130HU
and ≥130HU, respectively) using custom histogram macros in
ImageJ18 (Fig. 1(iii)). The Calcified Volume Fraction (CVF) for each
sample was determined as the ratio of calcified tissue volume to total
plaque tissue volume (Fig. 1(iv)). The calcified particle distribution was
examined using ImageJ ‘3D Objects Counter’ plugin19 with a calcified
particle threshold of 130HU1 (Fig. 1(v)). The volume of each particle
was calculated by multiplying the number of volume pixels by the
known voxel volume (3.86 × 10−6 mm3). The maximum radiographic
attenuation density for each calcified particle was also recorded as part
of this process (Fig. 1(vi)). The Calcified Particle Fraction (CPF) for
each sample is determined as the number of calcified particles divided
by the total plaque tissue volume. The Calcified Particle Index (CPI) is
Fig. 1. Complete image processing workflow. (i) Original Micro-CT image files (background artefacts circled in white). (ii) Replacing background artefacts ≥130HU
with 0HU. (iii) Histogram analysis of pixel density (Non-calcified tissue: ≥30HU, < 130HU, calcified tissue: ≥130HU). (iv) Plaque models displaying non-calcified
tissue (red) and calcified tissue (green). (v) ImageJ ‘3D Objects Counter’ plugin used to analyse the calcified particles (≥130HU). (vi) Calcified particle count, volume
and maximum radiographic attenuation density recorded. (vii) Image downsampling and creation of new stack representative of the in vivo Agatston scoring
resolution (0.7 × 0.7 × 3 mm) (vii) Calculation of ECCS approximation. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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the total number of calcified particles divided by the total calcification
volume. The Microcalcification Fraction (micro-CF) represents the
number of microcalcified particles (≤65.4 × 103μm3)6 expressed as a
fraction of the total number of calcified particles detected.
2.3.3.2. Extra-coronary calcium score approximations. The spatial
resolution of the processed image files were downsampled from
15.68 μm to 705.6 μm in the x- and y-planes, and from 15.68 μm to
2994.88 μm in the z-direction. The resulting downsampled image stack
approximates the spatial resolution which is defined for computing an
Agatston Score (0.7 × 0.7 × 3 mm)1 (Fig. 1(vii)). Custom macros
recorded the maximum attenuation density and area of calcification
(≥130HU) in each image slice and the ECCS approximation was then
calculated as described1 (Fig. 1(vii)). A complete image processing
workflow is presented in Fig. 1.
2.4. Coronary calcium score acquisition
Coronary CT scanning was also performed on thirty-seven of the
patients prior to or following endarterectomy using a Siemens Somotom
Sensation 64, Erlangen, Germany. The scanning parameters were
200 mm field of view, 3 mm slice thickness, acquisition 24 × 1.2 mm
and reconstruction increment of 1.5 mm. The x-ray source was operated
at 120 kV and all tomographic slices were obtained with a rotation time
of 0.33s and pitch of 0.2. CCS in the right coronary artery, left anterior
descending artery, left main artery and circumflex artery were acquired
using Syngo Calcium Scoring software (Siemens AG, Erlangen,
Germany).
2.5. Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics version
22. Descriptive statistics summarising patient characteristics using
mean ± SD or number (percentage) as appropriate are presented in
Table 1. Shapiro–Wilk and histogram shape analysis were performed to
assess the distribution of continuous data. All variables were de-
termined to be not normally distributed. Therefore, Mann-Whitney U
analysis was employed to compare calcification parameters, ECCS and
CCS results between the carotid and peripheral lower limb patient
groups. Spearman's correlation was used to assess the relationships
between ECCS approximations and calcification parameters. All con-
tinuous data results are presented using median with 25th to 75th
percentiles in square brackets. Statistical significance was defined as




Table 2 presents the calcification parameter results. Peripheral
lower limb lesions have significantly larger CVF (0.48 [0.29–0.54]
versus 0.17 [0.07–0.30]) and micro-CF (0.76 [0.40–0.89] vs 0.46
[0.39–0.70]) than carotid lesions (p < 0.0005 and p = 0.043). There
are no statistically significant differences between the CPF (7.53
[1.67–13.08] vs 3.47 [1.03–8.24], p = 0.242) or CPI (17.50
[4.97–28.49] vs 28.37 [11.20–54.91], p = 0.174) of peripheral lower
limb versus carotid lesions. Fig. 2 displays the total frequencies for all
300,099 calcified particle volumes analysed in this study (measured in
voxels) within defined particle volume bins, plotted against the mean
maximum attenuation density (HU) of the particles within each of the
volume bins. There is a high prevalence of microcalcifications evident
and an inverse relationship between calcified particle volume and mean
maximum radiographic attenuation density.
3.2. Correlating extra-coronary calcification score approximations with
calcification parameters
Fig. 3 presents scatterplots of the ECCS approximations versus (i)
the Calcified Volume Fraction (CVF), (ii) the Calcified Particle Fraction
(CPF), (iii) the Calcified Particle Index (CPI) and (iv) the Micro-
calcification Fraction (micro-CF). There is very strong positive corre-
lation between the ECCS approximations and CVF (rs = 0.865,
p < 0.0005). This significance extends to carotid (rs = 0.949,
p < 0.0005) but not peripheral lower limb data (rs = 0.421, p = 0.06).
However, there are weak positive correlations between ECCS approx-
imations and CPF (rs = 0.422, p = 0.007) and micro-CF (rs = 0.361,
p = 0.022). There is no correlation between ECCS and CPI
(rs = −0.162, p = 0.318). There are also no correlations for either
carotid or peripheral lower limb-specific data between ECCS and CPF,
CPI or micro-CF.
3.3. Coronary and extra-coronary calcium scores
Table 3 presents the calcium scoring results. CCS acquired for per-
ipheral lower limb patients (n = 19) are higher (1820 [526–2529])
than CCS acquired for carotid patients (n = 17) (803 [398–1616]) but
the difference was not statistically significant (p = 0.061). ECCS ap-
proximations for peripheral lower limb lesions (n = 20) (666
[400–1098]) are significantly higher than approximations for carotid
lesions (n = 20) (72 [5–155]), p < 0.0005.
4. Discussion
The CCS was devised as a predictor of major adverse cardiovascular
events2 but is unable to diagnose unstable plaques.4 It is now under-
stood that microcalcifications destabilise plaques6,20 and ‘spotty calci-
fications’ are often present in culprit lesions.7,8 Therefore, the purpose
of this study was to correlate ECCS approximations with defined cal-
cification parameters to assess the Agatston score's ability to determine
atherosclerotic calcification phenotype. We demonstrate the strong
positive correlation between ECCS and CVF but expose the weaker or
non-existent correlations with CPF, CPI and micro-CF. Moreover; we
examined the relationship between calcified particle volume and
maximum attenuation density and determined that larger calcified
particles have higher maximum densities.
The Agatston score is commonly used to quantify extra-coronary
calcification.3 However, data comparing Agatston scores in different
arterial beds are scarce and the need for revising recommendations has
been highlighted.21 Carotid calcium scoring could be critical in the
prediction of cerebrovascular events. Yet, research examining Agatston
calcium scores in carotid arteries discovered double symptomatic
Table 2
Calcification parameter results presented as median values with 25th to 75th percentiles in square brackets with p-values from Mann-Whitney U tests.
Calcification Parameters Carotid (n = 20) Peripheral Lower Limb (n = 20) p-value
Calcified Volume Fraction 0.17 [0.07–0.30] 0.48 [0.29–0.54] < 0.005
Calcified Particle Fraction 3.47 [1.03–8.24] 7.53 [1.67–13.08] 0.242
Calcified Particle Index 28.37 [11.20–54.91] 17.50 [4.97–28.49] 0.174
Microcalcification Fraction 0.46 [0.39–0.70] 0.76 [0.40–0.89] 0.043
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Fig. 2. Total calcified particle frequency within each defined volume bin versus the Mean maximum attenuation density for the calcified particles within that specific
volume bin. For Mean maximum attenuation density the bars represent the Mean value with error bars extending to one standard deviation of the data.
Fig. 3. ECCS approximations versus (i) Calcified Volume Fraction, (ii) Calcified Particle Fraction, (iii) Calcified Particle Index and (iv) the Microcalcification Fraction
for carotid and peripheral lower limb samples.
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peaks22 or inverse relationships.10,11 This should not be unexpected as
the Agatston method was not designed for extra-coronary sites.23 In this
manner, we found no correlation between ECCS and CPF, CPI or micro-
CF for ex vivo carotid and peripheral lower limb samples.
We determined that peripheral lower limb lesions have an overall
larger fraction of calcified tissue and higher micro-CF than carotid le-
sions. Our ECCS are also higher for peripheral lower limb samples than
carotids. This was not unexpected, previous work also shows that fe-
moral lesions have a higher calcium content than carotid lesions.24
Additionally, calcification is typically confined to the carotid bifurca-
tion25 whereas it can occur throughout lesions in the lower ex-
tremities.26
On average, coronary samples analysed at 6.7 μm contain
4199 ± 3007 calcified particles,20 which is more than our carotid
samples (3056 ± 5404) and less than our peripheral lower limb sam-
ples (11,949 ± 13,939) (presented as median values with 25th to 75th
percentiles in square brackets in Table 4). We examined extra-coronary
lesions at a micro-CT resolution of 15.68 μm which may result in more
partial volume effects and subsequently detect less calcified particles
than 6.7 μm resolution analysis. The results presented for coronary
calcified particles is also skewed to the right,20 indicating a high pre-
valence of microcalcifications in all three anatomical locations (Fig. 2).
However, another study utilising 2.1 μm micro-CT resolution found
almost 35,000 microcalcifications in coronary fibrous caps. Future
studies should endeavour to use close to 2 μm micro-CT resolution to
avoid underestimation of the number of microcalcifications present.6 As
far as the authors are aware, no previous works have compared the
calcified particle distribution of coronary, carotid and peripheral lower
limb lesions.
The Agatston score is currently weighted upward, assuming a worse
prognosis for increasing density.1 Our results indicate that larger cal-
cified particles have higher maximum attenuation density. Therefore
these larger, denser calcified particles could be considered a more
stable calcification phenotype.9,11 This is additional evidence arguing
against the upward weighted-cofactor scoring approach. It has been
shown that CT underestimates calcified plaque density27 and micro-
calcifications may present as ‘low density’ calcification, attributed to
partial volume effects.14 The steep incline of mean maximum attenua-
tion density from 23 X voxels to 212 X voxels (Fig. 2) could be indicative
of diminishing partial volume effects for microcalcifications, however,
more work is warranted in this regard.
Our study demonstrates that the Agatston score correlates extremely
well with CVF but not with CPF, CPI or micro-CF. These results com-
plement previous verdicts that larger particles (high-density, low risk)
take precedence in the Agatston methodology and that
microcalcifications (low-density, high risk) are not considered.8 Recent
works also found high degrees of correlation between Agatston calcium
scores, mass of calcium hydroxyapatite3 and volume scores.9 However,
it is known that absolute calcification volume is not a good measure of
plaque vulnerability.28
Limitations
There are some inherent limitations associated with this study.
Firstly, the sample cohort did not include coronary endarterectomy
specimens for comparison. However, coronary plaques are not typically
removed via endarterectomy and are therefore inaccessible, so we in-
cluded CCS as a substitute. The workspace of the micro-CT is fixed
according to image resolution; as a result, some of the larger specimen's
edges may have extended beyond the defined workspace. Background
image artefacts were manually removed by replacing the pixel values
with 0HU. Consequently, some particles may have been missed.
However, any errors which may have ensued are deemed negligible
with respect to the overall calcified particle count. We used a threshold
of ≥30HU, < 130HU to identify non-calcified tissue and ≥130HU to
identify calcification; although these values are well documented, they
are arbitrary. ECCS approximations were acquired via downsampling of
the high-resolution images to construct in vivo mimics. In this process
higher attenuation tissues may have been averaged with background
attenuation (0HU), this would not be the case in vivo. Additionally,
large clinical studies are required to confirm whether calcified particle
information is an improved method of identifying high-risk plaques.29 If
proven, our study validates the necessity for a novel calcium scoring
system capable of identifying high-risk calcification phenotype and thus
plaque stability.
Despite the aforementioned limitations, this high-resolution ex vivo
investigation proposes an explanation towards the ineffectiveness of the
Agatston calcium score at identifying individual high-risk plaques: it
does not correlate with calcified particle parameters. Further work is
warranted with respect to the role of calcification morphology, and its
location, in plaque rupture.5 Calcium scoring, which describes the
calcification morphology related to plaque vulnerability,7 rather than a
weighted score,23 could improve our prediction and prevention of
major adverse cardiovascular events.
5. Conclusion
The Agatston score cannot determine calcification phenotype, pro-
viding a potential explanation towards its inability to identify high-risk
atherosclerotic lesions. ECCS correlate extremely well with Calcified
Table 3
Calcium scoring results presented as median values with 25th to 75th percentiles in square brackets with p-values from Mann-Whitney U tests.
Calcium Scoring Results Carotid Peripheral Lower Limb p-value
Coronary Calcium Score 803 [398–1616]a 1820 [526–2529]b 0.061
Extra-coronary Calcium Score Approximation 72 [5–155]c 666 [400–1098]c < 0.0005
p-value < 0.0005 0.022
a n = 17.
b n = 19.
c n = 20.
Table 4
Total calcification volume and total calcified particle count for carotid and peripheral lower limb samples. Results are presented as
median values with 25th to 75th percentiles in square brackets.
Calcification Parameters Carotid (n = 20) Peripheral Lower Limb (n = 20)
Total Calcification Volume (mm3) 58.27 [16.47–100.11] 398.03 [233.33–625.88]
Total Calcified Particle Count 831 [322.50–2722] 5608 [938–23,642.50]
R.M. Cahalane, et al. Journal of Cardiovascular Computed Tomography 14 (2020) 20–26
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Volume Fraction (rs = 0.865, p < 0.0005), poorly with Calcified
Particle Fraction (rs = 0.422, p = 0.007) and Microcalcification
Fraction (rs = 0.361, p = 0.022), and does not correlate with Calcified
Particle Index (rs = −0.162, p = 0.318). Calcified particle volume is
inversely related to maximum-recorded attenuation density, supporting
reports that the upward weighted-cofactor scoring methodology needs
to be reviewed. Future scoring methodologies should focus on a mea-
sure of calcification in a meaningful way such as destabilising calcifi-
cation phenotypes to tailor treatment towards vulnerable lesions.
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Background and Purpose: The purpose of this study is to examine the ability of ex vivo 
derived Agatston, Volume and Density-Volume calcium scores or calcium density 
measurements to differentiate between carotid plaques based on preoperative cerebrovascular 
symptomatology.  
Methods: Thirty-eight carotid plaques were acquired from standard endarterectomy. Micro-
computed tomography (CT) was performed on the ex vivo samples. Image series were 
downsampled to represent the resolution of clinical Multidetector-CT. Agatston, Volume and 
Density-Volume carotid calcium scores were then calculated using coronary methodologies. 
The fractions of low- and high-density calcification were also determined.  
Results: The coronary calcium scores could not differentiate between carotid plaques from 
asymptomatic versus symptomatic patients. However, plaques from asymptomatic patients 
contained significantly lower fractions of low-density calcification and higher fractions of 
high-density calcification.  
Conclusions: Screening for carotid calcium density in non-contrast CT could reflect plaque 
stability.  
Abbrevia ions List 
CAC, coronary artery calcium; CVD, Cardiovascular Disease; HU, Hounsfield Unit; MDCT, 
Multidetector row computed tomography; Micro-CT, micro-computed tomography. 
Introduction 
Stroke is the second leading cause of death worldwide.
1
 The rupture of carotid plaques is a 
major cause of cerebrovascular infarctions.
2






















    
    
    
    
    
    
    
    







carotid stenosis benefit from endarterectomy. However, the identification and management of 







 calcium scores have been described to 
quantify coronary calcification and predict cardiovascular risk. It has been suggested to 
utilise calcium scoring in vessel-specific locations to predict downstream events. The efficacy 
of these coronary calcium scores in the carotid arteries have had limited investigation. 
Additionally, coronary calcium density has been inversely related to cardiovascular risk and 
advocated as a measure to be considered in future calcium scores.
6
  
There is much scope for the development of carotid-specific calcium scores capable of 
predicting cerebrovascular incidents. Therefore, the objective of this study was to investigate 
the ability of either carotid calcium scores or calcium density measurements to distinguish 
between excised plaques from patients based on preoperative cerebrovascular symptoms. 
Materials and Methods 
Data will be made available from the corresponding author upon reasonable request.  
Patient Examination and Sample Acquisition 
Patients undergoing carotid endarterectomy procedures at the University Hospital Limerick 
were recruited (n=38). This study received full ethical approval from the Research Ethics 
Committee and adheres to the principles of ICH-GCP and the Declaration of Helsinki. 
Patients were classified as symptomatic if an ipsilateral ischemic event (stroke or infarct 
(n=15) or transient ischemic attack (TIA) (n=19)) occurred preoperatively. Asymptomatic 
patients had incidental findings of carotid stenosis without cerebrovascular symptoms (n=4). 
Plaque specimens were acquired, stored and processed as previously described.
7
 The study 






















    
    
    
    
    
    
    
    







Micro-Computed Tomography Acquisition 
High-resolution micro-Computed Tomography (micro-CT) scanning was performed on the 
samples with a 0.4x optical magnification, low energy pass filter and 2.5s x-ray exposure 
time (Xradia 500 Versa, Zeiss, Germany). The x-ray source was operated at 50kV and 81μA 
and all tomographic slices were obtained with an isotropic image resolution of 15.68μm 
calibrated to Hounsfield Unit (HU) values. However, air was assigned a value of 0HU to 
reduce downscale averaging inaccuracies. The spatial resolution of the image series was 
scaled to approximate clinical Multidetector-CT (MDCT) (0.5mm)
3
. Representative 2D 
images slices and 3D sample projections for micro-CT versus MDCT resolutions are 






 and Density-Volume calcium scores
5
 are calculated as described 
using ImageJ (National Institutes of Health, USA). Calcification is defined as pixels ≥130 
Hounsfield Units (HU). Agatston Grades 1 (130-199HU) and 4 (≥400HU) represent low- and 
high-density calcium expressed as fractions of the total calcification. 
Agatston Score(lesion) = (Calcification Area)X(Maximal Cofactor) 
Agatston Score(total) = ∑Agatston Score(lesion) 
Volume Score (mm
3
) = (Calcified Pixels)X(Voxel Volume) 
Density-Volume Score = (Calcification Volume)X(Mean Cofactor) 
Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics v26. Shapiro–Wilk analysis 
was employed to assess the distribution of all continuous data. All datasets except one were 



























    
    
    
    
    
    
    
    







difference in calcification measurements between asymptomatic and symptomatic cohorts. 
Statistical significance was defined as a two-tailed p-value <0.05.  
Results 
The distribution of carotid Agatston scores across patient cerebrovascular categories is 
presented in Figure 2A. There is no statistical difference in the Agatston scores obtained for 
asymptomatic (487.04 [269.26–1172.33]) versus symptomatic lesions: transient ischemic 
attack (571.25 [270.27–821.75]) and stroke (74.52 [16.74–375.25]), p = 0.535. Similarly, 
there is no statistical difference in the volume of calcification within plaques from 
asymptomatic (61.52 [34.23–147.48]mm
3
) and symptomatic patients: transient ischemic 
attack (76.55 [36.95–103.52]mm
3
) and stroke (10.11 [3.47–48.70]mm
3
), p=0.535 (Fig.2B). 
The Density-Volume calcium scores for each cerebrovascular symptom category are 
displayed in Figure 2C. There is also no significant difference in the scores between 
asymptomatic (123.04 [68.47–294.97]) versus symptomatic cohorts: transient ischemic attack 
(188.48 [84.26–275.07]) or stroke patients (25.77 [10.42–126.70]), p = 0.766. 
This distribution of low- and high-density calcification fractions across patient cohorts is 
presented in Figure 2D.  Asymptomatic patients have significantly lower fractions of low-
density calcification (0.19 [0.18–0.22]) and higher fractions of high-density calcification 
(0.34 [0.33–0.35]) than transient ischemic attack (Low: 0.29 [0.24–0.34] and High: 0.24 
[0.14–0.30]) or stroke (Low: 0.29 [0.27–0.37] and High: 0.23 [0.18–0.28]) cohorts, p<0.005 
and p<0.05, respectively.  
Discussion 
The results from this study demonstrate that coronary calcium scoring methodologies cannot 






















    
    
    
    
    
    
    
    







measurements can distinguish between plaques from patients with or without cerebrovascular 
symptoms.  
Coronary calcium scoring methodologies were not originally developed for use in 
extracoronary locations.
8
 In that regard, it has been shown that the Agatston score cannot 
identify unstable lesions.
9
 The results from this study indicate that Agatston, Volume and 
Density-Volume scores cannot differentiate between plaques from asymptomatic or 
symptomatic patients, supporting the previous findings.
9
  
High-density calcification has a protective effect on plaque stability.
6,10
 The preliminary 
results from this study also confirm that asymptomatic carotid plaques contain higher 
amounts of high-density calcium. A single CT number is representative of the combined 
tissue densities within that voxel due to partial volume effects. Therefore, it is reasonable to 
consider that high-density calcium is a surrogate marker for macrocalcifications while low-
density calcification represents both calcified and non-calcified tissues. The latter is 
hypothesised to correlate with an increased number of calcified and non-calcified tissue 
interfaces, elevating the potential for debonding and rupture. In this study, the fractions of 
low-density calcification w re higher in symptomatic samples. 
This study has limitations. No major stroke patients underwent surgery and were therefore 
excluded. The asymptomatic cohort is also small. Additionally, the acquired ex vivo x-ray 
attenuation may not be directly comparable with in vivo values. Finally, the duration of time 
between symptoms and endarterectomy was not recorded.  
Despite the limitations, this study aimed to generate preliminary findings for clinical 
validation. We hypothesis that calcium density can be used as a risk stratification tool. 
Moreover, density fractions are measures unaffected by weighted cofactors, preserving 
























    
    
    
    
    
    
    
    







In summary, the observations from this study demonstrate that calcium density can 
distinguish between carotid plaques from patients based on cerebrovascular symptoms. The 
clinical utility and prognostic value of carotid calcium density measurements should be 
validated in larger cohorts.  
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Figure Legends 
Figure 1: (A) Representative 2D image slices at micro-CT versus MDCT resolutions. The 
areas of calcification are colour coded according to the 4 Agatston calcium density grades (Px 
= pixel). (B) 3D projections for a representative sample at micro-CT versus MDCT 
resolutions. 
Figure 2: Boxplots of carotid (A) Agatston, (B) Volume and (C) Density-Volume calcium 
scores. (D) Boxplots of the fractions of low- and high-density calcium within asymptomatic 
versus symptomatic carotid plaques. Statistical significance: **p<0.005, *p<0.05. 
Tables 
Table 1: Study cases. 
Case Age Sex Symptoms Preoperative Stenosis 
1 73 M TIA 70-99% 






















    
    
    
    
    
    
    
    







3 62 F Stroke or Infarct High Grade 
4 68 M TIA 70-79% 
5 67 F Stroke or Infarct 90-99% 
6 75 M TIA 90-99% 
7 73 F Stroke or Infarct 90-99% 
8 83 M TIA 50-69% 
9 59 F Stroke or Infarct 50-69% 
10 62 M TIA High Grade 
11 81 M TIA - 
12 75 M TIA High Grade 
13 64 M Stroke or Infarct 70-99% 
14 82 M Stroke or Infarct 90-99% 
15 72 M TIA - 
16 74 M TIA 70-79% 
17 81 F TIA High Grade 
18 69 M Stroke or Infarct 90-99% 
19 55 M Stroke or Infarct Nearly Complete Occlusion 
20 65 M TIA 60-69% 
21 59 M TIA 80-89% 
22 47 M Stroke or Infarct 60-69% 
23 75 F Stroke or Infarct High Grade 
24 62 M Stroke or Infarct 90-99% 
25 78 M TIA High Grade 
26 49 M Stroke or Infarct 80-89% 






















    
    
    
    
    
    
    
    







28 69 F None - 
29 68 F None - 
30 69 F TIA 70-79% 
31 66 M Stroke or Infarct 50-69% 
32 59 F TIA 90-99% 
33 80 M Stroke or Infarct 50-69% 
34 89 F TIA 70-79% 
35 77 M Stroke or Infarct 50-69% 
36 60 M None 90-99% 
37 82 M TIA 20-49% 
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a b s t r a c t
Calcification morphology can determine atherosclerotic plaque stability and is associated with increased
failures rates for endovascular interventions. Computational efforts have sought to elucidate the relation-
ship between calcification and plaque rupture in addition to predicting tissue response during aggressive
revascularisation techniques. However, calcified material properties are currently estimated and may not
reflect real tissue conditions. The objective of this study is to correlate calcificationmechanical properties with
three radiographic density groups obtained from corresponding Computed Tomography (CT) images.
Seventeen humanplaques extracted from carotid (n = 10) and peripheral lower limb (n = 7) arterieswere
examined using micro-computed tomography (mCT), simultaneously locating the calcified deposits within
their internal structure and quantifying their densities. Three radiographic density groups were defined
based on the sample density distribution: (A) 130–299.99 Hounsfield Units (HU), (B) 300–449.99 HU and
(C) >450 HU.Nanoindentationwas employed to determine the ElasticModulus (E) andHardness (H) values
within the three density groups.
Results reveal a clear distinction between mechanical properties with respect to radiographic density
groups (p < 0.0005). No significant differences exist in the density-specific behaviours observed between
carotid and peripheral samples. Previously defined calcification classifications indicate an associationwith
specific radiographic density patterns. Scanning Electron Microscopy (SEM) examination revealed that
density group A regions consist of both calcified and non-calcified tissues. Further research is required
to define the radiographic thresholds which identify varying degrees of tissue calcification.
This study demonstrates that the mechanical properties of fully mineralised atherosclerotic calcification
emulate that of bone tissues (17–25 GPa), affording computational models with accurate material
parameters.
Statement of Significance
Global mechanical characterisation techniques disregard the heterogeneous nature of atherosclerotic
lesions. Previous nanoindentation results for carotid calcifications have displayed a wide range. This
study evaluates calcification properties with respect to radiographic density obtained from Micro-CT
images. This is the first work to characterise calcifications from peripheral lower limb arteries using
nanoindentation. Results demonstrate a strong positive correlation between radiographic density and
calcification mechanical properties. Characterising calcifications using their density values provides clar-
ity on the variation in published properties for calcified tissues. Furthermore, this study confirms the
hypothesis that fully calcified plaque tissue behaviour similar to that of bone. Appropriate material
parameters for calcified tissues can now be employed in computational simulations.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
https://doi.org/10.1016/j.actbio.2018.09.010
1742-7061/ 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Abbreviations: CT, Computed Tomography; HU, Hounsfield Unit; mCT, Micro-Computed Tomography; PBS, Phosphate Buffer Solution; A, Density Group A; B, Density Group
B; C, Density Group C; S, Contact Stiffness; SEM, Scanning Electron Microscopy; E, Elastic Modulus; H, Hardness.
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1. Introduction
Calcification is a significant predictor of cardiovascular morbid-
ity and mortality [1], and calcification morphology plays a critical
role in determining atherosclerotic plaque stability [2]. Moreover,
calcifications in atherosclerotic plaques limit the technical success
of the minimally invasive endovascular stenting and angioplasty
approaches, with insufficient luminal enlargement [3,4] leading
to clinical failure with adverse events such as reocclusion, dissec-
tion and stent fracture [5,6]. Cutting Balloon Angioplasty and
Atherectomy, have been developed to aggressively debulk these
rigid inclusions and modify the plaque to improve the outcome
of stenting. Computational efforts have sought to analyse the rela-
tionship between calcification and stability [7] in addition to antic-
ipating the interaction of calcified tissues with recently developed
interventions [8]. However, computational studies investigating
these circumstances are predominantly impeded by insufficient
information on the mechanical properties of the calcification
[9,10]. The estimated calcification material parameters and mor-
phologies used may not accurately reflect true tissue properties.
The absence of accurate methodologies for predicting the calcified
tissue behaviours is obstructing rigorous computational research.
Global mechanical properties of atherosclerotic plaque tissues
have been extensively investigated on the macro scale using vari-
ous modes of characterisation such as uniaxial testing [11,12],
reviewed by Walsh et al. [13] and compression testing, reviewed
by Chai et al. [14]. These methods of material characterisation
neglect the highly heterogeneous nature of the lesions. Conse-
quently, the current literature reports variability in tissue mechan-
ical properties. Values for the compressive elastic modulus of
calcified carotid tissues range from 140 kPa (unconfined compres-
sion) [15] to 0.7 GPa (nanoindentation) [16], indicating the need
for individual plaque constituent characterisation. Nanoindenta-
tion is an experimental technique originally developed for deter-
mining the hardness properties of thin films and has successfully
transitioned to the characterisation of mineralised biological tis-
sues such as teeth and bone [17–20]. This method of high resolu-
tion indentation testing, with accurate positioning capabilities, is
an optimal approach for the precise mapping of small, irregular-
shaped heterogeneous material [21], such as calcified deposits
within atherosclerotic plaques [22]. The characterisation of the
elastic modulus and hardness properties of calcification will pro-
vide valuable information for computational simulations to allow
for insights into plaque tissue rupture and modification [23].
The evaluation of calcification density and its correlation with
tissue mechanics has been recommended as a valuable interpreta-
tion for further predicting these tissue behaviours [24]. Computed
tomography (CT) imaging is a non-invasive method that provides a
three-dimensional view of the internal structure of atherosclerotic
lesions, including identifying the presence of calcified deposits [25]
which can be used in pre-operative patient assessment prior to
surgical intervention [26]. The use of Hounsfield Units (HU) is
the standardised method of expressing CT density numbers. The
use of HU in surgical prognosis is widely described for mineralised
tissues [27–29]. The Agatston scoring system [25] is widely utilised
for the quantification of calcium within coronary lesions. In this
method, weighted cofactors are assigned to the calcification based
on the maximal computed tomography number (HU) in each
image slice: (1) 130–199 HU, (2) 200–299 HU, (3) 300–399 HU
and (4) 400 HU. The radiographic density distribution of carotid
and peripheral calcifications have been determined in this study
and the following density thresholds have been recommended to
create proportionate volumes for mechanical characterisation:
(A) 130–299 HU (B) 300–449 HU and (C) 450 HU. Radiographic
density has not yet been utilised to quantify the tissue mechanical
properties.
This research aims to investigate the capability of CT density
values (HU) to predict calcification mechanical properties of elastic
modulus and hardness. Mechanical properties and structural cate-
gories of arterial calcification from carotid and peripheral lower
limb regions obtained using nanoindentation will be correlated
with the corresponding density values obtained from Micro-
Computed Tomography (mCT) imaging.
2. Materials and methods
2.1. Sample acquisition
10 carotid and 7 peripheral lower limb (6 femoral and 1 iliac)
plaque specimens from 17 different patients were acquired from
standard endarterectomy procedures that were performed at the
University Hospital Limerick, Ireland in a manner that conformed
to the Declaration of Helsinki and was approved by the hospital’s
Ethical Research Committee. Patient demographics are presented
in Table 1. Immediately after surgical removal, all plaques were
frozen in phosphate buffer solution (PBS) at 20 C until time of
use.
2.1.1. Chemical fixation
To prepare the tissue for Micro-Computed Tomography (mCT)
analysis, all plaques underwent a tissue preservation process to
minimise damage and shrinkage to the tissue structure under the
intense voltage source [30]. The samples were defrosted and
cleaned in fresh PBS followed by fixation using 100% methanol.
The fixed samples were washed in 100% ethanol prior to a dehy-
dration process involving the specimen becoming subject to
ascending grades of ethanol concentrations. Chemical drying of
the samples was achieved using hexamethyldisilazane (Fig. 1(i)a).
2.2. Image acquisition mCT and Post processing
mCT (Xradia versa XRM 500 Carl Zeiss X-ray Microscopy Inc.)
was performed to analyse the internal structure of all plaque sam-
ples. The scanning was performed with a 0.4 optical magnifica-
tion and 2.5 s X-ray exposure time. The x-ray source was
operated at 50 kV and 81 lA and all tomographic slices were
obtained with a pixel resolution of 15.5 lm. Three-dimensional
reconstructions were generated using Xra-diaXRM reconstructor
(version 7.0.2817). The pixel values were rescaled using a standard
Hounsfield Unit (HU) calibration using air, water and hydroxyap-
atite phantom [31]. This procedure was kept constant for all sam-
ples (Fig. 1(i)b).
Each plaque model was reconstructed using 3D Slicer medical
image processing software (version 4.6.2, Open Source, 3DSlicer.
org). The calcified and non-calcified tissues were modelled
Table 1





Age, (average years ± standard
deviation)
73 ± 7.26 64 ± 7.93
Gender, (male/female) 7/3 6/1
Smoking, n (%) 10 (100) 7 (100)
Diabetes, n (%) 1 (10) 3 (43)
Hypertension, n (%) 9 (90) 5 (71)
Previous use of statin, n (%) 8 (80) 5 (71)
R.M. Cahalane et al. / Acta Biomaterialia 80 (2018) 228–236 229
separately based on their threshold values (>30 HU and >130 HU,
respectively). This procedure simultaneously locates the internal
calcified deposits within the samples and evaluates their density
in terms of HU values (Fig. 1(i)c). The following thresholds were
defined to create three proportional radiographic density groups,
as described in the Supplementary material: A: 130–299.99 HU,
B: 300–449.99 HU and C: 450 HU.
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.actbio.2018.09.010.
The calcifications were grouped into four structural categories
defined by Barrett et al. (2016): speckled, diffuse spherical nodes,
arc-shaped calcification and macro-inclusions [31] to qualitatively
analyse density groups patterns from the 2D mCT image tissue
cross sections.
2.3. Sample preparation
The plaque samples were embedded without vacuum in ‘Epox-
iCure,’ (Buehler, Illinois Tool Works Inc, Illinois), at room tempera-
ture in cylindrical moulds (Fig. 1(ii)a). The samples were cured in
the orientation which would allow the desirable cross-section to
be exposed for indentation. The areas of calcification within the
internal structure of the plaque specimens are easily identified in
the 3D reconstructed models (Fig. 1(i)c). The epoxy cylinders are
sectioned at this point using a low-speed diamond saw (IsoMet
Low Speed Saw, Buehler) running at 200 rpm with continuous
water irrigation (Fig. 1(ii)b). The samples were then polished using
an automated polisher (Phoenix 4000, Buehler) running at 150 rpm
first using progressive grades of silicon carbide grinding paper
(600, 800, 1200 lgrit) followed by polishing with 1 mm and
0.05 mm alumina powder suspensions (Fig. 1(ii)c). Between each
step the surface debris was removed using ultrasonic cleaning for
10 s. This procedure was kept constant for all samples.
Atomic Force Microscopy was carried out to validate this sam-
ple preparation procedure by obtaining a value for the resulting
sample surface roughness. It is recommended that the indentation
depth should be 20 times larger than the surface roughness value
to minimise calculation errors [32]. Surface roughness values are
presented in Fig. 2. An image of the exposed sample surface was
created using optical microscopy and manual image tiling, allow-
ing the specimen cross section to be matched to a specific mCT slice
(Fig. 1(ii)d). Upon lCT slice selection the three density groups A, B
and C were mapped using 3D Slicer onto the sample surface (Fig. 1
(iii)), creating the locations for nanoindentation to be carried out.
2.4. Nanoindentation
All nanoindentation measurements were obtained using the
G200 Nano Indenter (Keysight Technologies, formally Agilent
Fig. 1. Sample Preparation and Testing Procedure: (i) (a) Plaque specimens undergo a chemical preservation procedure described by [30] which protects the samples from the
intense voltage source and maintain their structural integrity for the rest of the testing procedure. (b) Samples are imaged using mCT, presented are selected image slices
associated with the preserved plaque sample. (c) The image files acquired in (b) are uploaded in 3D Slicer Medical Imaging Software and plaque models are reconstructed
using thresholds for non-calcified and calcified tissues. The generated models reveal the calcified deposits (green) embedded within the plaque tissue (red). This process
simultaneously locates the areas of calcification within the internal plaque structure and quantifies their densities. (ii) (a) Once the area of calcification has been identified the
sample is embedded in epoxy resin. (b) The epoxy ‘puck’ is sectioned at the site of calcification using a low-speed diamond saw to expose a cross section for indentation. (c)
The sectioned surface requires further preparation to yield the smooth surface finish required to minimise any calculations error from the nanoindentation data. The surface
is grinded with increasing grades of silicon carbide paper followed by polishing with alumina suspensions. (d) The exposed sample cross section is imaged using optical
microscopy and thus matched to a mCT image slice. (iii) Following CT image selection the radiographic density of the calcification is examined in 3D Slicer. The three
radiographic density groups are mapped onto the sample surface to provide the areas for nanoindentation. (iv) The location of the indents (blue triangles) are manually
positioned within the three density areas from the microscope window integrated into the nanoindentation interface. An SEM image displays a sample grid of 3  3 indents
within the density group C area. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Technologies), fitted with a Berkovich tip, which is commonly used
for the nanoindentation of mineralised tissues.
2.4.1. Viscoelastic behaviour
The default hold-time for the G200 instrument is 10 s. An insuf-
ficient hold time can result in an over-estimation of the elastic
modulus [33]. As creep times for calcification have been recorded
as high as 20 min [34] and a holding time greater than 15 s is rec-
ommended for bone tissue [35] a creep investigation was carried
out to determine an effective hold period to employ for calcifica-
tion in this study. Three indents were plotted in a single femoral
sample with a hold time of 16 min (960 s). Fig. 3 shows a represen-
tative graph of results for additional indentation depth (nm) versus
hold time and corresponding creep rate (nm/s) versus hold time.
The additional displacement saturates and the creep rate drasti-
cally slows after approximately 200 s. It can be determined that
the crucial effects of viscoelastic deformation have diminished
after this hold period. Therefore, a hold time of 240 s was selected
for this study.
2.4.2. Plaque specimens
The locations of the indents were spatially mapped according to
the three density groups previously visualised using mCT imaging
and 3D Slicer (Fig. 1(iv)). Indents were manually positioned on
the sample surface from the microscope window in the NanoSuite
software (Keysight Technologies, United States). Indents were pro-
grammed to a maximum depth of 2 mm using an indentation strain
rate of 0.05/s. In order to ensure accurate identification of the sam-
ple surface, the surface was initially approached from a distance of
1 mm at velocity of 10 nm/s. A spacing of at least 75 lm was kept
between indents to avoid neighbouring plastic deformation effects.
Data was recorded during the approximately trapezoidal loading,
hold and unloading phases of the testing and the Elastic Modulus
(E) and Hardness (H) properties of the tissue were calculated from
these readings.
2.4.3. Theory
The Oliver and Pharr method of obtaining Elastic modulus (E)
and Hardness (H) values from continuous stiffness measurement
(CSM) indentation data is widely described. Prior to the testing of
the set of samples analysed in this study the tip shape function
was assessed by carrying out indentations on the reference fused
silica sample and comparing the results obtained to the manufac-
turers’ specifications. Hardness is defined in Eq. (1) as the load (P)
divided by the projected contact area (A) [34]. The contact area (A)
is deduced by using the area function for the indenter tip geometry




The specimen modulus (Es) is related to the reduced modulus
(Er), as described in Eq. (2), provided the indenter modulus (Ei) is
known and the Poisson’s ratios of the specimen and indenter, ʋs
and ʋi respectively, are known or can be estimated. For a diamond
indenter, Ei = 1141GPa and ti = 0.07 and the Poisson’s ratio for arte-
rial calcification (ts) is assumed to be 0.3 in this study, in accor-
dance with values obtained for bone [36].










The contact stiffness (S) is obtained by evaluating the slope of
curve fit at the onset of unloading. The contact stiffness is related
to the reduced elastic modulus (Er) using the Eq. (3) [37]. Elastic










2.5. Scanning electron microscopy
SEM analysis was carried out at the sites of indentation to anal-
yse the degree of tissue calcification and assess the quality of the
indents placed onto the tissue surface. SEM imaging also allowed
for the examination of the surface morphology of the calcified tis-
sues. To maximise the conductivity of the samples and thus
improve the quality of the images obtained by Scanning Electron
Microscopy (SEM) the samples were first sputter coated in gold
using 35 mA for 120 s (EMITECH K550, Emitech Ltd., Kent, U.K.)
to ensure complete and even gold deposition. The microscope
was operated using an accelerated voltage setting of 20 kV with a
working distance of 15 mm.
2.6. Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics-22.
Shapiro–Wilk analysis was performed to assess the distribution of
the data sets and select the most appropriate statistical test to
employ. All datasets were not normally distributed. Therefore,
Mann-Whitney U tests were used to compare carotid and
peripheral lower limb data sets and Kruskal-Wallis H test with
Fig. 2. AFM surface profiles for a peripheral lower limb calcification following the
surface preparation procedure outlined in Section 2.3. Approximate Surface
Roughness values obtained are Ra = 40.4 nm.
Fig. 3. Representative results for additional displacement into sample surface (nm)
with respect to hold time (s) at max load (mN) and corresponding creep rate (nm/s)
vs hold time (s).
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Dunn-Bonferroni multiple pairwise comparisons were used to
assess the relationship between mechanical properties and radio-
graphic density groups. A p-value of less than 0.05 was deemed
to be statistically significant in this study.
3. Results
3.1. Mechanical
A total of 880 indents were plotted during the course of this
study: 225 in A (130–199.99 HU), 290 in B (300–449.99 HU) and
365 in C (450 HU). Out of 880 indents a total of 752 tests pro-
vided usable results, 17 of which were disregarded due to incorrect
indentation depth or having a loading curve indicative of incorrect
contact between the indenter tip and the sample. A total of 735
results were analysed and are presented in this article. Mechanical
properties were averaged between the 200 nm and 1800 nm
depths in all cases. The elastic modulus and hardness information
derived from the indents were categorised according to three HU
groups; A (n = 131), B (n = 260) and C (n = 343). Representative
load-displacement curves obtained for Density Group A, B and C
are depicted in Fig. 4.
Mean Elastic Modulus (E) and Hardness (H) values in the three
radiologically classified density groups were: EA = 8.47 GPa,
EB = 17.64 GPa, EC = 25.26 GPa, HA = 0.38 GPa, HB = 0.65 GPa and
HC = 0.92 GPa. Results are presented in Fig. 5(i) and (ii). Post-hoc
analysis revealed statistically significant differences between each
pair of the three density ranges with respect to mechanical
properties E and H (p < 0.0005 in all cases). A summary of indent
information, mean and standard deviations for mechanical proper-
ties with respect to density range are presented in Table 2.
The mechanical properties exhibited within each density range
were further analysed by comparing the carotid versus peripheral
calcification behaviours. Results are also presented in Fig. 5(i) and
(ii). Distributions for EA and HA values were not statistically signif-
icantly different between carotid and peripheral lower limb sam-
ples, p = 0.773 and p = 0.342, respectively. EB distributions were
not statistically significantly different between carotid and periph-
eral, p = 0.094, however HB distributions were, p = 0.011. Distribu-
tions for EC and HC values were also not statistically significantly
different between carotid and peripheral, p = 0.514 and p = 0.653.
A summary of indent information, mean and standard deviations
for total and carotid versus peripheral density ranges are presented
in Table 2.
3.2. SEM
SEM analysis was utilised to further analyse the calcification
structure and verify the location of the indents on single carotid,
iliac and femoral samples. Fig. 6(i) displays an indent in density
group A versus Fig. 6(ii) which displays an indent in density group
C. Grid lines represent the mCT image resolution of 15.5 lm. The
overlay of grid lines affords the approximation of pixel size with
respect to tissue constituents. A white arrow identifies the indent
shape in Fig. 6(i) which incorporates both non-calcified and calci-
fied tissues. Inclusions of microcalcification approximately 5 lm
in size can be seen embedded in the non-calcified tissue matrix
independent of the larger deposit, identified by white circles. In
contrast, Fig. 6(ii) presents an indent from density group C which
is completely calcified. Areas of cracking can be observed around
the border of the Berkovich shape.
3.3. Density patterns
Fig. 7 illustrates representative calcification structural classifica-
tions in this study within the mCT images, endorsing previous find-
ings for calcification structures identified in carotid lesions [31]:
speckled inclusions (Fig. 7(i)), diffuse spherical nodes (Fig. 7(ii)),
sheet-like structures (Fig. 7(iii)) and macro-nodes (Fig. 7(iv)). Caro-
tid samples consistently presented with spherical nodes (Fig. 7(ii)),
sheet-like inclusions (Fig. 7(iii)) and large calcifications (Fig. 7(iv))
whereas peripheral samples exhibit highly irregular shapes includ-
ing speckled inclusions (Fig. 7(i)) in addition to sheet-like structures
(Fig. 7(iii)) and large deposits (Fig. 7(iv)). Speckled inclusions are
Fig. 4. Representative loading curves for density groups A, B and C, displaying the
displacement into sample (nm) versus load on sample (mN).
Fig. 5. Total, carotid and peripheral lower limb mechanical properties. (i) Elastic Modulus (E) and (ii) Hardness (H), for the three radiographic density groups A, B and C. The
boxes encompass the middle 50% of the dataset, the line within the box represents the median value and the extruding bars extend to the 25th and 75th percentiles. Outliers,
greater than 1.5 times the Interquartile range, are represented by a circle.
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Table 2
Summary of indent information and mechanical data for Density Groups A, B and C separated into carotid and peripheral results with total results displayed in the right-hand
columns. Results are presented as Mean ± Standard Deviations for Elastic Modulus and Hardness with Median values given in brackets (GPa).
Density group Location No. of indents Elastic modulus Hardness
Total Total Total
A Carotid 67 131 8.71 ± 9.75 (4.1) 8.47 ± 8.84 (4.7) 0.39 ± 0.54 (0.14) 0.38 ± 0.49 (0.17)
Peripheral 64 8.20 ± 7.84 (5.3) 0.36 ± 0.43 (0.2)
B Carotid 112 261 19.42 ± 6.45 (19.1) 17.64 ± 6.63 (18.4) 0.75 ± 0.39 (0.68) 0.65 ± 0.3 (0.63)
Peripheral 149 17.59 ± 6.25 (18) 0.63 ± 0.30 (0.61)
C Carotid 148 343 25.21 ± 5.92 (25.1) 25.26 ± 6.18 (24.7) 0.95 ± 0.33 (0.91) 0.92 ± 0.32 (0.9)
Peripheral 195 26.10 ± 6.79 (24.5) 0.98 ± 0.36 (0.89)
Fig. 6. (i) Non-calcified (T) and calcified tissue (C) interface. Non calcified tissues are portrayed in dark grey with areas of calcification in light grey. The white arrow identifies
an indent implanted into Density Group A area. The resulting contact area within density group A incorporates both non-calcified and calcified tissues. The grid overlay
represents the 15.5 mm Micro-CT resolution. Micro-inclusions of calcification embedded in the soft tissue away from the primary calcified deposit are identified by white
circles. (ii) An indent placed onto the calcification surface within a Density Group C area, exhibiting evidence of cracking around the plastically deformed Berkovich tip shape.
The grid overlay depicts the 15.5 mm Micro-CT resolution.
Fig. 7. Representative calcification structural classifications and associated density patterns identified from mCT image slices. (i) Speckled sections ofmicro-inclusions as seen in
a peripheral lesion composed of density group A. (ii) Spherical nodes presented in a carotid sample showing increasing density towards the centre point. (iii) Sheet-like
calcification froma peripheral plaque consisting ofmixed density groups B and C. (iv)Macro-calcified deposit froma carotid sample displaying large amounts of density group C.
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typically low density, with a majority of pixels falling into density
category A. As speckled inclusions coalesce and form larger deposits
they typically increase in density with more pixels falling into den-
sity group B (Fig. 7(i)). Spherically shaped nodes typically exhibit all
three density ranges, with increasing density towards the centre
point (Fig. 7(ii)). Arc-shaped calcifications encompassing a portion
of the circumference of the lesions have pixels that fall into density
group B, C or a combination of both (Fig. 7(iii)). Furthermore, the lar-
ger the calcified deposit, the larger number of pixels appear to fall
into density category C (Fig. 7(iv)).
4. Discussion
Calcified components of atherosclerotic tissues have previously
been identified as key contributors to plaque stability and
endovascular treatment failure. In addition to this, clinicians lack
mechanisms for predicting lesion rupture and tissue response prior
to surgical intervention selection [23]. In this study, the mechani-
cal properties of arterial calcifications from carotid and peripheral
lower limb regions were correlated against three radiographic den-
sity ranges obtained from mCT images.
Significant differences in mechanical properties were identified
between the density groups (p < 0.0005). There is a larger differ-
ence in mechanical results between groups A and B than groups
B and C. Density group A encompasses the outer perimeter of the
calcified deposits and it is apparent from Fig. 6(i) that the threshold
of 130HU at an image resolution of 15.5 lm for identifying calcifi-
cation includes partially calcified tissue. Consequently, density
group A results are skewed due to the non-calcified tissue influ-
ence. Further work is warranted to define the radiographic thresh-
olds which identify varying degrees of tissue calcification at
differing clinical and laboratory image resolution capabilities.
Peripheral lower limb lesions, in particular femoral samples,
have been shown to contain a higher calcium content than those
originating from the carotid region [38]. Overall, no significant dif-
ferences were found when comparing mechanical behaviours
between carotid and peripheral samples: EA, EB EC, HA and HC
(p = 0.773, p = 0.094, p = 0.342, p = 0.514 and p = 0.653). There is
only statistical significance between HB for carotid and peripherals
(p = 0.011). The similar mechanical behaviours between density
groups from carotid and peripheral specimens indicates that this
approach captures any location-specific changes in calcium con-
tent and can be applied to both regions equivalently.
Three previous authors have characterised arterial calcified
deposits using nanoindentation [9,10,16]. Fig. 8(i) compares the
elastic modulus of density group A, B and C to this published data.
Previous E results for carotid calcifications exhibit a wide range
(0.69 ± 2.3 GPa), with outliers as high as 21 GPa [16]. The authors
concluded that the actual values expected for carotid calcifications
should be within the range of 15–25 GPa. E values reported for
Abdominal Aortic Aneurysms (AAA) [9] fall between the results
obtained for density range EB and EC obtained in this study. Kot
et al. also examined the properties of AAA calcifications in two
orthogonal directions. It was demonstrated that E and H did not
differ between the two directions, indicating isotropic behaviour
for calcifications [10]. The two directional results for EAAA also fall
between that of EB and EC in this study.
Arterial calcification is commonly related to other mineralised
tissues, such as bone [38,39]. Fig. 8(ii) presents the relation of cal-
cification density results in this study to that of other mineralised
biological tissues [18,19,40]. EA compares well published results
for E of ultrasectioned, wet human dental cementum [40], EB with
human vertebral trabecular bone (longitudinal direction) [18] and
EC with human tibial cortical bone (interstitial lamellae, longitudi-
nal direction) [19]. In all cases, the standard deviation for arterial
calcification properties were significantly larger than that of bone
or tooth tissue results. It could be argued that the former tissues
are highly organised structures [41], unlike arterial calcification
[22], deciphering the decreased deviations occurring with bone tis-
sues. This study confirms the assumption that fully calcified
atherosclerotic tissue has a modulus similar to bone tissue (17–
25 GPa) [18,19].
Calcification structure types identified in this study comple-
ment previously described structures in literature; (1) speckled
or spotty calcification [42,43], (2) diffuse moderately sized spheri-
cal nodes [24], (3) arc-shaped structures encompassing a signifi-
cant portion of the lesion circumference [4,24,42] and (4) large,
irregular macro-nodes [24,43]. The density ranges within these 4
structural classifications follow distinct patterns. The areas of
speckled calcification (type 1) consist of the lowest density range
A (green). It is hypothesised that these inclusions have a lower
degree of mineralisation due to their immaturity. Over time these
speckled areas may grow and eventually coalesce to form larger
nodes [22]. Moderately-sized spherical nodes (type 2) typically
increase in density towards the internal core, in line with previous
findings for calcified aortic valves [44]. This arrangement of density
could be associated with continuous deposition over time, result-
ing in compact calcification at the centre of deposits, with larger
deposits more likely to have a higher density. The arc-shaped cal-
cifications around the perimeter of the plaques (type 3) exhibited
density group B, C or a combination of both. The largest existing
spherical macro-nodes (type 4) exhibit large quantities of the high-
est density group C. In addition, it was noted that the lowest den-
sity A consistently occurred on the exterior of all nodes,
presumable due to partial volume averaging effects including
surrounding non-calcified tissues.
Using this density pattern theory, the indents plotted within the
AAA calcifications studied by Marra et al. and Kot et al. would
Fig. 8. (i) Comparison of the Elastic Modulus for Density Groups A, B and C with published nanoindentation data for arterial calcifications: Carotid calcifications [16], AAA
Calcifications (1) [10] and AAA Calcifications (2) [9]. (ii) Comparison of the Elastic Modulus for Density Groups A, B and C with published data for other mineralised biological
tissues: human molar cementum [40], human trabecular bone (longitudinal direction) [18] and human tibial cortical bone [19].
234 R.M. Cahalane et al. / Acta Biomaterialia 80 (2018) 228–236
presumably have been located in the centre of the deposits, imply-
ing a B or C density group. This provides a justification for EAAA to
exist between that of EB and EC in this study. This is also potential
evidence for corresponding density patterns between calcifications
from different arterial regions. Future works should examine calci-
fication morphologies that may be more prevalent or specific to
distinct atherosclerotic prone regions, which could be attributed
to local geometrical or haemodynamic patterns.
With this knowledge of calcification density with respect to
mechanical properties it is now possible to incorporate true calci-
fied tissue material properties for use computational models that
assess either the relationship between plaque vulnerability and
calcification or calcified tissue interaction with endovascular
device deployment. Accurate representations of calcified plaque
morphology and related mechanical properties should achieve
more realistic tissue heterogeneity and subsequently produce
more accurate computational predictions. In addition, should com-
mercially available clinical imaging techniques achieve sufficiently
high resolution [45,46], then this study would support superior
evaluation of calcification structure and properties in vivo.
5. Limitations
There are a number of unavoidable limitations affiliated with
this study. Chemical fixation of the tissue can lead to an increase
in mechanical properties [47]. The samples underwent a chemical
fixation process to minimise tissue damage and shrinkage under
the intense voltage source of the mCT using methanol, ethanol
and HMDS. The samples are embedded in ‘EpoxyCure’ to restrain
the lesions in place during sample preparation and testing. Minor
increases have been found between EAAA for epoxy-embedded
specimens compared with free specimens [9]. Grinding and polish-
ing techniques used to provide the fine surface finish required for
nanoindentation destroys specific surface structural features,
limiting this study’s capability for analysing specific anatomical
features. Moreover, the modification of tissue structure at the
surface may affect the resulting mechanical properties retrieved,
therefore indentation data was analysed between 200 and
1800 nm depths, avoiding shallow depths (<200 nm).
Optical microscope image reconstructions of the sample surface
were visually matched to a corresponding mCT image slice to allow
the three radiographic density groups to be mapped out. This
visual method of identifying a corresponding mCT image has inher-
ent limitations. However, the fine slice thickness (15.5 mm) min-
imises potential errors. Similarly, the optical microscope window
incorporated into the nanosuite software obligates the user to
manually select the position of the indents on the sample surface.
In this study a mCT map external to the nanoindenter software was
used to guide the position of the indents on the sample surface.
However, this may permit errors in the precise indent location.
For this reason the authors chose to utilise three radiographic den-
sity groups to overcome this positioning limitation by allowing any
migration to remain within the selected density group.
There is an increased amount of ‘failed’ indents in density group
A, partially calcified tissue. It is surmised that the tissue may have
polished at a quicker rate than the other regions, resulting in a
rougher surface. It is more challenging for the indenter tip to make
correct contact with a low and uneven surface, validating the
reduced rate of indent success in this area (58%) compared with
ranges B (90%) and C (94%). Further works may evaluate alternative
methods of surface preparation for partially calcified tissues.
Statistical significance was acquired relating the radiographic
density groups to mechanical properties due to the large number
of tests carried out. However, only representative results are pre-
sented in this study which relate radiographic density patterns to
specific calcification morphology. Methodologies to quantify this
relationship between radiographic density and calcification mor-
phology should be investigated in future works.
6. Conclusion
This study presents a method for estimating arterial calcifica-
tion mechanical properties from radiographic densities by correlat-
ing mechanical behaviours to three density ranges obtained from
mCT images. There is a positive correlation between each of the
three radiographic density groups defined in this study and associ-
ated mechanical behaviours (q<0.0005 in all cases). The wide vari-
ation in properties published for arterial calcifications has been
clarified in this work by the stratification of calcified constituents
according to radiographic density. This investigation confirms the
hypothesis that fully calcified plaque tissues exhibit similar
mechanical properties to bone tissue (17–25 GPa). This research
provides improved material parameters for use in computational
models which endeavour to associate specific calcification struc-
tures with plaque rupture and predict tissue modification during
aggressive endovascular debulking approaches.
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[39] M.J. Duer, T. Friščić, D. Proudfoot, D.G. Reid, M. Schoppet, C.M. Shanahan, J.N.
Skepper, E.R. Wise, Mineral surface in calcified plaque is like that of bone
further evidence for regulated mineralization, Arterioscler. Thromb. Vasc. Biol.
28 (2008) 2030–2034, https://doi.org/10.1161/ATVBAHA.108.172387.
[40] S.P. Ho, H. Goodis, M. Balooch, G. Nonomura, S.J. Marshall, G. Marshall, The
effect of sample preparation technique on determination of structure and
nanomechanical properties of human cementum hard tissue, Biomaterials 25
(2004) 4847–4857, https://doi.org/10.1016/j.biomaterials.2003.11.047.
[41] J.Y. Rho, L. Kuhn-Spearing, P. Zioupos, Mechanical properties and the
hierarchical structure of bone, Med. Eng. Phys. 20 (1998) 92–102, https://
doi.org/10.1016/S1350-4533(98)00007-1.
[42] S. Ehara, Y. Kobayashi, M. Yoshiyama, K. Shimada, Y. Shimada, D. Fukuda, Y.
Nakamura, H. Yamashita, H. Yamagishi, K. Takeuchi, T. Naruko, K. Haze, A.E.
Becker, J. Yoshikawa, M. Ueda, Spotty calcification typifies the culprit plaque in
patients with acute myocardial infarction: an intravascular ultrasound study,
Circulation 110 (2004) 3424–3429, https://doi.org/10.1161/01.
CIR.0000148131.41425.E9.
[43] G.J. Friedrich, N.Y. Moes, V.A. Mühlberger, C. Gabl, G. Mikuz, D. Hausmann, P.J.
Fitzgerald, P.G. Yock, Detection of intralesional calcium by intracoronary
ultrasound depends on the histologic pattern, Am. Heart J. 128 (1994) 435–
441, https://doi.org/10.1016/0002-8703(94)90614-9.
[44] R. Halevi, A. Hamdan, G. Marom, M. Mega, E. Raanani, R. Haj-Ali, Progressive
aortic valve calcification: three-dimensional visualization and biomechanical
analysis, J. Biomech. 48 (2015) 489–497, https://doi.org/10.1016/j.
jbiomech.2014.12.004.
[45] R. Gupta, A. Cheung, S. Bartling, J. Liasauskas, Flat-panel volume CT:
fundamental principles, technology and applications, RadioGraphics 28
(2008) (accessed February 13, 2018) http://pubs.rsna.org/doi/pdf/10.1148/rg.
287085004.
[46] J.A. MacNeil, S.K. Boyd, Accuracy of high-resolution peripheral quantitative
computed tomography for measurement of bone quality, Med. Eng. Phys. 29
(2007) 1096–1105, https://doi.org/10.1016/j.medengphy.2006.11.002.
[47] A.J. Bushby, V.L. Ferguson, A. Boyde, Nanoindentation of bone: comparison of
specimens tested in liquid and embedded in polymethylmethacrylate, J. Mater.
Res. 19 (2004) 249–259, https://doi.org/10.1557/jmr.2004.19.1.249.













Croghan S, Cahalane R, Cunnane C, Cassidy I, Mooney R, Mulvihill J, Davis N, Walsh 
M and Flood H, Evaluation of an Ex-Vivo Model of Catheter-Induced Trauma of the 
Paediatric Urethra using Porcine Tissue, European Urology Supplements, 2019, 
18(5):e2527. 
2020 
Gouse M, Cahalane R, Byrne M, Mani A, Silien C, Syed T, Mulvihill J and Tiernan P, 
Bevel Angle Study of Flexible Hollow Needle Insertion into Biological Mimetic Soft-
Gel: Simulation and Experimental Validation, Journal of the Mechanical Behavior of 
Biomedical Materials, 2020, In Press. 
Ross A, Walsh D, Cahalane R, Marcar L and Mulvihill J, An in vitro model for blood-
brain barrier permeability studies, Journal of Pharmaceutical Research, 2020, Manuscript 
in Preparation. 
Ross A, Cahalane R, Marcar L and Mulvihill J, Predicting the interaction of metallic-









Postgraduate Presentations and Research Achievements 







 Cahalane R, Barrett H, Kailas L and Walsh MT, Towards the Characterisation of 
Atherosclerotic Plaque Calcification: A Proof of Concept Nano-Indentation 
Approach, International Symposium on Biomechanics in Vascular biology 
and Cardiovascular Disease12, the Netherlands. 
2018 
 Cahalane R, Barrett H, Kavanagh E, Moloney T, O’Brien J and Walsh MT, 
Relating the Mechanical Properties of Atherosclerotic Calcification to 
Radiologically Classified Density: A Nanoindentation Approach, Poster 
Presentation, World Congress of Biomechanics, Convention Centre Dublin, 
Ireland. 
2019 
 Cahalane RM, Broderick S, Kavanagh E, Moloney M, Purtil H, Walsh MT and 
O’Brien J, Particle Analysis of ex vivo Calcified Atherosclerotic Lesions: Does 
the Agatston Score Measure Up? Poster Presentation, Society of Cardiovascular 
Computed Tomography Winter Meeting, Dublin, Ireland. 
 Cahalane R, Barrett H, Ross A, Mulvihill J, Purtill H, O’Brien J, Kavanagh E, 
Moloney M, Walsh MT and O’Connor E, On the use of circulating desphospho-
uncarboxylated matrix gla-protein to determine symptomatic atherosclerotic 
calcification phenotype, Poster Presentation, International Symposium on 
Biomechanics in Vascular biology and Cardiovascular Disease14, London, 
United Kingdom. 
 Cahalane R, Barrett HE, Ross A, Mulvihill J, Purtill H, Kavanagh E, Moloney 
M, O’Brien J, Vermeer C, O’Shea P, Egan S, Leahy F, Walsh MT and O’Connor 
EM, On the use of circulating desphospho-uncarboxylated matrix gla-protein to 
determine symptomatic atherosclerotic calcification phenotype, Poster 
Presentation, the 13th European Nutrition Conference, The Convention Centre, 
Dublin, Ireland. 
 






 Cahalane R, Barrett H and Walsh MT, Towards the Characterisation of 
Atherosclerotic Plaque Calcification: A Proof of Concept Nano-Indentation 
Approach, Early Stage Researcher Oral Presentation, Bioengineering in 
Ireland23, Queens University Belfast, Ireland. 
2018 
 Cahalane R, Barrett H, Kavanagh E and Walsh MT, Relating the Mechanical 
Properties of Atherosclerotic Calcification to Radiologically Classified Density: 
A Nano-Indentation Approach, Oral Presentation, Bioengineering in Ireland24, 
Dublin City University, Ireland. 
 Cahalane R, Barrett H, Kavanagh E, Moloney T, O’Brien J and Walsh MT, 
Relating the Mechanical Properties of Atherosclerotic Calcification to 
Radiologically Classified Density: A Nanoindentation Approach, Poster and Oral 
Presentation, Sir Bernard Crossland Symposium, University College Dublin, 
Ireland. 
2019 
 Cahalane R, Barrett H, Ross A, Mulvihill J, Purtill H, O’Brien J, Kavanagh E, 
Moloney M, Walsh MT and O’Connor E,  On the use of circulating osteogenic 
blood biomarkers to determine atherosclerotic calcification phenotype, Oral 
Presentation, Bioengineering in Ireland25, University of Limerick, Ireland. 
2020 
 Cahalane R and Walsh MT, Towards Improving the Diagnosis and Treatment of 
Carotid Arterial Disease: Targeting Calcification as a Basis for Patient 
Management, Medal Presentation, Bioengineering in Ireland26, Trinity College 
Dublin, Ireland. 
  






 Cahalane R, Barrett H, Kailas L and Walsh MT, Towards the Characterisation of 
Atherosclerotic Plaque Calcification: A Nano Indentation Feasibility Study, 
Poster Presentation, NUI Galway - University of Limerick Alliance 7th 
Postgraduate Research Day, Galway, Ireland. 
2018 
 Cahalane R, Broderick S, Kavanagh E, Moloney M, Purtil H, Walsh MT and 
O’Brien J, Particle Analysis of ex vivo Calcified Atherosclerotic Lesions: Does 
the Agatston Score Measure Up? Poster Presentation, Bernal Institute Research 
Day, University of Limerick, Ireland. 
 Cahalane R, Broderick S, Kavanagh E, Moloney M, Purtil H, Walsh MT and 
O’Brien J, Can the Agatston Score Identify Vulnerable Plaques? Elevator Pitch 
Presentation, Health Research Institute Research Day, University of Limerick, 
Ireland. 
2019 
 Cahalane R and Walsh MT, Towards Improving the Diagnosis and Treatment of 
Carotid Arterial Disease: Targeting Calcification as a Basis for Patient 
Management, Poster Presentation, Bernal Institute Research Day, University of 
Limerick, Ireland. 
  Cahalane R and Walsh MT, Towards Improving the Diagnosis and Treatment 
of Carotid Arterial Disease: Targeting Calcification as a Basis for Patient 
Management, Poster Presentation, Health Research Institute Research Day, 
University of Limerick, Ireland. 
 
  





 Winner of the Royal Academy of Medicine Section of Bioengineering Bronze medal 
for Best Overall Presentation at the Bioengineering in Ireland 2018. 
 2nd Place Poster Prize at Sir Bernard Crossland Symposium 2018. 
 3rd Place Elevator Pitch Presentation at Health Research Institute Research Day 2018. 
 2nd Place Mature Researcher Award at Bioengineering in Ireland 2019 
 Finalist in the Bioengineering in Ireland Biomedical Research Medal 2020. 
 
  




Funding Scholarships Awarded 
Table D-1: Funding Scholarships Awarded. 
Project Title Contribution Funding Body Amount € 
Postgraduate Scholarship 
Scheme 
Author Irish Research 
Council 
96,000 
New Foundations Scholarship 
Scheme 
Author Irish Research 
Council 
4,991 
Open Access Publication 
Funding 
Author Health Research 
Institute 
4,326 
Spatial Characterisation of a 
Patient Derived Colonic 
Tumour and Atherosclerotic 
Plaque using a Grid Referenced 
Tissue Preparation Technology 
and Targeted Transcriptomics 
Contributor Health Research 
Institute 
45,428 
Can Matrix GLA Protein 
(MGP) Determine Arterial 
Plaque Phenotype in ‘At Risk’ 
Cardiovascular Patients 










Certificates and Courses Completed 
Summer Schools 
 Generic and Transferable Skills Research Summer School 
o Research Integrity 
o Research Ethics 
o Developing Ideas and Arguments: Writing into Academic Communities 
o Planning Research and Publication 
o Digital Research Management 
o Research Networking 
 Public and Patient Involvement in Health Research Summer School 
Research Integrity 
 Epigeum Impact Online Courses 
o Research Integrity 
o Human Subjects Protection 
o The Humane Use and Care of Animals in Research 
o Conflicts of Interest 
o Safety and Health 
o Intellectual Property 
Specialist Modules and Training 
 Fundamentals of Continuum Mechanics 
 Fracture Mechanics 
 Luminex Magnetic Bead Multiplexing 
 Optics11 Life Biological Nanoindentation 
Courses 
 Basic Statistics for Researchers 
 Working with Long Documents 
 Teaching in Higher Education 
 Research Paper and Publication Seminar 
 Research and Endnote 
 Finding Research Information and Keeping Up to Date 





 How to Write a Great Research Paper, and get Published in a Top Journal 
 Hypatia Project: Gender initiatives in STEM education & communication 
 Introduction to Teaching in Higher Education Workshop 
 Cardiac Computational Modelling 
Masterclasses 
 Nature Research Academies: Writing and Publishing a Great Research Paper 
 Science Communication masterclass with Jonathan McCrea 
 
  




Science and Engineering Outreach Activities 
 Participation in the Engineering Ambassadors Program at the University of 
Limerick 
 Volunteer at the Limerick for Engineering Showcase 2018 
 Finalist in the Famelab Science Communication Competition Limerick Heat 2018 
 
 
 
